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1Psychosis Research Unit, Greater Manchester West Mental Health NHS Foundation Trust,
Manchester, UK
2School of Psychological Sciences, University of Manchester, Manchester, UK
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4The Spectrum Centre for Mental Health Research, University of Lancaster, Lancaster, UK
5School of Social Sciences, University of Manchester, Manchester, UK
6Centre for Biostatistics, University of Manchester, Manchester, UK
*Corresponding author anthony.p.morrison@manchester.ac.uk
†In memoriam
Background: Recovery in mental health is a relatively new concept, but it is becoming more accepted that
people can recover from psychosis. Recovery-orientated services are recommended for adult mental health,
but with little evidence base to support this.
Objectives: To facilitate understanding and promotion of recovery in psychosis and bipolar disorder (BD),
in a manner that is empowering and acceptable to service users.
Method: There were six linked projects using qualitative and quantitative methodologies: (1) developing
and piloting a service user-defined measure of recovery; (2) a Delphi study to determine levels of consensus
around the concept of recovery; (3) examination of the psychological factors associated with recovery
and how these fluctuate over time; (4) development and evaluation of cognitive–behavioural approaches
to guided self-help including a patient preference trial (PPT); (5) development and evaluation of
cognitive–behavioural therapy (CBT) for understanding and preventing suicide in psychosis including a
randomised controlled trial (RCT); and (6) development and evaluation of a cognitive–behavioural approach
to recovery in recent onset BD, including a RCT of recovery-focused cognitive–behavioural therapy (RfCBT).
Service user involvement was central to the programme.
Results: Measurement of service user-defined recovery from psychosis (using the Subjective Experience of
Psychosis Scale) and BD (using the Bipolar Recovery Questionnaire) was shown to be feasible and valid.
The consensus study revealed a high level of agreement among service users for defining recovery, factors
that help or hinder recovery and items which demonstrate recovery. Negative emotions, self-esteem and
hope predicted recovery judgements, both cross-sectionally and longitudinally, whereas positive symptoms
had an indirect effect. In the PPT, 89 participants entered the study, three were randomised, 57 were
retained in the trial until 15-month follow-up (64%). At follow-up there was no overall treatment effect
on the primary outcome (Questionnaire about the Process of Recovery total; p= 0.82). In the suicide
prevention RCT, 49 were randomised and 35 were retained at 6-month follow-up (71%). There were
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significant improvements in suicidal ideation [Adult Suicidal Ideation Questionnaire; treatment
effect= –12.3, 95% confidence interval (CI) –24.3 to –0.14], Suicide Probability Scale (SPS; treatment
effect= –7.0, 95% CI –15.5 to 0) and hopelessness (subscale of the SPS; treatment effect= –3.8, 95% CI
–7.3 to –0.5) at follow-up. In the RCT for BD, 67 participants were randomised and 45 were retained at
the 12-month follow-up (67%). Recovery score significantly improved in comparison with treatment as
usual (TAU) at follow-up (310.87, 95% CI 75.00 to 546.74). At 15-month follow-up, 32 participants had
experienced a relapse of either depression or mania (20 TAU vs. 12 RfCBT). The difference in time to
recurrence was significant (estimated hazard ratio 0.38, 95% CI 0.18 to 0.78; p< 0.006).
Conclusions: This research programme has improved our understanding of recovery in psychosis and BD.
Key findings indicate that measurement of recovery is feasible and valid. It would be feasible to scale up
the RCTs to assess effectiveness of our therapeutic approaches in larger full trials, and two of the studies
(CBT for suicide prevention in psychosis and recovery in BD) found significant benefits on their primary
outcomes despite limited statistical power, suggesting definitive trials are warranted.
Funding: The National Institute for Health Research Programme Grants for Applied Research programme.]
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Plain English summary
Psychosis (including disorders such as schizophrenia, which are characterised by hearing voices orparanoid beliefs) and bipolar disorder (BD) (characterised by mood swings) are common forms of
serious mental health problems. Clinical services typically define recovery in terms of absence of symptoms.
In contrast, service users conceptualise recovery as a unique process rather an end point, with key themes
including hope, rebuilding self and rebuilding life. Our research aimed to understand and promote
recovery in psychosis and BD, in a manner that is acceptable to and empowering of service users.
Six linked projects were conducted using a variety of methods to develop new ways of measuring recovery;
to understand what recovery means to service users and what factors promote recovery; to understand
how recovery, symptoms and psychological well-being are related; to examine what sort of factors predict
recovery; and to test three new interventions. All projects were conducted in collaboration with service
users and the research team included two service user researchers. Our research has made significant
additions to our understanding and promotion of recovery, including the development of two new
measures which were shown to be valid and acceptable to service users. We have shown that we can
measure recovery, that factors such as reduced negative emotions, increased self-esteem and hope are
predictive of recovery judgements and that the new interventions tested showed promising benefits
to people with psychosis and suicidal thinking and people with BD. These findings have important
implications for future research and for clinical practice.
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Mental health problems are one of the most significant burdens on society in terms of personal distress,
disability and economic cost. Recovery in the field of mental health is a relatively new concept given that
diagnoses such as schizophrenia have historically been thought of as severe and enduring mental illnesses
However, research over the last two decades has begun to challenge these assumptions and it is becoming
more accepted that people can recover from psychosis. Clinical recovery relates to the absence of
symptoms whereas the meaning of recovery to service users is much broader and recovery is seen as a
process, encompassing many aspects of life. Recovery-orientated services are recommended across
treatment settings in adult mental health services, but with little evidence base to support this.
Objectives
The overall objective of this programme of research was to complete a series of linked projects with the
aim of understanding and promoting recovery from psychosis and bipolar disorder (BD), in a manner that
is acceptable to and empowering of service users. The programme consisted of six projects and the
rationale and objectives for each are outlined below.
User-defined recovery conceptualisation and measurement
Recovery has become an increasingly important concept for mental health service providers and
policy-makers following guidance in numerous government policies and implementation. Despite this,
a working definition of the concept of recovery has never been formalised. This study aimed to generate a
concept of recovery from a service users’ viewpoint by adopting an inclusive approach, scrutinising factors
that are important to a multidimensional approach to recovery before using this information to develop a
service user-generated, self-report scale to assess recovery in relation to symptoms in psychosis.
Service user-defined recovery: a consensus study
There has been consistent agreement that mental health services should aim to be recovery orientated
and that it is possible to measure the effectiveness of these services. However, the problem of reaching
consensus about what we mean by recovery and producing a definition that is acceptable to service users
has yet to be resolved. The aim of the study was determine the level of consensus regarding service user
conceptualisations of recovery.
Understanding psychological and social predictors of recovery
There is a significant body of research examining psychosocial and neuropsychiatric factors that are
associated with recovery from psychosis. However, the research has also highlighted that there is a
significant difference between clinical- and consumer-defined recovery, strongly suggesting that previous
studies may not assess important aspects of recovery that are meaningful for the service user. This study
aimed to address the gap in the knowledge regarding subjective judgements of recovery, associated
factors and predictors. It explored factors associated with subjective judgements of recovery in people with
experience of psychosis before examining psychosocial and neuropsychiatric predictors of recovery
judgements in both cross-sectional and longitudinal studies. This allowed examination of whether or not,
and to what extent, recovery judgements are stable over time and whether or not the same kind of
psychosocial factors that are associated with cross-sectional recovery judgements can predict recovery
judgements longitudinally.
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Cognitive–behavioural approaches to guided self-help and group therapy
for recovery, taking patient preferences into account
Psychological treatments for psychosis such as cognitive–behavioural therapy (CBT) are currently
recommended and their efficacy is supported by well executed randomised controlled trials (RCTs).
However, the implementation of CBT for psychosis within NHS services is poor owing to a number of
limitations. As a result, further exploration of the best way to deliver psychological support to those who
experience psychosis is needed. This study aimed to examine preferences for psychological treatment using
a patient preference trial (PPT) and examine cognitive–behavioural approaches to self-help and group
therapy for recovery.
Cognitive–behavioural approach to understanding and preventing suicide in
people with psychosis
Suicide and suicide behaviour are of substantial public and social concern. It is well established that risk of
suicide is considerably elevated in those suffering from schizophrenia and psychosis. The objective of this
project was to explore the psychological mechanisms underlying the link between experience of psychosis
and suicidal ideations. This information was then used to inform a novel cognitive–behavioural treatment
for suicide prevention for people with experience of psychosis. A RCT was conducted to assess feasibility
and efficacy of the new treatment approach.
Cognitive–behavioural approach to recovery from a first episode of
bipolar disorder
The National Institute for Health and Care Excellence recommends the provision of structured
psychological therapy for individuals with BD. To date, controlled trials of structured psychological therapy
have focused on individuals with a chronic BD, although research suggests that cognitive–behavioural
interventions may be more powerful when applied earlier. This study aimed to understand the subjective
recovery experiences of people with recent onset BD and to develop a novel measure of recovery in BD
and a new intervention for early BD. This project also aimed to establish the acceptability and feasibility of
the new intervention [recovery-focused cognitive–behavioural therapy (RfCBT)].
Methods
User-defined recovery conceptualisation and measurement
Initially interviews were conducted with a group of eight service users who had recent experience of
psychosis. A qualitative approach [interpretative phenomenological analysis (IPA)] was used to guide the
interview structure and analysis. In the second phase of the study, themes identified from the qualitative
interviews were used along with themes from the existing literature to inform a Q-methodological
study. The Q-method integrates qualitative and quantitative approaches by providing participants with a
framework to explore individual importance of specific aspects of recovery and associations between
individual viewpoints. A total of 40 participants completed the Q-sort study. Information gathered in
phases 1 and 2 was used to generate items for a new self-report scale to assess recovery in psychosis.
The final phase of this study piloted the measure with a group of 100 participants to allow evaluation of
psychometric properties.
Service user-defined recovery: a consensus study
This study utilised a Delphi methodology to consult service users about their views on recovery in three
rounds. The current literature was first analysed to identify a list of statements felt to be relevant to
recovery. This list was then presented to a group of eight service users who were consulted about
language used, coverage of statements and any additions or changes. The list was then developed into a
questionnaire that was circulated to 381 service users with experience of psychosis. Participants were
asked to rate the importance of items to the concept of recovery using a 5-point Likert scale. Items that
were rated as essential or important by > 80% of the sample were included as standard. Items that were
rated as essential or important by 70–79% of the sample were rerated in the final round.
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Psychological factors associated with recovery from psychosis
Data for this study were collected in four stages. The first stage was a cross-sectional study on
122 participants with experience of psychosis and 45 control participants. Participants were asked to complete
measures relating to recovery, clinical functioning and social functioning and objective ratings of symptoms
and functioning were carried about the researchers. For the second stage, data collected throughout the
recovery programme were collated and utilised where appropriate to examine longitudinal predictors of
recovery (n= 110). In the third stage, a similar cross-sectional approach was utilised to assess recovery,
symptoms and functioning at baseline with 68 people with experience of psychosis. Experience sampling
methodology (ESM) was then used to measure fluctuations in cognitive and emotional functioning over a
period of 6 days using a watch and diary. Results were analysed using multilevel modelling.
Cognitive–behavioural approaches to guided self-help and group therapy
for recovery, taking patient preferences into account
This project was conducted in three distinct phases. First, a cross-sectional study on 90 participants with
experience of psychosis was conducted to assess symptoms and functioning along with preferences for
psychological therapy and reasons for these preferences. This informed a proof-of-concept randomised
study which was conducted with 29 participants who met criteria for non-affective psychosis. Participants
were randomly allocated to treatment as usual (TAU) or therapy (which consisted of a self-help recovery
guide, CBT delivered by telephone and peer support sessions). Participants’ symptoms and functioning was
assessed at baseline and 6 and 12 months post baseline. The final phase was a PPT with 95 participants
with a diagnosis of a schizophrenia spectrum disorder. Participants were allocated to TAU, low support
(consisting of the self-help recovery guide and weekly telephone CBT) or high support (low support with the
addition of group sessions every other week). Participants were assessed for subjective recovery and
symptoms and functioning as well as using objective symptoms and functioning measures. Results were
analysed using mixed qualitative and quantitative approaches and intention-to-treat analyses.
Cognitive–behavioural approach to understanding and preventing suicide in
people with psychosis
First, 79 participants with a diagnosis of a schizophrenia spectrum disorder completed a clinical interview
and self-report measures. This information was used to identify psychological mechanisms underlying the
relationship between psychosis and suicidal ideation. Second, these participants were asked to provide
feedback about the subjective experience of taking part in research looking at mental health and suicide.
Information from these studies was used to develop CBT for people with experience of psychosis aimed at
reducing risk of suicide. The final phase was a RCT to assess the efficacy of the novel treatment.
Cognitive–behavioural approach to recovery from a first episode of
bipolar disorder
An initial qualitative study was carried out to explore individuals’ views of recovery in early BD.
A semistructured interview was carried out with nine people who had been given a recent diagnosis of BD.
IPA was used to identify key themes. The second phase utilised these themes to develop a Bipolar Recovery
Questionnaire (BRQ), which was then piloted with 60 participants. Psychometric properties of the
questionnaire along with its relationships with other key variables were assessed. The final phase of the
study was a RCT with 69 participants with a diagnosis of BD to evaluate a novel RfCBT.
Results
User-defined recovery conceptualisation and measurement
The Subjective Experience of Psychosis Scale is a reliable and valid tool that can be used to evaluate
outcome from treatment and reflects the multidimensional experience of psychosis.
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Service user-defined recovery: a consensus study
A total of 94 statements about recovery were rated as essential or important by > 80% of respondents
including items which define recovery, factors which help recovery, factors which hinder recovery and
factors which show that someone is recovering. Key areas that are important to service users included
knowledge and understanding of mental health problems; coping and help-seeking skills; social support
and relationships; support from mental health services; choice and control; having goals, meaning and
purpose; quality of life, even in the context of continued mental health problems; hope for the future and
feeling positive about yourself and your future; self-esteem; and having a good, safe place to live.
Psychological factors associated with recovery from psychosis
Concurrently, moment to moment in everyday life and prospectively, negative emotions, self-esteem,
hopelessness but also symptoms (hallucinations and paranoia) predicted subjective recovery judgements.
Cognitive–behavioural approaches to guided self-help and group therapy
for recovery, taking patient preferences into account
Service users had strong preferences for treatment; however, the lack of treatment effects on the primary
outcome measure suggests the therapy itself may need additional refinements.
Cognitive–behavioural approach to understanding and preventing suicide in
people with psychosis
The relationship between positive symptoms of psychosis and suicidal ideation is mediated by perceptions
of defeat and entrapment while positive self-appraisals were found to buffer the impact of hopelessness.
Cognitive–behavioural suicide prevention for psychosis was superior on the primary outcomes of suicidal
ideation and hopelessness and secondary outcomes of depression, symptoms of psychosis and self-esteem.
Cognitive–behavioural approach to recovery from a first episode of
bipolar disorder
The BRQ was developed with extensive input from individuals with personal experience of BD and the
resulting questionnaire appears to be a reliable and valid measure of recovery in those with BD. RfCBT
is feasible and has potential clinical benefits for people with BD, demonstrating improvements in
personal ratings of recovery and substantial improvements in time to relapse for both depressive and
manic relapses.
Conclusions
This programme of research has provided significant advances in our understanding and facilitation of
recovery in both psychosis and BD. In terms of conceptualisation and measurement of user-defined
recovery, we have demonstrated the reliability and validity of several patient-reported outcome measures.
Our ‘experts by experience’ consensus study examining service user-defined recovery found a high level
of agreement about factors which define, help and hinder recovery, and we have found consistent
psychological factors that are associated with recovery from psychosis, including negative emotions,
hope and self-esteem. Our work on cognitive–behavioural approaches to the promotion of recovery have
demonstrated that recovery-focused trials are feasible with these populations, and it is apparent that
service users have strong preferences for treatment. This programme of research has resulted in a number
of deliverables for the NHS that will improve services and patient experience, including assessments,
intervention, recommendations and treatment manuals. There are a variety of implications for clinical
practice that have emerged from this programme, which are discussed in detail.
SCIENTIFIC SUMMARY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xxvi
There are several recommendations for future research that have arisen from this programme, including
(1) given the clear feasibility of the cognitive–behavioural approaches to recovery from BD and the
prevention of suicide in psychosis, definitive trials should be conducted; (2) the factors that help and hinder
recovery, which were identified by our consensus study, should be evaluated at both individual and
service level with large-scale quantitative research; (3) further work is required on the understanding of
the development of, and the role played by, preferences in uptake of and response to treatment;
(4) the development and evaluation of methods to help service users to make informed choices and
express treatment preferences; (5) the evaluation of training packages on the topic of understanding and
promoting recovery that incorporate the results from this programme and are jointly delivered by service
users and clinicians; and (6) the use of ESMs could be further developed in order to evaluate their potential
for use in routine assessment and monitoring of recovery.
Funding
Funding for this study was provided by the Programme Grants for Applied Research programme of the
National Institute for Health Research.
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Mental disorder and mental illness are two of the most significant burdens on society in terms of personal
distress, disability and economic cost. There are currently more people on incapacity benefit than there are
unemployed, with 40% having incapacity due to a primary mental health problem and a further 10%
having a secondary mental health problem.1 Our focus on mental health, and specifically psychosis,
is clearly consistent with priorities and needs, as psychosis is associated with significant personal, social
and economic costs, and psychosis accounts for a large proportion of the national health and social care
budget.2 Suicide risk and behaviour in patients with psychosis is a significant and serious clinical and social
problem. Approximately 4–10% of patients suffering from schizophrenia will eventually kill themselves.3
Suicide ideation and attempts are common, with over half of all patients having a history of attempted
suicide or having significant suicidal ideation at any one time.4,5 Suicidal ideation and planning are
important steps that lead to an attempt of self-harm that may lead to death with previous unsuccessful
suicide attempts increasing risk for later successful suicide.3,6 Similarly, bipolar disorder (BD) affects over
1 million people in England alone and has a prevalence rate of around 2%.7,8 In addition to repeated
periods of mania and depression, most individuals with BD experience extended periods of distressing
subsyndromal mood symptoms between episodes.9–11 Consequently, BD has significant impact emotionally
and functionally12 and is a substantial financial burden to society with a recent estimated cost to the English
economy at £5.2B per annum.8
Access to psychological treatments is a government priority; recently Lord Layard highlighted the challenge
presented by mental health and recommended the provision of psychological treatments.13 Although
psychological intervention approaches for psychosis such as cognitive–behavioural therapy (CBT) have been
demonstrated to be effective and recent National Institute for Health and Care Excellence (NICE) guidelines
for schizophrenia and BD have recommended that people be offered CBT,14,15 there are a number of
limitations to the delivery of CBT in routine services.16 Such limitations are the widespread lack of trained
therapists means that provision of this type of intervention is limited; the refusal rate for participating in
trials of cognitive–behavioural therapy for psychosis (CBTP) is relatively high, suggesting that not all service
users wish to engage in current modes of delivery of this therapy; there is some concern that the focus of
CBT interventions for psychosis have been overly restrictive; and that such CBT does not necessarily target
the priorities identified by service users.
Recovery-orientated services are recommended across treatment settings in adult mental health and
specifically in the implementation guidance for specialist and community teams, but with little evidence
base to support this. Recovery from psychosis is a relatively new concept given that psychotic disorders
have historically been thought of as a severe and enduring mental illness.17 However, research over the last
two decades has begun to challenge these assumptions and it is becoming more accepted that people
can, and do, recover from psychosis.18 Clinical recovery relates to the absence of symptoms whereas the
meaning of recovery to service users is much broader and recovery is seen as a process,19 having many
aspects such as empowerment and quality of life.20–22 It is also evident that there is not always a
relationship between symptoms and recovery.19 The dominant approach to identifying psychological
mechanisms involved in recovery from psychosis has focused on cognitive deficits (deficiencies in
intellectual functioning and basic information processes such as attention and memory).23 Most
investigations have considered attentional problems to be central to schizophrenia and BD but, despite
consistent findings of poor performance in patients,24 the precise role of deficits in psychosis remains
unclear. Deficits are apparent on all tasks24,25 and performance is similar in patients meeting criteria for BD
and schizophrenia.26,27 Furthermore, the severity of cognitive deficits does not predict positive symptoms,25
although they do predict social functioning.28 Recent studies have shown that the relationship between
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gross cognitive functioning and social functioning is mediated by social–cognitive skills (the ability to
understand social situations and respond appropriately),29 but the implications of this research for the
process of recovery have hardly been studied.
Although there is an increasing recovery literature for individuals with experience of psychosis, there has
been little or no research of this type specifically targeted at individuals with a diagnosis of BD. As with
psychosis in general, most individuals with a bipolar diagnosis will continue to experience psychiatric
symptoms despite psychiatric treatment.11 However, as the recovery literature increasingly shows, individual
definitions of recovery are diverse and rarely focus on eradication of symptoms.
Some authors have suggested that there is a lack of ‘empirical’ literature on recovery and that ‘no
empirical conceptualisations of recovery have been published’.30 Although recovery is being studied with
increasing frequency, a recent literature search revealed that there are few instruments that measure
recovery from the service users’ perspective in comparison to those that measure symptoms and
measurement of symptoms has not benefited from user involvement.31,32
With respect to psychological predictors of recovery, cognitive deficits might be expected to impact on the
recovery domain of rebuilding life (involving re-establishing positive relationships and meaningful daily
activities), whereas cognitive biases are more likely to be implicated in rebuilding the self and hope for the
future. Consistent with this, research has found that service users who experience paranoia shift their
beliefs about the extent to which they deserve persecution unpredictably over time and that these changes
are associated with changes in self-esteem and attributional processes.33 In the case of bipolar patients,
research suggests that coping strategies, which seem to affect the stability of self-esteem, differ between
different phases of the disorder.34 Dynamical models have the potential to explain why systems of
interacting cognitive processes sometimes settle in stable states that are resistant to perturbation
(which might be taken as an indicator of recovery).
Recovery from psychosis clearly involves the planning for the future and ensuring future well-being.
Feelings of loss and lowered expectations for future achievements can lead to depression and feelings of
hopelessness.35 Thus, part of the recovery process involves the challenges of remaining optimistic and
fulfilling full potential and well-being. While there is clearly a strong evidence base for CBTP, including
much of our own work,36–41 research indicates that CBTP does not significantly reduce suicide behaviour;42
thus, the development of CBT for suicide prevention is a priority. There are also other limitations with
respect to the delivery of CBTP mentioned above, so alternative modes of delivery need to be explored.
The most recent study of CBT for relapse prevention in BD found that there was a significant interaction
between the number of episodes and the outcome, with only those with fewer episodes benefiting
significantly.43 To date, no CBT interventions have been specifically designed for delivery to individuals early
in their illness course.
It is clear that mental health problems, including psychosis, suicide and BD, are a significant burden for
society. National guidelines recommended a recovery-orientated approach with psychological interventions,
such as CBT, be offered as part of routine practice. However, further research to investigate the
psychological mechanisms of recovery in psychosis, suicide and BD would be beneficial to inform the
development of evidence-based recovery-focused psychological interventions. Consideration of effective
modes of delivery for psychological interventions as well as service user choice and preference
are essential.
Aims
To complete a series of linked projects with the aim of understanding and promoting recovery from
psychosis and BD, in a manner that is acceptable to and empowering of service users.
INTRODUCTION
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Objectives and research questions
Our research programme consisted of six linked project themes, each of which were designed to further
our understanding of recovery. Objectives for each theme were:
1. to develop a valid and acceptable service user designed tool to assess the severity of multiple
dimensions of experiences of psychosis
2. to determine levels of consensus around the service user-defined recovery concept
3. to confirm the psychological factors that are associated with recovery from psychosis and examine the
longitudinal course of such factors
4. to develop and evaluate cognitive–behavioural approaches to guided self-help and group therapy for
recovery, taking patient preferences into account
5. to develop and evaluate a cognitive–behavioural approach to understanding and preventing suicide in
people with psychosis
6. to understand the process of recovery from BD and to develop and evaluate a cognitive–behavioural
approach to recovery from a first episode of BD.
An additional aim of the programme as a whole was the development, within the lifetime of the
programme, of key deliverables that will be important to the NHS, namely user-defined measures of
recovery and symptoms, manuals for telephone-assisted CBT, recovery groups, CBT for suicide prevention,
CBT for early BD and assessment of barriers to recovery. It can be noted that the original title of the
research application was psychological approaches to understanding and promoting recovery from
psychosis; the title of this report changed to incorporate the emphasis on BD as well as psychotic disorders
as this is a more accurate reflection of the aims and programme content.
Service user involvement in research
Involving service users in research has been advocated for many years and has been implemented to some
degree in many areas. Increasing such involvement and inclusion is important for a number of reasons.
First, professional researchers may not always effectively address the personal priorities or preferences of
research participants and so collaborative consultation with service users can be helpful in focusing and
shaping research to be more clinically meaningful and ethically sound. Second, service users often report
that they would value the opportunity to meet and speak with others who have similar experiences and so
including user researchers within research teams can help to increase such opportunities for research
participants and may improve participants’ personal engagement. Third, recognising the inherent value of
personal insight that service users can bring to research can help to improve service users’ own self-worth,
individually and collectively. This may be an especially important aim as people who experience psychosis
commonly report reduced self-esteem and disempowerment as a result of their experiences,
or their treatment.
The Recovery Research Programme has fully integrated service user involvement from the outset by
including two service users as grant holders, employing two part-time service user researchers throughout
the programme, including 10 service users as consultants and setting up a bimonthly service user reference
group [service user reference group (SURG)]. The service user researchers conducted all of the individual
qualitative interviews and led the analyses of these data. They also delivered elements of peer support
within the patient preference trial (PPT). The role of the service user consultants and service user reference
group was to act in a consultative and advisory capacity, making recommendations on a variety of
elements including the content and conduct of studies. The service user reference group was co-ordinated
by a service user researcher with support from the research programme manager and administrator.
Service users were paid for their time and travel expenses both for attending the meeting and preparation/
reading time. The group met at a regular time and day on a bimonthly basis (every other month)
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throughout the programme. All SURG meetings were minuted and items for action or suggestions for
amendments to studies were taken to individual project teams. Any amendments made were documented
and fed back to the SURG. If suggestions made by SURG were not able to be accommodated, reasons for
this decision were still fed back to the group and discussed.
The SURG agreed that they would be involved with:
l reporting on progress of service user involvement in individual research projects (each person involved
represents one project)
l supporting and representing other service users involved in individual projects in any issues that arise
from their involvement
l responding to any requests for input from individual academics/recovery programme meetings
l being consulted about any ‘add on’ projects to the recovery programme
l being involved in the recruitment of staff.
Some key contributions of the SURG to individual studies included reviewing all of the topic guides for the
qualitative interview studies, advocating strongly for a preference trial design in the PPT, providing input
to the development of the self-help recovery guide in the PPT and developed the distress management
protocol for the programme. A review of the service user involvement in the Recovery Research Programme
was conducted by a service user researcher (and co-ordinator of SURG). The review highlighted that SURG
has functioned well as a group and that their involvement had benefited the research and the individuals
involved. It was felt that opinions of service users were taken seriously and had a wider impact including
being nationally recognised as an example of good practice for service user involvement. It was noted that
future service user involvement should continue to improve communications between all members of the
research team (including service users) as well as involving service users from the outset in planning and
standardising service user involvement for each study.
Conduct of the research programme
It was important that the research programme was conducted in a cohesive way that allowed consistency
across the studies in terms of staff training and supervision, cross-programme meetings, standard
operating procedures (SOPs), provision of trial management to the bipolar and suicide prevention trials and
a cross-programme Data Monitoring Committee (DMC). This enabled the programme to be conducted in
an efficient and effective way. The chief investigator (APM), programme co-ordinator (HL) and programme
manager (MW) contributed to the provision of these cross-programme aspects. Individual project leads
(GH, RPB, CB, NT and SHJ) were responsible for the conduct of the studies within their themes, as well as
decisions regarding data analysis (in conjunction with the programme statisticians: GD and NS) and
decisions regarding dissemination and publication of findings within their themes.
Enabling cross-learning: staff training, supervision and
cross-programme meetings
To enable cross-learning and consistency across the research programme, staff were trained and
supervised centrally. Weekly group supervision meetings were held with the researchers to monitor
adherence to the study protocol and SOPs, as well as monthly meetings to ensure consistent scoring and
inter-rater reliability for the assessment measures used across the programme. In addition, project leads
met regularly to discuss progress on the individual studies in order for shared learning to take place across
the studies.
INTRODUCTION
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Standard operating procedures
Standard operating procedures were created across the programme as a whole to facilitate consistency,
quality and integrity of routine activities within the research studies. This included producing procedures
for recruitment, randomisation, safe working, management of distress and risk, data quality and safety
reporting. SOPs were generally prepared by the trial manager and approved by the project leads before
being shared with programme staff via a secure web-based portal hosted by the National Institute for
Health Research (NIHR). This ensured the SOPs were current, version controlled and accessible from any
location. SOPs minimised variation across the studies and promoted quality through consistent
implementation even if personnel changes occurred during the lifespan of the study. Compliance with
SOPs was monitored directly by supervisors and line managers.
In addition to the SOPs for each study and across the programme as a whole, the service user reference
group suggested the addition of a distress management protocol which included offering a follow-up
telephone call to all participants to ensure that they had not experienced any distress following the
research assessment. If any distress was reported the researcher would check immediate safety and
well-being, followed by signposting to the appropriate clinical care team or seeking consent to share this
with the participant’s clinical care team. Additionally, the distress protocol recommended that assessments
were not conducted on a Friday afternoon owing to the possibility of the participant feeling distressed over
the weekend and unable to easily contact their clinical care team.
Data Monitoring Committee
The DMC was set up to review the safety and efficacy of the research studies, with a particular focus on
the clinical trials of therapeutic interventions. The DMC consisted of an independent clinician and
statistician, and was attended by the programme co-ordinator/trial manager to provide updates and the
programme statistician to consult on the statistical aspects of the studies. Meetings were held twice a year
with additional ad-hoc meetings or teleconferences when necessary to review adverse events. It was
agreed that the DMC would review recruitment and retention and monitor safety and adverse events.
Cross-programme recruitment
There was a procedure for the facilitation of cross-recruitment between several of the individual studies to
ensure that participants who were keen to take part in more research were offered the opportunity to do
so. While many participants took part in more than one study, their data from previous studies were not
generally utilised (i.e. each study was independent and built on the findings of previous phases). When
possible in the time frames required for valid assessments, data could be reutilised to minimise participant
burden. However, in practice this was not possible for most participants owing to the short validity periods
of standardised clinical assessments. The only exception to this was the study examining longitudinal
predictors of recovery in psychosis, which utilised data from the clinical trials to examine change over time.
Cross-programme measures
There was an attempt to utilise similar measures across studies in order to allow comparisons to be made
and to maximise the possibility of combining samples when appropriate (e.g. in the study examining
longitudinal predictors of recovery in psychosis, which utilised data from the clinical trials to examine
change over time). The Questionnaire about the Process of Recovery (QPR) was used throughout the
programme, often as the primary outcome in a clinical trial, or as the dependent variable when examining
predictors of recovery. Initial studies used the original 22-item version as this was what was available.
It became apparent that the psychometric properties were not ideal for measuring recovery as a unitary
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and independent construct. In the first study for which this was required, which examined psychosocial
and neuropsychiatric predictors of recovery, an individualised statistical analysis was conducted that
resulted in a combined measure that utilised the visual analogue scale ratings in combination with five QPR
items. Subsequent studies used a 15-item version of the QPR, which was one-dimensional and had
improved psychometric properties [but this had not been available to the earlier studies (those before 2013)].
Structure of this report
Chapters 2–7 of this report presents findings from each of the six linked themes. Each chapter includes
a brief background to the theme followed by subsections representing each phase of the project.
Subsections for each phase consist of a brief overview of the objectives, methodology, results and
discussion. The final chapter brings together all of the findings from the six themes, includes an overview
of the development of key deliverables that will be important to the NHS and discusses implications for
future research and clinical practice.
Changes to protocol or original proposal
The original plan of research was titled ‘Psychological approaches to understanding and promoting
recovery from psychosis’. The original proposal outlined six key objectives and the methods used to achieve
these objectives as follows:
1. Development of a valid and acceptable tool to assess the severity of multiple dimensions of psychotic
experiences that can be reliably used by service users and further validation of a user-led measure of
recovery. To achieve this objective the original proposal contained three phases to this research:
i. Qualitative interviews conducted by, and with, services users to generate items relating to the
experience of psychotic symptoms.
ii. Q-sort methodology to generate potential themes and items for the new measure.
iii. Investigation of the psychometric properties of the new scale (including test–retest reliability and
concurrent and predictive validity).
2. Confirmation of psychological factors that are associated with recovery from psychosis and examination
of the longitudinal course of such factors.
i. A cross-sectional study exploring the relationship between cognitive functioning and social
functioning, and assessment of the extent to which cognitive functioning and cognitive biases are
associated with subjective domains of recovery of importance to patients.
ii. A longitudinal assessment of cognitive processes in recovered and non-recovered schizophrenia
spectrum patients including an experience sampling method (ESM) study of stability in
these processes.
iii. Examination of predictors of recovery. Based on the results from phases 1 and 2, production of a
final battery of variables most closely linked to the process of recovery, and testing of their ability to
predict specific domains in the patients participating in two of the trials. In each trial, the assessment
battery was administered at inception and at 6-month follow-up. This is to enable the prospective
assessment of predictors of recovery.
iv. Production of a manual for the recovery prediction battery. Based on the results from phases 1–3, the
optimum combination of measures were chosen to include in a brief, transdiagnostically valid battery
designed to assess intrapsychic impediments to recovery. A manual describing the final battery and
summarising our findings would be made available to clinicians and researchers elsewhere.
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3. Development and evaluation of cognitive–behavioural approaches to guided self-help and group
therapy for recovery, taking patient preferences into account.
i. Development of the self-help manual. The recovery manual was developed in a manual format by a
multidisciplinary group of mental health professionals and users informed from both the recovery
literature and cognitive–behaviourally oriented treatments for people with psychosis.
ii. Piloting the manual, estimating effect size and study of patient preferences. Participants were
randomly allocated to the manual plus telephone condition or treatment as usual (TAU). Baseline
and post-treatment assessments were completed in the same manner as in the proposed PPT.
Detailed feedback about the manual and telephone support was requested from participants.
iii. An additional sample of service users meeting the inclusion criteria above were interviewed as to
their hypothetical preferences in terms of treatment condition.
iv. The PPT. The three conditions to be evaluated in the PPT were TAU, manual plus low support
(telephone support), manual plus high support (telephone and group).
4. Development and evaluation of a cognitive–behavioural approach to understanding and preventing
suicide in people with psychosis.
i. To investigate the psychological architecture that drives suicide behaviour, including information
processing biases, suicide schema and appraisal systems using information processing tasks such as
autobiographical memory tasks to investigate bias, standardised assessment to investigate appraisal
and schema.
ii. To derive a method of assessing this architecture through semistructured interviews that will have
clinical utility.
iii. To formulate and develop a manualised cognitive–behavioural treatment programme for suicide
prevention in psychosis and to test the clinical acceptance and feasibility of this intervention. It was
hypothesised that the treatment would be acceptable, feasible and reduce suicide behaviour.
iv. At the end of the programme, to be in position to design a clinical trial to test the efficacy of
the intervention.
5. Understanding the process of recovery from BD and the development and evaluation of a
cognitive–behavioural approach to recovery from a first episode of BD.
i. A qualitative study to identify the key themes associated with recovery in individuals who have a
diagnosis of BD.
ii. On the basis of the information collected in phase 1, a questionnaire was constructed to conduct
a quantitative study of recovery from BD. This study evaluated the reliability and validity of
the measure.
iii. To evaluate a CBT-based recovery intervention for individuals with a first diagnosis of BD.
6. The development, within the lifetime of the programme, of key deliverables which will be important to
the NHS, namely user-defined measures of recovery and symptoms, manuals for telephone-assisted
CBT, recovery groups, CBT for suicide prevention, CBT for first episode BD and assessment of barriers
to recovery.
First, it can be noted that the original title of the research application was ‘Psychological approaches to
understanding and promoting recovery from psychosis’; the title of this report changed to incorporate the
emphasis on BD as well as psychotic disorders as this is a more accurate reflection of the aims and
programme content.
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An additional objective was added to this list during the course of the research programme (see Chapter 3)
to examine consensus around conceptualisations of recovery. It was felt that this was a valuable addition
to underpin the studies in this research programme and provide further clarity on the concept of recovery.
It should also be noted that the original plans for the Chapter 6 studies on recovery and suicide did not
include the qualitative study (phase 1) to examine the subjective experience of participating in this type of
research. However, based on service user feedback and suggestions from the SURG, the team decided to
add this phase to explore service user perceptions and inform the conduct of the future studies.
Finally, the original proposal stated that the outcome of the Chapter 4 studies on understanding
psychological and social predictors of recovery would be an assessment battery and manual for assessment
and prediction of recovery. However, this aim proved to be unrealistic given the idiosyncratic nature of
recovery, the differences between clinical populations and the diversity of approaches used to capture
information about recovery. However, we have included a section at the end of the conclusion of Chapter 4
that addresses recommendations for the measurement of recovery.
INTRODUCTION
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Chapter 2 User-defined conceptualisation and
measurement of recovery in psychosis
Background
Recovery has become an increasingly popular and important concept for mental health service providers
and policy-makers following guidance in a number of government policies and the national service
framework.44 Despite this, a working definition of the concept of recovery has never been formalised.
Consequently, current approaches to defining and measuring recovery in mental health utilise a variety of
approaches. For example, traditional models tend to focus on symptoms while other models are concerned
with a sense of well-being regardless of symptoms. Davidson et al.45 outlines this as two superseding
models. Similarly, although measurement of recovery is sometimes concerned with only a single factor
approach, such as assessment of symptoms, relapse rates or functioning,46,47 others consider recovery to be
a multifactorial long-term process incorporating hope for the future rebuilding self and rebuilding life.19
Alternative approaches have assessed recovery as a set of internal and external conditions.48 Despite the
diverse nature of understandings of the concept itself, the term recovery has become widely used and
recognised by professionals and service users alike. This highlights the importance of aiming for a shared
understanding of recovery to prevent misapplication and miscommunication.
Recovery from psychosis has traditional been viewed as achieving symptom alleviation.49 The gold standard
in research investigating therapies, treatments and medications would be large clinical studies such as
randomised controlled trials (RCTs), which aim to reduce frequency of symptoms. The primary outcome
measure in RCTs investigating CBT50–52 and medication53,54 has been symptom change scores using
standardised psychiatric interviews. Similarly, mental health services often use the criteria of symptom
alleviation as a benchmark for demonstrating effective practice, adopting the benchmark from RCTs.
As a result of this focus on symptom change, a number of measures of symptomatic recovery have been
developed including the Positive and Negative Syndrome Scale (PANSS55) and the Brief Psychiatric Rating
Scale.56 Symptoms have been shown to cause reduction in social and daily functioning as well as leading
to distress,47,57 demonstrating the need to consider symptoms of psychosis when examining recovery.
Although these measures have been shown to be reliable and useful in assessments of outcome in
psychosis, they may not be considered by service users to reflect the multifactorial nature of recovery from
psychosis. Other unidimensional approaches to measuring recovery from psychosis have included relapse
reduction,58 for which rehospitalisation, remission and reoccurrence of symptoms are taken into account.59
Periods without hospitalisation and remission of symptoms are used as indicators of periods in recovery.59
Alternatively, services have increasingly turned to assessment of quality of life as a measurement of
recovery in psychosis.60 This approach integrates more of the elements of service user-defined recovery
such as a range of life domains and individual values.61 Measures such as the Global Assessment of
Functioning (GAF62) scale and the Quality of Life Scale63 are commonly used. Research studies often use
these measures alongside the more traditional symptom and relapse measures.64
Although there has been a wealth of research developing these measures and utilising them in RCTs and
other studies, few have examined whether or not these outcomes are relevant and meaningful to service
users and their definitions of recovery. A recent review of measures of recovery31 included examination
of acceptability to service users and found that only one measure had been developed in collaboration
with service users to specifically to measure recovery from psychosis: the QPR.32 Further psychometric
testing of the QPR was recommended. This measure was utilised throughout the Recovery Research
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Programme allowing future examination of psychometric properties and utility as well as further
exploration of whether or not it covers key recovery themes as defined by service users.
Service user-defined recovery has been examined in a recent meta-analysis26 which identified five processes
that are important to recovery: (1) personal and self-empowerment; (2) motivational processes including
hope; (3) developing competencies such as seeking knowledge and making sense of distress; (4) social and
community participation; and (5) utilising available resources, including services and voluntary support
agencies. Development of a measure that takes into account these factors and other elements which
service users highlight as essential to recovery, as well as their relationship to symptoms, would further our
understanding of recovery and the ability of services to effectively measure recovery-focused outcomes.
In order to develop a measure of recovery that incorporates dimensions of symptoms, but which is
meaningful and relevant to service users, resolution around the meaning of recovery must first be
addressed. This would then progress to developing and validating a service user generated measure, which
would encompass this definition. The psychometric properties of this measure would then be established.
This chapter includes three distinct phases of a study to address this deficit. This study aims to alleviate
uncertainty about the concept of recovery by adopting an inclusive approach, scrutinising factors that are
important to a multidimensional approach to recovery before using this information to develop a service
user generated, self-report scale to assess recovery in relation to symptoms in psychosis. The three phases
to this study include (1) a qualitative approach to exploring service user experiences of recovery;
(2) a Q-methodology approach to further refine what factors are important to service user definitions of
recovery; and (3) utilisation of information from phases 1 and 2 to develop a service user designed
measure of recovery in relation to symptoms of psychosis and establish its psychometric properties.
Phase 1: conceptualisation and perceptions of recovery from
psychosis – a service users perspective
This research was previously published as Wood L, Price JF, Morrison AP, Haddock G. Conceptualisation of
recovery from psychosis: a service-user perspective. Psychiatrist 2010;34:65–47065 and much of this text
has been reproduced with permission from the Royal College of Psychiatrists.
Objectives
This study aimed to explore peoples’ subjective experiences of recovery using interpretative
phenomenological analysis (IPA) to elicit data from participants.
Method
Participants
Participants were invited to take part in the study if they had experience of psychosis in the last year, were
aged 16–65 years and were currently in contact with mental health services. Exclusion criteria included not
being able to speak English, not able to give informed consent and having taken part in other research
with the past 6 months. Participants were recruited from statutory care providers across the Greater
Manchester West Mental Health NHS Foundation Trust. Recruitment was conducted until the research
team felt that saturation of themes was achieved.
Design
The study utilised a semistructured interview approach, with an interview schedule developed by a clinical
psychologist and service user researcher (GH and MK). A service user group facilitated generation of
questions surrounding personal background, experience of symptoms, recovery and impacts of symptoms.
These questions were piloted with three service users and amendments were made following their
feedback. The final version included the following headings: information on initial contact with mental
health services, background on personal experiences, current experiences, what they felt had changed over
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time/recovered, how they feel they have changed (over time/recovered, ways of coping, impacts and
changes to their life).
Procedure
Recruitment for the study took place in early intervention services (EISs), assertive outreach (AO) teams and
community mental health teams (CMHTs). Participants were given a minimum of 24 hours to read the
information sheet before being asked to sign a consent form. A service user researcher conducted
the majority of the interviews (75%). All interviews were audio-recorded and transcribed verbatim by the
service user researcher and research assistant in order to help familiarise themselves with the data.
Analysis
Interpretative phenomenological analysis66 is an approach to qualitative research with a focus on how an
individual makes sense of an event or phenomenon. IPA involves collecting information from participants, in
this case using interviews, on a given experience and how the individual has interpreted and made sense of
that experience. IPA was utilised to explore the data in this study, as it is well suited to the exploration of
subjective experience.66 A core concept of IPA is that the analyst should become immersed in the data66 to
enable the researcher to gain an insider perspective. This was achieved by listening to the audio-recorded
interviews and reading through the final transcripts a number of times. Two researchers analysed all the
interviews independently and extracted pertinent themes. The third researcher acted as a mediator if there
was any disagreement.
Results
Eight people were interviewed (six males and two females) with an age range of 24–35 years. All had
experiences of delusions and/or hallucinations within the last 12 months and six were recruited from EISs
and two were from CMHTs.
Initially, 132 themes were generated from the interviews, which were condensed into 50 clear themes that
were representative of the expansive concourse. The process of condensing these themes involved
identifying overlapping and repetitive items and reaching consensus about removal of these items. These
were then fine-tuned to remove themes that were felt to reflect the same concepts as others. The final
50 themes broadly covered eight areas of recovery: symptoms, emotional aspects, the self, behaviour,
services and support, coping mechanisms, social functioning and occupational aspects. From these eight
broad themes, a logical grouping of four superordinate themes emerged.
The four superordinate themes were described as ‘impacts on mental health’, ‘self-change and
adaptation’, ‘social redefinition’ and ‘individualised coping mechanisms’. These themes were underpinned
by change, highlighting that recovery is a process, not an end point. These themes each had two further
subthemes that consisted of smaller themes (Box 1).
Theme 1: impacts on mental health
All people interviewed discussed alleviation of symptoms and/or negative emotions as key to their recovery.
Participants discussed specific changes in symptom characteristics as well as changes in their emotional state.
Reduction in symptoms of psychosis
All participants considered a change in symptom characteristics as important to their recovery.
. . . they’re not as aggressive as they were when the were really bad . . . they were really, really nasty
and they used to really upset me but they’re not as bad anymore . . .
(Reflecting the importance of the subordinate theme of ‘the content of experiences’.)
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BOX 1 Interpretative phenomenological analysis: key themes, subthemes and further themes of aspects important
to a change in recovery
Impacts on mental health
Reduction in symptoms of psychosis
l Preoccupation with experiences.
l The content of experiences.
l The frequency of experiences.
l The duration of experiences.
l Amount of distress.
l Conviction.
Emotional change
l Overcoming depression and low mood.
l Feeling of happiness and enjoyment.
l Overcoming anxiety and stress.
l Overcoming anger and frustration.
l Changes in the amount of emotions experienced.
Social redefinition
Occupational change
l Stable living conditions.
l Job seeking and maintaining employment.
l Financial stability.
Relationships and social behaviour
l Being less withdrawn and isolated.
l Finding the ability to trust others.
l Taking part in meaningful activities and hobbies.
l Developing and depending on relationships with friends and loved ones.
l Increasing social activity.
l Overcoming being judged and stigmatised.
Self-change and adaptation
Personal change and belief
l Positive self-beliefs.
l Redefining who you are.
l Feeling less vulnerable.
l Overcoming embarrassment.
l Regaining personal freedoms and rights.
l Having a positive outlook for the future.
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Emotional changes
Affective and emotional changes are often associated with experiences of psychosis:
. . . it was definitely the most difficult time I’ve ever experienced, and I’ve had depression since, on and
off since I was 14 maybe. But it [the depression that coincided with the psychosis] was far worst
than that.
(Showing the importance of the ‘overcoming depression and low mood’.)
Theme 2: self-change and adaptation
Experience of psychosis was shown to have great impact on one’s self. The themes illustrated the
importance of overcoming psychosis and being able to regain self-identity.
Behavioural change
l Improvements in sleep.
l Energy and lethargy.
l Motivation for change.
l Reduction in self-harm and suicidal ideation.
l Regaining independence.
l Changes in drug and alcohol use.
Individualised coping mechanisms
Support and treatment
l Benefits of medication.
l Benefits of therapies.
l Peer support.
l Support from loved ones and/or friends.
l Receiving help from mental health services.
l Concerns over side effects of medication.
l Importance of spirituality/religion.
Understanding and control
l Help seeking with experiences.
l Recognising the early signs of becoming unwell.
l Being able to cope with experiences.
l Understanding your experiences and/or diagnosis.
l Feeling empowered over your experiences.
l Having control over experiences.
l Thinking clearly about experiences.
l Having control over own thoughts.
BOX 1 Interpretative phenomenological analysis: key themes, subthemes and further themes of aspects important
to a change in recovery (continued)
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Personal change and belief
Interviewees described negative self-belief and negative personal change since experiencing psychosis.
Their previous self wanted to be redefined in spite of current experiences:
I feel better about myself now, the voices used to make me feel like a rubbish person, they made me
feel like I wasn’t worth anything, now I can control this I feel better about myself.
(The theme ‘ positive self-beliefs’ was key to personal change and belief.)
Behavioural change
The research also identified a number of behavioural changes; participants expressed the importance of
motivation, independence, and changing harmful behaviours:
‘I think I’m over most of it you know, but I think there’s still little things, like a routine of looking after
myself which can sometimes suffer, . . . sometimes my appearance can get quite bad’
(Illustrating the self-care is key to subordinate theme ‘regaining independence’)
Theme 3: social redefinition
Mental health problems were shown to have a direct impact on an individuals’ social role. Redefining and
reconciling their social circumstances was frequently spoken about in all interviews.
Occupational change
Changes in finance, work, and living arrangements are acknowledged to be great stressors to individuals
with and without mental health problems. A return to these situations was identified as a struggle but
something that people do want to tackle:
Not having much luck getting a job at the moment which is quite frustrating really.
I was in lots of debt and it was stressing me out.
(Illustrating subordinate themes ‘job seeking and maintaining employment’ and ‘financial stability’ are main
occupational issues.)
Relationship/social behaviour
Social isolation, the breakdown of social networks, judgement and stigmatisation is often a common with
mental health experiences. It was important to interviewees to rebuild these networks and relationships
to assist in recovery:
One of the main things [that made me feel better] is the support that my family gave me really,
although it was strained at times, after a while, not at first but after a while they would understand
what I was going through.
(All interviewee’s supported the theme ‘developing and depending on relationships with loved ones.)
Theme 4: individualised coping mechanisms
Developing an individualised coping mechanism was considered important to all people interviewed.
By accessing support and treatment, people were able to assist their recovery. Furthermore, gaining
insight and understanding was also shown to be important.
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Support and treatment
Interviewees had diverse views about what support and treatment they found beneficial illustrating the
individuality in appropriate support and treatment:
And [care co-ordinator] has been a great help, you know working through everything . . . and the
team [were helpful].
(Subordinate theme ‘receiving help from the mental health services’ was important to some
interviewee’s recovery.)
Understanding and control
Understanding and coping with experiences was highlighted by all interviewees as important to their
recovery. However, each individual had different approaches and found a range of things helpful:
I would have to think something rational and take control of my own beliefs and it was
really empowering.
(This quote reflects the need for subordinate theme ‘having control over experiences’.)
Discussion
This study found four main themes that are important to consider when conceptualising recovery: impacts
on mental health, self-change and adaptation, social redefinition and adapting an individual coping style.
The study also supported previous research that found recovery is felt to be a process rather than an end
point and that recovery in psychosis is multidimensional.
All participants felt the four themes were important to recovery, although there was varied emphasis
placed on each theme by each individual. Consistent with previous research, this highlights the
complexities of conceptualising recovery and indicates that recovery is not an outcome with clear-cut
differences between recovered and not recovered.
Self-change and adaptation was often felt to be central to recovery. Changes to character, personality and
identity were noted by all participants and reduced motivation, energy and confidence were often
reported. Previous research19 has indicated that rebuilding the self understandably plays a key part in
recovery and this study emphasises the importance of consideration of this factor in therapy and research.
Participants did report that symptom alleviation had a major impact of their recovery, highlighting the
importance of symptoms as an indicator of outcome. However, participants found that symptoms
are important in conjunction with a range of other factors. Indeed, for some service users there may be
a continued presence of symptoms but without their negative impacts.
It may be of particular interest that the emotional impacts of having psychosis were also identified. The
effects on depression, anxiety, anger and frustration illustrate that emotional change is also important to
consider. This could have significant implications for measurement of outcomes that do not typically
take factors such as anger and frustration into account.
The social impact of psychosis was also common throughout the themes and is often noted as a key area
of recovery. Financial stability, living arrangements and employment status were affected by having
experienced psychosis for the majority of participants. Participants discussed a decrease in social activity,
feeling alone and isolated and the huge impacts that psychosis had on relationships with loved ones.
Services that aim to be recovery orientated should consider the continued need for social relationships and
impacts on social behaviour.
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An important implication of the findings of this study is the need to understand recovery using a holistic
approach, which incorporates personal factors as well as symptoms. Social and personal change and
coping styles should be considered alongside symptom alleviation, with equal importance being given to
each factor. Assessment tools that take into account the important element of symptom alleviation
alongside these broader personal and social themes would be desirable with consideration of the impact
that these experiences have on life.
The main strength of this research is that the majority of the interviews were carried out by a service user
researcher. As the service user researcher had shared experience with the interviewee, it could be expected
that richer and more detailed information may have been elicited. This has been illustrated in other
service-user-led studies about recovery19 and impacts of diagnosis.67
In contrast, one main limitation to the study was also the service user researcher conducting the majority
of the interviews. The service user researcher felt that his personal experiences influenced the direction and
data extracted by the interview process. The central role of the researcher in interpreting qualitative data is
a core feature of IPA. The supervisory process and reflections of the service user researcher in discussion
with both colleagues and members of the SURG provided a forum for the researcher to balance their own
views with those of others, in relation to both the conduct of interviews and the analysis of the transcripts.
In conclusion, this study has demonstrated that recovery is a multifaceted process that incorporates
symptoms, social factors, personal adaption and development of individualised coping mechanisms. Future
research as well as development of services and therapy should consider these four factors with equal
weighting of importance to create a more holistic approach to recovery.
Phase 2: exploring service users perceptions of recovery from
psychosis – a Q-methodological approach
This research was previously published as, and much of this text has been reproduced with permission
from, Wood L, Price JF, Morrison AP, Haddock G. Exploring service users perceptions of recovery from
psychosis: a Q-methodological approach. Psychol Psychother 2013;86:245–61,68 John Wiley & Sons.
© 2012 The British Psychological Society.
Objectives
This study aimed to explore, using Q-methodology, the factors important to service users in relation to
recovery from psychosis.
Method
Development of the Q-sort
Q-methodology is undertaken in a number of steps.69 First, a database of relevant codes (Q-concourse) is
developed. This usually consists of a large database of diverse information from a variety of sources about
the topic being examined. The Q-concourse was developed from two main sources: themes identified from
the interviews conducted in phase 1 and also from existing literature. This Q-concourse codes are then
grouped together to form a final set of descriptive themes. These are then translated into statements cards
(this is called the Q-set). An initial set of 132 codes was condensed into 52 clear themes that were
representative of the expansive concourse by a multidisciplinary team that included service users. These
themes were then categorised by the research team and deemed to broadly cover eight areas of recovery:
symptoms, emotional aspects, social functioning, the self, cognitions, services, coping mechanisms and
occupational aspects. Participants (known as the P-set) are required to sort these statements in order of
importance in relation to one another using a forced normal distribution table.
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Participants
Forty participants were identified as being required to take part in the study, which was deemed to be a
sufficient number for a study of this design based on previous research.69,70 The inclusion criteria for the
participants in the study were: aged between 18 and 65 years, experienced delusions and/or hallucinations
for at least 1 year and in contact with a statutory mental health service in Greater Manchester in the
North West of England.
Participants’ self-report demographics are outlined in Table 1. Participants’ diagnoses were self-report,
with the majority (40%) reporting a diagnosis of schizophrenia, or experience of psychosis (20%).





















Delusions, n (%) 32 (75) 6 (75) 7 (70) 8 (88.9) 5 (100)
Average duration of
delusion (months) (range)
(3–360) 160 (12–120) (3–164) (24–360) (12–184)




(3–360) 152 (9–120) (3–240) (18–360) (12– 84)
Gender, n (%)
Male 25 (62.5) 1 (12.5) 7 (70) 8 (88.9) 3 (60)
Female 15 (37.5) 7 (87.5) 3 (30) 1 (11.1) 2 (40)
Nationality, n (%)
White 35 (87.5) 8 (100) 9 (90) 9 (100) 4 (80)
Black 3 (7.5) 0 (0) 1 (10) 0 (0) 0 (0)
Asian 1 (2.5) 0 (0) 0 (0) 0 (0) 0 (0)
Other 1 (2.5) 0 (0) 0 (0) 0 (0) 1 (20)
Employment status, n (%)
Unemployed 35 (87.5) 5 (62.5) 9 (90) 8 (88.9) 5 (100)
Student 2 (5) 2 (25) 1 (10) 1 (11.1) 0 (0)
Employed 2 (5) 1 (12.5) 0 (0) 0 (0) 0 (0)
Other 1 (2.5) 0 (0) 0 (0) 0 (0) 0 (0)
Education level, n (%)
Primary/secondary 18 (45) 3 (37.5) 4 (40) 5 (55.6) 1 (20)
Further/higher 22 (55) 5 (62.5) 6 (60) 4 (44.4) 4 (80)
Marital status, n (%)
Single 25 (62.5) 4 (50) 6 (60) 7 (77.8) 3 (60)
In a relationship 10 (2.5) 1 (12.5) 3 (30) 2 (22.2) 2 (40)
Separated/divorced 3 (7.5) 2 (25) 0 (0) 0 (0) 0 (0)
Other 2 (5) 1 (12.5) 1 (10) 0 (0) 0 (0)
SD, standard deviation.
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Procedure
Participants were shown the Q-sort matrix (Figure 1) and given 52 shuffled statement cards (the Q-set).
They were asked to read through them thoroughly to ensure they understood them before sorting the
cards into three piles, one that represented things that were important to their recovery, one for things
that were not important and ones that they were not sure about. They were then asked to consider the
‘most important’ pile and pick the two most important statements and place them on the far right of the
grid (column 12), they were then asked to pick the three next most important and place it onto column
11, and so forth until they placed all the most important cards onto the grid. The same procedure was
repeated with the least important pile and the not sure pile until the table was full. Participants were given
the opportunity to move the statements around until they were happy with their final sort and were asked
follow-up questions about the reasoning behind the rating of the two highest and two lowest items, if
they thought any recovery items were missing, and for any further comments.
Data analysis
A Q-method software package (PQ method version 2.11; Kent State University, Kent, OH;
URL: http://schmolck.userweb.mwn.de/qmethod/pqmanual.htm) was used to analyse the data. Principal
component analysis (PCA) with varimax rotation was implemented to sort factors and to explain the
maximum amount of variance. Q-method analysis factors groups of people together as opposed to items
in traditional factor analysis.
Results
Q-method analysis resulted in a four-factor solution that 32 out of the 40 participants loaded on. These
other eight participants were excluded from the factor arrays and do not contribute to the interpretations
detailed below. In the Q-sort people are factor analysed instead of items. Therefore, to explain the most
variance we had to lose eight participants from the factor analysis to come up with a factor solution that
explained the most variance in recovery views. With this type of analysis, a loss of participant data cannot
be avoided. The factor solution explained 36% of the variance and had an Eigenvalue of 2.74. Eight
participants loaded onto factor 1 (accounting for 10% of the variance), 10 participants loaded onto factor
2 (10%), nine participants loaded onto factor 3 (9%) and five people loaded onto factor 4 (7%). Factors
identified will be referred to as ‘viewpoints’.
Least important Not sure Most important
0 1 2 3 4 5 6 7 8 9 10 11 12
FIGURE 1 Q-sort response matrix.
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Most important viewpoints of recovery
All 52 items were endorsed (placed in columns 9–12) by at least two of all 40 participants (5%).
The number of endorsements and percentage of endorsements are shown in Table 2.
Interpretation of viewpoints
The Q-sort resulted in four viewpoints: collaborative support and understanding, emotional change though
social and medical support, regaining functional and occupational goals, and self-focused recovery.
The correlations between the factor scores indicated no overlap between factors.
TABLE 2 Number of statements endorsed
Statement
Numbers endorsing each
statement (9, 10, 11, 12)
n %
35. How much support I get from loved ones in helping with my experiences 26 65
45. How much I have changed as a person/personality since I have had these experiences 21 52.5
33. How my experiences effect my relationships with friends and loved ones 18 45
31. How my experiences effect how positive I am for the future 17 42.5
1. How depressed my experiences make me feel 16 40
26. How my experiences effect how happy I feel 14 35
49. How concerned I am of the side effects of taking medication for my experiences 13 32.5
42. How clearly I can think about my experiences 13 32.5
40. How much I feel mental health services are helpful with my experiences 13 32.5
34. How much I understand my experiences 13 32.5
29. How trusting of others I am as a result of my experiences 13 32.5
15. How helpful I feel my medication is with my experiences 13 32.5
39. How bothered I am about the stigma/being judged about my experiences 12 30
27. How anxious or stressed I am from my experiences 12 30
25. How well I was able to recognise the early signs of becoming unwell 12 30
22. How my experiences have effect my memory and concentration 12 30
17. How convinced I am that my experiences are real 12 30
41. How my experiences alter my ability to control my own thoughts 11 27.5
30. How much I socialise as a result of my experiences 11 27.5
3. How unpleasant my experiences/voices are 11 27.5
28. How withdrawn I am as a result of my experiences 11 27.5
2. How much I dwell on my experiences 11 27.5
19. How my experiences effect the quality/and or amount of sleep I get 11 27.5
47. My ability to find work as a result of my experiences 10 25
11. How positive I view my experiences to be 10 25
51. How motivated I feel about changing my experiences 9 22.5
43. The amount to which I can cope with my experiences 9 22.5
37. How ashamed and/or embarrassed I feel about my experiences 9 22.5
continued
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Tables for each factor array, indicating where all statements were ranked for all four viewports are
provided in Table 3.
Viewpoint 1: collaborative support and understanding
This viewpoint (n= 8) consisted of people who felt that positive and collaborative engagement with others
and services was key to their recovery. This group of people was positively motivated to overcome their
experiences and willingly accepted help from others to achieve this. This group did not focus on the
negative aspects of having a mental health problem. Aspects such as ‘the amount of alcohol and drug
use that worsens my experiences’ (−6), ‘the amount I think about harming myself as a result of my
experiences’ (−5) and similar aspects were not considered important.
Viewpoint 2: emotional change through social and medical support
This viewpoint (n= 10) consisted of people who considered emotional stability through support and
treatment as a key factor to the recovery process. The affective impacts of having psychosis were
TABLE 2 Number of statements endorsed (continued )
Statement
Numbers endorsing each
statement (9, 10, 11, 12)
23. How my experiences effect my ability to look after myself 9 22.5
21. How my experiences effect the amount of anger and frustration I feel 9 22.5
13. The amount I think about harming myself as a result of my experiences 9 22.5
5. How much control I have over my experiences 8 20
48. How financially stable I am as a result of my experiences 8 20
18. The amount of support I get from other service users 8 20
16. How helpful I feel psychological therapies are with my experiences 8 20
46. My living arrangements as a result of my experiences 7 17.5
20. How my experiences effect my personal freedoms and rights 7 17.5
12. How much religion/spirituality was involved with my experiences 7 17.5
9. How loud my voices are 6 15
50. How vulnerable I feel as a result of my experiences 6 15
44. In alcohol and drug use that worsens my experiences 6 15
4. How pleasant my experiences/voices are 6 15
10. My belief that my experiences come from my own mind 6 15
7. How much time in my life they take up 5 12.5
52. How concerned I am that my experiences will happen again 5 12.5
38. How my experiences effect the amount of emotion I feel 5 12.5
32. How enjoyable I find hobbies/activities as a result of my experiences 5 12.5
8. Amount to which my voices are inside my head compared to outside my head 4 10
6. How often my experiences happen 4 10
14.How my experience effect how energetic I feel 3 7.5
36. How empowered I feel over my experiences 2 5
24. How active I was in seeking help with my experiences 2 5
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prioritised whereas the symptoms of psychosis were not considered as important. This group do not find
the psychiatric characteristics of symptoms or occupational aspects of any importance.
Viewpoint 3: regaining functional and occupational goals
This viewpoint (n= 9) consisted of people who considered functional and occupational goals as key to
their recovery. It was important to this group of people to regain life functioning and aspects that hindered
this process were considered important to change in their recovery. This group did not find the internal
cognitive aspects important.
Viewpoint 4: self-focused recovery
This viewpoint (n= 5) consisted of people who were internally focused in recovery. Aspects found
important to this group involved the self and feelings of isolation. It seemed this group felt persecuted and
unsupported by services and felt that they could only be dependent on themselves for recovery. Aspects
that were not important to this group appeared to relate to support from others and psychiatric aspects
of symptoms.
Additional feedback
Five participants left additional feedback outlining how they found completing the questionnaire and how
useful the Q-sort was in helping understand their experiences. All feedback was positive about the procedure.
Discussion
Results suggest that there are different aspects to recovery from psychosis that are not necessarily linked to
alleviation or removal of symptoms. Furthermore, it highlights the importance of ensuring that treatment
is idiosyncratic in facilitating people’s recovery.
The four-factor solution provides an interesting insight into recovery and the different types of recovery
styles. Four Q-sorts were generated: collaborative support and understanding, emotional change through
social and medical support, regaining functional and occupational goals, and self-focused recovery.
The qualitative feedback obtained from the questionnaire illustrated that a number of participants found
that the Q-sort helped them further understand their recovery, indicating that the recovery Q-sort may be
a therapeutic tool in its own right. The identification of four different recovery styles highlights the
importance of tailoring care packages to individual needs. Arguably, people that loaded onto the first
three viewpoints may benefit from therapies such as CBT, which are goal orientated, collaborative,
person-centred and utilise guided discovery. Those who support ‘self-focused recovery’ may need a more
self-directed recovery programme to assist empowerment and self-change.
Utilisation of Q-methodology allowed for the recovery themes to be examined by a wider group of service
users. It would therefore be hoped that these four recovery viewpoints are representative of the service user
population as a whole. It is interesting to note that two of the viewpoints appeared to be endorsed
predominantly by one sex (females predominantly endorsed collaborative support and understanding,
whereas males predominantly endorsed regaining functional and occupational goals); future research could
examine whether or not this finding is replicable and valid, and may indicate the importance of examining
sex differences in recovery styles. The main limitation of the study was that the factor solution only explained
36% of the variance, with eight people not loading onto any factors. Therefore, it is acknowledged that only
tentative interpretations can be drawn from the results. However, this research lays a platform for further
research into this area.
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Phase 3: the Subjective Experiences of Psychosis Scale –
psychometric evaluation of a scale to assess outcome
in psychosis
This research was previously published as Haddock G, Wood L, Watts R, Dunn G, Morrison AP, Price J.
The Subjective Experiences of Psychosis Scale (SEPS): psychometric evaluation of a scale to assess outcome
in psychosis. Schizophr Res 2011;133:244–971 and much of this text has been reproduced with permission
from Elsevier.
Objectives
This project aimed to develop a service-user-generated, valid, reliable, multidimensional tool to assess
dimensions of symptoms of psychosis that can be used to assess and monitor experiences of psychosis.
Method
Development of the Subjective Experiences of Psychosis Scale
Potential items for the new scale [the Subjective Experiences of Psychosis Scale (SEPS)] came from three
sources: (1) items identified from the existing literature on outcomes within mental health; (2) themes
generated from phase 1; and (3) material generated from phase 2. A total of 146 items were identified
from these methods which were reduced down to 52 items within three distinct categories: (1) impact of
experiences of psychosis on mental health and well-being; (2) impact of support (such as treatment,
support from friends and family, alcohol) on experiences of psychosis; and (3) severity of different
dimensions of experiences of psychosis (e.g. frequency and pleasantness). Both positive and negative
aspects of experiences of psychosis were identified in all three categories.
This initial draft scale was further scrutinised for content and face validity by a SURG resulting in the
following changes: reducing the number of items to eliminate redundant or repeated items, introducing
a scoring method that represented both the positive and negative aspects of psychosis for all items,
including a scored example and rewording the instructions.
These modifications resulted in a 45-item self-report scale, consisting of three subscales assessing positive
and negative aspects of experience of psychosis. Subscale 1 was ‘positive impacts of experiences’ and
‘negative impacts of experiences’, respectively, (31 items each), subscale 2 was ‘positive impact of support’
and ‘negative impact of support’ on experiences of psychosis (eight items each) and subscale 3 was
‘positive dimensions’ (two items) and ‘negative dimensions’ of experiences of psychosis (four items). Items
were scored from 1 (not at all) to 5 (very much) with the addition of a ‘not applicable’ box for subscale 2.
Participants
Participants were required to meet the following inclusion criteria:
1. an International Classification of Diseases, Tenth Edition (ICD-10) diagnosis of schizophrenia, schizotypal
disorder and delusional disorder
2. recent experience of delusions or hallucinations verified by the PANSS55 and Psychotic Symptoms Rating
Scale (PSYRATS)72
3. aged between 18 and 65 years.
Materials
Measurement of symptoms of psychosis was assessed using the PANSS55 and PSYRATS.72 Depression,
hopelessness, anxiety and self-esteem were assessed using the Calgary Depression Scale,73 Beck
Hopelessness Scale (BHS74), Beck Anxiety Inventory (BAI75) and the Self-Esteem Rating Scale (SERS76),
respectively. Functioning was assessed using the GAF scale.77 In addition, we explored how the SEPS
related to self-reported progress in recovery from psychosis and using the QPR.32 All measures have been
shown to have good reliability and validity with psychosis samples.
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Procedure
Participants were recruited from mental health teams in the north-west of England via mental health
professionals. The study was carried out over three stages. Stage 1 required participants to fill out the
SEPS and self-report measures and participate in PANSS and PSYRATS interviews. Data from stage 1 were
used to carry out a PCA and investigation of internal consistency and concurrent validity of the SEPS. In
stage 2, which was completed 1–2 weeks later, participants completed the SEPS again to investigate
test–retest reliability.
In stage 3, which involved exploration of the SEPS in relation to the other measures over time, participants
were required to repeat the assessments carried out in stage 1. Participants were given the option to take
part in any, or all, of the stages.
Statistical analysis
An initial PCA was carried out on the SEPS and the internal consistency of identified subscales was
computed using Cronbach’s alpha. Intraclass correlations (ICCs) and Spearman’s rank-order correlation
analysis were used to examine test–retest reliability, concurrent validity and sensitivity to change between
the SEPS and the other measures.
Results
One hundred participants took part in the study and participation in different aspects of the research are
shown in Table 4 along with the demographic details of the sample.
Initial data scrutiny
From the initial pool of items for the SEPS examined in stage 1, items with very low endorsements (< 20%
of sample) and either high or low inter item correlations (< 0.200 or > 0.900) were removed. In addition,
items with low test–retest scores and which contributed to a decrease in internal consistency were
examined further. Together with these considerations and initial PCA feedback from participants and from
the SURG, a number of items were removed resulting in a final number of 41 items on which all
subsequent analyses were carried.
Principal component analysis: in the first instance, the data set was checked for suitability of PCA by
examining the correlation matrix to ensure no multicollinearity or singularity. A PCA was then performed
on each of the three SEPS subscales using varimax rotation. From examination of the scree plots and
Eigenvalues, all three analyses resulted in two-factor solutions, with loadings > 0.4 taken as significant.
The subscales and factors defined in this analysis were used in all further psychometric analyses. The three
subscales had 29, 6 and 6 items, respectively. Each subscale consisted of two factors positive and negative
items. Total variance explained by these subscales was relatively low.
Subscale 1: impact of experiences
Two factors contributed to 40.13% of explained variance, with factor 1 (‘positive impacts of experiences
of psychosis’) contributing to 21.54% of the variance and factor 2 (‘negative impacts of experiences of
psychosis) contributing to 18.59% of the variance.
Subscale 2: impact of support
Two factors contributed to 54.29% of the total variance explained, with factor 1 (‘positive impact of
support on experiences of psychosis) contributing to 29.49% of the variance and factor 2 (‘negative
impact of support on experiences of psychosis) contributing to 24.80% of the variance.
Subscale 3: dimensions of experiences of psychosis
The two identified factors explained 60.12% of cumulative variance; factor 1 (‘negative dimensions of
experiences of psychosis) contributed to 33.47% of the variance, and factor 2 (‘positive dimensions
of experiences of psychosis’) contributed to 26.65% of the variance.
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Reliability
Cronbach’s alpha statistics were calculated for each subscale and these ranged from acceptable to good
(Table 5). ICCs, using a two-way random model and absolute agreement were also computed to provide
further evidence for the reliability of the SEPS. All subscales within the SEPS showed moderate to good
ICCs (see Table 5). Furthermore, the positive and negative aspects of each subscale were not significantly
correlated with each other, although there was a moderate correlation between the positive and negative
support items (ρ= 0.364; p< 0.01).
Test–retest means, standard deviations (SDs) and correlation coefficients of the subscale scores of the SEPS
are also shown in Table 5. The subscales had good retest reliability overall although the positive support
subscale was only moderate. The majority of individual items in the subscales also indicated good retest
reliability with only five items with correlations below 0.2.










Male 75 27 59 22
Female 25 8 16 8
Age (years)
Mean (SD) 38.14 (10.23) 37.25 (10.23) 37.79 (10.63) 38.40 (10.42)
Range 18–65 19–63 18–65 19–65
Marital status
Single 72 27 53 22
Married 6 2 5 1
Partner 12 0 8
Cohabiting 0 2 0 3
Separated/divorced 9 3 8 3
Widowed 1 1 1 1
Employment status
Unemployed 77 25 58 22
Voluntary work 5 1 3 1
Student 8 4 7 3
Full time 5 3 4 2
Part time 1 0 0 0
Retired 3 2 2 2
Home worker 1 0 1 0
Ethnicity
White 85 30 63 27
Asian 5 1 3 1
Black 5 1 4 1
Other 5 3 5 1
SD, standard deviation.
USER-DEFINED CONCEPTUALISATION AND MEASUREMENT OF RECOVERY IN PSYCHOSIS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
28
Validity
Means and SDs for all measures are shown in Table 6. The relationship between the SEPS and measures of
symptoms of psychosis, affect, esteem, function and recovery can also be found in Table 6.
Relationship between the Subjective Experiences of Psychosis Scale and
psychosis symptom measures
The positive impacts of experiences and positive impact of support were not correlated with any of the
symptom measures. However, there was a modest, negative correlation between the positive dimensions
items of subscale 3 and the PSYRATS delusions subscale.
Negative impacts of experiences showed small to moderate correlations with all PANSS subscales apart
from the PANSS negative subscale. There were moderate correlations with PSYRATS auditory hallucinations
and delusions subscales. There were no significant correlations between negative support and any symptom
measures. A similar picture to subscale 1 was observed for the negative dimensions of experiences, with
moderate correlations with all PANSS and PSYRATS subscales but no correlation between the PANSS
negative subscale.
Relationship between the Subjective Experiences of Psychosis Scale and
measures of affect, esteem, functioning and recovery
The positive impacts of experiences and positive impact of support were not correlated with any measures.
However, positive dimensions showed small, positive correlations with progress on recovery on the
intrapersonal and interpersonal subscales of the QPR and showed a moderate positive correlation with
self-esteem on the SERS positive subscale.
Negative impacts of experiences correlated moderately with depression, intrapersonal aspects of recovery,
hopelessness, anxiety and self-esteem (both positive and negative subscales of the SERS). Negative impact
of support was not correlated with any affect or functioning measures other than a small, positive
correlation with anxiety. A similar picture to the impact of experiences subscale was observed for negative
dimensions, with small to moderate correlations with depression, intrapersonal aspects of recovery,
hopelessness, anxiety and negative self-esteem. In addition, there was also a moderate relationship
between negative dimensions of symptoms and lower functioning on the GAF scale (Table 7).


















Positive impact 0.95 0.461** 0.151 to 0.687 57.80 (25.83) 58.63 (28.28) 0.558**
Negative impact 0.93 0.829** 0.689 to 0.909 71.46 (24.87) 68.37 (25.46) 0.827**
Subscale 2
Positive support 0.80 0.323 –0.014 to 0.592 12.89 (6.63) 12.94 (6.66) 0.359*
Negative support 0.79 0.657** 0.417 to 0.812 7.83 (4.29) 7.86 (5.12) 0.575**
Subscale 3
Positive dimensions ρ= 0.535** 0.736** 0.536 to 0.858 4.40 (1.87) 4.49 (2.06) 0.723**
Negative
dimensions
0.66 0.640** 0.391 to 0.801 13.40 (3.35) 12.40 (3.47) 0.606**
*Correlation significant at 0.05.
**Correlation significant at 0.01.
SD, standard deviation.
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TABLE 6 Descriptive statistics of the measures
Measure Mean (SD) (n= 75) Range (n= 75)
SEPS
Subscale 1
Positive impact 56.80 (25.85) 29–119
Negative impact 68.77 (24.72) 29–127
Subscale 2
Positive support 14.09 (6.54) 1–30
Negative support 7.84 (4.87) 1–22
Subscale 3
Positive dimensions 4.60 (2.09) 2–10
Negative dimensions 12.81 (3.90) 4–20
PANSS
Positive 14.69 (4.33) 9–26
Negative 13.52 (4.23) 7–26
General 29.49 (6.58) 17–47
Total 57.71 (11.92) 33–88
PSYRATS
Auditory hallucinations 25.06 (7.42) 11–37
Delusions 12.38 (5.41) 3–22
Calgary Depression Scale 5.72 (4.39) 0–17
QPR
Intrapersonal subscale 58.60 (11.18) 29–84
Interpersonal subscale 18.40 (2.63) 11–25
Total 77.00 (12.57) 45–109
BHS 12.76 (5.58) 1–20
BAI 17.43 (12.88) 0–56
SERS
Positive self-esteem 41.45 (13.08) 11–70
Negative self-esteem 32.91 (11.42) 10–58
GAF scale
Symptoms 34.23 (8.13) 21–57
Functioning 41.49 (9.83) 25–70
Total 34.21 (8.13) 21–60
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Sensitivity to change of the Subjective Experiences of Psychosis Scale
Sensitivity to change was derived by calculating the change in score (baseline score minus follow-up score)
on each measure. The change scores for each section within the SEPS were then correlated with all
measures, which can be found in Table 8.
Relationships between change on the Subjective Experiences of Psychosis
Scale and psychosis symptom measures
Change in the positive subscales did not correlate with change in any symptom measures. Change in
negative impacts of experiences showed moderate, positive correlations with the PANSS general subscale
and total PANSS scores. Change in negative support did not correlate with change on any of the psychosis
measures. Change in negative dimensions showed moderate correlations with delusion severity measured
by the PSYRATS delusions scale and with the PANSS general subscale scores.
Relationship between change on the Subjective Experiences of Psychosis
Scale and measures of affect, esteem, functioning and recovery
There was no relationship between change in the positive aspects of any subscale and any other measures.
Negative aspects on the SEPS were related to esteem and progress in recovery and suggested that
increases in negative impact, poor support and increase in self-reported symptoms was related to
decreases in self-esteem and recovery.















PSYRATS hallucinations –0.050 0.593** –0.080 0.136 –0.060 0.551**
PSYRATS delusions –0.106 0.374** –0.135 –0.003 –0.280* 0.473**
PANSS positive 0.115 0.269* –0.770 0.046 –0.029 0.535**
PANSS negative 0.083 0.149 0.023 0.104 –0.077 –0.097
PANSS general –0.023 0.435** –0.062 0.081 –0.036 0.373**
PANSS total 0.035 0.356** –0.100 0.084 –0.050 0.339**
Calgary Depression Scale –0.109 0.408** –0.071 0.152 0.005 0.333**
QPRIntra 0.150 –0.493** 0.214 –0.122 0.291* –0.330**
QPRInter –0.104 –0.146 0.120 –0.022 0.278* –0.058
QPR total 0.120 –0.467** 0.216 –0.120 0.322** –0.307**
BHS –0.047 0.392** –0.126 0.053 –0.192 0.258*
BAI –0.059 0.439** 0.153 0.269* 0.020 0.370**
SERS positive –0.181 –0.326** 0.087 –0.045 0.335** –0.204
SERS negative –0.059 0.506** –0.038 0.170 –0.166 0.301**
GAF scale symptoms –0.094 –0.202 –0.120 –0.047 –0.041 –0.394**
GAF scale functioning –0.064 –0.145 –0.041 –0.092 0.094 –0.209
GAF scale total –0.039 –0.154 –0.053 –0.024 0.048 –0.314**
*Correlation significant at 0.05.
**Correlation significant at 0.01.
QPRInter, Questionnaire about the Process of Recovery interpersonal subscale; QPRIntra, Questionnaire about the Process of
Recovery intrapersonal subscale.
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Feedback and distress
Participants took between 5 and 30 minutes to complete the SEPS. Ninety-nine participants (99%) rated
the degree of distress experienced from completing the SEPS. Seventy-five participants (75%) reported that
they experienced no distress from completing the scale. Fourteen (14%) reported experiencing ‘a little’
distress, five (5%) reported ‘moderate’ distress and 5 (5%) rated ‘quite a lot’ of distress. When distress was
disclosed, the researcher debriefed the participant, ensuring they had the opportunity to discuss any
concerns and consent was sought to share this information with the participant’s clinical team if this was
considered appropriate.
Discussion
The SEPS is a reliable and valid self-report measure of psychosis experiences. It has been developed with
the direct input of service users, both in terms of project design and investigation and in the development
of the content and format of the measure to ensure that the items and presentation reflect their
experience of psychosis. The scale is easy to use, takes a relatively short time to complete and appears to
be extremely meaningful for many service users. It has good retest reliability and the subscales have good
internal consistency. Although the total variance explained by the two-component solution is relatively low,
negative factors on the SEPS related well to widely used objective interview measures of psychosis such as
the PANSS55 in relation to concurrent experiences and change over time. These are important aspects
when evaluating outcome and they emphasise the validity of this method of self-report assessment of
psychosis experiences.
TABLE 8 Relationship between change on the SEPS and change on measures of psychosis symptoms, affect,













PSYRATS hallucinations 0.029 0.262 –0.027 0.202 0.172 0.455
PSYRATS delusions 0.062 0.365 –0.082 0.196 0.235 0.394*
PANSS positive –0.246 0.123 –0.153 0.040 0.147 0.125
PANSS negative 0.076 0.355 0.153 0.282 0.270 0.169
PANSS general –0.024 0.436* –0.175 0.259 –0.044 0.385*
PANSS total –0.040 0.431* –0.084 0.281 0.121 0.333
Calgary Depression Scale –0.204 0.304 –0.327 0.002 –0.058 0.243
QPRIntra –0.215 –0.408* –0.014 –0.441* –0.176 –0.175
QPRInter –0.013 –0.283 0.291 –0.137 0.075 –0.268
QPR total –0.201 –0.463** 0.103 –0.407* –0.135 –0.210
BHS –0.046 0.158 0.225 0.167 –0.194 0.200
BAI –0.125 –0.077 –0.283 –0.317 –0.085 –0.019
SERS positive –0.010 –0.635** –0.145 –0.309 0.216 –0.527**
SERS negative 0.008 0.113 0.357 0.200 0.085 0.086
GAF scale symptoms 0.066 –0.054 0.064 –0.191 –0.128 –0.188
GAF scale functioning 0.042 –0.307 0.003 –0.344 0.034 –0.207
GAF scale total 0.052 –0.089 0.016 –0.141 –0.047 –0.165
*Correlation significant at 0.05.
**Correlation significant at 0.01.
QPRInter, Questionnaire about the Process of Recovery interpersonal subscale; QPRIntra, Questionnaire about the Process of
Recovery intrapersonal subscale.
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The scale covers distinct areas that have been outlined in previous service user informed research. For
example, social, relationship and support factors, which have been outlined as key areas for recovery from
psychosis19 and which play an important role in service provision.14 In addition, the scale also assesses specific
characteristics of symptoms, some of which are included in other scales; however, the items in this scale are
the dimensions that service users highlight as being most relevant. The diverse subscales of the SEPS cover a
vast array of topics not yet scrutinised in a single measure, thus illustrating its comprehensiveness. These
complex dimensions are essential when aiming to understand idiosyncratic experiences of psychosis and is in
keeping with the idiosyncratic nature of the recovery process.19
In addition, the development of the scale highlighted the importance of considering the positive impacts of
psychosis experiences, an area not addressed in other outcome scales for psychosis. The psychometric
investigation revealed that the positive aspects of psychosis are not solely the converse of the negative
aspects but are independent and salient aspects that relate more to positive self-esteem and progress in
relation to recovery than to psychosis symptomatology. This is consistent with other findings which have
reported on positive functions of psychosis. For example, some people who hear voices report associated
benefits such as companionship or comfort.78,79
Further investigation of the role of positive aspects of psychosis is needed; however, the findings here
suggest that assessing and monitoring positive as well as negative aspects of symptoms may be important
to fully document an individual’s recovery profile. In addition, the exploratory analyses with measures of
affect, esteem, recovery and functioning highlighted the close relationship between psychosis experiences
and these phenomena, implying that these issues need to be considered in treatment delivery.
There are a number of limitations to this study. One of the main limitations was the moderate sample size
used for psychometric testing. Test–retest reliability and sensitivity to change analysis used only 35 and
30 participants, respectively. Furthermore, PCA was carried out with 100 participants when it is often
recommended that 10 times the number of items is required for an adequate sample size.80 Additionally,
alternative means of determining the component structure of the measure (such as parallel analysis) could
have resulted in an alternative number of components to extract, therefore, future confirmatory studies
could utilise this approach.
In addition, although the sample represented the users of mental health services within the geographical
area where recruitment took place, this may not be representative of the population in general. The
sample consisted of mainly white, British males. The low proportion of female participants and those from
ethnic minorities suggest limitations in the generalisability of these findings.
Finally, the SEPS is a self-report tool for which participants are required to make a subjective judgement
about their experience of psychosis. Although this is a strength of the tool in that it could be argued that
self-reporting perceptual experiences is more likely to provide a true representation of the experience than
one provided by an observer, it is also a potential weakness. Self-report methods are subject to a number
of responder biases that may lead to data inaccurately reflecting the construct being measured and may
result in overinflated relationships between variables.81 The findings should be interpreted in the light of
these limitations.
Despite these limitations, the SEPS appears to be a valid and reliable self-report measure of both positive
and negative aspects of psychosis experiences including the impact of such experiences, support that
improved or exacerbated such experiences and dimensions of such experiences. As this measure was
developed in collaboration with service users at each stage of the research process, this ensures that it can
be used to assess and monitor important aspects of psychosis experiences that are relevant to users own
concerns, which may help mental health professionals to engage people in services and to develop and
monitor meaningful outcomes.
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Conclusions
The research studies within this chapter aimed to explore user-defined conceptualisation and measurement
of recovery in psychosis. A key objective was to develop a measure of recovery in psychosis that was
meaningful and relevant to service users, and incorporated dimensions of symptoms. To achieve this
objective the research was split into three phases:
1. a qualitative approach to explore service user experiences of recovery
2. a Q-methodology approach to further refine what factors are important to service user definitions
of recovery
3. utilisation of information from phases one and two to develop a service user designed measure of
recovery in relation to symptoms of psychosis and establish its psychometric properties.
The research within this chapter provided additional support for previous studies suggesting recovery is a
multifaceted process that should be understood and supported using a holistic approach. For example, the
first phase found four main themes that are important to consider when conceptualising recovery: impacts
on mental health, self-change and adaptation, social redefinition and adapting an individual coping style.
This highlights the need to consider coping styles and social and personal change alongside symptom
alleviation, with equal importance being given to each factor. An important implication of this study was
the need for assessment tools, which take into account the important element of symptom alleviation
alongside the broader personal and social themes with consideration of the impact that these experiences
have on the lives of service users.
The second phase suggested similar factors which are important in recovery: collaborative support and
understanding, emotional change through social and medical support, regaining functional and
occupational goals, and self-focused recovery. Interestingly, a number of participants found that the Q-sort
technique helped them further understand their recovery, indicating that the recovery Q-sort could be
utilised as a therapeutic tool in its own right. In support of phase 1 of this research, this study also
highlighted the importance of tailoring care packages to individual needs.
Taking the findings from phases 1 and 2 into account, the final phase of this research was to develop and
validate a measure of recovery in relation to symptoms of psychosis: the SEPS. The SEPS was shown to be
a reliable and valid self-report measure of experiences of psychosis. It was developed with direct input
from service users, both in terms of project design and investigation, and in the development of the
content and format of the measure to ensure that the items and presentation reflect their experience of
psychosis. The scale is easy to use, takes a relatively short time to complete and appears to be extremely
meaningful for many service users. It has good retest reliability and the subscales have good internal
consistency. Additionally, the scale highlights the importance of considering the positive impacts of
psychosis experiences, an area not addressed in other outcome scales for psychosis. It appears that positive
aspects of psychosis are not solely the converse of the negative aspects, but are independent and salient
aspects that relate more to positive self-esteem and progress in relation to recovery than to psychosis
symptomatology. Further investigation of the role of positive aspects of psychosis is needed; however, the
findings here suggest that assessing and monitoring positive as well as negative aspects of symptoms may
be important to fully document an individual’s recovery profile.
In conclusion, the research in this chapter has confirmed that recovery in psychosis is a multifaceted
process and highlights the importance of the positive and negative aspects of experiences of psychosis.
The research has led to the development of a user-defined measure that has been shown to be reliable
and valid, as well as meaningful and relevant to service users. The use of the recovery Q-sort and the SEPS
measure may help mental health professionals to engage people in services and to develop and monitor
meaningful outcomes and user-defined recovery.
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Chapter 3 What does recovery mean to service
users with experience of psychosis? A Delphi study
with experts by experience
This research has been published previously as Recovery in psychosis: a Delphi study with experts byexperience [published online ahead of print April 12 2014]. Schizophr Bull 2014.82 Reproduced under
the guidance of Oxford University Press.
Background
Mental health services typically define recovery from psychosis in terms of absence of symptoms, decreases
in duration of hospital admissions and reduced rate of rehospitalisation.83 Clinical research trials often
attempt to quantify recovery by demonstrating significant improvements in symptoms and other so-called
‘deficits’ to the degree that they could be considered within the ‘normal’ range.84 In stark contrast, service
users conceptualise recovery very differently to this,18 believing that recovery is a unique process rather
than an end point with key recovery themes including hope, rebuilding self and rebuilding life.19 Many
qualitative studies and service user accounts demonstrate these similar themes of recovery and indicate
that there is potential for all individuals to recover to some extent.20
This new found optimism about the potential for recovery from psychosis has been adopted in various
health policies,85–89 which have a focus on collaborative working between clinicians and service users,
rebuilding lives with or without ongoing symptoms and recognising the importance of hope and
empowerment. Despite this recognition of what may be required for recovery-oriented mental health
services, it is not always clear how health professionals can provide effective recovery-oriented services that
can be evaluated for their performance in supporting people to recover.90
Various measures of service user-defined recovery have been developed over the last two decades, with
items covering a variety of themes including hope, confidence and empowerment, awareness and
understanding, help seeking, social support and goals or purpose.31 Only two measures have been
developed specifically to measure service user-defined recovery from psychosis: the Psychosis Recovery
Inventory91 and the QPR.92 None of the user-defined recovery measures has been adopted as a routine
outcome measure in mental health services in the UK to date, although various services are piloting local
measures. There is continued debate about whether or not recovery can be measured as an outcome
when it is defined as a process, although it has been suggested that if measurement of recovery is a
collaborative process involving service users and clinicians, it could be a feasible and valid method for
evaluation of effective recovery-oriented services.30
Although there has been a reasonable level of agreement that mental health services should aim to be
recovery-oriented and that it is possible to measure the effectiveness of these services, the problem of
reaching consensus about what we mean by recovery and producing a definition that is acceptable to
service users, while being practical and achievable by clinicians and services, has yet to be resolved. There
is a multitude of service user accounts of recovery93–96 and qualitative studies exploring recovery,19,97,98
which identify various common themes but most, if not all, conclude that recovery is a unique process that
can be different for everyone. This makes it extremely difficult for clinicians and services to provide
recovery-oriented services. The extent to which service users agree about what constitutes recovery and
what helps their recovery has yet to be explored.
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Various methods and techniques can be employed to help reach consensus about a given debated topic.99
One such technique is the Delphi method, which is a systematic process of engaging a group of ‘experts’
in the chosen field in two or more rounds of questionnaires, with the aim of identifying items which the
panel agree are important to the chosen topic. The Delphi method has been utilised previously to identify
essential elements in schizophrenia care,100 indicators of relapse,101 essential elements of EISs,102 first aid
guidelines for psychosis103 and components of CBTP.104
Expert panels used in the Delphi method usually consist of expert clinicians and academics, although two
studies to date have also utilised small groups of service users.103,105 On the topic of recovery from
psychosis, it could be argued that service users themselves are the experts. Indeed, many of the documents
that endorse the recovery approach accept that it should be defined by service users. Many NHS initiatives
aim to view the patient as the expert106 and mental health services are increasingly taking this approach of
valuing service users as ‘experts on their own experience’.107
This study utilises the Delphi methodology to consult a large group of service users about what recovery




Participants who took part in this Delphi exercise were services users who identified themselves as having
experience of psychosis. Participants were included in the study if they have (or have had in the past)
experience of psychosis, are over the age of 16 years and are able to understand English. Participants were
recruited via convenience sampling through mental health services (including CMHTs and EISs), non-NHS
groups/voluntary groups and networks, and advertising of the study by leaflets, posters, e-mail networks,
websites, social media and local media (including press releases). This study was supported by the Mental
Health Research Network who provided clinical studies officers to advertise and recruit participants using
the methods described above. Recruitment took place across seven trusts in the North West of England:
Cheshire and Wirral Partnership NHS Foundation Trust, Cumbria Partnership NHS Foundation Trust,
Greater Manchester West Mental Health NHS Foundation Trust, Lancashire Care NHS Foundation Trust,
Manchester Mental Health and Social Care Trust, Mersey Care NHS Trust and 5 Boroughs Partnership NHS
Foundation Trust.
Procedure and analysis
This study was approved by the National Research Ethics Service Committee East Midlands. The Delphi
process consisted of three stages based around those identified by Langlands et al.103
Stage 1
Elements identified as pertinent to the definition or conceptualisations of recovery from psychosis were
identified through a literature search of journals, policy documents, recovery measures and websites. This
list was reviewed by the authors and collated into an initial list of statements (n= 141). Owing to the
complexities of including a large panel of service users as the experts to be consulted, the authors decided
to use a smaller panel of service users (a local service user reference group with 10 members, all of whom
have personal experience of psychosis and using mental health services) during stage 1 to further refine
this initial statement list. This resulted in the addition of a further three items, rewording of several items to
increase acceptability to service users (e.g. including the word ‘experiences’ alongside ‘symptoms’ and
removing the word ‘illness’ where possible) and deletion of seven items which were felt by the service
users to be duplications.
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Stage 2
In this stage the finalised list of 137 statements from stage 1 was collated and formatted into an online
questionnaire and an alternative paper version. A demographics sheet was added to collect data on age,
sex, mental health trust, diagnosis and length of diagnosis. Participants were given the option to state
‘prefer not to say’ for all demographic items. Participants were also asked if they would like to provide a
postal or e-mail address so they could be invited to take part in the final stage of the study, although this
was optional to allow complete anonymity if preferred.
Participants were then asked to rate the importance of each item on the statement list, in relation to
defining recovery from psychosis, on a 5-point Likert scale (1 – essential, 2 – important, 3 – do not
know/depends, 4 – unimportant and 5 – should not be included). A total of 426 participants completed
the stage 2 questionnaire, although 45 were not included in the final sample (26 were deemed to be
ineligible owing to reporting no experience of psychosis, 14 people did not complete the questionnaire,
one person added a note to say they had already completed the study before and four people posted the
questionnaire after the deadline). Results from the remaining 381 eligible participants were entered into an
anonymised database and analysed by obtaining group percentages.
In accordance with the methods used by Langlands et al.103 the following criteria were used to determine
items for inclusion, exclusion and rerating.
1. Items rated by 80% or more participants as essential or very important to defining or conceptualising
recovery are included as standard.
2. Items rated as essential or important to defining or conceptualising recovery by 70–79% of respondents
in stage 2 were rerated in stage 3.
3. Any statements that did not meet the above two conditions were excluded.
This resulted in the inclusion of 71 items, the exclusion of 30 items and 36 items to be rerated in stage 3.
Stage 3
In stage 3, participants were asked to rerate only those items that 70–79% of respondents had rated
as essential or important during stage 2 (n= 36 items). Two hundred and six participants provided contact
details to be invited to take part in stage 3. The majority of participants opted to be sent a postal paper
version rather than complete the questionnaire online. A total of 154 postal questionnaires were distributed
in stage 3 and 52 participants were sent the online questionnaire link. One hundred participants completed
the final stage resulting in a further 23 statements being included and 13 statements being excluded.
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Results
Table 9 provides an overview of the demographic information collected during stages 2 and 3.
A total of 94 items were retained in the final statement list after being rated as important or essential by
> 80% of participants. No items reached consensus for not being included (rated as should not be
included by > 80% of participants). Figure 2 illustrates the number of items which were included, rerated
and excluded at each round of the study.
The final 94 items were divided into four categories: defining recovery (n= 19 items), factors that help
recovery (n= 43 items), factors that hinder recovery (n= 11 items) and factors that show someone is
recovering (n= 21 items).
TABLE 9 Participant characteristics
Characteristics Stage 2 (n= 381) Stage 3 (n= 100)
Sex
Male 223 (59.6%) 43 (43%)
Female 151 (39.6%) 56 (56%)
Not stated 7 (1.8%) 1 (1%)
Age (years)
17–20 7 (1.8%) 1 (1%)
21–29 53 (13.9%) 9 (9%)
30–39 94 (24.7%) 16 (16%)
40–49 108 (28.3%) 29 (29%)
50–59 72 (18.9%) 27 (27%)
60 or older 40 (10.5%) 17 (17%)
Not stated 7 (1.8%) 1 (1%)
Diagnosis
Schizophrenia 152 (39.9%) 32 (32%)
BD 66 (17.3%) 28 (28%)
Prefer not say 62 (16.3%) 11 (11%)
Other 26 (6.8%) 8 (8%)
Psychosis 24 (6.3%) 8 (8%)
Depression 20 (5.2%) 1 (1%)
Schizoaffective disorder 16 (4.2%) 5 (5%)
No diagnosis 15 (3.9%) 7 (7%)
Length of diagnosis
Within the last year 36 (9.4%) 5 (5%)
1–4 years ago 64 (16.8%) 15 (15%)
5–10 years ago 78 (20.5%) 25 (25%)
More than 10 years ago 177 (46.5%) 50 (50%)
Not stated/no diagnosis 26 (6.8%) 5 (5%)
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FIGURE 2 Summary of items included, rerated and excluded at each stage.
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Tables 10–13 show the final statements in their respective category, with percentage of participants who
rated the item as essential or important. Items with extremely high consensus obtained in stage 2 (> 90%)
are highlighted in green. The percentage in brackets represents the responses of participants who reported
a diagnosis of schizophrenia, schizoaffective disorder or psychosis. Only one of the differences in
percentage agreements between the sample as a whole and this subgroup was significant [item ‘Believing
that something good will happen eventually’ χ2(2, N= 100)= 4.822 p= 0.028; indicating that this item
was less important to those in this subgroup than the sample as whole]. Table 14 shows the items that
were excluded in stages 2 and 3.







Recovery is the achievement of a personally acceptable quality of life 2 91 (89)
Recovery is feeling better about yourself 2 91 (90)
Recovery is a return to a state of wellness 2 89 (87)
Recovery is the process of regaining active control over one's life 2 88 (86)
Recovery is being happy with who you are as a person 2 87 (86)
Recovery is a way of living a satisfying, hopeful and contributing life, even with the
limitations caused by symptoms/experiences of psychosis
2 87 (85)
Recovery is about building a meaningful and satisfying life, as defined by the person
themselves, whether or not there are ongoing or recurring symptoms or problems
2 86 (84)
Recovery is knowing that you can help yourself become better 2 86 (82)
Recovery is the unique journey of an individual living with mental health problems to build a
life for themselves beyond illness
2 85 (82)
Recovery is learning how to live well in the context of continued mental health problems 2 84 (82)
Recovery is understanding how to control the symptoms of psychosis 2 83 (83)
Recovery is when there is meaning and purpose to life 2 83 (82)
Recovery is a process of changing one's orientation and behaviour from a negative focus on
a troubling event, condition or circumstance to the positive restoration, rebuilding,
reclaiming or taking control of one's life
2 83 (82)
Recovery is believing that you can meet your current personal goals 2 82 (81)
Recovery involves the development of new meaning and purpose in one's life as one grows
beyond the catastrophic effects of mental health problems
3 89 (89)
Recovery is a process or period of recovering 3 88 (89)
Recovery is a deeply personal, unique process of changing one's attitudes, values, feelings,
goals, skills and roles
3 88 (84)
Recovery is accepting that mental health problems/symptoms/experiences are a part of the
whole person
3 86 (84)
Recovery is regaining optimum quality of life and having satisfaction with life in
disconnected circumstances
3 81 (86)
Shading denotes > 90% consensus achieved.
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Having a good, safe place to live 2 96 (95)
Having the support of others 2 94 (93)
Having a good understanding of your mental health problems 2 94 (89)
Living in the kind of place you like 2 91 (92)
Knowing what helps you get better 2 91(89)
Knowing how to take care of yourself 2 91 (90)
Recognising the positive things you have done 2 90 (87)
Knowing that there are mental health services that do help 2 90 (89)
Working on things that are personally important 2 89 (89)
Being strongly motivated to get better 2 89 (88)
Being able to identify the early warning signs of becoming unwell 2 89 (88)
Having a positive outlook on life 2 88 (87)
Having a plan for how to stay or become well 2 88 (87)
Having goals/purpose in life 2 87 (86)
Accomplishing worthwhile and satisfying things in life 2 87 (86)
Being able to develop positive relationships with other people 2 87 (83)
Knowing that there are things that you can do that help you deal with unwanted
symptoms/experiences
2 86 (82)
Being able to handle stress 2 85 (85)
Feeling part of society rather than isolated 2 85 (83)
Being hopeful about the future 2 85 (83)
Learning from mistakes 2 85 (85)
Accepting that you may have set backs 2 85 (82)
Being able to come to terms with things that have happened in the past and move
on with life
2 84 (83)
Receiving treatment for distressing/unusual thoughts and feelings 2 84 (81)
Taking medication as prescribed 2 84 (83)
Having healthy habits 2 83 (84)
Having a desire to succeed 2 82 (82)
Health professionals and service users working collaboratively as equals 2 82 (84)
Knowing that even when you don’t care about yourself, other people do 2 82 (81)
Spending time with people to feel connected and better about yourself 2 82 (80)
Being able to fully understand mental health problems/experiences 2 80 (79)
Having courage 2 80 (80)
continued
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When health services do not provide help and support to recover 2 84 (83)
When a person feels lost or hopeless for much of the time 2 82 (79)
When a person feels isolated or alone even when with family of friends 2 81 (77)
When a person feels discriminated against or excluded from the community because of
mental health problems
3 91 (93)
Health professionals who do not accept that their views are not the only way of looking at
things
3 89 (93)
The impact of a loved one’s mental health problems on their family 3 88 (82)
When a person can’t find the kind of place you want to live in 3 87 (84)
When a person deliberately stopping taking medication although the doctor recommends
taking it regularly
3 83 (80)
Medication that can affect concentration and memory 3 83 (87)
When no one will employ the person owing to past mental health problems 3 81 (84)
When other people are always making decisions about the person’s life 3 80 (80)







Allowing personalisation or choice within health services 2 80 (77)
Knowing that even when you don’t believe in yourself, other people do 2 80 (78)
Knowing that you can handle what happens next in your life 3 90 (89)
Knowing that all people with experience of psychosis can strive for recovery 3 88 (86)
Being able to make sense of distressing experiences 3 85 (82)
Making a valuable contribution to life 3 84 (86)
Knowing that recovery from mental health problems is possible no matter what you
think may cause them
3 83 (82)
When services understand/consider the culture and beliefs of the individual 3 83 (82)
Continuing to have new interests 3 81 (75)
Knowing that you are the person most responsible for your own improvement 3 80 (84)
Being able to assert yourself 3 80 (82)
Shading denotes > 90% consensus achieved.
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When the person is able to find time to do the things they enjoy 2 93 (93)
When the person is able to ask for help when they need it 2 92 (90)
When the person can trust themselves to make good decisions and positive changes in life 2 92 (88)
When the person knows when to ask for help 2 91 (89)
When the person is able to take control of aspects of their life 2 90 (87)
When the person feels reasonably confident that they can manage their mental health
problems
2 90 (87)
When the person is able to actively engage with life 2 90 (88)
When the person feels like they are coping well with mental or emotional problems on a
day to day basis
2 89 (88)
When symptoms/experiences of psychosis interfere less and less with daily life 2 88 (87)
When the person is able to define and work towards achieving a personal goal 2 88 (87)
When fear doesn’t stop the person from living the life they want to 2 85 (80)
When the person knows a great deal about coping strategies 2 85 (84)
When symptoms/experiences of psychosis don’t get in the way of doing things they want or
need to do
2 84 (83)
When the person finds places and situations where they can make friends 2 83 (82)
When the person feels in touch with their own emotions again 2 83 (79)
When the person knows a great deal about their own symptoms/experiences 2 82 (80)
When the person knows a great deal about their treatment options 2 82 (79)
When the person is able to access independent support 2 81 (75)
When coping with mental health problems is no longer the main focus of a person’s life 2 81 (76)
When the people who are important to someone are actively supporting their mental health
treatment
2 81 (83)
When symptoms/experiences of psychosis are a problem for shorter periods of time each
time they occur
3 85 (84)
Shading denotes > 90% consensus achieved.
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Recovery is the intended consequence of the skilful use of the full range of effective
treatments
2 65 (63)
Personal recovery can occur in the context of continuing symptoms/experiences 2 64 (65)
Recovery is to fully return to how a person was before they were unwell 2 57 (60)
Recovery is an act of obtaining usable resources from apparently unusable sources
(e.g. in psychosis where the experience itself has personal value)
2 46 (45)
Recovery is a spontaneous and natural event 2 35 (37)
Recovery is having an idea of who you want to become 3 67 (66)
Factors that help recovery
Knowing that although your symptoms may get worse, you can handle it 2 69 (65)
Meeting people who have had similar experiences 2 69 (67)
Feeling able to take chances in life 2 69 (64)
When services allow the individual to decide if and when to begin the recovery process and
direct it
2 68 (67)
Having a variety of friends 2 68 (70)
Having faith 2 64 (67)
Knowing that things happen for a reason 2 53 (51)
Being with people at a church, temple or prayer meeting who understand the journey to
recovery
2 37 (38)
Understanding that recovery does not mean going back to the way things used to be 3 79 (73)
Believing that something good will eventually happen 3 75 (64)a
Factors that hinder recovery
Recovering from the consequences of mental health problems is sometimes more difficult
than recovering from the problem itself
2 68 (65)
Lack of access to peer support (which means support from other people who have personal
experience of mental health problems)
2 67 (63)
Stigma associated with mental health problems 2 66 (67)
When health services do not allow an individual to direct the recovery process 2 64 (60)
When a person’s family try to control their treatment too much 2 63 (60)
Lack of access to service user led education and training 2 62 (57)
Mental health services which promote dependency on services (rather than independence
from services)
2 62 (59)
An ‘expert’ and ‘patient’ relationship between health professional and service user
(rather than a partnership/collaboration)
2 62 (61)
Taking medication itself is like having a handicap 2 52 (53)
Medication that can slow people down physically and mentally 3 79 (78)
Feeling like life has been ruined by mental health problems 3 78 (78)
Feeling angry about what has happened in the past 3 69 (60)
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Discussion and conclusions
This is the first study to attempt to reach a consensus about understanding recovery from psychosis. It is
also one of a small number of studies that consult services users as experts on their own experiences.103,105
A high level of consensus was reached for a range of items, which were deemed important in defining
recovery, understanding what helps and hinders recovery and what would show that someone
is recovering.
In line with other studies involving service user-defined recovery, this study also found that the concept of
rebuilding life, self and hope is essential in defining recovery.19 In contrast with previous studies exploring
service user-defined recovery, the Delphi methodology allowed collation of views from a large sample of
individuals with psychosis. Although it was agreed that recovery is a unique process that is different for
each individual, the Delphi method allows us to identify areas of recovery which appear to be the same for
the majority of people. In the subsection for defining recovery, the highest level of consensus was reached
for ‘recovery is the achievement of a personally acceptable quality of life’ and ‘recovery is feeling better
about yourself’. This indicates the importance of routine measures of quality of life and self-esteem when
evaluating recovery-oriented services as well as a focus on working with service users to improve quality of
life and esteem rather than a focus solely on symptoms and relapse prevention. Service users did not feel
that items such as ‘recovery is to fully return to how a person was before they were unwell’ or ‘recovery is
to have an idea of you want to become’ were important to defining recovery so these items were removed
from the final list.







Factors that show recovery
When the person feels their experiences have made them more sensitive towards others 2 69 (72)
When the person hasn’t been rehospitalised in the last 4 to 6 months 2 69 (65)
When the person talks to someone outside of their family regularly 2 69 (68)
When the person feels their recovery has helped challenge other peoples views about getting
better
2 68 (70)
When the person hasn’t had a relapse of symptoms in the last 4 to 6 months 2 68 (66)
When the person actively seeks information on mental health problems/experiences from
different sources (e.g. books, internet)
2 63 (63)
When the person can control whether they relapse or not by will power 2 55 (56)
When the person enjoys sex again 2 51 (47)
When you regularly spend time doing an activity with or for another person (not including
self care/personal home maintenance)
3 79 (76)
When the person has thought about a relapse prevention plan 3 79 (73)
When the person feels their experiences have changed them for the better 3 78 (76)
When the person is taking their medication as prescribed most of the time 3 78 (80)
When the person knows a great deal about the medication available to them 3 74 (69)
When the person is actively participating in self-help or service user run activities 3 69 (60)
When symptoms/experiences of psychosis don’t bother the person too much 3 68 (69)
a The difference between the schizophrenia, schizoaffective disorder and psychosis subgroup compared with the sample
as a whole was significant at p< 0.05.
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Service users endorsed a number of factors which may facilitate their recovery, with the highest levels of
agreement reached for environmental factors (such as a safe place to live), social support and items
focusing on personal understanding of mental health problems and recovery. The role of services was also
deemed to be important, although it was knowledge that there are services which can help with mental
health problems which was rated the highest, rather than the impact of the services or treatments on offer
per se. Personal factors such as having goals and purpose, hope for the future and motivation/desire to
succeed were also felt to be important, in agreement with previous research.19,97,98 Factors such as
‘knowing that although your symptoms may get worse, you can handle it’ and ‘meeting people who have
had similar experiences’ were not felt to be helpful to recovery for everyone so these items were removed.
There was less agreement about what factors may hinder recovery. Participants agreed that lack of services
to provide help and support would hinder recovery as well as feeling lost hopeless or isolated. Participants
also highlighted stigma as a potential barrier to recovery, including discrimination such as not being able to
gain employment. Interestingly, although a high proportion of people felt that not taking medication as
prescribed could hinder recovery, the same proportion of people also felt that side effects of medication,
such as concentration problems and memory loss, could also hinder recovery. As highlighted in previous
research addressing treatment choice,108 knowledge of treatment options is an important factor for services
to consider as well as the need to address this conflict of believing that compliance with medication is
essential to recovery, while also believing that the side effects may prevent recovery. Allowing treatment
choice both in terms of alternative medications which may produce less side effects, but also
non-pharmacological options such as CBT, may help to promote recovery.
The final section of the Delphi study addressed which items people felt would show someone was
recovering. As discussed, several measures of recovery from psychosis have already been developed based
on service user accounts91 and one measure was designed collaboratively with service users.92 However, no
previous studies have been able to ask a large sample of service users to rate the importance of items
included in these measures and other similar measures of recovery. This study found a high level of
consensus from service users about what would show that someone is recovering. Service users felt that
engaging in and enjoying activities was essential, as well as feeling able to make ‘good’ decisions in life.
Items around effective help-seeking behaviours (such as knowing when and how to ask for help) were also
important to recovery. As well as being able to ask for help, having personal skills to manage or cope with
day-to-day life were also rated highly. As could be expected, reduced impact of symptoms on daily life
were seen as evidence of the recovery process although they were only ninth in the ranked list of factors
that show someone is recovering. It may be important for services to rethink their approach to viewing
reduction in symptoms as a key outcome for mental health. Participants did not feel that factors such as
reduced hospitalisation or relapses were essential for demonstrating recovery.
There are several limitations to this study. First, recruitment only took place across the north-west of
England, which may mean that results are not representative of other areas of the UK or in other
countries. Service users in different areas may have access to different types of services and/or have varying
levels of knowledge regarding recovery. Indeed, a number of postal questionnaires for this study were
returned with notes about the individual’s service and how they had never heard about the potential for
recovery. Future research could investigate these varying levels of awareness of recovery and how this
impacts on what service users want for their own recovery.
Another limitation is the heterogeneity of diagnoses in the sample. The study was primarily aimed at
individuals with experience of psychosis and as a result of initial feedback on the design of the study from
a group of service users, a decision was made not to exclude participants based on diagnosis. It would
have also been difficult in practical terms to exclude people based on the diagnosis they have been given
owing to the anonymity in the study and the nature of the online study option. Instead of using diagnosis
as an exclusion criteria, the study asked a screening question about whether or not the individual defined
themselves as having experience of psychosis. As can be seen in the participant characteristics table, this
resulted in individuals who had received a wide variety of diagnoses taking part in the study. Although
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each question reiterated that the study was asking about relevance to recovery from psychosis, it may be
that participants prioritised their own experiences when thinking about the concept of recovery. Therefore,
the results of this study may represent a more transdiagnostic approach to understanding recovery.
However, percentage agreements for the sample as whole compared with the percentage agreement for
participants reporting a diagnosis of schizophrenia, schizoaffective disorder or psychosis, were generally
very similar and only one of the differences was significant. The significant difference was found for item
‘believing something good will eventually happen’, although both the schizophrenia subgroup and the
sample as whole did not feel this item should be included overall. Future research could aim to explore this
issue further by recruiting specifically through clinicians to identify only those groups with a particular
diagnosis, although this would potentially exclude some service users. An alternative approach may be to
ask people which difficulties they are currently prioritising. Although the variety of diagnoses in the study
could be seen as a limitation, it was also interesting to note the number of people with a diagnosis of BD
that chose to take part in the study, despite it being advertised as a study about recovery from psychosis.
This may be a reflection of the high proportion of people with a diagnosis of BD who experience
psychosis.15 This interest in the concept of recovery and willingness to participate in the study may pave
the way for a similar study in the future that explores recovery by diagnosis type.
It may also be interesting for future studies to explore differences in recovery conceptualisations and goals
throughout the recovery process. The majority of participants in this study, particularly in the final stage,
had established diagnoses (> 5 years) so further investigation of the impact of length of time since
diagnosis or first experience of psychosis would not have been appropriate. However, it would be useful
for this area to be examined further to understand recovery for those with recent onset of symptoms and
experiences compared with those with more established diagnoses and experiences. This would ensure
that services are effectively geared towards their client groups. For example, EISs may require a different
approach to CMHTs.
Although research has indicated that it is essential for recovery to be defined by service users themselves,
it is also important to consider the views of clinicians working in mental health services. Without some
agreement between clinicians and services users, or at least some adoption by clinicians of what is
important to service users when understanding recovery, mental health services will struggle to effectively
meet the needs of its client group. It would be interesting to ask clinicians to rate similar statements about
recovery and examine agreement between the two groups. Ultimately, it will be up to services and the
clinicians within those services to understand what is important to their service users, and to take this on
board when offering treatment and ongoing support.
There are many implications from the results of this study. First, service users agreed that awareness and
understanding of recovery was essential. Collaborative approaches to this training by clinicians and service
users would best promote the recovery approach. Similarly, the audience for this training may include
clinicians, service users and carers who want to understand more about recovery from psychosis and other
mental health problems. Continued evaluation and development of such a training programme would be
important to assess their impact on learning outcomes. Any training package should be made easily
accessible to the target audience, utilising a variety of formats such as web based training or workshops.
This study also acts a starting point for identifying service user priorities regarding recovery. It is apparent
that less focus on reducing relapse and more promotion of quality of life and achievement of personal
goals are required for truly recovery-oriented services. This work, alongside traditional approaches to
symptom reduction and increased personal coping and life skills, may be effective. Similarly recovery
oriented services should ensure that communities are aware of the services on offer and should actively
promote recovery awareness.
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Finally, further consideration of the measurement of recovery should be undertaken. This study is the first
of its kind to approach a large group of individuals with personal experience of psychosis and ask them
what they believe demonstrates that someone is recovering. This may be a useful technique to develop
user informed tools for measuring the effectiveness of recovery-oriented services. Identification of
treatment and support priorities for recovery followed by routine measurement and audit of these priorities
may indicate the effectiveness of services. This may also enable a comparison of services across the UK to
ensure that there is equality of access to high-quality effective services. There is potentially scope to utilise
the items rated as essential or important to service users as an audit tool for benchmarking of services.
Similarly, the items rated as essential or important to ‘show that someone is recovering’ may provide a
useful tool for measuring individual recovery. There are several measures already developed for this
purpose; however, none has undergone a similar process of consulting service users about their
applicability and importance. The items could be used as a stand-alone tool for an individualised
assessment of the recovery process and goals. There may also be potential for the items to be developed
and used as a patient-reported outcome measure (PROM) to assess service user’s own views on their
mental health and recovery. Use of PROMs in the field of mental health have been shown to be
particularly positive, suggesting further exploration of a recovery-related PROM would be beneficial.
Future research should consider exploring recovery across a range of diagnoses as well as consulting
clinicians about their views on recovery. This study demonstrates it is feasible and helpful to consult service
users on topics such as recovery. The fact that such a large number of individuals with a variety of mental
health problems and experiences were willing and keen to take part in this study, opens up the possibility
of encouraging service users to share their views to have a real impact on the services they receive. This
would give them a stake in making services successful and promoting recovery awareness. Similar research
in other areas of the UK and in other countries may also be beneficial to assess cross-cultural differences
in approaches to, and definitions of, recovery.
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Chapter 4 Understanding psychological and social
predictors of recovery
Background
Despite recent interest in the concept of recovery from psychosis, there remains no clear and unambiguous
definition among the users of mental health services, clinicians and academics. It has been argued that
extrapolating definitions of recovery from the physical health arena to the domain of severe and enduring
mental illness would mean that few people would ever experience full recovery,17 although this has been
disputed.109 Within a biomedical framework, recovery has been defined in terms of symptom remission,
decreases in the duration of hospital admissions and reduced rate of rehospitalisation.83 However,
a purely symptom-focused definition of recovery has often been shown to be unrelated to social and
occupational functioning.109,110
Narrative accounts of recovery formulated by service users with experience of psychosis liken the concept
to a personal journey93 or process of growth and change.111 These accounts have been supplemented by
qualitative studies utilising a more scientific approach to elicit general themes from semistructured
interviews.97,98 One recent study involving the users of mental health services revealed themes of rebuilding
life, rebuilding self and having hope for a better future as being important in the definition of recovery, as
well as highlighting the deeply personal nature of the process.19 Such idiosyncrasy and nonlinearity have
also been noted in subsequent studies.112,113 A review of experiential accounts of recovery111 attempted to
pull together the previous qualitative accounts revealing a model of recovery involving four measurable
processes: hope, re-establishment of identity, finding meaning and taking of responsibility.
The difficulties in definition and measurement of recovery, created by both the distance from biomedical
conceptualisations and the inherent variability in a subjective recovery journey, have been noted.31,111
However, various measures have been developed and validated within clinical samples and there are two
that measure recovery specifically in people with experience of psychosis: the Psychosis Recovery
Inventory91 and the QPR.32 This difference in consumer and clinical conceptualisations of recovery has been
highlighted in a study that explored the correlation of outcome measures of recovery from the two
perspectives.114 The authors did not find much of a relationship between clinical and consumer-defined
recovery, strongly suggesting that routinely used measures of outcome may not assess important aspects
of recovery which are meaningful for the service user.
On the other hand, there is a significant body of research examining psychosocial and neuropsychiatric
factors that are associated with recovery from psychosis. Quantitative assessment of personal recovery from
psychosis based on such research has shown that measures of recovery and quality of life are often
associated with measures of psychological functioning such as well-being, emotional disturbance and
self-esteem.32 A study of 161 patients with severe mental illness (schizophrenia, BD and depression) found
a strong association between empowerment and recovery,115 and a longitudinal study of 128 patients with
a diagnosis of schizophrenia found that internal locus of control was associated with long-term recovery.116
Studies of predictors of recovery using more traditional psychiatric definitions focused on symptom
remission or non-recurrence have found that neuropsychiatric factors are relevant. For example, a study
on 436 patients with schizophrenia spectrum diagnoses117 found that better insight was associated with
good outcomes (defined as a single episode with no persistent symptoms); however, other evidence
suggests that increasing insight is often associated with poor outcomes such as greater suicidality in people
with psychosis.118 Neurocognitive deficits have also been examined in relation to dimensions of recovery and
have been found to be associated with social behaviour deficits, but not with subjective quality of life.23
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Several studies have found both psychosocial and neuropsychiatric factors to be associated with recovery
and related concepts such as quality of life. A study of 201 patients with a diagnosis of schizophrenia
showed that psychological factors (optimism, personal agency and internal stigma), as well as symptoms,
explained a large proportion of the variance in quality-of-life ratings.119 Multiple factors including both
psychiatric (symptoms and intellectual functioning) and psychosocial (self-esteem and optimism) were
found to be related to recovery in 103 individuals meeting criteria for schizophrenia spectrum disorders.120
The main limitation of this existing research is that it relies almost entirely on cross-sectional data. To
overcome this, ESMs allow such psychological processes to be explored longitudinally both day to day and
moment to moment. The ESM is a type of intensive diary technique, which requires participants to repeatedly
record their experiences and the context in which they occur, typically many times a day over several days.
Diary reports are typically cued electronic devices, such as pre-programmed digital watches, personal digital
assistants or mobile phone apps. It has been used often to record psychotic symptoms such as hallucinations
and delusions in everyday life121,122 and to explore the role in mental illness of such processes as negative
affect and stress sensitivity (e.g. Myin-Germeys et al.123 and Myin-Germeys and van Os124).
A recent study125 used ESM in 177 patients with schizophrenia spectrum diagnoses to demonstrate that
negative affect played a significant role in both symptomatic remission status (a traditional approach to
defining recovery) and real-life functioning in everyday life (a more user-orientated definition); this raises
the possibility that emotion could be a mediating factor between psychosocial and neuropsychiatric
variables and recovery.
The present exploratory study aims to address the gap in knowledge regarding judgements of recovery,
associated factors and predictors. It will explore factors associated with subjective judgements of recovery
in people with experience of psychosis before examining psychosocial and neuropsychiatric predictors of
recovery judgements in both a cross-sectional and longitudinal sample. This information will be used to
develop and carry out a study that will use the ESM to examine recovery judgements and associated
factors on a momentary basis over the period of a week. This will allow examination of whether or not,
and to what extent, patients’ recovery judgements are stable over time and whether or not the same kind
of psychosocial factors that have been shown to be associated with recovery judgements in cross-sectional
studies, for example self-esteem and hope for the future predict recovery judgements longitudinally.
Phase 1: subjective judgements of perceived recovery
from psychosis
This research has been published previously as Subjective judgements of perceived recovery from psychosis
by Beck R, et al. Journal of Mental Health Col.21:6 (2012) pp. 556–66.126 This is an Accepted Manuscript
of an article published by Informa Healthcare in Journal of Mental Health on 2012, available online:
http://informahealthcare.com/doi/full/10.3109/09638237.2012.710765.
Objectives
This study aimed to elicit subjective judgements of recovery utilising different approaches to its
measurement. This study also aimed to investigate the association between recovery judgements and
psychological and social factors.
Method
Participants
Data for the present study are a secondary analysis of a large study of psychosocial and neuropsychiatric
predictors of recovery from psychosis.127 Participants were aged 16–65 years, with a schizophrenia spectrum
diagnosis as well as sufficient level of English literacy to complete the measures and the capacity to provide
informed consent. A total of 122 participants entered the study (88 male, 34 female), four of whom
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completed only half of the measures. The majority of participants were white British (84.4%). Diagnoses,
confirmed using ICD-10 checklists were as follows: schizophrenia (n= 75), schizoaffective disorder (n= 10),
substance-induced psychosis (n= 5), unspecified non-organic psychosis (n= 15), acute and transient
psychotic disorder (n= 12), persistent delusional disorder (n= 4) and post-partum psychosis (n= 1).
Measures
The Process of Recovery from Psychosis Questionnaire32
The QPR is a 22-item questionnaire, which was collaboratively developed with service users. The
questionnaire measures subjective recovery in two domains: intrapersonal functioning (17 items) and
interpersonal functioning (five items). An example of an item on the intrapersonal scale is ‘I have been able
to come to terms with things that have happened to me in the past and move on with my life’ and the
interpersonal scale, ‘meeting people who have had similar experiences makes me feel better’. Participants
rate their agreement with statements on a 5-point Likert scale rating from ‘strongly disagree’ to ‘strongly
agree’. Respondents may score between 0 and 88. The subscales have good internal consistency and
test–retest reliability over short periods.32 Cronbach’s alpha coefficients for the intrapersonal and
interpersonal scales for this sample were α= 0.94 and α= 0.66, respectively.
Dichotomous recovery question
Appended to the QPR, participants were asked: ‘Do you consider that you have recovered from your
illness? (Yes/No)’.
Recovery Analogue Scale
Appended to the QPR: ‘Please place a cross on the line below to indicate the extent to which you think
you have recovered from your illness’ (10-cm analogue scale with left anchor ‘completely recovered’ and
right anchor ‘not recovered at all’) to gauge the extent to which participants believe they are recovered.
Beck Hopelessness Scale
The BHS74 is a 20-item self-report scale assessing negative expectations about the future. Participants
respond ‘true’ or ‘false’ to the items and responses are summed to obtain a total hopelessness score
(range= 0–20). Cronbach’s alpha value for this sample was α= 0.92.
The Brief Self-Esteem Rating Scale – Short Form
The SERS76 is a 20-item measure of explicit self-esteem, assessing both positive (10 items) and negative
(10 items) beliefs about the self. Participants rate how often each of the statements reflect their feelings
about the self, on a 7-point Likert scale of ‘never’ to ‘always’. Cronbach’s alpha values for the positive and
negative scales for this sample were α= 0.92 and α= 0.91, respectively.
Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale (HADS)128 is a 14-item self-report measure. Of these items,
seven assess depression, while the remaining seven items assess anxiety, over a period of the preceding
week. Cronbach’s alpha coefficients for the anxiety and depression scales for this sample were α= 0.86
and α= 0.83, respectively.
Procedure
Prior to commencement of the study, a dedicated service user panel was consulted on all aspects of
design, including wording of information sheets, inclusion of questionnaires, length of assessments,
semantic concerns and appropriate amount of payment. Participants were recruited from CMHTs, inpatient
settings, early intervention (EI) teams and the voluntary sector to ensure heterogeneity in experience of
psychosis and service provision in the Greater Manchester area. Individuals were approached via their care
co-ordinator. Those who were interested in taking part were briefed about the study and provided with a
participant information sheet. They were then given a minimum of 24 hours to decide whether or not to
take part. On agreeing to take part, a research assistant met with the participant to take informed consent
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and administer questionnaires, over a single visit or two visits at the participant’s request. Participants were
remunerated for their time.
Statistical analyses
Chi-squared tests were performed in order to examine the association between sociodemographic
variables and self-selected group (‘recovered’ vs. ‘not recovered’). For these purposes, sociodemographic
variables were transformed into dichotomous variables using the following criteria: not in education,
employment or training (NEET) status: (1=NEET; 2= in education, employment or training); marital status
(1=married/cohabiting; 2= not living with a partner); religiosity (1= no religious beliefs, 2= religious
beliefs); level of education [1= compulsory education (primary/secondary) only; 2= further education post
age 16 years]; mental health provider (1= EISs, 2= other community services). Data were analysed using
Predictive Analytics SoftWare statistics 18 [Statistical Package for the Social Sciences (SPSS) Inc., Chicago,
IL, USA]. All variables were scrutinised before inferential analysis and valid parametric analysis were
conducted. Correlational analyses were performed to determine the association between recovery
measures. Correlations were also calculated between each of the recovery measures and the psychological
variables: positive and negative self-esteem, hopelessness, anxiety and depression. Regression analyses
using forward entry were conducted with our recovery measures as dependent variables.
Results
Demographic characteristics for the sample are shown in Table 15. Table 16 provides an overview of means
and SDs of scores on each recovery measure. On the dichotomous recovery measure, ‘do you feel you have
recovered from your illness? Yes/No’, 41.8% (n= 57) of participants responded yes, placing themselves in the
‘recovered’ group, while 58.2% (n= 71) of participants responded no, placing themselves in the ‘not
recovered’ group. In order to explore the consistency between the measures of recovery, the data were
explored visually with histograms of scores on Recovery Analogue Scale (RecA) for each of the dichotomous
recovery question groups (Figure 3). The ‘not recovered’ group displayed a wider range of responses on the
analogue scale, while the responses of those in the ‘recovered’ group clustered around the top end of the
analogue scale. Additionally, a scatterplot (Figure 4) demonstrates the association between recovery
percentage scores and QPR total scores, split by ‘recovered’ and ‘not recovered’ self-selected grouping.
All measures of recovery were found to be significantly correlated with each other (Table 17).
Each recovery measure was significantly correlated with all of the psychological variables, with the
exception of Questionnaire about the Process of Recovery interpersonal subscale (QPRInter) score and
negative self-esteem (r=− 0.162, not significant). Chi-squared analyses were conducted to establish
whether or not there were any significant relationships between the sociodemographic characteristics and
responses of yes/no on the dichotomous recovery variable. No significant associations were found between
the dichotomous recovery variable and each of the demographic variables: sex {χ2 [degrees of freedom (df)
1]= 0.54, not significant}, NEET status [χ2 (df 1)= 0.07, not significant], marital status [χ2 (df 1)= 0.37, not
significant], religiosity [χ2 (df 1)= 0.50, not significant], level of education [χ2 (df 1)= 1.90, not significant],
mental health provider [χ2 (df 1)= 2.80, not significant].
A Pearson correlation between age and self-selected grouping revealed a significant correlation, showing
older age to be associated with the ‘not recovered’ group (r=− 0.25; p< 0.05). Age was also correlated
with recovery percentage (r=− 0.28; p< 0.01) and Questionnaire about the Process of Recovery
intrapersonal subscale (QPRIntra) scores (r=− 0.23; p< 0.05). In order to further investigate the
contribution of psychological factors to subjective recovery judgements in people with experience of
psychosis, three regression analyses were conducted. First, in order to investigate the contribution of
self-esteem (positive and negative), mood (anxiety and depression) and optimism to self-rated recovery, a
multiple regression analysis was performed using hierarchical direct entry with the RecA as the dependent
variable. The multiple R was 0.63 and significant [F(5,112)= 13.99; p< 0.001]. The adjusted R2 was 0.37
indicating that a moderate amount of the variance was accounted for by these predictor variables.
Summary statistics for the regression are shown in Table 18.
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TABLE 15 Sample characteristics, n= 122
Sample characteristic % (n)
Age (years) Mean 35.5± 11.5
Sex Male 72.1 (88)
Female 27.9 (34)








Marital status Single 82.8 (101)
Married/common law 9 (11)
Separated/divorced 8.2 (10)









TABLE 16 Descriptive statistics for each of the recovery measures
Minimum Maximum Mean SD
Recovery percentage 0.00 100.00 61.62 24.67
QPRIntra 8.00 68.00 44.67 12.68
QPRInter 5.00 20.00 13.92 3.07
QPR total score 21.00 88.00 58.59 14.67
QPRInter, Questionnaire about the Process of Recovery interpersonal subscale; QPRIntra, Questionnaire about the Process of
Recovery intrapersonal subscale.
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FIGURE 3 Histograms to show the distribution of scores on the analogue scale gauging recovery percentage, split

















FIGURE 4 Scatterplot to show the correlation between recovery percentage and QPR total scores, split by
dichotomous ‘yes/no’ recovery measure.
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Second, a multiple regression analysis was performed using hierarchical direct entry with the same
predictor variables and QPRIntra as the dependent variable. The multiple R was 0.86 and significant
[F(5,113)= 59.21; p< 0.001]. The adjusted R2 was 0.72 indicating that a large amount of the variance was
accounted for by these predictor variables. Summary statistics for the regression are shown in Table 19.
Finally, a logistic regression analysis was performed using direct entry with the dependent variable being
the dichotomous recovery rating and the predictor variables as above. The final results of this analysis
(Table 20) showed a significant model (χ2= 50.6, df= 5; p< 0.001), with anxiety (odds ratio= 1.33;
p< 0.001) and positive self-esteem (odds ratio= 0.94; p< 0.05) being the significant predictors.
TABLE 17 Pearson correlation coefficients between recovery measures and psychological variables
1 2 3 4 5 6 7 8 9
1. Recovered/not
recovered
– 0.581** 0.542** 0.240** –0.534** –0.420** –0.486** 0.419** 0.393**
2. Recovery
Percentage
– – 0.582** 0.187* –0.551** –0.572** –0.524** 0.444** 0.350**
3. QPR Intrapersonal – – – 0.580** –0.630** –0.705** –0.792** 0.629** 0.677**
4. QPR Interpersonal – – – – –0.187* –0.322** –0.386** 0.162 0.394**
5. HADS Anxiety – – – – – 0.699** 0.627** –0.754** –0.468**
6. HADS Depression – – – – – – 0.743** –0.695** –0.635**
7. BHS Total – – – – – – – –0.661** –0.638**
8. SERS negative – – – – – – – – 0.605**
9. SERS positive – – – – – – – – –
*Correlation is significant at the 0.05 level (two-tailed).
**Correlation is significant at the 0.01 level (two-tailed).
TABLE 18 Regression summary statistics for RecA
Sample characteristic β t-test p-value
SERS negative −0.082 −0.659 0.512
SERS positive −0.019 −0.180 0.857
BHS −0.181 −1.520 0.132
HADS Anxiety −0.279 −2.261 0.026
HADS Depression −0.332 −2.590 0.011
TABLE 19 Regression summary statistics for QPRIntra
Sample characteristic β t-test p-value
SERS negative −0.043 −0.519 0.605
SERS positive 0.289 4.122 0.000
BHS −0.428 −5.449 0.000
HADS Anxiety −0.247 −3.033 0.003
HADS Depression −0.090 −1.062 0.290
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Discussion
The correlations between the measures of recovery suggest that, in general terms, the measures are
comparable and fulfil the intention of tapping into the construct of recovery. The significant correlations
between the measures of recovery and the psychological factors suggest that higher levels of self-esteem
and hope, along with lower levels of depression and anxiety, were associated with more positive
judgements of recovery across the disparate measures. Chi-squared analyses did not reveal any significant
associations of sociodemographic characteristics with the dichotomous recovery outcome variable,
suggesting that these social factors were not implicated in the subjective recovery judgements of our
sample. Visual inspection of the data regarding different methods of measuring recovery judgements also
show general consistency in within-person ratings across all measures; however, the range of scores
between individuals on the correspondent measures were widely dispersed.
The data, split by the self-selected ‘recovered’ or ‘not recovered’ groupings, showed a trend towards those
scoring higher on the QPR rating themselves higher on the analogue scale. Those in the ‘not recovered’ group
show a wider range of responses on the analogue scale, while the ratings of those in the ‘recovered’ group
cluster around the top end of the analogue scale. The responses of both the ‘recovered’ and ‘non-recovered’
group on the analogue scale are shown to be normally distributed, with the ‘recovered’ group displaying a
higher mean. Furthermore, there were several notable outliers endorsing a ‘yes’ judgement to recovery, yet
rating themselves comparatively low on the analogue scale or vice versa. Such variations in within-person
responding across measures of recovery are of interest; it appears that individuals tend to discriminate between
dichotomous and continuous responses, for instance, endorsing the ‘not recovered’ status yet scoring high on
an analogue scale. This is indicative of differing personal thresholds for the definition of ‘recovered’ and
provides empirical evidence consistent with a perspective of recovery as a personal journey that does not
necessarily have an end point. Thus, the conclusions from first-person reports and qualitative studies19,93 appear
generalisable. People appear to hold an individual representation of what it means to be recovered.
These individual representations may explain the differences in within-person ratings on the dichotomous
versus analogue measures and may be associated with stable dispositional characteristics. Given that
self-esteem was a significant correlate, individual characteristics such as trait-like optimism or perfectionism
and other attributes associated with self-esteem, may be important in making judgements of recovery. If
judgements of recovery are likely to fluctuate, as noted by narrative accounts describing recovery as
dynamic, it is likely that certain people may be mindful to their status as liable to change when making an
overall judgement. Indeed, several participants commented on how some days they do feel recovered and
other days do not, finding it difficult to make a cross-sectional judgement.
TABLE 20 Logistic regression statistics for dichotomous recovery variable
Sample characteristic β SE Odds ratio p-value
SERS negative 0.015 0.031 10.015 0.627
SERS positive –0.060 0.030 0.942 0.044*
BHS 0.147 0.075 10.159 0.051
HADS Anxiety 0.281 0.087 10.325 0.001*
HADS Depression -0.092 0.097 0.912 0.344
*Correlation is significant at the 0.05 level (two-tailed).
SE, standard error.
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The idiosyncratic nature of recovery judgements reported here is consistent with the literature. It may also
help to explain the differing emphases found in tools designed to measure recovery, as well as having
implications for the use of these tools in clinical practice and the need for further research to examine
whether or not the measures are sensitive to change over time. As noted earlier, personal narratives of
recovery and many of the measures of recovery include hope as a central theme19,97,98 and this is reflected
in our results of this study, which show a significant association between hope and subjective judgements
of recovery. The association between recovery and emotion/self-esteem is consistent with research linking
aspects of recovery from psychosis to levels of anxiety and depression.32 The findings from the regression
analyses are also consistent with the literature, again supporting the generalisability of the small qualitative
studies and first-person accounts, and suggest significant overlap between self-ratings of recovery and
self-esteem, mood and hope about the future. Given that this pattern of results was most comprehensive
for the QPR scale, with all three components being associated with recovery, and with over 70% of the
variance being explained, it may be that this approach to measuring recovery may be the most fruitful.
There are some methodological limitations that need to be considered. The study utilised self-report
methodology, with participants being required to read and complete all the measures themselves (with help
from a researcher if needed). The usual problems with regard to understanding the scale items and biases in
responding thus apply. In particular, the anchoring of the analogue recovery scale could be considered counter
intuitive and confusing, with ‘most recovered’ being the left anchor. The study employed a cross-sectional
design, allowing associations to be made but no causation and temporal nature of effects can be determined.
For analyses involving sociodemographic factors, these were transformed into dichotomous variables to
undertake chi-squared analysis, which did not reveal any significant associations with subjective judgements of
recovery. Measurement of social factors in a more precise, ordinal fashion would allow more powerful analysis,
which may demonstrate the importance of such factors. Prospective longitudinal research methods could
examine fluctuations in the recovery process over time and response to treatments, while innovative
methodologies such as ESMs could examine the day-to-day variation in recovery judgements and how these
are related to psychological and environmental factors. Judgements about recovery from psychosis, while
showing a trend, are idiosyncratic. Thus, subjective recovery can be regarded as an internal concept, variable
between individuals, and appearing to be personally defined. Within-person discrepancies in responding across
disparate measures further show the importance of subjectivity in interpretation and definition. Here, the
addition of a concurrent qualitative assessment would be desirable in supplementing the findings with richer,
more detailed, data potentially indicating the most pertinent factors for consumer recovery.
There may not be a ‘one size fits all’ measure of recovery, which could go some way to explaining the lack
of a ‘gold standard’ in measurement to date. The general agreement that the construct is open to personal
interpretation having multiple facets that differ in amplitude between individuals should be embraced in
clinical settings, which are increasingly taking a focus on the promotion of recovery. Such a working model
for care also builds on embedded positive concepts in mental health practice, including building on
personal strengths and promoting diversity. As an example, the collaborative recovery model129 represents
such an approach, with an emphasis on nurturing constructs associated with recovery such as hope,
autonomy and goal ownership. The regular assessment of recovery judgements would help to evaluate the
extent to which services are recovery oriented and also help individuals to monitor their progress.
The strong association between recovery and psychological factors, such as self-esteem, optimism and
emotional disturbances, also highlights the importance of assessment and monitoring of these factors. It also
raises that possibility that psychological interventions specifically focused on factors such as self-esteem in
people with psychosis130 may be ideally suited to the facilitation of recovery. Recognition of the association of
such factors with levels of subjective recovery could help to foster collaborative identification of personal
difficulties, agreement of shared goals and identification of targets for mental health service provision.
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Phase 2: psychosocial and neuropsychiatric predictors of
subjective recovery from psychosis
This research was previously published as, and much of this text has been reproduced from, Morrison AP,
Shryane N, Beck R, Heffernan S, Law H, McCusker M, et al. Psychosocial and neuropsychiatric predictors of
subjective recovery from psychosis. Psychiatry Res 2013;208:203–9,127 with permission from Elsevier.
Objectives
This study aimed to investigate factors associated with subjective judgements of recovery from psychosis,
examining how both psychosocial and neuropsychiatric factors are related to subjective perceived recovery
and how such predictors are mediated via the experience of negative emotions. Our primary hypothesis
was that the relationship between perceived recovery and such predictors will be mediated via the
experience of negative emotions.
Method
Participants
Participants were aged 16–65 years, with a schizophrenia spectrum diagnosis with a sufficient level of
English literacy to complete the measures and capacity to provide informed consent. At study entry, there
were 122 participants (88 male, 34 female), four of whom completed only some of the measures. The
majority were white British (84.4%). Diagnoses, confirmed using ICD-10 checklists, were as follows:
schizophrenia (n= 75), schizoaffective disorder (n= 10), substance-induced psychosis (n= 5), unspecified
non-organic psychosis (n= 15), acute and transient psychotic disorder (n= 12), persistent delusional
disorder (n= 4) and post-partum psychosis (n= 1). Participants were recruited from EISs (n= 40), other
community-based mental health teams (n= 81) and an inpatient unit (n= 1).
Measures
Measures of recovery
The Process of Recovery from Psychosis Questionnaire32
The QPR is a 22-item questionnaire that was collaboratively developed with service users. The
questionnaire measures subjective recovery in two domains: intrapersonal functioning and interpersonal
functioning. Participants rate their agreement with statements on a 5-point Likert scale ranging from
‘strongly disagree’ to ‘strongly agree’. The subscales have good internal consistency and test–retest
reliability with participants with experience of psychosis.32 Cronbach’s alpha value for the intrapersonal and
interpersonal scales for this sample are α= 0.94 and α= 0.66, respectively. It was chosen for this study
because it assesses constructs such as hope, empowerment, self-understanding and integration with social
networks, which have been shown to be central to user-defined recovery from psychosis.
Recovery Analogue Scale
Appended to the QPR was the following: ‘please place a cross on the line below to indicate the extent to
which you think you have recovered from your illness’ (10-cm analogue scale with left anchor ‘Completely
recovered’ and right anchor ‘Not recovered at all’). This was to provide a 0–100 visual analogue scale rating of
the extent to which participants believed they were recovered (i.e. another dimension of self-defined recovery).
Psychosocial measures
The Self-Esteem Rating Scale – Short Form76
The Self-esteem Rating Scale (SERS)76 is a 20-item measure of explicit self-esteem, assessing both positive
(10 items) and negative (10 items) beliefs about the self. Participants rate how often each of the
statements reflects their feelings about the self, on a 7-point Likert scale of ‘Never’ to ‘Always’. Cronbach’s
alpha values for the positive and negative scales for this sample are α= 0.92 and α= 0.91, respectively.
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Hospital Anxiety and Depression Scale128
The HADS is a 14-item self-report measure. Of these items, seven assess depression, while the remaining
seven items assess anxiety, over a period of the preceding week. Cronbach’s alpha values for anxiety and
depression scales for this sample are α= 0.86 and α= 0.83, respectively.
Multidimensional Locus of Control Scale131
The Multidimensional Locus of Control Scale is a 24-item locus of control questionnaire with three subscales
measuring internality (α in the present study= 0.57), belief in powerful others (α= 0.76) and belief in chance
(α= 0.76). Responses to items on this questionnaire are obtained on 5-point scales (‘agree strongly‘, ’agree
somewhat‘, ‘neither agree nor disagree‘, ‘disagree somewhat’ and ‘disagree strongly’).
Neuropsychiatric measures
Positive and Negative Syndromes Scale
The PANSS55 is a clinician-administered 30-item semistructured interview consisting of seven items assessing
positive symptoms (e.g. hallucinations, delusions, conceptual disorganisation), seven items assessing
negative symptoms (e.g. blunted affect, passive/apathetic social avoidance) and 16 items assessing global
psychopathology (e.g. depression, anxiety, lack of insight, guilt). All items are scored between 1 (not
present) and 7 (severe). A number of studies have demonstrated the reliability and validity of the PANSS.55
PANSS raters (RB, SH) were trained using a standardised approach and had good reliability. Given the
overlap between the global psychopathology subscale and our other measures [e.g. HADS, Insight Scale
(IS)], we only utilised the positive and negative symptom subscales.
Birchwood Insight Scale
Insight was measured with the IS,132 which is an 8-item self-report scale designed to be sensitive to change
and which captures three widely accepted dimensions of insight: perceived need for treatment, awareness
of illness and relabelling of symptoms as pathological. Higher scores indicate greater levels of insight. In
this study the scale had an alpha coefficient of 0.66.
Brief Assessment of Cognition in Schizophrenia
The Brief Assessment of Cognition in Schizophrenia (BACS)133 is a battery of neurocognitive tests that
assesses the aspects of neurocognition found to be most impaired and most associated with outcome in
patients with a diagnosis of schizophrenia (general cognitive performance, working memory and executive
functioning). The BACS requires about 30 minutes to complete and has high reliability.
Procedure
Prior to commencement of the study, a dedicated service user panel was consulted on all aspects of
design, including wording of information sheets, inclusion of questionnaires, length of assessments,
semantic concerns and appropriate amount of payment. Participants were recruited from CMHTs, inpatient
settings, EI teams and the voluntary sector to ensure heterogeneity in experience of psychosis and service
provision in the Greater Manchester area. Individuals were approached via their care co-ordinator. Those
who were interested in taking part were briefed about the study and provided with a participant
information sheet. They were then given a minimum of 24 hours to decide whether or not to take part.
When an individual agreed to take part, a research assistant met with the participant to take informed
consent and administer questionnaires, over a single visit or two visits at the participant’s request.
Participants were remunerated for their time.
Statistical analyses
We hypothesised that recovery judgements, as measured by RecA, QPRIntra and QPRInter would form a
single, latent dimension of recovery beliefs. We also hypothesised that the variables measuring negative
emotion and related processes, namely anxiety, depression and negative self-esteem, would form a single
latent dimension of negative emotion. We posited these measurement hypotheses as straightforward,
robust and plausible ways of operationalising our multifaceted key constructs. If these hypotheses are
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supported, then the specification of the mediation model to test the primary hypothesis can be done in a
structural equation modelling (SEM) framework using latent variables. Using latent variables allows for the
separation of ‘true’ from ‘error’ (more accurately, ‘specific’) construct variance, giving the model greater
statistical power and validity than using observed variables alone.134
A series of factor analyses [exploratory factor analysis (EFA) and confirmatory factor analysis (CFA)] and SEM
were specified to test our measurement modelling and mediation hypotheses. Using a SEM approach to
estimating mediation models has been shown to reduce bias in the parameter estimates for the mediation
effects and to give adequate power to detect mediation effects with samples as small as 100.134 All models
were fitted using Mplus 6.1 (Muthén & Muthén, Los Angeles, CA, USA) and estimated by maximum
likelihood. Because of the sensitivity of mediation models to parametric assumptions and the modest
sample size available in this study, we computed parameter standard errors (SEs) using bias-corrected
bootstrapping based on 1000 bootstrap replications.135 Latent variables in all factor models were
statistically identified by setting the factor loading of one of the factor indicators to one. Alpha for
hypothesis testing was set at 0.05 and all hypothesis tests were two-tailed.
To have confidence in hypothesis tests of parameter estimates, it is reasonable (though not strictly necessary)
to require that an over-identified statistical model as a whole should provide a reasonable fit to the data.
Model fit was assessed following the recommendation that a combination of the standardised root
mean-square residual (SRMR) < 0.08 and the Cumulative Fit Index (CFI) > 0.95 provides an optimal trade-off
between type I and type II errors in models estimated by maximum likelihood in smaller samples.136
Results
Data from 12 participants had to be dropped because of missing data, leaving a final sample size of 110.
Participant characteristics for the sample are shown in Tables 21 and 22.
Measurement model of recovery
The unidimensional CFA model of QPRIntra, QPRInter and RecA proved to be a poor one. Although RecA
and QPRIntra were well correlated (r= 0.58), RecA and QPRInter were not (r= 0.19). Although no formal
measures of goodness of fit were available for this just identified unidimensional CFA model1, the
estimated solution was improper, with negative residual variances for the interindicator and a non-positive-
definite hessian matrix. The a priori measurement hypothesis for recovery was therefore rejected. We
subsequently embarked on exploratory psychometric analysis of the QPR, to search for a coherent subset
of the 22 QPR items that would reflect the desired notion of recovery beliefs. This use of exploratory, as
opposed to a priori confirmatory, measurement modelling runs the risk of capitalising on chance and
sampling variability. However, our goal here was only to find an internally reliable and interpretable set of
recovery beliefs; the measurement model was not selected based on its providing a good fit with the other
variables that would comprise the mediation model.
A two-factor EFA model of the 22-item QPR was estimated by maximum likelihood. Model fit statistics
were somewhat mixed, the CFI indicating moderate but not close fit (CFI= 0.91), the SRMR indicating
close fit (SRMR= 0.05), but the chi-squared test resoundingly significant [χ2 (df 188)= 308.46; p< 0.01].
Neither varimax, oblimin nor geomin rotation could recover an approximate simple structure for the two
factors, with many items having significant loadings on both factors. Using the oblique geomin rotation
(suitable when item complexity is high, i.e. items load on more than one factor), only two out of the five
items considered a priori comprising the interpersonal subscale had strong loadings on only the second
(i.e. ‘interpersonal’) factor.
The hypothesised two-factor solution did not appear well supported in these data. However, a subset of
the QPR items had strong loadings (> 0.7) on just one of the factors, and we decided to use these items
as a unidimensional scale of recovery beliefs. These items were: (1) ‘I feel better about myself’, (2) ‘I feel
able to take chances in life’, (6) ‘I feel that my life has purpose’, (12) ‘I can take charge of my life’ and
(19) ‘I can actively engage with life’. Alpha reliability for these items was 0.88.
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A second unidimensional CFA model was fitted by maximum likelihood, using these five QPR items and
RecA as indicators. Model fit statistics were excellent [χ2 (9)= 11.42, p= 0.25; CFI= 0.99; SRMR= 0.03].
All standardised factor loadings were highly significant and between 0.61 (RecA) and 0.79 (Questionnaire
about the Process of Recovery item number 12). This factor was labelled Recov.
Measurement model of negative emotion
Anxiety, depression, and negative self-esteem were well correlated, between r= 0.66 and r= 0.72. A
unidimensional CFA model of these three indicators was estimated. As stated above, overall goodness of
fit statistics are not available for such a just identified model. However, with standardised factor loadings
all highly significant (depression 0.78, negative self-esteem 0.83 and anxiety 0.86), the hypothesis of
unidimensionality was clearly plausible. This factor was labelled Nemo.
Joint model of recovery and emotion
A joint CFA model of Recov and Nemo was fitted, to further test the measurement reliability of these
constructs as operationalised above. Two correlated latent factors were specified, each factor indicated
uniquely by the variables listed above, with no cross-loadings. Model fit statistics for this now
over-identified model were good, indicating close fit between the model and the data [χ2 (26)= 53.70,
p< 0.01; CFI= 0.96; SRMR= 0.05].
The correlation between the recovery and emotion factors was very high, r= –0.83 (SE= 0.05), casting
some doubt on the discriminant validity of these two related constructs. We, therefore, fitted two further
models in an ad hoc test of the dimensionality of the recovery and negative emotion constructs. The first
model was a unidimensional CFA model, the single latent factor indicated by all nine of the Recov and
Nemo variables. The second model had two latent factors. The first factor was again a general factor,
indicated by all nine variables. The second factor was indicated by the Nemo variables only and would,
therefore, represent any correlations among these variables not accounted for by the general factor.
TABLE 22 Sample characteristics
Variable Mean SD
Age (years) 35.5 11.5
Months of untreated psychosisa 37.7 74.6
Months in most recent therapyb 6.9 11.3
RecA 61.6 24.7
QPRIntra recovery 44.6 12.7
QPRInter recovery 13.9 3.1
Dep 6.2 4.3
Anx 9.0 5.0
Negative self-esteem (SEn) 32.6 12.6
PANSS positive symptoms (Pos) 15.5 5.6




MLCSi, Multidimensional Locus of Control Scale – internality subscale.
a Based on n= 89 owing to missing data.
b Based on n= 53 owing to missing data.
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The two factors were specified as uncorrelated, the association between the latent factors being
represented by the cross-loadings on the Nemo variables. These two models were nested, meaning that
the parameters of the first (unidimensional) model were a subset of those in the second model. The
improvement in fit
of the second model over the first model could therefore be formally tested using a likelihood ratio
chi-squared test.
The likelihood ratio chi-squared test was significant [χ2LR (3)= 41.90; p< 0.01], the second factor improving
model fit significantly and supporting the hypothesis of separate recovery and negative emotion factors,
despite their high correlation.
Latent mediation model of recovery on predictors, mediated by
negative emotion
Finally, we specified a SEM mediation model to test our primary hypothesis. Recov was the dependent
variable and Nemo the mediator. Both the dependent and mediator variables were regressed on the
predictor variables Pos, Neg, Multidimensional Locus of Control Scale – internality subscale (MLCSi), BACS
and IS. This was, therefore, a model of partial mediation, with direct effects of the predictors on the
dependent variable as well as indirect effects via the mediator (Figure 5).
The substantive conclusions regarding our mediation hypotheses would be assessed using significance tests
of the indirect effects (i.e. the product of the coefficients for the mediator regressed on the predictors and
the outcome variable regressed on the mediator). Because indirect effects are based on products of
parameters, confidence limits based on asymptotic (i.e. normal) theory are expected to be biased; we








IS QPR1 QPR2 QPR6
Dep Anx SEn
QPR12 QPR19 RecA
FIGURE 5 Latent mediation model of recovery. (See Table 23a–c for parameter estimates.) χ2 (df 61)= 109.92,
p< 0.01; CFI= 0.93; SRMR= 0.06. QPR, Questionnaire about the Process of Recovery item number.
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Tables 23a–c show the results of the mediation model. The mediator, Nemo, had a very strong, negative
and significant relationship with Recov, accounting for an R2 of 68%. Of the predictor variables, only
MLCSi had a significant direct effect on Recov, with a positive relationship. MLCSi also had a significant,
positive, indirect effect on Rec, which was composed of a negative relationship between MLCSi and Nemo
and a negative relationship between Nemo and Rec. The only other significant indirect effect was for Pos,
a negative relationship. Pos was positively associated with Nemo, which was negatively related to Recov.
The standardised effect sizes of these significant mediation effects were –0.311 for Pos and 0.211 for
MLCSi, corresponding, by Cohen’s rule of thumb, to ‘medium’ sized effects.137 The R2 for Recov in the full
model was very large, 72%. The majority of this was due to the R2 of 50% uniquely associated with the
total indirect effects.138
TABLE 23a Parameter estimates for the latent mediation model shown in Figure 5. Direct, i.e. unmediated, effects
on Recov
Variable Unstandardised direct effect Bootstrap SE p-value Standardised direct effect
Nemo –0.227 0.079 0.004 –0.610
Pos –0.021 0.038 0.581 –0.076
Neg –0.029 0.030 0.330 –0.090
MLCSi 0.098 0.035 0.005 0.253
BACS 0.042 0.025 0.097 0.161
IS 0.005 0.035 0.883 0.010
Bold signifies significance at p< 0.05.
TABLE 23b Parameter estimates for the latent mediation model shown in Figure 5. Indirect effects on Recov,
mediated by Nemo
Variable Unstandardised indirect effect Bootstrap SE p-value Standardised indirect effect
Pos –0.086 0.037 0.020 –0.311
Neg –0.003 0.022 0.903 –0.008
MLCSi 0.082 0.037 0.026 0.211
BACS –0.008 0.017 0.615 –0.032
IS –0.055 0.034 0.103 –0.107
TABLE 23c Parameter estimates for the latent mediation model shown in Figure 5. Predictors of the mediator (Nemo)
Variable Unstandardised effect Bootstrap SE p-value Standardised effect
Pos 0.380 0.074 0.000 0.510
Neg 0.012 0.088 0.894 0.013
MLCSi –0.359 0.093 0.000 –0.346
BACS 0.037 0.065 0.572 0.052
IS 0.243 0.127 0.055 0.175
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A final model was fitted to check the robustness of these results to the possibly confounding effects of Sex
(binary), Age (years), relationship status (single vs. not single) and employment status (NEET vs. not NEET).
Both Recov and Nemo were regressed on these four extra predictors and the mediation model was rerun.
Comparing the difference in model chi-squares between this and the original model using a likelihood
ratio test found no significant improvement by including the four extra predictors [χ2LR (28)= 32.995;
p= 0.236], and so presented no evidence of confounding by these variables. Zero-order correlations for
the variables are provided in Table 24.
Discussion
We found that subjective recovery judgements were directly associated with negative emotion (anxiety,
depression and negative self-esteem) and internal locus of control, lower levels of negative emotion and
higher levels of internal locus of control were associated with higher judgements of recovery. We also
found that positive symptoms and internal locus of control were indirectly associated with recovery
judgements via their relationship with negative emotion. There was a trend towards such an indirect effect
of insight on recovery judgements (higher insight associated with higher negative emotion). There did not
appear to be any effect of negative symptoms or neurocognitive functioning on self-rated recovery or
negative emotion.
These findings are broadly consistent with the findings of other studies of the relationship between
psychosocial factors and broad definitions of recovery. Our demonstration that internal locus of control
and negative emotion were directly related to recovery judgements is consistent with previous findings
regarding the importance of locus of control, empowerment, optimism, self-esteem and personal
agency.115,116,119,120 However, our study, which is relatively unique in comprehensively assessing both
psychosocial factors and neuropsychiatric factors, found no evidence for a relationship between negative
symptoms or neurocognitive functioning and subjective recovery, which is compatible with the equivocal
findings to date. We found that insight and positive symptoms were related to recovery judgements via
their influence on negative emotion; thus, higher insight and psychosis symptoms may increase distress
that has a negative influence on subjective recovery. It is possible that this relationship, in turn, may be
mediated by the appraisal of symptoms and an individual’s explanatory framework or conceptualisation of
illness. The finding regarding locus of control and insight are also compatible with research demonstrating
that biological explanations of mental health problems tend to be associated with greater stigma and
pessimism in comparison with psychosocial explanations in studies of both the general public139–141 and in
relation to internalised stigma in people with psychosis.142
Overall, our findings are consistent with recent models of recovery that encompassed processes such as
hope, re-establishment of identity, finding meaning in life and taking responsibility.111,143 Thus, it would
appear that self-rated perceptions of recovery are related to increased control and reduced distress, rather
than the severity of neurocognitive deficits or psychiatric symptoms. The relationship between severity of
psychosis symptoms and increased insight and self-rated recovery judgements was mediated by the effect
that they had on negative emotion (i.e. increasing distress). The lack of a relationship between recovery
and both negative symptoms and neurocognitive deficits may be understandable given recent evidence
suggesting that the impact of these processes on functioning may be mediated by defeatist beliefs about
performance144 (which are likely to be associated with self-esteem, locus of control and negative emotions).
There are a number of methodological limitations to consider regarding this study. First, we had a relatively
modest sample size. However, using a SEM approach to estimating the mediation effects and using
bias-corrected bootstrapped SEs to evaluate the significance of these effects has been shown to give
unbiased estimates and adequate statistical power for moderate effect sizes in samples as small as
100.134,135 The size of the indirect, mediation effects in this study were large, suggesting that sample size
and statistical power was not a critical issue. Second, our sample was also diagnostically heterogeneous,
which may be problematic, for example if different groups conceptualise recovery very differently; however,
we used multiple indicators of recovery and a latent variable measurement model to address measurement
error, and the diverse sample should provide greater generalisability to clinical services and settings, which
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also have considerable diagnostic heterogeneity. The predominance of male participants may, however,
adversely affect generalisability. Third, there are a number of assumptions that must be made if the
significant associations found in the mediation model are to be interpreted as causal effects, including the
absence of unmeasured confounding between the mediator and outcome variables.145 Although our
measurement model showed discriminant validity between the negative emotion mediator and recovery
outcome, the fact that our research design was cross-sectional and that no instrumental variable for the
mediator (i.e. one predicting emotion but not recovery) was available, does not give us a basis to make the
assumption of lack of confounding. However, our results are consistent with a causal account and we are
currently conducting a prospective study of recovery from psychosis to test this. In addition, recent attempts
to develop broader criteria for defining recovery have included domains of functioning such as involvement
in work or study, independent living and social networks,146–148 which were not utilised in our analysis.
However, zero-order correlations revealed that such factors were not related to perceived recovery in our
sample, so they were excluded from the model to avoid over-parameterisation. Finally, our choice of
measures is subject to criticism; for example, some may argue we should have employed the five-factor
solution of the PANSS, and many of our measures were self-report. Incorporation of other potentially
relevant variables such as social cognition would be desirable in future research.
There are several clinical implications of this research. It suggests that we can measure recovery and negative
emotion and that these are distinguishable, but related, concepts. The finding that internal locus of control
is directly associated with recovery suggests that services should promote internality by involving service
users as active agents in their own care, providing responsibility for decision-making and recognition of
strategies within their control that contribute to positive outcomes. Recent web-based interventions to
promote such empowerment have shown promise.149 Characteristics of service models such as collaborative
care, shared decision-making and promotion of self-management strategies should facilitate service
user-defined recovery, although there are also some potential problems of promoting empowerment and
involvement in decision-making in unresponsive settings. For example, a recent study showed decision-
making training for people with psychosis resulted in their psychiatrists viewing them as more disruptive;150
therefore, such interventions should be applied within the context of concurrent systemic change.
Strategies targeted at reducing negative emotion and counteracting the negative effects of positive
symptoms and increased insight, such as the provision of normalising explanations,151 reduction of
internalised stigma152 and improvement of self-esteem130 should also promote recovery. Conversely, a
reduction of the emphasis that services place on psychosis symptoms and traditional psychiatric insight,
which can convey pessimistic messages of hopelessness and lack of personal agency, should be beneficial
in promoting recovery.
Phase 3: longitudinal predictors of subjective recovery
from psychosis
This research was previously published as, and reproduced from, Law H, Shryane N, Bentall RP, Morrison AP.
Longitudinal predictors of subjective recovery in psychosis [published online ahead of print November 2015].
Br J Psychiatry 2015. http://bjp.rcpsych.org/content/early/2015/11/05/bjp.bp.114.158428)153
Objectives
This study aimed to explore longitudinal predictors of recovery with a particular focus on the role of
negative emotion. We hypothesised that recovery at time 2 would be predicted by recovery at time 1 and
negative emotion at time 1.
DOI: 10.3310/pgfar04050 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 5
67
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Morrison et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
Method
Participants
Data for this study were collected throughout the recovery programme from all appropriate studies to
create a comprehensive data set. Participants were recruited from EI teams, CMHTs, inpatient settings and
voluntary services across the north-west of England. Participants were included in the data set if they were
aged 16–65 years, had a diagnosis of schizophrenia spectrum disorder, sufficient understanding of the
English language to allow them to complete the measures and the capacity to provide informed consent.
A total of 110 participants were assessed at baseline and 6 months.
Measures
The Process of Recovery Questionnaire
The original version of the QPR92 is a 22-item self-report measure with two subscales which was developed
collaboratively by a team of service user researchers and clinicians. Items are rated on a 5-point Likert scale
ranging from ‘strongly disagree’ to ‘strongly agree’ and measure key service user-defined elements of
recovery including hope, self-esteem, social integration and empowerment. Higher scores on the measure
are indicative of recovery. A factor analysis of the psychometric properties of the QPR suggested an
amended 15-item one-dimensional version of the measure provided the most interpretable and reliable
solution. The 15-item total is used in this study; Cronbach’s alpha for the 15-item version in the sample
used in this study is 0.947.
The Positive and Negative Syndrome Scale
The PANSS55 is a 30-item semistructured clinical interview including seven items to assess positive symptoms
(such as hallucinations and delusions), seven items to assess negative symptoms (such as blunted affect
and emotional withdrawal) and 16 items to assess global psychopathology (such as anxiety, guilt and
depression). All items are rated from 1 (not present) to 7 (severe). The PANSS has been used in a variety of
studies and has been shown to have good reliability and validity.154
The Personal and Social Performance scale
The Personal and Social Performance (PSP) scale155 is a measure of functioning rated by an observer across
four domains: socially useful activities, personal and social relationships, self-care and aggression. The scale
has been shown to have adequate internal consistency (α= 0.76).156 Total scores range from 1 to 100,
with 100 indicating no functional difficulties. The majority of participants were rated for functioning using
PSP. For a small number of participants (n= 27) the functioning subscale of the GAF scale77 was used
instead. The GAF scale is also a measure of functioning which is used by an observer to rate symptoms,
social, psychological and occupational functioning.
The Calgary Depression Scale for Schizophrenia
The Calgary Depression Scale for Schizophrenia73 is a nine-item scale with items rated on a 3-point
Likert scale. Global scores range from 0 to 27. The scale measures items on depression, hopelessness,
self-depreciation, guilty ideas of reference, pathological guilt, morning depression, early wakening, suicide
and observed depression.
The Beck Hopelessness Scale
The BHS74 is a 20-item self-report measure designed by clinicians to measure thee dimensions of
hopelessness: feelings of the future, loss of motivation and expectations. Statements are rated by
participants as true or false for their attitudes over the last week. The psychometric properties of the BHS
have been examined in various studies and the measure has been shown good reliability and validity.157–159
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The Self-Esteem Rating Scale – Short Form
The SERS76 is a 20-item self-report measure assessing both positive and negative beliefs about the self.
Items are rated on a 7-point Likert scale ranging from ‘never’ to ‘always’. The scale demonstrated good
internal consistency and reliability and adequate convergent validity.76
Procedure
Recruitment took place across EI teams, CMHTs, inpatient settings and voluntary services across the
Greater Manchester area to ensure heterogeneity of service provision and experience of psychosis.
Potential participants were approached by the care team and offered information about the study.
Interested participants were given a minimum of 24 hours to read the participant information sheet and
decide whether or not to take part. Those who agreed to take part met with a researcher to complete
a consent form and the baseline study measures. The researcher then attempted to contact all participants
again 6 months later to repeat the set of measures in a follow-up assessment. Participants were
recompensed for their time.
Statistical analysis
All models were fitted in Mplus version 7 (Muthén & Muthén, Los Angeles, CA, USA) and estimated
by maximum likelihood. SEs were estimated using the Huber–White Sandwich estimator, robust to
non-normality and heteroscedasticity in the outcome variables. Model log-likelihoods and the likelihood
ratio tests were computed using Satorra–Bentler adjustments for non-normality. Nested models were
compared using Satorra–Bentler-corrected likelihood ratio chi-squared tests.
Results
Sample characteristics
Demographic characteristics of the sample are shown in Table 25. The average age of participants was
37.3 (SD 11.62) years. Diagnoses at referral were schizophrenia (n= 50), schizoaffective disorder (n= 13),
persistent delusional disorder (n= 7), unspecified non-organic psychosis (n= 4), and acute and transient
psychotic disorder (n= 2). The remaining 30 participants had not been given a diagnosis but were
experiencing psychosis. Participants were recruited from EISs (n= 27), other community-based mental
health teams (n= 45) and an inpatient service (n= 1). Data on service type at referral were missing for
37 participants.
Model variables
Variables are sufficed 1 to indicate time 1 (baseline) assessments and 2 to indicate time 2 (6-month
follow-up) assessments.
Core variables
l Recovery 1 (Rec1) and recovery 2 (Rec2). This variable consisted of the 15-item total QPR score at
time 1 or time 2, respectively.
l Negative emotion (Nemo1 and Nemo2). A composite variable for negative emotion was constructed by
taking the mean of scores from the Calgary Depression Scale and the SERS-N. The SERS-N is scored
from 10 to 70 whereas the Calgary Depression Scale is scored from 0 to 27. To avoid the composite
measure being dominated by the higher scores of the SERS-N, the raw SERS-N scores were divided by
seven before taking the composite mean, which gave both contributing scales similar means and SDs.
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Test variables
l Symptoms (PANSS1 and PANSS2). A composite variable representing the overall mean of the seven
positive, seven negative and 16 general PANSS scale items was created.
l Hopelessness (Hopeless1 and Hopeless2). Total score from BHS was utilised.
l Positive self-esteem (SERS-P1 and SERS-P2). Total score from the positive subscale of the SERS.
l Functioning (Func1 and Func2). Functioning score utilised the PSP scale if available and the functioning
subscale of the GAF scale if not.
Exogenous covariates
All of these variables were measured at time 1:
l Age.
l Education or employment. A binary variable indicating whether or not the participant was engaged in
paid employment (full or part time), study or voluntary work (coded as 1) versus being unemployed,
retired or in receipt of disability living allowance (coded as 0).
l Marital status. A binary variable indicating whether or not the participant was married or living with a
common-law spouse (coded as 1) versus being single, divorced or widowed.
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l Religious beliefs. A binary variable indicating whether or not the participant was a theist, that is
believed in the existence of a deity (coded as 1).
l Early intervention. A binary variable indicating whether or not the participant was recruited from an EIS.
Model of recovery and negative emotion
Both Rec and Nemo were highly correlated within time point (r= –0.66 in both time points). This
correlation was reduced to r= –0.45 at time point 2, after controlling for the previous time point.
Table 26 shows that both recovery and negative emotion were significant predictors of recovery at time 2,
but that only negative emotion was a significant predictor of negative emotion at time 2.
The R2 for recovery at time 2 was 31.8% and for negative emotion 58.3%. The large R2 for negative
emotion at time 2 was mainly accounted for by its relationship with negative emotion in the previous
time point.
Further development and testing of the model
The core model of recovery and negative emotion (as illustrated in Figure 6) was compared with test
Models 2.1–2.4 using Satorra–Bentler corrected likelihood ratio chi-squared tests for nested models.
In each test model, the core model was added to by including extra predictors of the outcome variables
(recovery and negative emotion at time 2). In Model 2.1, the extra predictors were the overall PANSS
symptom scores at times 1 and 2. In Model 2.2 the extra predictors were hopelessness time 1 and
hopelessness time 2 scores. Positive self-esteem was the extra predictor in Model 2.3 and functioning was
included in Model 2.4.
TABLE 26 Parameter estimates for core model of recovery and negative emotion
Predictor of Rec2 Ba SE p-value βb
Rec1 0.26 0.08 0.001 0.35
Nemo1 –0.85 0.31 0.006 –0.27
Predictor of Nemo2 Ba SE p-value βb
Rec1 –0.02 0.02 0.213 –0.09
Nemo1 0.64 0.07 < 0.001 0.70
a B= unstandardised beta coefficient.




FIGURE 6 Core model (Model 1): recovery and negative emotion at time 2 predicted by recovery and negative
emotions at time 1.
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Table 27 shows the results of the likelihood ratio tests comparing each of Models 2.1–2.4 with the
core model.
All models improved on the fit of the core model, with the largest improvements seen in the prediction of
recovery scores at time 2 owing to hopelessness and positive self-esteem.
A further model was then fitted, which combined the predictors that were tested separately in Models
2.1–2.4 into a single Model 2.5.
The parameter estimates for Model 2.5 are shown in Table 28.
Recovery at time 2 was predicted significantly by symptoms at time 1 and hopelessness and positive
self-esteem at time 2. After accounting for these influences, recovery at time 1 was no longer a significant
predictor of recovery at time 2.
Negative emotion at time 1 was a significant predictor of negative emotion at time 2, along with
symptoms, hopelessness and positive self-esteem at time 2.
Checking for endogeneity
There was a possibility that regressing closely related constructs on one another within each data collection
time point would be stretching assumptions of exogeneity with regard to these constructs. To test for this
we ran a model, Model 2.6, which regressed recovery and negative emotion at time 2 on the other test
variables from time 1 only, not including the other time 2 variables as predictors.
TABLE 27 Omnibus tests comparing the fit of core Model (Model 1) with the test Models 2.1–2.4 using corrected










Model 1 9 –592.30 – –
Compared with





13 –576.61 32.93 < 0.001 Rec2
14.3%
Nemo2 4.7%
Model 2.3: positive SE 13 –578.56 22.75 < 0.001 Rec2
14.1%
Nemo2 3.7%




All models n= 110.
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From Table 29, we see that symptoms and positive self-esteem at time 1 are significant predictors of
recovery beliefs at time 2, each with broadly equal magnitude. These predictors accounted for 44% of the
variance in recovery at time 2.
By far the strongest predictor of negative emotion at time 2 is the time 1 score on this variable. No other
time 1 variables were significant predictors of negative emotion at time 2. The R2 for this model was 61%.
The fact that recovery and negative emotion have different sets of predictors is evidence in support of the
fact that these are distinct constructs.
Checking for confounding
In the previous analyses, no attempt was made to control for the effects of potential demographic and
other confounding factors. Such variables available in this study were age, sex, marital status, employment
status, religious beliefs and whether or not the participant was drawn from an EI or other service.
Fitting the same series of models above, but this time conditioning the outcome variables (i.e. Rec2 and
Nemo2) on these covariates, the pattern of model improvement was identical to that seen in Table 29
(Table 30). In these models, the only variable that had any significant effects was sex.
TABLE 28 Parameter estimates for full Model 2.5
Predictor of Rec2 Ba SE p-value βb
Rec1 0.01 0.08 0.94 0.01
Nemo1 –0.09 0.38 0.81 –0.03
PANSS1 –3.49 1.56 0.03 –0.17
Hopeless1 –0.18 0.13 0.17 –0.11
SERS-P1 0.00 0.07 0.98 0.00
Func1 –0.09 0.06 0.12 –0.15
PANSS2 –0.32 2.38 0.89 –0.01
Hopeless2 –0.50 0.14 0.00 –0.26
SERS-P2 0.24 0.06 0.00 0.33
Func2 0.14 0.07 0.05 0.23
Predictor of Nemo2 Ba SE p-value βb
Rec1 0.00 0.02 0.93 –0.01
Nemo1 0.57 0.07 0.00 0.63
PANSS1 –0.57 0.47 0.22 –0.09
Hopeless1 –0.03 0.04 0.40 –0.07
SERS-P1 0.02 0.02 0.26 0.09
Func1 –0.01 0.01 0.68 –0.03
PANSS2 1.46 0.62 0.02 0.21
Hopeless2 0.11 0.04 0.01 0.20
SERS-P2 –0.04 0.02 0.02 –0.19
Func2 0.00 0.02 0.99 0.00
a B= unstandardised beta coefficient.
b β= standardised beta coefficient.
Note
All models n= 110.
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TABLE 29 Parameter estimates for full Model 2.6
Predictor of Rec2 Ba SE p βb
Rec1 0.07 0.08 0.35 0.10
Nemo1 0.08 0.41 0.86 0.02
PANSS1 –6.65 1.67 0.00 –0.32
Hopeless1 –0.28 0.17 0.10 –0.17
SERS-P1 0.18 0.08 0.03 0.25
Func1 0.03 0.04 0.43 0.06
Predictor of Nemo2 Ba SE p βb
Rec1 0.00 0.02 0.92 –0.01
Nemo1 0.58 0.09 0.00 0.65
PANSS1 0.61 0.44 0.17 0.10
Hopeless1 –0.02 0.04 0.59 –0.05
SERS-P1 –0.02 0.02 0.21 –0.09
Func1 –0.02 0.01 0.11 –0.10
a B= unstandardised beta coefficient.
b β= standardised beta coefficient.
Note
All models n= 110.
TABLE 30 Omnibus tests comparing the fit of core Model 1 with the test Models 2.1–2.4, controlling for age, sex,









Model 1 21 –581.01 – –
Compared with
Model 2.1: symptoms 25 –568.52 27.07 < 0.001
Model 2.2: hopelessness 25 –565.50 32.76 < 0.001
Model 2.3: positive SE 25 –565.97 26.36 < 0.001
Model 2.4: functioning 25 –571.55 19.68 0.001
Note
All models n= 110.
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We decided to fit an additional model with sex as a predictor, but this time exploiting the fact that we
could plausibly assume that sex was a truly exogenous variable and so include it as a predictor of both the
time 1 and time 2 outcomes.
The results for this model, Model 3, are shown in Table 31.
The pattern of significant results in Model 3 is identical to that in Model 2.6 with the notable exception
that although sex is not a significant predictor of recovery beliefs at time 1, it is a significant and
substantial predictor of recovery beliefs at time 2, with men having an average recovery score 4 points less
than women. This is despite the fact that sex was not a significant predictor of negative emotion at either
time point.
TABLE 31 Parameter estimates for path Model 3
Predictor of Rec2 Ba SE p-value βb
Rec1 0.07 0.07 0.36 0.11
Nemo1 –0.19 0.39 0.63 –0.07
PANSS1 –5.73 1.66 0.00 –0.32
Hopeless1 –0.23 0.16 0.15 –0.17
SERS-P1 0.20 0.08 0.01 0.33
Func1 –0.01 0.04 0.91 –0.01
Male –4.33 1.37 0.00 –0.24
Predictor of Nemo2 Ba SE p-value βb
Rec1 0.00 0.02 0.89 –0.01
Nemo1 0.55 0.09 0.00 0.67
PANSS1 0.74 0.43 0.09 0.13
Hopeless1 –0.02 0.04 0.69 –0.04
SERS-P1 –0.02 0.02 0.31 –0.08
Func1 –0.02 0.01 0.06 –0.15
Male –0.58 0.43 0.17 –0.11
Outcome variables, predicted by male Ba SE p-value βb
Rec1 0.74 2.66 0.78 0.03
Nemo1 –1.03 0.67 0.12 –0.15
PANSS1 0.14 0.09 0.14 0.14
Hopeless1 –0.69 1.31 0.60 –0.05
SERS-P1 4.08 2.80 0.15 0.14
Func1 –7.27 3.34 0.03 –0.22
a B= unstandardised beta coefficient.
b β= standardised beta coefficient.
Note
All models n= 110.
Bold text indicates significance (p< 0.05).
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Discussion
This exploratory study found that subjective recovery scores at time 2 were predicted by negative emotion,
positive self-esteem and hopelessness and, to a lesser extent, by symptoms and functioning at time 1.
Additionally, current recovery score was predicted by current hopelessness and positive self-esteem.
Current recovery score was not predicted by past recovery scores after accounting for past symptoms and
current hopelessness and positive self-esteem.
The strongest predictor of negative emotion was past negative emotion. Other predictors of negative emotion
included current scores for symptoms, hopelessness and positive self-esteem. The analysis supports the notion
that recovery and negative emotion are distinct but related constructs, each with a distinct set of predictors.
The findings are consistent with the literature on defining recovery, which suggest that rebuilding the self
and hope are key components of recovery.19 The results also support previous research on recovery and
related concepts such as quality of life. For example, in one study psychological factors such as hope and
internalised stigma accounted for variance in ratings of quality of life,119 while a similar study found that
psychosocial factors including self-esteem and optimism were related to recovery.
This present study also found that sex was a significant predictor of recovery, with men having lower
recovery scores than women. The finding that men have generally lower recovery scores is consistent with
previous research investigating the role of sex in outcomes for people with a diagnosis of schizophrenia.160
However, the present finding is intriguing because sex was not a predictor of recovery beliefs at baseline,
only at the 6-month point, suggesting possibly different processes at work for recovery beliefs of men and
women. Sex was not a predictor of negative emotion at either time point, suggesting that the relationship
between recovery and sex was not mediated by negative emotion. We could speculate on other processes,
for example sample selection may have played a part if males and females find their ways into services at
different rates at different stages of illness and recovery. In addition, this research only explored
demographic categories of male and female. Further research using a more sociocultural approach to
examine the sex roles and identity (see Nasser et al.161 for review) may improve our understanding of the
role of sex in both negative emotion and recovery.
There are a number of methodological limitations to the study. First, the study used a relatively modest
sample size and all analyses are exploratory. Further research could examine a larger group that would
allow for more extensive testing with a larger number of potential predictors and parameters. Second, the
sample was mostly male and diagnostically heterogeneous, which may mean that conceptualisations of
recovery were very different within the sample. However, the sample was recruited across a variety of
services and settings to ensure it was representative of the target clinical population. Finally, although this
study was fairly unique in assessing both neuropsychiatric and psychosocial factors that may predict
recovery over time, the follow-up period was relatively short (6 months). Further research could aim to
examine the course of recovery and associated predictors over a longer time frame.
Future research could also aim to examine the impact of insight on recovery judgements and explore the
impact of insight on negative emotion. Previous research has suggested mixed results with regards to
insight and recovery. For example, in one study improved insight was associated with improved
outcomes,117 while other studies have suggested that increased insight can be associated with increased
negative outcomes including greater suicidality.118 Developing an understanding of the role of insight in
relation to recovery and negative emotion would be beneficial.
There are several potential implications from this research. Interventions that aim to reduce negative
emotion while promoting self-esteem and hope may be beneficial to promoting recovery. Strategies such
as improvement of self-esteem130 and reduction of internalised stigma,152 for example, may lead to
improved recovery outcomes. Emphasis in services should move away from traditional symptom and
functioning approaches and towards a more psychosocial approach, which takes into account this key role
of negative emotion on personal recovery outcomes.
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Phase 4: how do I know if I am better? Judgements of recovery
from psychosis in everyday life
Objectives
In this study, we used ESM to address two important questions about recovery judgements:
1. To explore whether or not, and to what extent, patients’ recovery judgements are stable over time.
This question is important as instabilities in recovery judgements might compromise the assessment of
patients’ subjective well-being, and might potentially have prognostic and treatment implications.
2. To test whether or not the same kind of psychosocial factors that have been shown to be associated
with recovery judgements in cross-sectional studies, for example self-esteem and hope for the future,
predict recovery judgements longitudinally over moment-to-moment situations in real life.
Method
Participants
This study was reviewed and approved by the NHS North West 10 Research Ethics Committee Greater
Manchester North (REC reference 10/H1011/36) and was sponsored by the University of Bangor.
Sixty-eight service users meeting criteria for a diagnosis on the schizophrenia spectrum disorders (ICD-10
schizophrenia, delusional disorder, schizoaffective disorder and psychotic disorder not otherwise specified)
were recruited into the present study. Service users were recruited from CMHTs, hospital inpatient wards
and day hospitals across several trusts in the North West, including Greater Manchester West Mental
Health NHS Foundation Trust, Cheshire and Wirral NHS, Pennine Care, 5 Boroughs Partnership, and
Manchester Mental Health and Social Care Trust. Inclusion criteria were: aged between 16 (required for
informed consent) and 65 years; being in current contact with mental health services; ability to provide
informed consent; and sufficient competency in English to complete the assessments.
Procedure
Participants completed baseline clinical and questionnaire assessments and were then instructed to
complete the ESM diaries. Some service user participants were later followed up at 3 and 6 months to
assess changes in and stability of recovery; these data are not reported here.
Baseline measures
Positive and Negative Syndromes Scale162
The PANSS is a clinician-administered 30-item semistructured interview consisting of seven items assessing
positive symptoms, seven items assessing negative symptoms and 16 items assessing global
psychopathology (e.g. depression, anxiety, lack of insight, guilt). All items are scored between 1 (not
present) and 7 (severe). A number of studies have demonstrated the reliability and validity of the PANSS.163
PANSS raters (JD, PT, SA, SM) were trained using a standardised approach and had good reliability. Given
the overlap between the global psychopathology subscale and our other measures (e.g. HADS, IS), we only
utilised the positive and negative symptom subscales.
The Process of Recovery from Psychosis Questionnaire92
The QPR is a 22-item questionnaire that was collaboratively developed with service users. The
questionnaire measures subjective recovery in two domains: intrapersonal functioning and interpersonal
functioning. Participants rate their agreement with statements on a 5-point Likert scale rating from
‘strongly disagree’ to ‘strongly agree’. The subscales have good internal consistency and test–retest
reliability over short periods.92 However, the Cronbach’s alpha value for the intrapersonal and interpersonal
scales in our sample were α= 0.936 and α= 0.656, respectively, the latter being relatively poor. Therefore,
we utilised a 15-item total score that has been derived from factor analyses and shown to be superior to
the two subscales; in our sample, the Cronbach’s alpha value for the 15-item total score was α= 0.930.
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Participants were also asked to make a simple binary judgement, yes or no, about whether or not they
considered themselves to be recovered.
The Brief Self-Esteem Rating Scale – Short Form76
The SERS is a 20-item measure of explicit self-esteem validated for use with patients with psychosis,
assessing both positive (10 items) and negative (10 items) beliefs about the self. Participants rate how
often each of the statements reflect their feelings about the self on a 7-point Likert scale of ‘never’ to
‘always’. Cronbach’s alpha values for the positive and negative scales for this sample are α= 0.919 and
α= 0.908, respectively.
Hospital Anxiety and Depression Scale128
The HADS is a 14-item self-report measure. Of these items, seven assess depression, while the remaining
seven items assess anxiety over a period of the preceding week. Cronbach’s alpha values for anxiety and
depression scales for this sample are α= 0.859 and α= 0.834, respectively.
Experience sampling methodology
The ESM is a pseudorandom time sampling assessment that has previously demonstrated feasibility, validity
and reliability in people diagnosed with psychosis.121,123,164 All service user participants received an
electronic digital watch to wear, which was programmed to bleep 10 times a day on a pseudorandom
schedule between 07.30 and 22.00 over the course of 6 days. Participants were asked to complete a short
diary around their recovery on hearing a bleep.
The items included in the ESM diary measured psychological experiences on a 7-point Likert scale. The
items were adapted from our previous studies121,122,165 and integrated recovery-related variables including
positive and negative affect, self-esteem, activity-related stress, self-efficacy, rumination, recovery status
and savouring ability.
Measures of self-esteem (four items) and single-item measures of visual hallucinations, auditory
hallucinations and current paranoia were taken from previous ESM studies.121,122,165 From these studies we
also took single-item measures of appraisals of symptoms: whether or not visual hallucinations were
present, whether or not auditory hallucinations were pleasant and whether or not persecution was
believed to be deserved. Two additional measures were piloted by a team of service user researchers
before inclusion in the study.
Momentary recovery was generated as the mean of the three ESM recovery items: (1) ‘I felt limited by
psychological problems’; (2) ‘I have worries about psychiatric problems’; and (3) ‘I have felt mentally well’.
Items (1) and (2) were first reverse coded so the overall recovery score would be on a positive scale, that is
higher values indicate better recovery. Momentary recovery was negatively skewed but residuals of the
models seemed Normally distributed enough for the assumption to hold.
Three items derived from the BHS166 were included to measure hopelessness: ‘my future seems darks to
me’, ‘I feel optimistic about the future’ and ‘the future seems vague and uncertain to me’.
Analysis
All analyses were performed in Stata version 11.0 (StataCorp LP, College Station, TX, USA) using the
xtmixed command, and Mplus version 7.1 (Muthén & Muthén, Los Angeles, CA, USA). To test the factor
structure of the predictor scales, we used a two-level CFA with participant and beep as the levels,
postulating a one-factor solution for each scale to test that the items did load onto a single factor.
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Fluctuations in scores were calculated as the absolute difference between ESM measures at two
consecutive time points.
As the ESM measures have a three-level hierarchical structure (beeps nested within days nested within
participant), we use multilevel modelling to account for the clustering in outcomes within participants. We
fitted three-level random intercept models containing in the error structure: a random intercept for each
participant, a random intercept for each day within a participant and a beep-specific error term.
In order to test the hypothesis that the ‘Right Now’ variables are correlated with recovery at time 1 we
considered predictors and outcomes at concurrent entry points; the results will demonstrate if there is an
association between the predictors and outcomes which, if significant, might suggest that they occur
simultaneously. To test the hypothesis that the Right Now variables at time 0 predict recovery at time 1
lagged values of the predictors were used in the multilevel models instead of concurrent predictor values.
Results
Participant characteristics
A total of 80 service users took part in the study (Table 32 shows summary table of participant
characteristics). Demographic information was missing for 10 participants. The majority of participants
were referred based on having experience of psychosis but no diagnosis specified (n= 35, 58%),
while 36.7% (n= 22) had a diagnosis of schizophrenia and 3 participants (5%) had a diagnosis of
schizoaffective disorder.
Summary data for completed measures can be seen in Table 33.
Is there a relationship between baseline recovery and fluctuations
in recovery?
We compared fluctuations in momentary recovery between groups defined according to whether their
baseline ratings were ‘yes’ (recovered) or ‘no’ (Table 34). Baseline recovery was entered into the model as
a fixed effect and allowing different residual variance of the two baseline recovery groups. The ‘recovered’
group at baseline have significantly higher mean recovery scores recorded in everyday life than the ‘not
recovered’ group, but there was more variation in recovery in the ‘not recovered’ baseline group.
For the baseline QPR recovery (Table 35), the total baseline score (of the 15 items) was entered as a fixed
effect. This score was then split into tertiles and entered into the random part of the model to allow the
residual variance to be different for each group, as with the binary baseline recovery. Group 1 included
total baseline scores of 30–49, group 2 scores of 50–56 and group 3 scores of 57–73. The results imply
that for a unit increase in baseline QPR score, mean momentary recovery scores increase by 0.09.
However, showing a similar pattern to the binary baseline recovery variable, there is more variation in
momentary recovery judgements for those with lower baseline QPR scores than for those with higher
baseline QPR scores.
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TABLE 32 Participant characteristics
Characteristics Service users (N= 68a), n (%)
Age (years), mean (SD) 38.6 (10.6)
Sex (Male) 36 (60.0)
Current living arrangements
Spouse/partner 7 (11.7)
Spouse/partner and children 5 (8.3)
Alone 22 (36.7)
Children 4 (6.7)
Parents only 7 (11.7)




























Full time 3 (5.0)






a Demographics data were missing for eight participants.
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Which experience sampling methodology variables correlate with current
momentary recovery judgements?
Table 36 shows the relationship between momentary recovery judgements and individual ESM measures
taken at the same time point. There are significant correlations between the concurrent variables and
momentary recovery judgements. As expected, positive measures (self-esteem) are positively correlated
with recovery, whereas the symptom measures are negatively correlated with recovery. For example,
for a unit increase in self-esteem, momentary recovery increases by 0.38, whereas for a unit increase in
hopelessness momentary recovery decreases by 0.35.
TABLE 34 Fluctuations in momentary recovery
Variable
Fixed effects Random effects
Coefficient SE p-value Level Variance SE
Baseline recovery (yes/no) 0.77 0.38 0.043 Person 1.26 0.13
Day 0.51 0.03
Beep: not recovered 0.71 0.01
Recovered 0.50 0.02
TABLE 33 Descriptive statistics
Variable Subscale Mean (SD) n
QPR total 52.5 (9.04) 68
PANSS Positive 12.6 (4.0) 60
Negative 11.6 (3.5) 60
General 24.8 (5.9) 60
SERS Positive 43.9 (11.8) 60
Negative 33.7 (14.0) 60
BHS total 7.4 (5.4) 60
PSP total 73.2 (13.4) 60
TABLE 35 Model of QPR baseline scores and recovery judgements
Variable
Fixed effects Random effects
Coefficient SE p-value Level Variance SE
Baseline QPR 0.09 0.02 0.000 Person 1.04 0.12
Day 0.22 0.03
Group 1: low recovery 0.57 0.03
Group 2: medium recovery 0.49 0.03
Group 3: high recovery 0.37 0.02
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All of the current variables were entered into one model (Table 37), excluding the pleasantness of
hallucinations and deservedness ratings for which there were not sufficient data (including these variables
would cause the model to use only 145 observations whereas, excluding them the model uses 2273
observations). In this model, self-esteem, hallucinations (visual and auditory), and paranoid are all
significantly associated with recovery judgements.
Do variables at the previous time point predict momentary
recovery judgements?
Lagged variables for predictor ESM variables were generated, restricting lag to be within day. Each line in
Table 38 corresponds to a separate model with the lagged variables as the predictors, controlling for
baseline recovery group (yes/no binary judgement) as this was found to be a significant predictor of
recovery scores in a previous analysis. It can be seen that self-esteem, hopelessness and the symptom
measures (but not participants’ appraisals of their symptoms, as indicated by the pleasantness of their
hallucinations or their beliefs about whether or not they deserved to be persecuted) predicted the extent
to which they believed they were recovered.
TABLE 36 Relationship between momentary recovery judgements and individual ESM measures
Variable
Fixed effects Random effects
Coefficient SE p-value Level Variance SE
Self-esteem 0.38 0.02 0.000 Person 1.06 0.20
Day 0.18 0.02
Beep 0.46 0.01
Hopelessness –0.35 0.02 0.000 Person 1.03 0.19
Day 0.17 0.02
Beep 0.45 0.01
Visual hallucinations (I see phenomena) –0.14 0.02 0.000 Person 1.53 0.28
Day 0.18 0.02
Beep 0.49 0.02
Visual hallucinations (these are pleasant) 0.17 0.03 0.000 Person 1.52 0.47
Day 0.07 0.03
Beep 0.33 0.03
Auditory hallucinations (I hear voices) –0.13 0.02 0.000 Person 1.51 0.28
Day 0.19 0.02
Beep 0.48 0.02
Auditory hallucinations (these are pleasant) 0.13 0.03 0.000 Person 1.42 0.38
Day 0.20 0.04
Beep 0.43 0.03
Paranoia –0.42 0.02 0.000 Person 0.75 0.14
Day 0.15 0.02
Beep 0.45 0.01
Deservedness –0.22 0.03 0.000 Person 1.30 0.24
Day 0.25 0.03
Beep 0.48 0.01
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TABLE 37 Model of recovery judgements and symptoms of psychosis
Variable
Fixed effects Random effects
Coefficient SE p-value Level Variance SE
Self-esteem 0.23 0.02 0.000
Hopelessness –0.18 0.02 0.000
Visual hallucination –0.07 0.02 0.003
Auditory hallucinations –0.06 0.02 0.002




TABLE 38 Lagged model of predictors of recovery judgements
Variable
Fixed effects Random effects
Coefficient SE p-value Level Variance SE
Self-esteem 0.15 0.03 0.000 Person 1.17 0.23
Day 0.18 0.02
Beep 0.43 0.02
Hopelessness –0.13 0.02 0.000 Person 1.19 0.23
Day 0.18 0.02
Beep 0.43 0.02
Halluc1 (I see phenomena) –0.06 0.03 0.045 Person 1.30 0.25
Day 0.16 0.02
Beep 0.43 0.02
Halluc2 (these are pleasant) –0.03 0.04 0.408 Person 1.02 0.34
Day 0.13 0.05
Beep 0.29 0.03
Halluc3 (I hear voices) –0.09 0.02 0.000 Person 1.21 0.24
Day 0.16 0.02
Beep 0.43 0.02
Halluc4 (these are pleasant) 0.02 0.03 0.486 Person 1.45 0.41
Day 0.19 0.04
Beep 0.42 0.03
Paranoia –0.19 0.03 0.000 Person 0.97 0.19
Day 0.17 0.02
Beep 0.43 0.02
Deservedness 0.02 0.03 0.499 Person 1.49 0.29
Day 0.20 0.03
Beep 0.43 0.02
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Table 39 shows the results when all variables were entered into a single model, controlling for baseline
recovery group. Again, because of the small number of observations for the symptom appraisal variables,
these were excluded, enabling an analysis with 169 observations instead of 172. As can be seen, in this
analysis all of the variables with the exception of visual hallucinations are significant predictors. Substantially
similar results were obtained by using baseline QPR scores instead of the binary recovery classification.
Sensitivity analysis
The results above include data from all participants regardless of the total number of observations
completed per person. In line with common practice of only including data from participants who have
completed at least one-third of the potential observation, a sensitivity analysis was conducted to identify
any changes to the results. Analysis 3 (in which lagged variables were used to predict recovery judgements)
was repeated including only participants who had completed at least 20 observations overall: 54 out of the
68 service users. Results were very similar to the full sample, with only a slight decrease in magnitude of
the effect for each of the predictor variables. The only variable to significantly change was visual
hallucinations, which now had an effect size of –0.05 (SE 0.03; p-value 0.056).
Discussion
To our knowledge, this is the first study to use experience-sampling methodology to explore the concept
of recovery from psychosis in everyday life. We found that recovery judgements are variable in some
patients but more stable in others, which is in keeping with the conceptualisation of recovery as an
idiosyncratic process.19,143 We also found that, generally, those who reported themselves as being
recovered using the questionnaire measure at baseline reported higher levels of recovery when required to
make those ratings in everyday life, which demonstrates a certain consistency in recovery judgements
regardless of the methodology used; this is consistent with findings regarding use of different self-report
approaches to defining recovery.126 Those with lower baseline questionnaire recovery scores showed
greater fluctuations in recovery judgements in everyday life. Hence, low baseline recovery is associated
with instability of recovery judgements, which is an interesting finding, since stability would be expected to
form part of any criteria by which people judge themselves or others to be recovered. Both concurrently
and prospectively, self-esteem and hopelessness but also, less expectedly, symptoms (hallucinations and
paranoia), predicted whether or not patients felt themselves to be recovered. In general, the effect sizes for
self-esteem, hopelessness and paranoia were large compared with those for hallucinations. Thus, it would
appear that self-esteem and hope are important factors in the recovery process, which confirms previous
findings from both qualitative19,143 and quantitative127 studies. Previous research has indicated that the role
TABLE 39 Predictors of recovery judgements controlling for baseline recovery group
Variable
Fixed effects Random effects
Coefficient SE p-value Level Variance SE
Self-esteem 0.12 0.03 0.000
Hopelessness –0.06 0.03 0.030
Visual hallucinations –0.02 0.03 0.624
Auditory hallucinations –0.07 0.02 0.002
Paranoia –0.11 0.03 0.000
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of symptoms in recovery judgements appears to be indirect, mediated via the role of negative emotions
such as anxiety and depression; it is possible that the strength of findings for paranoia may be due to the
overlap with anxiety, as both are concerned with threat appraisals, but it may be that the interpersonal
nature of paranoia as a symptom makes it more important to perceived recovery than hallucinatory
experiences. It may also be that hallucinatory experiences as symptoms are less relevant to perceived
recovery because they are, at times, pleasant, whereas it is unlikely that people would experience paranoid
ideation as pleasant. The role of symptoms in subjectively perceived recovery is clearly relevant, but we
require further research to clarify this.
A number of limitations of this study require acknowledgement. Despite methodological advantages of
ESM over classical self-report measures,167 some researchers have voiced concerns regarding participants’
compliance with, and hence the reliability of, pencil and paper methods of experience sampling,
recommending the use of electronic diaries.168 Although this could be a serious limitation in studies
employing predetermined entries, previous studies have demonstrated comparable compliance in electronic
and paper diary studies, when using a random-entry design, which we employed in our study. There was a
predominance of male participants in this study, which may affect generalisability. The average age of
participants was 38.6 years which may indicate that further work to explore recovery from psychosis in EI
populations would be beneficial because this age group may conceptualise and judge recovery differently
to those with more established diagnoses. For a significant proportion of the sample, diagnosis was
unconfirmed. Although experiences of psychosis were verified using the PANSS structured interviews, this
is likely to have led to diagnostic heterogeneity that may be considered as a limitation of the study.
However, this diagnostic heterogeneity is likely to be representative of the clinical populations
accessing services.
There are a number of implications arising from this research. Future longitudinal research should further
investigate the role of symptoms and psychological factors (such as negative affect, self-esteem and hope)
in relation to perceived recovery over a longer time frame, in order to examine the casual and temporal
relationships between such factors. Clinical implications include the desirability of using recent technology
for monitoring of subjective recovery and related factors in everyday life (e.g. via mobile phone applications
that could provide feedback to service users and care teams). The promotion of recovery in clinical services
could be facilitated by regular assessment and monitoring of perceived recovery, as well as the
incorporation of targets such as self-esteem, hope and positive affect into goals within care plans and
service specifications or operational policies. The promotion of recovery within individuals could utilise
psychosocial approaches to increase hope, self-esteem andmood; these could include individual or group
therapies that are specifically focused on these issues, life skills courses (including education about
definitions of recovery, recovery rates and recovery-related skills) or peer-delivered support.
Conclusions
The research studies in this chapter aimed to address the gap in knowledge regarding judgements of
recovery, associated factors and predictors. The research was split into four phases:
1. an exploration of subjective judgements of recovery in people with experience of psychosis
2. a cross-sectional investigation of psychosocial and neuropsychiatric predictors of subjective recovery
from psychosis
3. an examination of longitudinal predictors of subjective recovery
4. an ESM study to examine recovery judgements and associated factors.
The research in this chapter found further support for the idea that recovery is multifaceted and
idiosyncratic, as well as having significant relationships with psychological factors such as self-esteem, hope
and emotion. This research was the first to examine measurement and prediction of subjective recovery
using a variety of approaches (including cross-sectional, longitudinal and moment-to-moment techniques).
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The first phase found significant correlations between measures of recovery and psychological factors;
higher levels of self-esteem and hope, along with lower levels of depression and anxiety, were associated
with more positive judgements of recovery. The different methods of measuring recovery judgements
(yes/no response, percentage agreement and QPR scores) highlighted a general consistency in within-person
ratings across all measures; however, the ranges of scores between individuals were widely dispersed.
The second phase of this research found that subjective recovery judgements were directly associated with
negative emotion (anxiety, depression and negative self-esteem) and internal locus of control; lower levels
of negative emotion and higher levels of internal locus of control were associated with higher judgements
of recovery. Positive symptoms and internal locus of control were indirectly associated with recovery
judgements via their relationship with negative emotion. There did not appear to be any effect of negative
symptoms or neurocognitive functioning on self-rated recovery or negative emotion. This research provided
support for the measurement of recovery and negative emotion, and suggests that these are
distinguishable, but related, concepts.
The third phase of the research found that subjective recovery scores at time 2 (6-month follow-up) were
predicted by negative emotion, positive self-esteem, hopelessness and to a lesser extent by symptoms and
functioning at time 1 (baseline assessment). Additionally, in support of the earlier phases of this research,
current recovery score was predicted by current hopelessness and positive self-esteem. The strongest
predictor of current negative emotion was past negative emotion. Other predictors of negative emotion
included current scores for symptoms, hopelessness and positive self-esteem. The analysis provides further
support for the notion that recovery and negative emotion are distinct but related constructs, each with a
distinct set of predictors. It was also found that sex was a significant predictor of recovery, with men
having lower recovery scores than women. The present finding is intriguing because sex was not a
predictor of recovery beliefs at baseline, only at the 6-month point, suggesting that there may be different
processes at work over time for recovery beliefs of men and women. Sex was not a predictor of negative
emotion at either time point, suggesting that the relationship between recovery and sex was not mediated
by negative emotion.
The final phase of this research was the first study to use ESM to explore the concept of recovery from
psychosis in everyday life. Recovery judgements were found to be variable in some patients but more
stable in others, which is in keeping with the conceptualisation of recovery as an idiosyncratic process.19,143
Those with lower baseline questionnaire recovery scores showed greater fluctuations in recovery
judgements in everyday life. Hence, low baseline recovery is associated with instability of recovery
judgements, which is an interesting finding, as stability would be expected to form part of any criteria by
which people judge themselves or others to be recovered. Both concurrently and prospectively, self-esteem
and hopelessness but also, less expectedly, symptoms (hallucinations and paranoia), predicted whether or
not patients felt themselves to be recovered. In general, the effect sizes for self-esteem, hopelessness and
paranoia were large compared with those for hallucinations. Thus, it would appear that self-esteem and
hope are important factors in the recovery process, which confirms previous findings from the earlier
phases of this research and the current literature.19,32,97,98,119,120
This research in this chapter is indicative of differing personal thresholds for the definition of ‘recovered’
and provides empirical evidence consistent with the idea that recovery is a personal journey that does not
necessarily have an end point. It suggests that there may not be a ‘one size fits all’ measure of recovery
and the idea of a personalised recovery approach should be embraced in clinical settings. Regular
assessment of recovery judgements, as well as psychological factors such as self-esteem, optimism and
emotional disturbance, would help to evaluate the extent to which services are recovery oriented and also
help individuals to monitor their progress. The possibility of using recent technology for monitoring of
subjective recovery and related factors in everyday life (e.g. via mobile phone applications that could
provide feedback to service users and care teams) should also be considered.
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The finding that internal locus of control is directly associated with recovery suggests that services should
promote internality by involving service users as active agents in their own care, providing responsibility for
decision-making and recognition of strategies within their control that contribute to positive outcomes.
Strategies targeted at reducing negative emotion and counteracting the negative effects of positive
symptoms and increased insight, such as the provision of normalising explanations,151 reduction of
internalised stigma152 and improvement of self-esteem130 should also promote recovery. Conversely, a
reduction of the emphasis that services place on psychosis symptoms and traditional psychiatric insight,
which can convey pessimistic messages of hopelessness and lack of personal agency, should be beneficial
in promoting recovery.
Overall, this work, in combination with the findings from Chapters 2, 3 and 6, suggest that measurement
of recovery should be individually tailored to the preferences and needs of the service user and the service.
The identification of such choices for the assessment of monitoring of subjective recovery should include
consideration of the frequency of monitoring, the purpose of such assessment (e.g. to identify goals or to
monitor change) and the specific aspects of recovery that are prioritised by the service user. For example,
beginning with a generic self-report assessment of recovery [such as is provided by the QPR for people
with psychosis or the Bipolar Recovery Questionnaire (BRQ) for those with BD] could be supplemented by a
more detailed discussion of recovery targets and preferences (such as is provided by the Q-sort exercise in
Chapter 2 or the Delphi-rating exercise in Chapter 3). Once these methods have elicited a more
idiosyncratic operationalisation of recovery for that person, a more comprehensive assessment battery
incorporating measures of self-esteem, hope and optimism, social functioning, locus of control, positive
and negative emotion and the subjective impact of symptoms could be designed for that individual.
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Chapter 5 Development and evaluation of
cognitive–behavioural approaches to guided self-help
and group therapy for recovery, taking preferences
into account
Background
Treatment guidelines in the UK currently recommend psychological treatments for psychosis, such as
CBT.14 RCTs have consistently demonstrated the efficacy of such treatments.71 Despite the high internal
validity of these trials, external validity can be compromised by confounding variables such as effects of
preference.169 Service users typically have little choice about the mode and content of therapy and may be
less likely to benefit from treatments they do not choose to receive.170,171 Service user involvement in
mental health and research trials is advocated,83,172,173 and allowing service user choice is increasingly
highlighted as important.18,19
The partially randomised preference trial design (PRPT174) has been used to enable treatment choice and
overcome preference effects in evaluations of various treatments, including psychological therapy.175 In
PRPTs, participants are allocated to their preferred treatment if they have a strong preference and
randomised if they do not express a strong preference and consent to randomisation. In comparison with a
RCT, the PRPT design does have significant methodological limitations, which suggest that PRPT designs
are often viewed as unsuitable, but if they are utilised attempts can be made to overcome some limitations
by statistically adjusting for potential unmeasured biases, although this does not overcome their limitations
fully.176 PRPTs can also encounter difficulties when certain treatment options are favoured less than
others,177 in particular TAU.178 It is therefore useful to establish likely preferences prior to such a trial.169
Trial participation decisions are complex and involve consideration of benefits to self and others.179 Barriers
to participation include inconvenience, treatment preferences, aversion to randomisation, uncertainties
regarding treatments, concerns regarding information and consent, and clinicians acting as a barrier.180
The likelihood of participation in schizophrenia treatment trials is influenced by perceptions of risk,
personal benefits and altruistic reasons,181,182 although this has been little researched to date. Hypothetical
willingness to participate in clinical trials ranges from 70% to 96%.183 The majority of studies regarding
specific psychological treatments for psychosis have focused on treatment outcomes and processes rather
than content.108 In a general review of preference trials,175 the proportion of participants willing to accept
random allocation varied considerably (from 26% to 88%). Further exploration of treatment preferences
and feasibility of the PRPT design for research investigating CBT would be beneficial.
Despite recommendations that CBT should be given to all individuals who experience psychosis,83 the
implementation of CBP within NHS services is poor16 owing to a number of factors. First, the widespread
lack of trained therapists means that provision of this type of intervention is limited. Second, the refusal
rate for participating in trials of CBP is relatively high, suggesting that not all service users wish to engage
in current modes of delivery of this therapy. There is also some concern that the focus of CBT interventions
for psychosis have been overly restrictive and that CBT does not necessarily target the priorities identified
by service users. Although there have been several developments of novel therapeutic approaches within
primary care (such as stepped care and the use of computerised and telephone treatments),184,185 there has
been little exploration of novel approaches within services for serious mental illness. However, these
adapted CBT approaches may lend themselves well to this client group, who may have difficulty in
accessing traditional face-to-face talking treatments and are more likely to have difficulty in attending and
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travelling to appointments. As a result, further exploration of the best way to deliver psychological support
to those who experience psychosis is needed.
This study will address these concerns around service user treatment preferences and modes of delivery for
psychological support. The first phase will begin by investigating hypothetical preferences for psychological
treatment in a sample of individuals experiencing psychosis. This will provide information about the
decision-making process as well as preferred modes of delivery for psychological therapy. The second
phase will consist of a pilot study to explore implementation of the preferred modes of therapy including
development of a recovery-focused self-help package. The information obtained in the first and second
phase will be used to facilitate the final phase of this study: a PPT to evaluate the recovery-focused
self-help package of treatment for people who experience psychosis.
Phase 1: preferences for psychological therapy in psychosis –
trial participation, mode of treatment and willingness to
be randomised
This research has been accepted for publication and reproduced with permission from Sumner K,
Haddock G, Hartley S, Kilbride M, McCusker M, Pitt L, et al. Preferences for psychological therapy in
psychosis: trial participation, mode of treatment, and willingness to be randomised. J Ment Health
2014;23:67–71.186
This is an Accepted Manuscript of an article published by Informa Healthcare in Journal of Mental Health
in 2014, available online: http://informahealthcare.com/doi/full/10.3109/09638237.2013.841865.
Objectives
This study aimed to examine preferences for hypothetical psychological treatment in a sample of people
with experience of psychosis.
The objectives of the study were to examine:
1. participants’ decisions regarding trial participation and reasons
2. preferences for psychological therapy and reasons
3. associations between demographic/symptom characteristics and preferences.
Method
Participants
Participants were included in the study if they were aged 18–65 years, had sufficient English language
skills, were in contact with mental health services, met ICD-10 criteria187 for non-affective psychosis and
had been considered by their clinical team to be symptomatically stable for at least 1 month.
Recruitment
Participants were recruited from community secondary mental health services in three NHS trusts in the
north-west of England. Of 119 service users identified by mental health professionals, 90 gave informed
consent to take part. Participants were interviewed in their home or a clinical service base, receiving £10 as
a token of appreciation.
Measures
Assessments included a sociodemographic questionnaire, the PANSS55 and the GAF77 scale. Inter-rater
reliability was high for the PANSS [ICC coefficient 0.96, 95% confidence interval (CI) 0.93 to 0.98] and
GAF scale (ICC coefficient 0.95, 95% CI 0.85 to 0.99).
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Participants were provided with an information sheet (with counterbalanced presentation) describing
hypothetical treatment options: (1) TAU, (2) self-help manual with telephone CBT and peer support
(weekly 30-minute sessions for up to 6 months) in addition to TAU [self-help and telephone support (SHT)]
or (3) as SHT plus a fortnightly 2-hour group support session for up to 6 months [self-help and group
support (SHG)] facilitated by a psychological therapist and a peer supporter. TAU in secondary care mental
health services typically consists of the provision of support by a care co-ordinator and monitoring of
psychiatric medication. Telephone CBT has been shown to be equivalent to face-to-face CBT in other
populations185 and provides increased flexibility about therapy contact which may be particularly helpful
with this client group; it was offered as an option here as a way of maximising the flexibility for delivery of
CBT. Participants were asked about their hypothetical preferences for participation in a future study,
preferred treatment, willingness to be randomised and reasons for their choices. A qualitative interview
method was chosen to ensure participants’ understanding and allow open-ended responses and
clarification of reasons for preferences.
Data analysis
The data were analysed using SPSS version 17. Missing items were substituted with the mean when
< 10% of the scale items were missing. Comparisons between the groups opting for each of the
treatment options (TAU, SHT or SHG) were performed using chi-squared tests for categorical data, t-tests/
analysis of variance (ANOVA) tests for parametric continuous data, and Mann–Whitney U-tests for
non-parametric continuous data. Owing to the use of multiple comparisons, a stringent significance level
of p< 0.01 was used.
Content analysis was used to explore reasons reported by participants for their choices, which involved
categorising participants’ reasons into mutually exclusive themes188 following discussion with a researcher
with lived experience of mental health challenges. The agreement between two raters (KS and SW) for
each of the categories was as follows: willingness to participate, 84.4%; unwillingness to participate,
69.2%; preference for TAU, 70.6%; preference for SHT, 91.2%; preference for SHG, 73.8%; willingness




Ninety participants were included. The majority of participants were white (n= 77), male (n= 68),
unemployed (n= 63) and met criteria for a diagnosis of schizophrenia (n= 59). The remainder met criteria
for other ICD-10 defined non-affective disorders, for example schizoaffective disorder or delusional
disorder. The mean age of participants was 37.22 years (SD 11.34 years; range 19–63 years). Means for
the clinical measures were 28.6 (SD 7.32) for the PANSS general scale, 14.19 (SD 5.57) for the positive
scale and 12.05 (SD 3.58) for the negative scale, and 47.98 (SD 12.90) for the GAF scale. The median
number of years since first experience of psychosis was 8 years (range 1–34 years) and the median number
of hospital admissions of participants was two (range 0 to ≥ 11 admissions).
Key findings
Participants’ willingness to participate in the proposed PRPT was high and SHT was the most popular
option. Most participants reported that they would prefer not to agree to randomisation. The results are
reported in further detail below, along with the results of the content analysis of participants’ reasons for
their preferences.
Willingness to participate in the proposed PRPT
The majority of participants (90%, n= 81) stated that they would be willing to consider participating
in a PRPT evaluating psychological therapy for psychosis. Results of the content analysis are reported in
Table 40, which illustrates the diversity of participants’ views about participating in a psychological
treatment trial.
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Preferences for treatment
Most of the participants who were willing to participate in the PRPT had a preference for therapy as
opposed to TAU only (Table 41). The telephone support option (SHT) was favoured more than the
telephone plus group support option (SHG). Results of the content analysis highlighting the reasons for this
are displayed in Table 42.
Willingness to be randomised
Of the 81 participants who reported that they would consider taking part in the PRPT, the majority
(57%, n= 46) said they would be unwilling to be randomised to treatment group. Results of the content
analysis highlighting the reasons for this are shown in Table 43.
Characteristics associated with preferences
None of the assessed sociodemographic and clinical variables was found to be significantly associated with
preferences for therapy or willingness to be randomised. Comparisons of those who were willing and
unwilling to participate could not be performed owing to the low number who were unwilling (n= 9).
TABLE 41 Preferences for treatment




No preference 1 1
TABLE 40 Reasons for willingness and unwillingness to participate
Major themes (frequency) Examples
Willingness to participate
1. Benefits to self (n= 46) ‘Anything I can do that might help myself and prevent
future relapses’
2. Benefits to others (n= 42) ‘It gives people a broader view of what’s happening with
mental health problems’
3. To gain information/knowledge/understanding (n= 17) ‘It’s good to have more information from people who have
had the experiences so I know what to do in the future’
4. For an experience/activity/out of interest (n= 15) ‘It’s something to do, I’m unemployed’
5. Desire for social/normalising aspect/sharing experience
(n= 15)
‘I want to socialise with people’
6. Positive view of therapy, manual or group support
(n= 10)
‘The telephone therapy sounds good’
7. Dissatisfaction with current services (n= 2) ‘Psychiatrists forget about you’
Unwillingness to participate
1. Dislike of/lack of desire for aspect of treatment/therapy
in general (n= 9)
‘When I meet with authority figures I feel like more of a
patient than a human being’
2. Potential for distress (n= 2) ‘Discussing my symptoms confuses and depresses me’
3. Satisfaction with current treatment (n= 2) ‘I’m happy with the level of support I receive at the
moment and get quite a lot of support’
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TABLE 42 Themes arising from analysis of reasons for treatment preference
Major themes (frequency) Examples
TAU
1. Dislike of/lack of desire for aspect of therapy/therapy in
general (n= 9)
‘I like to be the one in control, I’m not a sociable person
unless I’ve known someone for a while’
2. Therapy viewed as unnecessary at present (n= 7) ‘I don’t think CBT would do much to help my situation
now, I’m beyond the stage where it would be needed’
3. Satisfaction with current support (n= 5) ‘Because it [usual treatment] works with me’
4. Preference for manual alone (n= 5) ‘I don’t need any telephone support, but having a guide
on its own would be useful’
5 Assist the research (n= 2) ‘I want to help the study’
Self-help with telephone support or SHT
1. Dislike of/lack of desire for group support (n= 31) ‘I don’t like talking about problems in a group’
2. Desire to receive therapy/therapy viewed as helpful
(n= 16)
‘It would be a standard telephone call each week, when
I’m ill I do not seek help so this would be useful’
3. Desire to receive self-help manual (n= 9) ‘The self-help manual seems interesting’
4. Group support unnecessary (n= 8) ‘I don’t feel I need a group at this moment’
Self-help with telephone and group support or SHG
1. Social aspect/normalising/sharing experiences (n= 19) ‘I’m not over the moon about cognitive therapy but I like
the idea of meeting people with the same experiences’
2. Benefits to self/highest level of support is most
beneficial (n= 17)
‘I’d try anything that might help’
3. To gain knowledge/information/understanding (n= 5) ‘I need to know where I’m going and need to know more
about things’
4. For an experience/activity/out of interest (n= 3) ‘Somewhere to go, something to do’
5. Desire for group support (n= 5) ‘The group will be useful and interesting’
TABLE 43 Themes arising from analysis of reasons for willingness and unwillingness to be randomised
Major themes (frequency) Examples
Willingness to be randomised
1. To assist the research/make a contribution (n= 14) ‘To have the opportunity to take part means a lot, to make
a contribution’
2. No strong preference/no urgent need for additional
support (n= 12)
‘I don’t mind, it’s not a problem being chosen or not
chosen’
3. Positive view of randomness/chance/lack of
decision-making (n= 10)
‘I feel safer being randomly chosen’
4. Belief in fairness/all deserve a chance (n= 5) ‘Not everyone can get what they want when they want it’
Unwillingness to be randomised
1. Lack of desire for/dislike of aspect of therapy/therapy in
general (n= 27)
‘I can’t see the point of the other preferences, they
wouldn’t work for me, wouldn’t be productive’
2. Desire to receive preferred option/to have a choice
(n= 21)
‘I might get high support and not want to take that and
then I’d lose the option of low support’
3. Allocation should be based on need/assessment (n= 4) ‘An assessment should be made of a person to see what
they actually need’
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Discussion
Key findings
Hypothetical preferences indicated that willingness to participate in a PRPT of a cognitive–behavioural
psychological treatment for psychosis was high in comparison with other psychiatric research studies.183
Both personal and altruistic benefits were evident, as has been found in other research.181 Reasons for
potential participation included a desire to gain information or understanding, to have a new experience or
activity, or to share experiences with others, suggesting that there may be gaps in service provision in
these areas. Reasons for non-participation in the future trial largely reflected a negative view of the
treatment offered, or satisfaction with current treatment, consistent with a cost–benefit analysis.
The majority of the sample had a preference for therapy in addition to TAU, consistent with previous
research regarding psychological therapy for other mental health problems.190 The telephone support
condition (SHT) was more popular than the telephone plus group support option (SHG), although
considerable numbers of participants opted for each. A substantial number of participants opted for TAU
alone, in contrast with previous findings.178 Many of those who opted for TAU in the current study
reported perceived lack of need or desire for the additional therapy. Reasons for preferring SHT indicated
a desire to receive therapy or gain information and the lack of desire for group support, often due to a
specific dislike of group situations. In contrast, reasons for preferring SHG often reflected a positive view of
the social or group support, or the higher level of support available. Notably, participants’ reasons for their
treatment preferences showed wide individual variation.
Most participants reported unwillingness to be randomised, (in line with King et al.’s175 review) and cited a
desire to receive the preferred treatment or for allocation to be based on necessity, or therapy being
viewed as unhelpful. Reasons for willingness to be randomly allocated included altruistic reasons, a
personal positive belief in chance and the absence of a strong preference. Participants seemed able to
understand randomisation despite previous research191 indicating that this may not be the case. None of
the sociodemographic and clinical variables measured was significantly associated with preferences,
supporting the need for an individualised approach.
Limitations
The sample may be biased owing to recruitment via mental health services, although it is likely that
findings are generalisable to future similar trials. Further, the reported high rate of willingness to
participate in the proposed PRPT may reflect participants’ general acceptance of research. Bespoke,
non-validated measures were used to determine preferences, which is not ideal. In addition, hypothetical
rather than actual preferences were assessed, although the two have been found to be relatively
consistent.192 It is possible that cognitive functioning (which was not assessed) and/or the presence of
symptoms may have impacted on participants’ ability to make decisions.193 However, participants were able
to give coherent reasons for their preferences, and clinical severity was not related to preferences.
Implications for research and clinical practice
The findings indicate that many service users with experience of psychosis welcome choice about
psychological treatment and highlight the importance of individual differences. Future research may involve
the more detailed investigation of the PRPT design (including feasibility and statistical considerations and
differences in outcomes compared with RCTs), in-depth qualitative research, development of standardised
measures of preferences and interventions to improve the understanding of research. Finally, it would be
of interest to determine whether or not the participants’ stated hypothetical preferences and reasons are
reflected in real decisions.
This research adds to the growing literature regarding psychological treatment for individuals with
experience of psychosis, for which the ethics of treatment choice may be particularly pertinent owing to
the experience of marginalisation. The results indicate that preference trials are feasible in terms of overall
popularity and proposed treatment options, including TAU. Randomisation was often viewed negatively;
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therefore, preference designs may enhance recruitment and prevent ‘resentful demoralisation’.170
Preferences were not associated with any of the variables measured, suggesting that it is difficult to predict
preferences on the basis of individual characteristics and that all service users should be supported to state
their choices.
Phase 2: a proof of concept study of a recovery-focused
self-help package for people with psychosis
Objectives
This study aimed to obtain information to facilitate the implementation of a PPT to evaluate a
recovery-focused self-help package of treatment for people who experience psychosis.
The main objectives of the proof of concept study were as follows:
1. To determine the appropriateness and perceived usefulness of the manual and telephone help by
monitoring the number of people who refuse participation, the number of sessions when clients are
available, any problems arising concerning telephone access and from gaining feedback from clients
participating in the study.
2. To determine in what ways the manual and delivery modes might be modified to increase the perceived
appropriateness and usefulness of the manual and telephone help.
Method
Pilot study context and design
This self-help therapy and recovery proof of concept study constituted phase 2 of project 4 in the recovery
programme of research. This followed from phase 1 work developing the self-help recovery guide for
psychosis and exploring people’s hypothetical preferences for different levels of therapeutic support. The
proof of concept study used a randomised design whereby participants were allocated to either receive
TAU or extra therapeutic support in the form of the recovery guide plus telephone CBT provided in
30-minute sessions over 6 months, in addition to monthly peer support sessions. Participants met with a
researcher at the start of the project and at 6 months and 12 months to assess their experiences,
emotions, functioning and recovery using a range of measures.
Recruitment
The proof of concept study aimed to recruit 30 participants from three NHS trusts: Pennine Care, Greater
Manchester West and Manchester Mental Health and Social Care Trust. Participants met the following
inclusion criteria:
l aged 18–65 years
l in contact with mental health services
l met ICD-10 criteria for non-affective psychosis (schizophrenia, schizophreniform disorder,
schizoaffective disorder, delusional disorder)
l at least 1 month of stabilisation if the person had experienced a symptom exacerbation in the last
6 months
l able to provide written informed consent
l able to read the self-help manual/assessments
l able to use the telephone.
Results
In total, 29 participants were recruited over a 6-month period. Figure 7 details the recruitment progress of
those initially identified as potentially eligible.
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Retention and therapy uptake
Of the 29 people in the study at the start, 27 were followed up at 6 months and the full 29 were followed
up at 12 months, demonstrating an excellent retention rate for the project as a whole.
As a result of the random allocation, 15 people continued with their TAU with no extra support provided
by the project and 14 people were offered therapy and peer support sessions and the recovery guide.
Therapy session uptake
Of the whole therapy sample:
l mean number of therapy sessions conducted: 14
l mean number of therapy sessions offered: 17
l mean per cent of therapy sessions conducted, of those offered: 79%
l number of withdrawals from therapy: 5 (out of 14).
Among those who did not withdraw:
l mean number of therapy sessions conducted: 17
l mean per cent of therapy sessions offered: 20
l mean per cent of therapy sessions conducted, of those offered: 87%.
Sections of the guide used
The session notes of those participants in therapy were reviewed in order to discern which guide sections
were utilised. A summary of this information is provided in Figure 8, showing that most participants were
able to utilise chapters 1 and 2 of the self-help guide, and a good proportion also used additional chapter 3
sections (chapter 1, What is Recovery from Psychosis, chapter 2, Making Sense of Yourself and chapter 3,
Your Current Situation).
Quantitative analyses
An additional aim of the pilot study was to assess the potential impact of the guide and therapy on
people’s functioning, recovery and experiences of psychosis.
The primary outcome was a measure of recovery; the QPR.32 Analysis of the data showed that there were
no significant differences between the therapy and TAU groups on the QPR measure at baseline, 6 months
or 12 months. Other measures showed variations in their initial starting scores and change scores.
Allocation group (i.e. TAU vs. therapy) significantly predicted 12-month follow-up scores while controlling



















FIGURE 7 Recruitment rates and refusals.
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general symptoms of psychosis. Those in the therapy condition had higher mean scores on these measures
at 12 months, which suggested the possibility that the additional therapy (consisting of a combination of
the recovery guide, telephone-delivered CBT and peer support) actually hindered recovery. When we only
included those people in the therapy group that had more than five therapy sessions in total, only the
effects for negative self-esteem and general symptoms of psychosis remained significant.
The possibility that this intervention was delaying recovery was considered by the study team and the
independent DMC. However, it was decided that the small sample size of the study made it difficult to
make any firm conclusions on the basis of these analyses. Given that the preference design of the next
phase meant that people were able to choose which arm of the trial they were allocated to and the
qualitative feedback (see Qualitative feedback) was largely positive, it was decided that the next phase
was merited.
Qualitative feedback
Feedback interviews were conducted by a service user researcher with four participants receiving telephone
therapy. The interviews explored participants’ views on the guide (Table 44), telephone therapy (Table 45),
reasons for taking part, peer support (Table 46), CBT model and suggestions for changes. A selection of














































FIGURE 8 Sections of the guide used.
TABLE 44 The guide
Positives Negatives
Good to see other people I could identify with
Written in clear and easy to understand language
Being able to work at your own pace was good
Provided different techniques for getting better
Got a sense of pride, sense of achievement, another
string to your bow
It has been a great help. I do feel it has aided me in my
first steps to recovery. If I hadn’t got the guide and
help – I don’t know where I would be now – I think
things would probably have got a lot worse
A lot of reading in the first few sections which I wasn’t
keen on
I didn’t like the scales, I could be a 5 on one day and the
next day I could be a 2. I left a lot of them blank. I am not
keen on them personally
A bit more demanding than I thought – filling in the
different sections and thinking about my mental health
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amount of comments in each category). Many suggestions were incorporated in revisions for the current
trial, including reducing the amount of text, reducing the number of rating scales to complete, adding
more blank copies of formulation diagrams and tables, offering longer and more telephone sessions and
offering group sessions.
Conclusions
Attrition from the study was low and uptake of sessions offered was high, providing support for the
appropriateness of the materials and mode of delivery. Moreover, qualitative feedback indicated a high
degree of satisfaction from service users who participated in the therapy and provided useful information
on how the materials and therapy delivery might be changed in order to better meet service user needs.
The small sample size of the study makes it difficult to make any conclusions about the efficacy of the
therapy in terms of service user outcomes.
Phase 3: a preference trial of recovery-focused
cognitive–behavioural therapy for psychosis delivered over the
telephone with support from a self-help guide and group
sessions (Self-help Therapy and Recovery Trial)
Objectives
This study aimed to evaluate a self-help recovery intervention that was jointly developed and delivered by
service users and CBT therapists, in the context of a PPT.
The Self-help Therapy and Recovery Trial (STAR-T) aimed to bring together factors of recovery, CBT, service
user involvement and patient preference to evaluate a self-help recovery intervention that was jointly
developed and delivered by service users and CBT therapists, in the context of a PPT for individuals who
experience psychosis.
TABLE 46 Peer support
Positives Negatives
Nice to have someone prepared to listen
Gives you a different angle from the therapy angle to talk
more generally and not as structured a conversation
Good that is unstructured because I can say what I want but
bad if you don’t know what you are going to talk about
Gave me a sense of camaraderie
Found it quite stressful at time but not right not to
have it
Frequencies of contact not as great so could
be stressful
TABLE 45 Telephone therapy
Positives Negatives
Easier in some ways than face to face – can put phone down
and stop talking, have a cigarette and coffee if nervous
Meeting person (therapist and peer supporter) helps you touch
base and get an image of the person
Built a positive relationship with therapist despite being wary
to start with about telephone therapy
Felt it helped – could get my point across, therapist made
some good suggestions and helped with the guide
Hard getting used to talking to someone on phone
but got used to it
Would prefer face to face therapy – you don’t get
face to face contact – can’t read body language
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Recruitment was undertaken in three North West England NHS Trusts: Greater Manchester West Mental
Health NHS Foundation Trust, Manchester Mental Health and Social Care Trust and Five Boroughs
Partnership NHS Foundation Trust.
Participants met the following inclusion criteria:
l ICD-10 diagnosis of a schizophrenia spectrum disorder
l aged 18–65 years
l in contact with mental health services
l able to use the telephone
l able to read English
l able to provide written informed consent
l at least 1 month of stabilisation if the person has experienced a symptom exacerbation in the last
6 months.
Design
The STAR-T trial had three arms: TAU, low-support treatment (self-help recovery guide plus weekly CBT
sessions delivered over the phone) and high-support treatment (the same as the low-support treatment,
plus group therapy sessions). Participants were able to either choose their preferred treatment arm or they
could choose to be randomised to treatment.
Procedure
Informed, written consent was obtained from all participants prior to the initiation of any assessment.
All participants were given a payment of £10 for each assessment set as a token of appreciation.
Assessments were carried out at three time points: baseline, 9 months after baseline (post therapy) and a
final follow-up at 15 months after baseline. Following the completion of the assessment procedures,
participants were contacted by the trial manager, who conducted a semistructured interview to ascertain
participants’ preferences for allocation. Participants were provided with an information sheet listing the
four options (TAU, low-support treatment, high-support treatment or randomisation) and a short
description of each. Based on the information gathered during this interview, participants were either
allocated to their preferred therapy option or randomised to receive one of the therapy options.
Randomisation was conducted remotely by an independent clinical trials unit and was performed using
random permuted blocks.
Measures
Trial feasibility outcome: we will consider whether or not the trial design permitted the planned
comparisons between randomised and non-randomised participants.
Primary outcome measure: QPR.92
Secondary outcome measure: SEPS.71
Other measures: included those of general symptom severity, delusion and hallucination severity,
depression and anxiety. General symptom severity was assessed using the PANSS55,154,194 and delusion and
hallucination severity was assessed using the PSYRATS,72 with PANSS scores.195
Sociodemographic information was gathered relating to ethnicity, living arrangements, employment or
education, marital status and religious beliefs.
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Intervention
There were three intervention arms in the current study: TAU, low support and high support. TAU
consisted of participants receiving their usual care only, alongside assessment visits at baseline, 9 months
and 15 months. The low-support and high-support interventions were both provided in addition to usual
care and assessments over 9 months. Low support consisted of the provision of the recovery guide,
alongside weekly recovery-focused cognitive–behavioural therapy (RfCBT) sessions, which lasted
approximately 45 minutes and were delivered over the telephone.
The recovery guide is a supported self-help resource that includes two core chapters (relating to the
meaning of recovery, goals, resources and understanding the development of problems) and two chapters
with numerous optional sections to facilitate work on overcoming obstacles (such as anxiety, paranoia, low
self-esteem) or reaching wider recovery goals (such as finding employment, enjoying oneself and relaxing,
developing social networks). The recovery guide was developed over approximately 1 year. It was
produced in collaboration with both service users and staff from community-based mental health teams
including EISs and CMHTs. Focus groups were held with both sets of participants in order to elicit what
relevant questions such a guide should address and what kind of information would be useful in
addressing these topics. In addition, several service users read drafts of the individual sections of the guide
and provided extensive feedback in both written form and via additional focus groups. Participants were
given the opportunity to work on the guide independently and also within telephone therapy sessions.
Participants in phase 1 of the trial also received up to five sessions of peer support, provided by a
researcher with lived experience of mental health challenges and delivered over the telephone.
The high-support arm consisted of all of the same elements of the low-support arm, with the addition of
group sessions. Group sessions were delivered over 6 months of the 9-month therapy window and were
offered roughly every 2 weeks, lasting 2 hours. Participants in the high-support arm attended a local
group alongside two facilitators: a therapist and a researcher with lived experience of mental health
challenges. The sessions followed the ethos of the recovery guide, exploring issues relating to recovery,
cognitive–behavioural principles, normalising experiences and also provided a venue for participants to
share ideas and experiences.
Therapy manuals for the purpose of replication and the fidelity scale used to assess therapist adherence to
the intervention are available from the first author.
Analysis
The aim of the analysis was to evaluate the effects of the interventions and to assess whether or not they
were unaffected by the mechanism of treatment selection (that is, by patient preference or random
allocation). In the absence of significant numbers of participants accepting randomisation (see Preferences)
this aspect of the analysis plan had to be abandoned. The outcome data were analysed using appropriate
regression (analysis of covariance) models in order to assess the effects of treatment receipt, regardless
of the mechanism of treatment selection, using several baseline covariates to allow for any possible
confounding of the effect of treatment receipt on outcome. All analyses were carried out using Stata.
Results
The primary outcome analysis is provided in Table 47, as well as the demographic and therapy allocation data.
Preferences
Figure 9 shows the distribution of chosen treatment choices within the trial. Three participants were
randomised to treatment arm while the rest were allocated to their therapy of preference.
A total of 89 subjects chose (n= 86) or were randomised (n= 3) to treatment. Of those who were
randomised, one participant was allocated to each group. One subject who chose TAU but changed to
low support was assigned to their original choice (i.e. TAU) for the provision of summary statistics and all
the analyses.
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TABLE 47 Participant characteristics at the time of consent
Variable n %
Age (years)






Black/minority ethnic group 13 14
Mixed race 4 4
Not reported 2 2
Occupation
Employed/studying 24 73
Not working/studying 69 25
Not reported 2 2
Education
Education post 16 years 51 44
No education post 16 years 42 54
Not reported 2 2
Living arrangements
Alone 60 63
With family members/partner 31 33
Supported accommodation 2 2
Not reported 2 2
Martial status
Married/civil partnership/cohabiting 10 11
Single 83 87
Not reported 2 2
Diagnosis
Schizophrenia 39 41
Schizoaffective disorder 12 13
Psychosis NOS 35 36
Delusional disorder 3 3





NOS, not otherwise specified.
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In order to evaluate the predictors of patient treatment choice, a multinomial regression model was fitted
with a trinary outcome (TAU, low support or high support) for the 86 subjects who chose their therapy.
The model included the following treated as quantitative variables: age, education, baseline scores for
PANSS positive and PSP, and sex as a categorical variable. The relative risk ratio was significant for PANSS
positive at baseline for the high support vs. TAU outcomes (p= 0.046) and sex was marginally significant
for this comparison (p= 0.063).
Primary outcomes analyses
In all outcome analyses the baseline score was entered as a covariate along with baseline PANSS positive
and PSP totals. Consistent with the choice model above, age, education and sex were also included in
each linear regression model.
Table 48 shows the estimated treatment effects from fitting models to the three primary outcomes at
9 and 15 months as choice or randomisation to therapy.
Considering all three treatment groups at 9 months, there was no evidence of an overall treatment effect
for the QPR total primary outcome (p= 0.58). For QPR total, the adjusted mean difference comparing high
support to low support was –0.86 units meaning that on average the high-support group were less
recovered on QPR but this was not significant (p= 0.82). Comparing high support and low support with
TAU, the adjusted mean difference was –2.70 units, that is, on average the ‘extra’ support group were less
recovered on QPR, but this was not significant (p= 0.30).
At 15 months there was no overall treatment effect for QPR total (p= 0.82). The adjusted mean difference
comparing high support with low support was –0.29 units meaning that on average the high-support
group were less recovered than low support but this was not significant (p= 0.94). The estimated mean
difference between ‘extra’ support and TAU was 1.75, but non-significant (p= 0.53).
Missing primary outcome data and sensitivity analyses
The extent of missing follow-up QPR total data is shown in Table 49. For each treatment allocation, a
separate logistic regression model was fitted using the same covariates as in the choice and standard
outcomes model to predict who provided QPR total outcome data 9 months after baseline completion.
Each model was used to generate an expected probability of providing outcome data and the reciprocal of
this estimated probability was used as an inverse probability weight for use in sensitivity analyses of the
9-month primary QPR outcome. The same procedure was undertaken for the intrapersonal and









FIGURE 9 Treatment allocation on the basis of stated preferences.
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TABLE 48 Summary of primary outcomes analyses at 9 and 15 months
Month 9 Treatment comparison
Treatment difference
(score difference) SE p-value 95% CI lower 95% CI upper
QPR Overall 0.577
LS–TAU –2.42 2.90 0.406 –8.22 3.38
HS–TAU –3.28 3.61 0.367 –10.50 3.94
HS–LS –0.86 3.68 0.817 –8.23 6.51
HS and LS–TAU –2.70 2.61 0.304 –7.93 2.52
QPRIntra Overall 0.576
LS–TAU –1.76 2.40 0.466 –6.56 3.04
HS–TAU –2.89 2.95 0.332 –8.80 3.02
HS–LS –1.13 3.03 0.71 –7.19 4.93
HS and LS–TAU –2.14 2.15 0.324 –6.45 2.16
QPRInter Overall 0.501
LS–TAU –0.84 0.71 0.242 –2.26 0.58
HS–TAU –0.45 0.88 0.616 –2.21 1.32
HS–LS 0.39 0.88 0.659 –1.38 2.16
HS and LS–TAU –0.71 0.64 0.274 –2.00 0.58
Month 15 Treatment comparison Treatment difference SE p-value 95% CI lower 95% CI upper
QPR Overall 0.821
LS–TAU 1.83 3.02 0.548 –4.25 7.91
HS–TAU 1.54 3.96 0.699 –6.42 9.50
HS–LS –0.29 3.95 0.942 –8.23 7.65
HS and LS–TAU 1.75 2.77 0.531 –3.82 7.31
QPRIntra Overall 0.753
LS–TAU 1.99 2.64 0.453 –3.31 7.30
HS–TAU 0.94 3.62 0.796 –6.34 8.22
HS–LS –1.05 3.65 0.775 –8.39 6.29
HS and LS–TAU 1.71 2.42 0.483 –3.16 6.58
QPRInter Overall 0.361
LS–TAU –0.09 0.71 0.903 –1.51 1.34
HS–TAU 1.15 0.90 0.208 –0.66 2.97
HS–LS 1.24 0.91 0.18 –0.58 3.06
HS and LS–TAU 0.30 0.66 0.653 –1.02 1.62
HS, high support; LS, low support.
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This method assumes that for subjects with a particular combination of baseline covariates the value of the
outcome is independent of whether observed or not (‘missing at random’ assumption). The results of
fitting the regression models with inverse probability weights showed no evidence of significant difference
between these results and the basic approach.
Secondary outcomes analyses
The same basic analyses were performed on a pre-specified selection of secondary outcomes: four out of
the six SEPS subscales and PANSS positive and negative subscales; the results are shown in Table 50.
Inverse probability weight sensitivity analyses were not performed. The only significant result was for the
SEPS negative experience outcome at 15 months for which there was an estimated difference in adjusted
means comparing high support with TAU of 16.85 units (95% CI 1.36 to 32.35; p= 0.03) (Table 51).
Discussion
Unfortunately, as the trial was unable to compare treatment effects, both with and without randomisation
to treatment, the data analysis had to be based on what, in effect, was an underpowered observational
study, subject to all of the threats to its validity that such a study entails. It appears that, although patients
had a strong preference for particular treatments, there is little evidence that it had any effect on their
outcomes. The interventions appeared to be ineffective despite the likely selection effects (confounding)
induced by letting the participants have their preferred treatment. The failure to randomise also has
important implications for future evaluations of these interventions and there is little to suggest that an
appropriately designed randomised trial would be feasible.
The STAR-T trial is the first PPT to be conducted with people who experience psychosis and, therefore,
service user preferences, in terms of therapy allocation, are of particular interest. Only 3 out of the 89
participants chose to be randomised, showing that participants had strong preferences about their
treatment. This finding suggests that services may need to assess treatment preferences and offer
increased flexibility in what they offer, to provide service users with informed choice and involve individuals
in collaborative health-care decisions, as recommended by national guidelines for the treatment of
psychosis.14 However, it is also worth noting that, although the participants were able to choose their form
of treatment, our trial showed little evidence that such choices effected outcomes or engagement.
Historically, people who experience psychosis may not have been involved in many treatment decisions,
despite the majority of patients being able to make safe and appropriate choices about their treatment.196
However, informed and shared decision-making can increase feeling of empowerment and positive
self-esteem197 to key aspects of user-defined recovery from psychosis.19 It seems likely that if individuals are
receiving a treatment they have chosen, uptake rates will be higher and may also aid the process of recovery,
as well as improving therapeutic relationships with clinical staff; however, we did not observe this in our trial.
Treatment preferences within the trial were surprisingly balanced, with a third of participants choosing
their TAU, suggesting that many participants were happy with the treatment they were receiving and did
not want any additional psychological support. These were found to be the main reasons for participants
not choosing therapy in a qualitative study of theoretical patient preferences completed by Sumner et al.186
in preparation for the STAR-T trial. This has additional clinical implications and reflects the fact that not
everyone feels they would benefit from psychological therapy.
TABLE 49 Missing QPR data by follow-up month
Month TAU, n (%) LS, n (%) HS, n (%)
9 6 (18.2) 7 (21.2) 10 (43.5)
15 10 (30.3) 10 (30.3) 12 (52.2)
HS, high support; LS, low support.
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LS–TAU 2.97 7.41 0.691 –11.91 17.84
HS–TAU 6.58 9.84 0.507 –13.17 26.32
HS–LS 3.61 9.73 0.712 –15.92 23.14




LS–TAU –1.31 4.17 0.754 –9.69 7.06
HS–TAU 0.93 5.13 0.856 –9.36 11.23
HS–LS 2.25 5.32 0.674 –8.43 12.92




LS–TAU –0.18 0.66 0.788 –1.49 1.14
HS–TAU 0.68 0.84 0.422 –1.01 2.37
HS–LS 0.86 0.84 0.313 –0.83 2.55




LS–TAU 1.56 1.04 0.140 –0.53 3.64
HS–TAU 1.42 1.32 0.285 –1.22 4.07
HS–LS –0.13 1.30 0.919 –2.75 2.48
HS and LS–TAU 1.52 0.95 0.116 –0.39 3.42
PANSS Overall 0.553
Positive LS–TAU 0.02 0.80 0.981 –1.59 1.63
HS–TAU 1.05 1.03 0.311 –1.01 3.10
HS–LS 1.03 1.04 0.325 –1.05 3.11
HS and LS–TAU 0.34 0.74 0.647 –1.13 1.81
PANSS Overall 0.385
Negative LS–TAU –0.89 0.92 0.339 –2.74 0.96
HS–TAU 0.70 1.25 0.580 –1.81 3.20
HS–LS 1.59 1.24 0.204 –0.89 4.06
HS and LS–TAU –0.47 0.87 0.593 –2.20 1.27
HS, high support; LS, low support.
a Treatment differences are adjusted for age, sex, education and baseline scores for PANSS positive, PSP and the
corresponding baseline score for each outcome.
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LS–TAU –2.40 7.72 0.758 –17.94 13.15
HS–TAU 12.09 10.54 0.257 –9.13 33.31
HS–LS 14.49 10.55 0.176 –6.74 35.72




LS–TAU 6.46 6.04 0.290 –5.69 18.61
HS–TAU 16.85 7.70 0.034 1.36 32.35
HS–LS 10.39 8.27 0.215 –6.26 27.05




LS–TAU –0.19 0.64 0.772 –1.47 1.10
HS–TAU 0.22 0.81 0.792 –1.42 1.85
HS–LS 0.40 0.81 0.624 –1.23 2.04




LS–TAU 1.00 1.05 0.349 –1.12 3.11
HS–TAU 2.66 1.37 0.058 –0.09 5.41
HS–LS 1.66 1.43 0.251 –1.22 4.54
HS and LS–TAU 1.52 0.95 0.118 –0.40 3.44
PANSS Overall 0.451
Positive LS–TAU 1.03 1.11 0.361 –1.21 3.26
HS–TAU 1.70 1.45 0.245 –1.21 4.61
HS–LS 0.68 1.42 0.636 –2.18 3.54
HS and LS–TAU 1.22 1.03 0.240 –0.84 3.28
PANSS Overall 0.971
Negative LS–TAU –0.20 0.93 0.831 –2.07 1.67
HS–TAU 0.03 1.31 0.982 –2.60 2.66
HS–LS 0.23 1.28 0.860 –2.35 2.81
HS and LS–TAU –0.14 0.87 0.869 –1.89 1.60
a Treatment differences are adjusted for age, sex, education and baseline scores for PANSS positive, PSP and the
corresponding baseline score for each outcome.
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Within this trial, there were no significant differences in outcome between groups. However, at the
15-month follow-up, the majority of participants remained stable regardless of treatment group. Given
that this is a group with typically high rates of relapse,198 it is possible that by choosing their own
treatment, people received the level of support they needed and this was sufficient to keep them stable
over a significant period of time; however, it is also likely that people remained stable owing to the
benefits associated with participation in a clinical trial.199
Attendance rates in the high-support group were particularly poor and this may be owing to a number of
issues. The concept of low-support therapy (self-help manual and telephone support) was originally
appealing to many services users as it meant therapy could be received at home and at a time that was
convenient for them. Therefore, it may be the case that although participants liked the idea of receiving
additional support through the high-support group therapy sessions, practical access and organisational
issues may have affected attendance. In addition, those who chose high-support therapy were more likely
to have increased positive symptoms (compare with those who chose TAU). This may have been why these
individuals felt the need for additional support but may have also added to access difficulties.
In addition, while many individuals may have liked the idea of receiving additional support, the social
aspects of the group therapy may have been difficult for some individuals. Future work should consider
ways in which participants could receive extra help, without the potential pressure of a group situation,
perhaps through additional one-on-one sessions with a service user researcher (with lived experience of
psychosis) or through additional telephone sessions.
High-support therapy was chosen by the fewest number of participants and also had the highest rates of
attrition. This, combined with the lack of significant treatment effects, may reflect that although having
treatment choice was acceptable to service users, the therapy itself may need additional refinements.
However, the findings from this trial show that people who experience psychosis have strong preferences
about treatment and services should consider additional flexibility in treatment options, as well as shared
decision-making, to accommodate this. The concept of service user-defined recovery remains somewhat
subjective and it may be the case that the outcome measures were not sufficiently sensitive to individual
changes during the trial. It is also possible that the power was underpowered to detect such changes;
however, our results suggest that the interventions, as currently developed, did not effect recovery
outcomes. Therefore, further work is needed to develop and refine recovery-focused treatment strategies,
in order to ensure we have evidence-based psychological interventions, which are focused on the
preferences and needs of service users.
Conclusions
This chapter contained studies that aimed to explore service user treatment preferences and modes of
delivery of psychological support. The research was conducted in three phases:
1. an investigation of hypothetical preferences for psychological treatment in a sample of individuals
experiencing psychosis
2. a pilot study to explore implementation of the preferred modes of therapy including development of a
recovery-focused self-help package
3. a PPT to evaluate the recovery-focused self-help package of treatment for people who
experience psychosis.
The research studies within this chapter are the first to explore treatment preferences in relation to
recovery. The studies also contributed to the development of a collaboratively designed supported self-help
resource known as the recovery guide. The recovery guide is a supported self-help resource that includes
two core chapters (relating to the meaning of recovery, goals, resources and understanding the
development of problems) and two chapters with numerous optional sections to facilitate work on
overcoming obstacles (such as anxiety, paranoia, low self-esteem) or reaching wider recovery goals (such as
finding employment, enjoying oneself and relaxing, developing social networks).
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The first phase of this research found that, hypothetically, participants were willing to participate in a
partially randomised preference trial of a cognitive–behavioural psychological treatment for psychosis, with
reasons for potential participation including a desire to gain information or understanding, to have a new
experience or activity, or to share experiences with others. Reasons for non-participation in the future trial
largely reflected a negative view of the treatment offered or satisfaction with current treatment, consistent
with a cost–benefit analysis.
The majority of the sample had a preference for therapy in addition to TAU and the telephone support
condition (SHT) was more popular than the telephone plus group support option (SHG), although
considerable numbers of participants opted for each. A substantial number of participants opted for TAU
alone and reported a perceived lack of need or desire for the additional therapy. Participants’ reasons
for their treatment preferences showed wide individual variation. Most participants reported unwillingness
to be randomised (in line with the review by King et al.175) and cited a desire to receive the preferred
treatment or for allocation to be based on necessity, or therapy being viewed as unhelpful. None of the
sociodemographic and clinical variables measured was significantly associated with preferences, supporting
the need for an individualised approach.
The second phase of this research was a pilot study to evaluate the feasibility of the therapy package and
modes of delivery. Attrition from the study was low and uptake of sessions offered was high, providing
support for the appropriateness of the materials and mode of delivery. Moreover, qualitative feedback
indicated a high degree of satisfaction from service users who participated in the therapy and provided
useful information on how the materials and therapy delivery might be changed in order to better meet
service user needs. The small sample size of the study makes it difficult to make any conclusions about the
efficacy of the therapy in terms of service user outcomes.
The final phase of this research utilised the information on patient preferences and modes of delivery of
therapy from the first two phases, to conduct a partially randomised preference trial. Only 3 out of the
89 participants in the study chose to be randomised, showing that participants had strong preferences
about their treatment. Unfortunately, as the trial was unable to compare treatment effects, both with
and without randomisation to treatment, the data analysis had to be based on what, in effect, was an
underpowered observational study, subject to all of the threats to its validity that such a study entails. It
appears that, although patients had a strong preference for particular treatments, there is little evidence
that it had any effect on their outcomes. The interventions appeared to be ineffective despite the likely
selection effects (confounding) induced by letting the participants have their preferred treatment. The
failure to randomise also has important implications for future evaluations of these interventions and there
is little to suggest that an appropriately designed randomised trial would be feasible.
The research in this chapter indicates that many service users with experience of psychosis welcome choice
about psychological treatment, suggesting that services may need to assess treatment preferences and
offer increased flexibility in what they offer, to provide service users with informed choice and involve
individuals in collaborative health-care decisions, as recommended by national guidelines for the treatment
of psychosis.14 However, it is also worth noting that, although the participants were able to choose their
form of treatment, our trial showed little evidence that such choices effected outcomes or engagement.
The research also highlights the importance of individual differences and adds to the growing literature
regarding psychological treatment for individuals with experience of psychosis, for which the ethics of
treatment choice may be particularly pertinent owing to the experience of marginalisation. Feedback from
participants suggests that the recovery guide may be a useful resource for provision of supported self-help
in clinical services.
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Chapter 6 Development and evaluation of a
cognitive–behavioural approach to understanding
and preventing suicide in people with psychosis
Background
Suicide and suicide behaviour are of substantial public and social concern. It is well established that risk of
suicide is considerably elevated in those suffering from schizophrenia and psychosis.6,200,201 Suicide ideation
and suicide attempts are common, with up to 50% of patients experiencing suicidal ideation at any point
in time or having a history of previous attempts.3,6 The psychological processes underlying suicidal ideation,
as well as resilience to suicide, are key areas for research in order to advance our understanding of
suicide behaviour.
It is assumed that there is a progressive continuum from ideation, intent, action and completion.200 Thus,
suicidal ideation is a risk factor for self-harm and completed suicide and a legitimate clinical target in its
own right. A meta-analysis of cognitive–behavioural interventions to reduce suicide behaviour202
demonstrated that individual, but not group, CBT was effective in significantly reducing suicide behaviour
in adults, but not adolescents, in the short and medium term. This result held despite considerable
variability both in the target populations and in the CBT interventions. However, there is a paucity of
studies that have attempted to diminish suicide behaviour in psychosis, despite the well established high
risk in this group. CBTP reduces positive and negative symptoms of psychosis, depression and anxiety but
has less effect on hopelessness203 and suicidality.42 Psychological interventions are most likely to be
successful when they are clearly derived from a theoretical understanding of underlying mechanisms.200,204
Advances in understanding the cognitive architecture underpinning suicidality have resulted in the
development of empirically validated theoretical models, such as the Schematic Appraisal Model of Suicide
(SAMS),204,205 which was modified from the Cry of Pain model.206 The SAMS has three core psychological
components, namely the presence of negative information processing biases, extensive ‘suicide schema’
and a negative and suicide-focused appraisals system.204 To date, empirical evidence supports a multitiered
appraisals system together with the operation of suicide schema in people experiencing suicidality,
psychosis and post-traumatic stress disorder.207–210 The Cognitive–Behavioural Suicide Prevention in
Psychosis (CBSPp)211 was founded on the SAMS. Thus, the specific cognitions targeted by CBSPp are
information processing biases and appraisals of defeat, entrapment, emotional dysregulation, social
isolation and poor interpersonal problem-solving.211 Although CBSPp arose from work with psychosis and
post-traumatic stress disorder, it has the potential to be applied transdiagnostically.211
Further research to investigate the efficacy of CBSPp is warranted. However, there are reservations about
research among individuals diagnosed with schizophrenia,212 which have been endorsed by both
psychiatrists and service users alike.213 These participants may be at further risk from experiencing distress
when the research concerns sensitive subjects such as trauma or suicide.214 Further investigation of the
experience of participants diagnosed with schizophrenia spectrum disorders, particularly when taking part
in research on the topic of suicide is therefore warranted.
This chapter describes the three study phases used to develop and investigate the efficacy of CBSPp. First,
a qualitative, open-ended methodology was employed to explore the nature and variety of the negative
and positive experiences reported by participants taking part in a clinical study researching psychosis and
suicide. This study was conducted based on recommendations from the SURG on the importance of
investigating the feasibility and acceptability of asking people with experience of psychosis and suicidality
to take part in research trials. The study was designed to assess potential feasibility for the main trial and
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to inform the nature and conduct of the subsequent phases of this project. In the second phase,
psychological processes underlying suicide behaviour and resilience factors in a sample of participants with
schizophrenia spectrum disorders were investigated. Phase 1 was used to inform the methodology and
feasibility of the CBSPp RCT and phase 2 was used to inform the development of the CBSPp intervention.
Finally, the third phase utilised a RCT to evaluate the CBSPp.
Phase 1: the subjective experience of participation in
schizophrenia research
This research was previously published as, and much of this text is reproduced with permission from,
Taylor PJ, Awenat Y, Gooding P, Johnson J, Pratt D, Wood A, et al. The subjective experience of
participation in schizophrenia research: a practical and ethical issue. J Nerv Ment Dis 2010;198:343–8.215
Objectives
This study aimed to investigate the subjective experiences of research participation in individuals with a
diagnosis of a psychotic disorder. The focus was on the experiences of participants taking part in a clinical
study researching psychosis and suicide.
Method
Participants
The sample consisted of 79 outpatients from the Greater Manchester area who consented to take part in
a larger study investigating psychological factors predicting vulnerability to suicide (mean age= 42.3 years,
SD= 11.7 years; 23 women). All participants met the following inclusion criteria: (1) a chart diagnosis
(ICD-10) of a schizophrenia spectrum disorder; (2) being over the age of 18 years; (3) psychosis not caused
primarily by drug misuse or organic disorder; (4) currently not at very high risk of suicide as judged by their
keyworker or other appropriate health-care professional; and (5) capable of providing informed consent as
judged by their keyworker or other appropriate health-care professional. The majority of participants had a
diagnosis of schizophrenia (n= 72, 91.1%). The remainder had received diagnoses of other schizophrenia
spectrum disorders (e.g. schizoaffective disorder, atypical psychosis, and psychosis not otherwise specified).
The majority of participants were white British (n= 63, 79.7%), with the remainder being either mixed
British (n= 6, 7.6%), Asian (n= 3, 3.8%), Afro-Caribbean (n= 1, 1.3%), or other (n= 4, 5.1%). Ethnicity
data were missing for two participants.
Measures
A feedback form was provided to allow written feedback about the experience of taking part in the study.
This form included three open questions, beneath which there was space for participants to respond:
Question 1, How did you find it talking about the issues raised in the study? Question 2, What was your
general experience like, taking part in this study? Question 3, How do you feel about research in this area?
Questions 1 and 2 both assessed participant’s personal experiences of the research. The focus of the first
question was on participant’s reactions to the content of the research, whereas the second question looked
at the overall experience of the research process. The third question assessed general views and attitudes
towards clinical psychological research. There was also room for participants to provide any additional
comments. The question number is displayed in parenthesis next to all quotes cited in this article. The form
was completed by the participant with a researcher present to provide support and answer questions.
Procedure
The larger study was the first in a planned series looking at factors conferring vulnerability to suicidality in
schizophrenia. This research was reviewed and approved by an NHS research ethics committee. Informed
consent was obtained from all participants before taking part in the study. Participants were informed that
their responses would be kept confidential except in circumstances where they suggested they were going to
harm themselves or somebody else, in which case a relevant member of their care team would be informed.
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The study lasted between an hour and an hour and a half with a researcher present throughout. The study
involved completing a range of self-report measures, tasks and a clinical interview assessing negative
cognitions, attitudes and psychopathology, including depression and suicidality. At the end of the study,
each participant was asked to provide feedback about their experience during the study on the form
provided, in particular noting down anything they liked, disliked or found distressing about the study.
Qualitative thematic analysis
The use of qualitative thematic analysis has been advocated within psychology as an analytic tool because
of its inherent methodological and theoretical flexibility216,217 allowing the identification and interpretation
of central themes emerging from the data. The main aim of this analysis was to uncover key themes
reflecting participants’ opinions, motivations, and experiences of taking part in the research. In this
instance an inductive, exploratory approach was employed. A realist stance underlined this analysis,
whereby participants’ responses were assumed to reflect genuine aspects of their experience, motivations,
and views. The qualitative analysis was initially conducted by two members of the research team: a service
user with personal experience of having a severe and enduring mental health condition, currently working as
an Honorary Research Fellow within the Division of Clinical Psychology (University of Manchester) and a
Doctoral student in clinical psychology. Responses to each question on the feedback form were studied
separately in turn, with responses reread multiple times to identify key features. Data were then hand sorted
and responses with similar content were gathered together into categories, which were then divided
into emerging themes. Questions raised in Polit and Hungler’s218 qualitative content analysis framework
(e.g. ‘What is going on here?’, ‘What is this?’, ‘What does this mean?’) were applied to each item of data
to aid the process of coding and analysis. Themes were then studied and interpretations applied. Themes
were based on the prevalence of particular patterns within the data, but also in terms of relevance and
importance of these patterns to the research aims.217 Further examination, checking and group discussion
were carried out by the remaining members of the research team. A single item of data contributed to < 1
theme in some cases. The results were also discussed with the SURG at the University of Manchester. SURG
is a body of service users who aid in the development and conduct of mental health research both through
providing consultation and feedback and actively conducting research themselves. Consultation of this
group provided a form of member checking of the interpretations made by the research team, as advocated
by Glaser and Strauss,219 to assure qualitative validity and rigor.
Results
Descriptive statistics
Six (7.6%) participants failed to provide any feedback. Reasons for this were not formally recorded, but
anecdotally the most common reason cited was that participants had nothing they wanted to say. A
further three participants completed the feedback form for questions 1 and 2, but left the third question
blank and a single participant did not respond to question 1 alone. Responses to each question were rated
for the presence of negative and positively valenced content. Table 52 reports the frequency of positive
and negative content in responses to each question. It should be noted that some responses included both
positive and negative content [e.g., ‘I found it interesting although difficult at times (Q1)’, ‘Quite










How did you find it talking about the issues raised
in the study?
36 (45.6) 0.90 12 (15.2) 0.88
What was your general experience like taking part
in this study?
38 (48.1) 0.90 7 (8.9) 1.00
How do you feel about research in this area? 48 (60.8) 0.85 2 (2.5) 1.00
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depressing, overall positive (Q1)’] and were subsequently rated separately for both positive and negative
content. This was only apparent in three cases for the first question and one for the second question. If a
conservative approach is taken, whereby these mixed responses are classified just as negative, then for the
first question, 33 (41.8%) responses were positive and 12 (15.2%) responses negative, whereas for the
second question, 36 (45.6%) responses were positive and 7 (8.9%) responses negative. These results are
very similar to those obtained when positive and negative elements were considered separately (see Table 52).
A second independent judge rated a subset of the responses (n= 47, 59.5%). Inter-rater agreement between
judges was good, with kappa scores averaging at κ= 0.92. These are reported by question and valence in
Table 52. The remainder of responses were neutral in content [e.g., ‘Okay (Q1)’, ‘All right (Q1)’, ‘I didn’t mind,
it was fine (Q1)’].
Thematic analysis
Five key themes were identified through the qualitative analysis of the feedback data. These themes were
reviewed and validated by members of a SURG. A summary of these themes and associated responses is
displayed in Table 53.
Altruism
This theme included comments that revealed a desire to participate in the research not particularly for
personal gain, but rather for ‘the greater good’ of others in the future: ‘Happy to help others (additional
comment)’, ‘If it helps other people in the long run then it’s worth it (Q3)’, and ‘I was glad to help (Q3)’.
Sometimes this included a particular desire to help those with similar experiences and mental health
problems to the participants themselves: ‘Very interesting and helpful for other sufferers (Q3)’, ‘If this helps
people with illness I am all for research (Q3)’, ‘A little bit more help for people like me (Q3)’, and ‘Good,
how else will the helpers help people without understanding (Q3)’.
TABLE 53 Themes and associated responses
Themes Responses
Altruism Overall positive, enjoyed helping. It was okay, glad that they did it (Q2)
If it helps people with illness I am all for research (Q3)
Good, how else will the helpers help people without understanding (Q3)
Very interesting and helpful for other sufferers (Q3)
Little bit more help for people like me (Q3)
If it helps other people in the long run then it’s worth it (Q3)
Happy to help others (additional comments)
I hope it(s) benefitiol (beneficial) to mental health
Good idea to maybe think 1 d you could stop these problems for people (Q3)
Good because people need help (Q3)
I feel like it is helping other’s if it stop’s somebody from comiting (committing) suicide. It’s a good
thing (Q3)
I was glad to help (Q3)
Helpful on both sides (Q3)
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TABLE 53 Themes and associated responses (continued )
Themes Responses
The value of research Necessary and needed (Q3)
Very important (Q3 × 3)
Worthwhile (Q3)
Think it’s a good thing (Q3)
Think it’s great (Q3)
Good thing (Q3)
It’s something that needs to be done. Psychology is in it’s infancy (Q3)
Very good idea (Q3)
Very useful (Q3)
Should be more research (Q3)
Could be quite useful (Q3)
About time (additional comments)
More researches should be done (additional comments)
Positive and promising (Q3)
Important (Q3)
The research is necessary and ongoing (Q3)
It’s one way of finding out about things (Q3)
Not enough of it (Q3)
Worthwhile (Q3)
I agree (Q3)
Therapeutic It helps me with my problems when discussing issues with my health (Q1)
Comfortable, makes me aware of myself (Q1)
Helpful (Q1)
Released (Q1)
The interview reminded me of some of my problems in the past, but I found it helpful to talk
about them (Q1)
Didn’t bother me, glad to get it out of my system (Q1)
Very good, it helps me gain clarity (Q2)
Made me think (Q2)
I felt released and calm (Q2)
Helpt (helped) me (Q2)
Very helpful (Q2)
I really enjoyed it, remembered a lot of things in my life (Q2)
Said things I’ve not said to my psychiatrist, because it’s confidential it was a bit of a release (Q2)
I felt quite comfortable talking about my issues. The suicide attempt was a few months ago, but
being asked these question(s) makes me realise I’m not alone and my thought and emotion are
quite common (Q1)
Great. The talking did me good (Q2)
continued
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TABLE 53 Themes and associated responses (continued )
Themes Responses
Great, I feel much better now I can open up about things that have happened in my life. Before,
I couldn’t let it out and that made me depressed (Q1)
Very easy. Especially feeling you can confide. To tell the truth (Q1)
Brilliant. Good therapy (Q1)
I found it quite therapeutic (Q1)
Therapeutic (Q2)
Relaxing (Q2)
Enjoyable experience Alright, enjoyed doing it (Q2)
Fun (Q2)
I enjoyed it (Q2)
I am enjoying myself thoroughly all question and find that good think with one and another (Q3)
I enjoyed the session with Judith and Peter (additional comments)
Enjoyed the experience (Q1)
I enjoyed the first part of the course (Q1)
I found it quite enjoyable (Q3)
Enjoyed it (Q1)
Negative experiences Alright. Asking questions about the devil were distressing (Q1)
Quite depressing (Q1)
Distressing to some degree (Q1)
I found it interesting although difficult at times (Q1)
Always difficult to talk about, overall okay (Q1)
I was scared at first, but alright during the study (Q2)
Not good to some degree (Q2)
Anxious, didn’t like cards or words (Q2)
Felt a bit nervous (Q1)
It was a bit difficult for me to talk about my issues but I had no problems with it (Q1)
I was a bit nervous but the researcher was friendly and explained the research process to me (Q2)
Fine, a little difficult when asked to talk about my ‘breakdown’ (Q1)
I got very tired (Q2)
Difficult (Q1, Q3)
A little bit difficult, but on the whole OK (Q1)
Uneasy (Q1)
Hard, OK (Q1)
On the whole alright, but I had some difficulty thinking of the memories (Q2)
Find it hard to bother with (Q3)
Words and letters in parentheses provided for clarification, to indicate multiple responses or report question number;
Q1=How did you find it talking about the issues raised in the study? Q2=What was your general experience like, taking
part in this study? Q3=How do you feel about research in this area?
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Value of being involved in research
This theme captured positive comments related to the value and benefits of research in general. This
theme is distinct from the previous one in that responses were not linked to a specific motive for
participating in research. Responses reflected the belief that clinical research was a worthwhile and
valuable pursuit: ‘Worthwhile (Q3)’, ‘Very important (Q3)’, was necessary ‘Necessary and needed (Q3)’, ‘It’s
something that needs to be done, psychology is in its infancy (Q3)’, ‘The research is necessary and ongoing
(Q3)’, and of which more is required ‘More research should be done (additional comment)’, ‘Should be
more research (Q3)’, ‘Not enough of it (Q3)’.
Therapeutic effect
Many service users described a personal therapeutic effect that they associated with taking part in the
research: ‘It helps me with my problems when discussing issues with my health (Q1)’, ‘I felt quite
comfortable talking about my issues. The suicide attempt was a few months ago, but being asked these
question(s) makes me realise I’m not alone and my thoughts and emotions are quite common (Q1)’,
‘Brilliant. Good therapy (Q1)’, and ‘Therapeutic (Q2)’. In particular, a subset of participants suggested the
interview had cathartic properties, expressing a feeling of relief and release related to talking to the
researcher about their mental health problems and experiences: ‘Didn’t bother me, glad to get it out of my
system (Q1)’, ‘I felt released and calm (Q2)’, and ‘Very easy. Especially feeling you can confide. To tell the
truth (Q1)’. In one instance, awareness of the confidentiality of the research was highlighted as an
important factor in allowing the participant to talk openly and experience catharsis: ‘I said things that I have
not said to my psychiatrist, because it’s confidential it was a bit of a release (Q2)’. Therapeutic gains were
linked to other psychological domains, including enhanced awareness of past problems ‘The interview
reminded me of some of my problems in the past, but I found it helpful to talk about them (Q1)’ and
increased self-awareness ‘Makes me aware of myself (Q1)’, and ‘Very good, it helps me gain clarity (Q2)’.
Enjoyable experience
A number of participants simply reported that they enjoyed taking part in the study ’Alright, enjoyed doing
it (Q2)’, ‘Fun (Q2)’, ‘I enjoyed the session with Judith & Peter (the researchers) (additional comment)’, and
‘I found it quite enjoyable (Q3)’.
Negative experiences
Seventeen participants raised points that reflected negatively on their experience of being involved in the
study: ‘Quite depressing (Q1)’, ‘Distressing to some degree (Q1)’, and ‘I got very tired (Q2)’. Participant’s
negative experiences included difficulty and distress associated with disclosure and discussion of their
mental health difficulties: ‘It was a bit difficult for me to talk about my issues, but I had no problems with
it (Q1)’, ‘Fine, a little difficult when asked to talk about my ‘breakdown’ (Q1)’, and ‘Always difficult to talk
about, overall okay (Q1)’. It should be noted in the above responses that despite the instances of distress,
participants asserted that they found this questioning and the research generally acceptable. In one
instance, this distress was linked in particular to a discussion about the participant’s auditory hallucinations
in which they would hear the devil, suggesting a particular sensitivity to this topic: ‘Asking questions about
the devil were distressing (Q1)’. Negative experiences also included anxiety and nervousness ‘Felt a bit
nervous (Q1)’, ‘Anxious, didn’t like cards or words (Q2)’, although two participants also suggested these
feelings could be successfully allayed: ‘I was a bit nervous but the researcher was friendly and explained
the research process to me (Q2)’, and ‘I was scared at first, but alright during the study (Q2)’. Three
responses suggested a sixth theme, which was the need to be heard, whereby participants indicated that
their involvement in the research process gave them ‘a voice’ or an opportunity to talk openly about
their experiences: ‘It gave me a chance to tell my story (Q2)’, ‘It’s about time we were asked (Q3)’, and
‘It enabled me to talk about something I know a little about (Q1)’. This theme was underrepresented in
the data, but was considered interesting and could be an area of focus for future research.
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Discussion
The current study aimed to investigate the subjective experiences of taking part in research for participants
with a diagnosis of a psychotic disorder. The findings of this study are largely positive. Negative content
was apparent in only a minority of responses, with prevalence ranging between 2.5% and 15.2% across
questions. In contrast, positive content was more frequent, with prevalence ranging between 45.6% and
60.8% across questions. These findings are in line with a recent review suggesting a similar prevalence of
negative and positive reactions to research in patient samples.214 The qualitative analysis of feedback
responses allowed an investigation into the nature and range of individuals’ experiences during the study.
This analysis supports previous qualitative findings that research can have a number of benefits for those
who participate. These include a sense of catharsis and therapeutic gain and a perception of helping
others.220,221 It should be clarified that the therapeutic effect reported by participants reflects their
subjective experiences. Whether or not this therapeutic effect endures after the study and translates into
a genuine improvement in well-being requires further investigation. The theme of therapeutic effect may
stem in part from the unique interpersonal context of the research. The research environment may provide
a context in which issues pertaining to mental health and suicide can be discussed in a confidential, open
and non-judgemental way. Fear of treatment and involuntary hospitalisation may prevent some service
users from discussing aspects of their mental health with health-care professionals,222,223 whereas for others
certain issues may not be raised in routine assessments.224 The research environment may differ in that the
focus is not primarily on treatment, and confidentiality is emphasised along with the boundaries of this
confidentiality. Consequently, some participants may see research as an additional forum to voice their
problems, which lies outside of the usual context of care and treatment. Of course, research cannot be
seen to provide any form of alternative to participants’ standard care. The current study also supports past
findings that patients with diagnoses of schizophrenia predominantly express positive views about mental
health research, viewing it as an important and valuable endeavour,213 and rating the possible benefit to
others as an important reason for participating.213,225 This motivation for participation in mental health
research has also been endorsed by other populations, such as bereaved parents.220 Anxiety and
nervousness surrounding participation was also reported; however, it seems that for a few participants at
least, these feelings were only present at the beginning of the study and were successfully reduced once
the study began. It seems likely that the researcher may play an important role in quelling such anxieties,
through careful explanation of the study procedure and identification of any particular concerns. Other
negative experiences included distress and difficulty linked with the disclosure and discussion of personal
mental health problems. The specific features of the study content that lead to distress may be
idiosyncratic, reflecting personal sensitivities to certain topics.221 Consequently, it may not always be
possible to ascertain who will or will not be distressed by a particular feature of the study and, therefore,
raises the importance of having adequate procedures in place for dealing with instances of participant
distress. Such procedures need to be flexible enough to deal with the potential variation in the nature and
degree of distress experienced. In the study from which the current feedback was taken, these procedures
involved concluding the study with a detailed and interactive debriefing. This included a brief task
designed to restore positive mood through encouraging a focus on the participant’s favoured activities and
positive characteristics. This study also made use of multiple follow-up calls to assess individuals’ well-being
after the study. In two instances, these calls led to concerns about a participant’s well-being. In these
cases, these concerns were passed on to the participant’s keyworker or other relevant health-care
professional with the participant’s consent. Maintaining strong links with a participant’s care team was
therefore another important factor in managing participant distress. Interestingly, negative responses were
more frequent for the first two questions, which assessed personal experiences of the research, than the
third, which assessed more general views towards clinical psychological research. This suggests participants
may experience distress related to particular aspects of the study, but still maintain the overall value of
such research. This possibility is supported by the observation that a number of participants reporting
distress also stated in the same response that they found the study acceptable.
It is therefore relevant for future research of this nature to recognise that participants may hold mixed and
dissonant views of this nature. These results may have implications for how informed consent is obtained.
It is important for a potential participant to be fully aware of the nature and content of the study,
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particularly when the focus is on personal mental health issues, as this is an area some may find
distressing. An awareness of this content will allow individuals to predict the degree of distress that the
study may cause them and subsequently whether or not to participate. In the current study, participants
were provided with information sheets at least 24 hours before consent was sought. These outlined the
study procedure and content, and provided examples of the questions participants would be asked.
Unfortunately, it was beyond the scope of the current study to assess participant’s satisfaction with the
informed consent process, although this is an important issue that has received attention elsewhere
(e.g. Anderson and Mukherjee226).
Adequate debriefing procedures are important after research, including encouragement of participant
feedback, so that negative experiences can be identified and discussed with the researcher. Such
debriefings may also have an educational or informative value to participants.227 Considering the finding
that many participants may engage in research with altruistic motives, a reiteration of the research’s
purpose and aims may also be beneficial, allowing participants to determine whether or not their
involvement has been worthwhile. As a final point, researchers should show caution in describing the
possible benefits of research participation. Although positive experiences are frequent, they cannot be
guaranteed and research should not be viewed in any way as a substitute for clinical therapeutic
interventions. Several limitations of this study need to be recognised. First, it is possible that some
participants may have been uncomfortable or in other ways unwilling to report on the negative aspects
of their experience. This may partly account for the low rates of such experiences apparent in the feedback
responses. In such cases participants may have provided neutral responses, rather than describe their true
negative experiences. Similarly, negative responses that were intermixed with neutral content [e.g., ‘Always
difficult to talk about, overall okay (Q1)’] may simply reflect participants trying to ameliorate the impact of
their negative comments (or soften the blow). Still, such acquiescent or deferential responding seems
less likely to account for the substantial numbers of positive responses identified in the study. Second,
the written feedback format resulted in often quite terse responses from participants. It is likely a
semistructured interview methodology would have provided a deeper and more detailed exploration of
participant’s experiences. However, participants had already endured 1–1.5 hours of questions and an
additional detailed interview may have overburdened some individuals. Future research investigating
participant distress could employ semistructured interviews conducted a few days following the study, so
as to assess the ongoing impact of participation on the individual. The questions used in this study could
inform future studies exploring the issues and experiences involved when participating in research studies.
Phase 2: investigating the psychological mechanisms
underlying suicide behaviours – the role of defeat, entrapment
and resilience
This research was previously published as Taylor PJ, Gooding PA, Wood AM, Johnson J, Pratt D, Tarrier N.
Defeat and entrapment in schizophrenia: The relationship with suicidal ideation and positive psychotic
symptoms. Psychiatr Res 2010;178:244–8;209 and Johnson J, Gooding PA, Wood AM, Tarrier N. Resilience
as positive coping appraisals: Testing the schematic appraisals model of suicide (SAMS). Behav Res Ther
2010;48:179–86,205 and much of this text is reproduced with permission from Elsevier.
Objectives
First, this study aimed to test whether or not perceptions of defeat and entrapment mediate the
relationship between positive symptoms of psychosis and suicidal ideations. The second aim of the study
was to explore resilience to suicide, in particular whether or not positive self-appraisals buffer the impact
of hopelessness.
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Method
Participants and procedure
A total of 90 participants were recruited from CMHTs, AO teams, EISs and voluntary organisations across
the North West. Participants were included in the study if they met the following criteria: (1) a clinical
diagnosis based on ICD-10 criteria for schizophrenia spectrum disorder; (2) aged ≥ 18 years or over;
(3) English speaking; (4) currently not considered to be an acute and serious suicide risk by their key
worker or appropriate health-care professional; and (5) able to provide informed consent as judged by
their keyworker or appropriate health-care professional. Participants were excluded from the study if drug
use or organic disorder was judged to be the major cause of the psychosis. Participants were referred by
their key worker or other health-care professional and completed the study measures in one or two
sessions. This study was approved by a national research ethics committee prior to commencing.
Measures
Entrapment
The entrapment scale228 comprises 16 items assessing feelings of being trapped by internal and external
events (e.g. ‘I feel trapped inside myself’). Items are rated on a 5-point scale ranging from ‘Not at all like
me’ to ‘Extremely like me’. No previous reports of internal consistency for this measure in a psychosis
group could be found. The alpha coefficient for the current study was 0.95.
Defeat
The defeat scale228 comprises 16 items assessing perceptions of defeat including those of failed struggle and
low social rank (e.g. ‘I feel that I am one of life’s losers’). Items are rated for their prevalence in the past week,
on a 5-point scale ranging from ‘Never’ to ‘Always/all the time’. No previous reports of internal consistency for
this measure in a psychosis group could be found. The alpha coefficient for the current study was 0.86.
Resilience
The Resilience Appraisals Scale (RAS205) is a 12-item scale consisting of three four-item subscales assessing
positive self-appraisals. These subscales focus on appraisals of perceived ability to cope with emotions,
perceived ability to cope with difficult situations and perceived ability to gain social support. Items for the
emotion coping scale include ‘I can handle my emotions’ and ‘In difficult situations, I can manage my
emotions’. Items for the situation coping subscale include ‘I can usually find a way of overcoming problems’
and ‘If faced with a set-back, I could probably find a way round the problem’, and items for the social
support subscale include ‘My family or friends are very supportive of me’ and ‘If I were to have problems,
I have people I could turn to’. Responses are scored on a 5-point scale ranging from ‘Strongly disagree’ to
‘Strongly agree’. Johnson et al.205 have found the scale to have a robust three factor structure and report
evidence of convergence with other measures of appraisals. Findings also suggest scores are distinct from
measures of current life stress.205 Alpha reliabilities were 0.88 for the total scale, 0.92 for the emotion coping
subscale, 0.92 for the situation coping subscale and 0.93 for the social support subscale.205
Hopelessness
The BHS74 comprises 20 true or false items assessing the prevalence of hopelessness in the past week
(e.g. ‘My future seems dark to me’). This measure has a reported alpha coefficient of 0.93 and a
test–retest reliability of r= 0.85 over 3 weeks.229 This measure has been used extensively in individuals
diagnosed with schizophrenia (e.g. Tarrier et al.230 and White et al.231).
Suicidal ideation
The Beck Suicidal Ideation Scale (BSS232) is a 21-item scale assessing the prevalence of suicidal ideation,
planning and intent in the past week and previous attempt history. For each item, participants choose
between three responses of increasing suicidal ideation (e.g. ‘I have no desire to kill myself’; ‘I have a
moderate to strong desire to kill myself’). In previous research in a sample with psychosis the BSS has
demonstrated an alpha coefficient of 0.96 and test–retest reliability over 1 week of r= 0.88.233
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Symptoms of psychosis
The Brief Psychiatric Rating Scale Expanded version (BPRS-E234,235) is a 24-item interviewer-rated assessment
of psychopathological symptoms. Each item refers to a particular symptom and is rated for frequency and
severity on a 7-point scale ranging from 1 (‘not present’) to 7 (‘extremely severe’). For the purposes of the
current study, separate positive and depressive symptom total scores were calculated by summing scores
on the relevant item (i.e. positive symptoms= unusual thought content, suspiciousness, bizarre behaviour,
grandiosity, hallucinations, hostility; depression= depression; anxiety, guilt, self-neglect, somatic concern),
based on empirically identified components.63 The suicide subscale was excluded from the depressive
symptoms total score to avoid confounding depression with suicidal ideation. The positive and depressive
symptom components were found to have alpha coefficients of 0.74 and 0.75, respectively. Ratings were
made by one of two doctoral-level students or a trainee clinical psychologist. ICC coefficients between
the three raters for a subset of interviews (n= 19) ranged between 0.87 and 0.92, suggesting good
inter-rater reliability.
Analysis
Defeat and entrapment as mediators of the relationship between positive
symptoms and suicide behaviours
The hypothesised mediational model was tested via SEM. Covariances were analysed via SPSS Amos
version 7.0 (IBM, Chicago, IL, USA) using maximum-likelihood estimation.236 In this model defeat and
entrapment were represented as a single latent variable (referred to as defeat/entrapment hereafter). The
chi-squared goodness-of-fit statistic was scaled to compensate for the small sample using a formula by
Bartlett.237 Monte Carlo simulations have found this scaled chi-square to function acceptably in models
with sample sizes to parameter ratios of 5 : 1.238 A significant value (p< 0.05) of this statistic suggests
poor fit.
Model fit was also assessed via combinational rules found to minimise type I and type II errors suggesting
cut-off scores of < 0.09 for the SRMR and > 0.95 for the CFI as indicants of good fit.136
Mediation was formally tested via bootstrapping with 1000 random samples. This method involves
generating CIs through a process of random resampling. Bootstrapping provides an alternative test of
mediation to the commonly used Sobel test that is suitable for smaller samples.239
Positive self-appraisals as moderators of the relationship between
hopelessness and suicidal ideation
Initially, correlation analyses were carried out to explore associations between key variables. A hierarchical
regression analysis was then conducted to examine whether or not positive self-appraisals measured by the
RAS moderated the association between hopelessness and suicidal ideation. In the first step of this
analysis, hopelessness scores were entered into the regression model. In the second step, RAS scores were
entered. In the third step, the interaction term between hopelessness and the RAS was entered. At each
step, standardised variables were used to avoid multicollinearity.240 If the addition of the interaction term in
the third step added significant predictive variance to the regression model, it indicated a moderating
effect of positive self-appraisals as measured by the RAS on the association between hopelessness and
suicidal ideation.241 This analysis was then repeated for each of the subscales of the RAS to investigate
whether or not positive self-appraisals of emotion coping, situation coping and social support would have
a moderating impact when examined in isolation.
Results
Participant characteristics
A sample of 90 participants was initially recruited for the study. Of these, six failed to meet diagnostic
criteria and six had substantial missing data and were therefore excluded. This resulted in a final sample of
78 participants (23 female; mean age= 42.5 years, SD= 11.8 years) with diagnoses of schizophrenia
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(n= 71, 91.0%), schizoaffective disorder (n= 4, 5.1%), psychosis not otherwise specified (n= 2, 2.6%),
and atypical psychosis (n= 1, 1.3%) in accordance with ICD-10 criteria. The majority of participants were
white (n= 63, 80.8%), mixed British (n= 6, 7.7%), Asian (n= 3, 3.8%), Afro-Caribbean (n= 1, 1.3%) and
other (n= 4, 5.1%). Ethnicity data were missing for one participant. Participants had an average duration
of illness of 17.5 years (SD= 11.0 years). Age, sex and duration of illness were not significantly associated
with suicidal ideation (p> 0.05). Only 22 participants (28.2%) reported no history of suicide attempts,
with 17 (21.8%) reporting a single attempt and 39 (50.0%) reporting multiple past attempts, ranging in
number from 2 to 11. No record was taken of the nature or severity of these attempts. Descriptive
statistics and correlations for the measures used are reported in Table 54. Multicollinearity was not a
problem in the data (tolerance > 0.2242), although defeat and entrapment were highly correlated (r= 0.85),
supporting the decision to analyse these as a single latent variable. One further participant was later
excluded from the analysis on positive self-appraisals owing to missing data for the resilience measure.
Defeat and entrapment as mediators of the relationship between positive
symptoms and suicide behaviours
The hypothesised mediation model with associated fit indices, standardised regression weights and multiple
squared correlations is displayed in Figure 10. This model fit the data well and all direct paths were
significant (p< 0.05). The results of the bootstrap analysis suggested that the indirect effect of positive
symptoms on suicidal ideation was also significant; p= 0.002 (95% CI 0.14 to 0.39). The above model
assumed full mediation, for which no direct effect of positive symptoms on suicidal ideation remained after
accounting for perceptions of defeat/entrapment. In order to test this assumption, a second partial










FIGURE 10 Model depicting full mediation of positive symptoms on suicidal ideation via defeat/entrapment.
Rectangles represent observed variables in the model. Defeat and entrapment have been used as indicators of a
single latent variable, represented by an oval.





Symptoms Hopelessness DepressionMean SD Mean SD
1. Suicidal ideation 5.64 6.67 1.91 1.43 0.52 0.56 0.29 0.53 0.51
2. Defeat 28.56 16.02 0.85 0.35 0.71 0.61
3. Entrapment 24.67 18.55 0.49 0.70 0.64
4. Positive symptoms 13.10 5.95 3.53 0.79 0.32 0.46
5. Hopelessness 7.41 5.51 2.45 1.20 0.64
6. Depression 12.18 4.91 2.41 0.43
p< 0.05.
a The variables suicidal ideation, positive symptoms and hopelessness were square-root transformed and depression
logarithmically transformed to correct for positive skew. This resulted in skew that was acceptably low (z-value< 1.96).
Correlations are only provided for transformed versions of variables.
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in terms of improvement in the scaled chi-squared statistic and Akaike information criterion (AIC). It has
been suggested that differences of ≤ 2 on the AIC provide substantial support for the more parsimonious
model.243 The partial mediation model failed to demonstrate a significant improvement in fit, χ2−K (1)= 0.02,
not significant, AIC= 1.98, providing support for the more parsimonious full mediation model.
In order to test the robustness of the mediation model, the analysis was repeated controlling for the effect
of hopelessness (BHS) and depressive symptoms (BPRS-E). The model continued to demonstrate good fit,
χ2−K (4, n= 78)= 5.54; p= 0.24, SRMR= 0.02, CFI= 0.99. All direct and indirect paths remained significant
and standardised coefficients differed by β≤ 0.30.
Secondary analysis
A secondary exploratory analysis was undertaken to examine the individual positive symptoms that
contributed most to suicidal ideation. Correlations between individual positive symptoms and suicidal
ideation are reported in Table 55.
Only suspiciousness and hallucinations were significantly associated with suicidal ideation. In order to
investigate whether or not the link between these individual symptoms and suicidal ideation was mediated
by perceptions of defeat and entrapment, a SEM was calculated with suspiciousness and hallucinations as
predictors, defeat/entrapment as a mediator and suicidal ideation as an outcome variable. Suspiciousness
and hallucinations had means of 2.72 (SD= 1.76) and 3.00 (SD= 2.14), respectively. Prior to the analysis,
the variable suspiciousness was square root transformed to correct for mild positive skew, resulting in a
mean of 1.56 (SD= 0.53). This model with associated fit indices, standardised regression weights and
multiple squared correlations is displayed in Figure 11. The model fit the data well and all direct paths
were significant, with the exception of the direct effect of hallucinations on defeat/entrapment. The
indirect effect of suspiciousness on suicidal ideation was also significant (95% CI 0.18 to 0.46; p= 0.002),














FIGURE 11 Model depicting full mediation of suspiciousness and hallucinations on suicidal ideation via
defeat/entrapment.
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Positive self-appraisals as moderators of the relationship between
hopelessness and suicidal ideation
Descriptive statistics and zero-order correlations
Zero-order correlations, means and SDs for the variables are displayed in Table 56. Results suggested that
hopelessness scores were moderately correlated with suicidal ideation. Similarly, positive self-appraisals
according to the RAS were found to be moderately inversely correlated with suicidal ideation, as were the
two RAS subscales of emotion coping and situation coping. There was no correlation between the social
support subscale of the RAS and suicidal ideation. Inverse correlations between hopelessness, total RAS
scores and each of the RAS subscales were also found.
Regression analyses
As can be seen in Table 57, positive self-appraisals measured according to the RAS were found to
moderate the association between hopelessness and suicidal ideation. Once hopelessness scores had been
entered, positive self-appraisals predicted suicidal ideation both in addition to hopelessness, β= –0.252,
and when interacting with hopelessness, β= –0.218, supporting a moderating impact of self-appraisals
on hopelessness.
From Figure 12 it can be seen that for those with high levels of positive self-appraisals, increased
hopelessness corresponded with only minimal increases in suicidal ideation.
Subscales of the Resilience Appraisals Scale
Next, each of the RAS subscales was examined as a moderator of hopelessness. A significant moderating
impact was found for the subscale of emotion coping, which predicted suicidal ideation both in addition
to hopelessness scores, β= –0.351, and also interactively with hopelessness β= –0.228. As shown in
Figure 13, this pattern was similar to that found for the overall scale and suggests that for those who are
high on emotion coping appraisals, there is minimal increase in suicidal ideation at higher levels of
hopelessness. By contrast, neither the situation coping subscale nor the social support subscale was found
to predict suicidal ideation either in addition to hopelessness, or in interaction with hopelessness.
COGNITIVE–BEHAVIOURAL APPROACH TO UNDERSTANDING AND PREVENTING SUICIDE
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TABLE 57 Hierarchical regression analyses predicting suicidality as measured by the BSS
Moderator variable Step Variable entered β SE β Total R2 ΔR2
Positive Self–Appraisals
(RAS)
1 BHS 0.536*** 0.097 0.287
2 BHS 0.395** 0.115 0.331 0.044*








1 BHS 0.536*** 0.097 0.287
2 BHS 0.360** 0.106 0.380 0.092**
RAS Emo –0.351** 0.106
3 BHS 0.389*** 0.104 0.419 0.039*
RAS Emo –0.311** 0.105





1 BHS 0.536*** 0.097 0.287
2 BHS 0.437*** 0.110 0.318 0.031
RAS Situ –0.203 0.110
3 BHS 0.442*** 0.109 0.342 0.024
RAS Situ –0.194 0.109





1 BHS 0.536*** 0.097 0.287
2 BHS 0.558*** 0.103 0.292 0.005
RAS Social 0.071 0.103
3 BHS 0.553*** 0.104 0.295 0.003
RAS Social 0.067 0.104
BHS – RAS 0.065 0.109
Social
interaction
*p< 0.05, **p< 0.01, ***p< 0.001.
RAS Emo, RAS Emotion Coping subscale; RAS Situ, RAS Situation Coping subscale; RAS Social, RAS Social
Support subscale.
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Discussion
Defeat and entrapment as mediators of the relationship between positive
symptoms and suicide behaviours
It was found that perceptions of defeat and entrapment, conceptualised as a single variable, accounted for
a large proportion (31%) of the variance in suicidal ideation. As hypothesised, defeat and entrapment fully
mediated the association between positive symptom severity and suicidal ideation. This result held while
controlling for levels of hopelessness and depression suggesting it was robust and not simply an artefact of
the conceptual overlap between variables. An additional exploratory analysis revealed that suspiciousness
in particular was related to suicidal ideation and that this effect was also fully mediated by defeat
and entrapment.
These results support the SAMS model which argues that negative appraisals result in perceptions of
defeat and entrapment in psychosis. These in turn lead to suicidal ideation.204 Defeat and entrapment,
defined as perceptions of loss or rejection without escape or likelihood of improvement,228 may represent
one particularly maladaptive psychological response to the difficulties posed by living with psychosis, which
may provoke suicidal ideation and behaviour as a means of escape or protest.206
The current study supports the link between the severity of positive symptoms of psychosis, in particular
experiences of suspiciousness or paranoia, and suicidal ideation.244–246 Moreover, it was found that this
relationship was explained by perceptions of defeat and entrapment, which were amplified as symptoms
became increasingly distressing and enduring. Suspiciousness may be particularly entrapping and defeating
as such experiences can carry a sense of ongoing personal threat and negative implications concerning
social rank.247 It is possible that paranoia represents a psychosis-specific risk factor for suicide that functions
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FIGURE 13 Appraisals of emotion coping ability (RAS Emotion Coping subscale) moderate hopelessness (BHS)
to predict suicidality (BSS).
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It could be that the current results concerning defeat and entrapment are simply an artefact of the
demoralisation syndrome identified in some individuals diagnosed with schizophrenia. This syndrome,
which follows an individual’s negative awareness of the impact of the illness on their goals and future
aspirations, has also been associated with suicide248,249 and shares some conceptual similarities with defeat
and entrapment. However, this explanation is unlikely, as hopelessness and depression are proposed as key
symptomatic features of the demoralisation syndrome in schizophrenia248,249 and both of these variables
were controlled for in the current analyses.
The results of this study raise the possibility that perceptions of defeat and entrapment could be used
alongside better established indicators of suicide such as depression and hopelessness200,230,250–253 to identify
patients diagnosed with schizophrenia who are at heightened risk of suicide. Further investigation of the
utility of defeat and entrapment in predicting suicidal behaviour is therefore warranted. The results also
suggest that psychological therapies aimed at reducing suicidal ideation in individuals diagnosed with
schizophrenia could focus specifically on reducing perceptions of defeat and entrapment, alongside
interventions aimed more directly at alleviating clients’ symptoms. Psychosocial interventions, including
psychotherapy, have been suggested as one important approach in the prevention of suicide in individuals
diagnosed with schizophrenia.253 A recent meta-analysis has also supported the overall efficacy of CBT in
suicide prevention.202 CBT may therefore provide one useful framework within which perceptions of defeat
and entrapment could be targeted.254 A more detailed discussion of therapeutic approaches to dealing
with defeat and entrapment in psychosis is described elsewhere.204
Positive self-appraisals as moderators of the relationship between
hopelessness and suicidal ideation
Positive self-appraisals moderated the impact of hopelessness, such that individuals with high levels of
positive self-appraisals were significantly less likely to experience suicidal ideation even at the highest levels
of hopelessness. When specific types of self-appraisals were examined in isolation, appraisals of emotion
coping ability appeared to moderate the impact of hopelessness, but appraisals of situation coping and
social support did not show this moderating impact.
These results support previous research that suggests that positive self-appraisals may confer resilience
against risk, reducing the likelihood that risk will lead to suicidal thoughts.255 Interest into concepts of
suicide resilience has grown in recent years, but generally this research has explored potential resilience
factors by examining their direct linear association with suicidal thoughts,256,257 which does not
demonstrate a buffering or resilience role for the variable. Instead, resilience needs to be understood as
a separate dimension to risk, which can exist alongside it, acting to attenuate the likelihood that risk will
lead to suicidality. By finding an interaction between positive self-appraisals and hopelessness in a sample
of individuals with schizophrenia-spectrum diagnoses, the current results both support these previous
findings and expand on them in four main ways.
First, the current results indicate that positive self-appraisals may also be a resilience factor for clinical
populations, specifically for individuals with schizophrenia-spectrum disorders, who are at particularly high
risk of suicidality.258,259 Risk factors for suicidality have been studied extensively for this group and a range of
factors have been found to increase the likelihood of suicide.6,253 One of the strongest psychological factors is
hopelessness.260,261 Although an understanding of risk factors can increase the prediction of suicide risk and
inform clinical interventions, it is limited. The current results suggest that some factors can act as buffers and
that when they are studied in interaction with risk, they can increase predictive validity. This may improve
identification of individuals who are at risk from suicide and reduce the number of false positives.
Second, the present study investigated an interaction between positive self-appraisals and hopelessness.
Previously, positive self-appraisals were studied in relation to life events in a student sample,255 but as life
events may not be an accurate predictor of suicide amongst individuals with psychosis200 the current study
focused on a clinical risk factor, namely, hopelessness. The finding that positive self-appraisals can also
buffer against hopelessness demonstrates that their buffering impact is not limited to life events and
COGNITIVE–BEHAVIOURAL APPROACH TO UNDERSTANDING AND PREVENTING SUICIDE
NIHR Journals Library www.journalslibrary.nihr.ac.uk
126
suggests that positive self-appraisals may be an important resilience factor for a range of risk factors.
Although this will need to be explored by further research, the current findings suggest that positive
self-appraisals could be an important resilience factor.
Third, the present study used a concept of suicide resilience based on the Schematic Appraisals Model of
Suicide (SAMS204). This model suggests that cognitive biases and a suicide schema interact with appraisals
of the self and the situation to lead to suicidal thoughts and behaviours. In particular, the self-appraisals
construct is thought to have a central role, impacting on all other relevant processes. This suggests that
positive self-appraisals could be especially beneficial, potentially buffering against maladaptive processes
taking place elsewhere in the model. Johnson et al.255 found support for this proposed central role of
positive self-appraisals among a student sample and the current study extends this by finding further
evidence for the importance of the self-appraisal construct among individuals with psychosis-spectrum
disorders. This suggests that the processes described by the SAMS may be relevant among both clinical
and non-clinical samples and supports other findings which identify the SAMS as a useful framework for
understanding suicidality among individuals with psychosis spectrum disorders.209
Fourth, by exploring each of the subscales of the positive appraisals measure (RAS255) the current findings
indicate which types of positive self-appraisals may be relevant for individuals with non-affective psychosis.
The measure comprises three subscales designed to capture an individual’s appraisal of their ability to cope
with their emotions, their ability to cope with difficult situations and their ability to gain social support.
When each of these subscales was studied, the only one found to moderate the impact of hopelessness
was ability to cope with emotions. This subscale is designed to reflect an individual’s confidence in their
ability to manage their emotions and contains items such as ‘I can handle my emotions’ and ‘In difficult
situations, I can manage my emotions’. The present results suggest that although the overall construct of
the self-appraisal may be relevant, emotion coping appraisals could be a key aspect of resilience.
Interestingly, the present study found that although scores on the appraisals of social support and
appraisals of situation coping subscales were moderately correlated with suicidal ideation, when entered
into a regression analysis they did not predict suicidality either in addition to, or when interacting with,
hopelessness. This may appear counterintuitive, as research from previous studies has suggested that social
support and aspects related to situation coping, such as problem-solving can reduce the likelihood of
suicidality (e.g. Hawton et al.6 and Chang262). One possible explanation for this finding is that although
emotion coping appraisals can moderate hopelessness when considered in isolation, social support and
problem-solving confidence could have a compensatory impact on each other. This would imply that high
levels of one could compensate for low levels of the other and this possibility is supported by the finding
that although neither subscale was a buffer when considered in isolation, the overall appraisals scale was
significant. It should be noted that this suggestion is tentative and further research is necessary before any
conclusions can be drawn.
Limitations and future research
There were four main limitations to the study. First, it was cross-sectional, which limits the extent to which
findings can be interpreted for causality; longitudinal research in the future would allow exploration of
causality. Second, the study was examining psychological processes and resilience on suicidal thoughts and
not completed suicide. Some research has suggested that these are distinct phenomena that may need to be
studied separately;263 however, other research has found that suicidal thoughts and behaviours exist on a
continuum with completed suicide, which suggests they may share underlying mechanisms and be a relevant
criterion through which to investigate suicidality and suicide prevention strategies.264–266 Third, owing to
ethical guidelines, the study did not include participants who were judged to be an acute and serious suicide
risk and so results may not generalise to this subpopulation. Despite this, participants who were actively
suicidal were included and the results can be expected to generalise to the large majority of individuals with
psychosis. The final caveat of this study is the relatively small sample size; however, the models depicted met
recommendations of over five participants per parameter being estimated.267,268 Replication of the present
results in a larger sample would still be beneficial for strengthening the generalisability of these results.
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Future research would also benefit from the further refinement and exploration of the defeat and
entrapment construct in relation to psychosis. This should involve additional investigation of the
phenomenology of this construct and its operationalisation within the context of psychosis. The use of a
case–control methodology to further investigate defeat and entrapment in relation to suicide would also
be of interest. Such research would be beneficial in confirming the present findings and determining
whether or not they extend to completed suicide.
Implications for clinical practice
When assessing individuals for suicide risk, it may be important to account for the presence of resilience
factors in addition to risk factors and to be mindful that some factors, such as the self-appraisal, may alter
the impact of risk. The self-appraisals investigated by the study concerned the individual’s view of their
ability to cope and can be understood as reflecting a form of self-efficacy.269 In particular, appraisals of
ability to cope with emotions appeared to have a buffering impact and could be a key aspect to focus on.
For individuals who have a low level of positive self-appraisals, risk factors such as hopelessness may be
particularly deleterious and such individuals may be regarded as especially high risk. By contrast, for
individuals who are high on positive self-appraisals, hopelessness may cease to be considered a risk factor
for suicidal ideation. This is not to suggest that it should not be monitored as it could still have relevance
to psychological well-being and clinical symptomatology, but it should not be considered to be a relevant
predictor for suicidal thoughts and behaviours in this group.
In addition, as positive self-appraisals can alter the impact of clinical risk factors, these may be an important
aspect to incorporate into clinical interventions. Reducing an individual’s level of risk is an important part of
any suicide treatment programme, and practical interventions, such as the removal of firearms, potentially
lethal substances and other means of suicide, can have a strong impact on likelihood of suicide.270 However,
the present results suggest that developing positive self-appraisals may indirectly reduce the likelihood of
suicide risk by attenuating the impact of risk. Thus, they may represent a particularly beneficial area to
target when conducting treatment interventions. Tarrier and Gooding271 suggest that the use of techniques
such as positive data logging, in which clients record specific examples of times they have demonstrated
positive qualities, may be useful in developing a more positive self-concept.
Phase 3: a randomised controlled trial of Cognitive–Behavioural
Prevention of Suicide in psychosis
This research was previously published as Tarrier N, Kelly J, Maqsood S, Snelson N, Maxwell J, Law H,
Dunn G, Gooding P. 2014. The cognitive behavioural prevention of suicide in psychosis: A clinical trial.
Schizophr Res 2014;156:204–10272 and much of this text is reproduced with permission from Elsevier.
Objectives
This study aimed to evaluate the Cognitive–Behavioural Prevention of Suicide in psychosis
protocol (CBPSp).
Specifically, it was hypothesised that CBSPp in addition to TAU would have significant advantages over
TAU alone in reducing (1) measures reflecting suicidal behaviour including hopelessness and (2) measures
associated with other symptom clusters of psychosis including depression, thought disorder and low
self-esteem.
Method
This was a single-blind RCT that aimed to test the feasibility and potential efficacy of a novel intervention
(CBSPp) designed to reduce suicidal behaviours in those suffering from schizophrenia spectrum disorders.
Participants assigned to the treatment condition in addition to TAU were compared with those allocated to a
TAU condition alone. Ethical approval was obtained from Stockport Research Ethics Committee (08/H1012/97).
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Participants
Between April 2009 and October 2010, CMHTs, EI teams and AO teams across four National Mental Health
Service trusts, including Greater Manchester West, Manchester Mental Health and Social Care, Pennine Care
and Five Boroughs in the north-west of England, were approached to facilitate recruitment. Participants
were recruited into the study if they were (1) aged between 18 and 65 years; (2) had a Diagnostic and
Statistical Manual of Mental Disorders-Fourth Edition (DSM-IV) diagnosis of schizophrenia, schizophreniform
disorder, schizoaffective disorder, delusional disorder or psychotic disorder not otherwise specified;
(3) identified as having previous suicide attempts or experiencing current suicidal ideation; (4) under the
care of an appropriate clinical team and currently in contact with mental health services; (5) receiving
appropriate antipsychotic medication; and (5) not currently receiving CBT or other empirically validated
psychological treatments. Participants were excluded if they (1) currently suffered serious suicidal intent and
were currently considered a danger to themselves by their clinical team; (2) had a primary diagnosis of
bipolar depression or substance induced psychosis; and (3) suffered from an organic brain disease.
Procedure
Mental health staff identified potential participants on their caseload who met the recruitment criteria.
Once diagnosis was confirmed and written consent was obtained, the baseline assessments were
administered by research assistants, independent of therapy. Following the baseline assessment,
participants were randomised using a clinical data management system and allocated to either the
experimental treatment group in which participants were to receive CBSPp in addition to TAU or the
control in which participants were to receive only TAU. Randomisation was controlled by staff not directly
linked to the trial to ensure independence and blindness to the trial allocation arms. Participants were
informed of the randomisation outcome via a letter, which also contained a note reminding them not to
disclose any information about their care or treatment during assessments, which would break the blind
requirement. In cases for which the research assistants were unblinded, protocols were followed whereby
blinds were documented and the assessment packs were to be scored by another research assistant.
Masking was further maintained by ensuring that therapists and research assistants were located in
different offices so that therapy files and assessment data were stored separately. In addition, clinical staff
were repeatedly instructed not to disclose any knowledge of therapy or group allocation to assessors.
Participants who were allocated to the treatment arm were then contacted by one of the trial therapists to
arrange their first session. Therapists were given a copy of the completed baseline assessments prior to
starting their therapy sessions to aid their clinical formulations and prevent unnecessary repetition of
questioning of participants. Participants were assessed at baseline and then at 4- and 6-month follow-up
time points. Prior to each assessment point, care co-ordinators were approached by a member of the
research team to obtain a comprehensive risk assessment.
A routine telephone follow-up call was made the day after each assessment and 7 days later to ensure
that the assessments had not caused any distressing after-effects for the participant. Therapists and
assessors received regular (every 2 months) clinical supervision.
Measures and assessments
Standardised measures consisting of a short semistructured clinical interview and self-report questionnaires
were used.
Primary outcome measures
These were measures of suicidal thoughts, behaviours and hopelessness, specifically:
The Adult Suicidal Ideation Questionnaire273
The Adult Suicidal Ideation Questionnaire (ASIQ) is a 25-item self-report questionnaire that assesses suicidal
intent in adults. Respondents report the frequency of thoughts about death in the last month using a
7-point Likert scale (almost every day; couple of times a week; about once a week; couple of times a month;
about once a month; I had this thought before, but not in the past month; I never had this thought).
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The Suicide Probability Scale274
The Suicide Probability Scale (SPS) consists of 36 statements with four subscales [hopelessness (12 items),
suicidal ideation (eight items), negative self-evaluation (nine items) and hostility (seven items)]. Responses
are measured on a 4-point Likert scale (none or a little of the time, some of the time, good part of the
time, most or all of the time).
Beck Scale for Suicide Ideation275
The BSS is a 21-item self-report questionnaire, which explores the presence and severity of suicidal intent.
Higher scores indicate greater suicidal ideation. The measure has a reliability of 0.90 with inpatient samples
and 0.87 with outpatient samples and test–retest reliability of 0.54.
Secondary outcome measures
These were included to reflect mood, symptoms of psychosis and associated outcomes:
1. PANSS55
2. Calgary Depression Scale73
3. SERS76
4. GAF scale,77 which provides a total score and two subscale scores: symptoms and disability
5. BHS.74
Training and monitoring/supervising trial therapists
Trial therapists were two clinical psychologists (JK and JM) who had extensive experience in delivering
CBTP. Prior to the commencement of the trial, the therapists received extensive training to familiarise them
with the therapy manual. During the trial, group supervision with the treatment developer (NT) was
provided on a fortnightly basis and peer supervision occurred on a weekly basis.
Intervention
Cognitive–Behavioural Suicide Prevention in Psychosis was based on a treatment manual202,211 and was
derived from an explanatory model of suicide behaviour: the SAMS.204 The intervention consisted of three
phases to address and change the three components of the SAMS. Modification of:
1. information processing biases
2. appraisals, with a focus on defeat, entrapment, social isolation, emotional dysregulation and
interpersonal problem-solving
3. suicide schema.
In addition, the sessions focused on the processes thought to underlie resilience to suicide. The
psychological therapy consisted of up to 24 individual therapy sessions delivered twice a week across
12 weeks at a convenient location for the participant (usually their home). Telephone contact or SMS
messaging was utilised when, and if, appropriate to support the therapy sessions.
Statistical analysis
All analyses were carried out using Stata. Random effects (i.e. random intercepts) models for repeated
measures data were fitted to both 4- and 6-month outcome variables with the baseline value of the
outcome variable being used as a covariate (allowing for a follow-up time by covariate interaction in all
models). Stata’s xtreg command was used. After preliminary examination of the data, treatment effects
were assumed to be the same for both follow-up times, the estimate of the effect of treatment arising
from fitting the random effect model being that which is common to both follow-up times. Because most,
if not all, of the outcomes were positively skewed, CIs for the treatment effects were routinely estimated
through the use of the bootstrap,276 using the percentiles based on the results of 1000 replications (using
the trial participant as the sampling unit).
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Results
Of the 131 potentially eligible participants, 49 were randomised, 25 to CBSPp plus TAU and 24 to TAU
alone (Figure 14). Of the CBSPp group, 16 participants were reassessed at 4 months and 17 were
reassessed at 6 months. In the TAU alone group, 19 were reassessed at 4 months and 18 were reassessed





Allocated to therapy (n = 25)
• 0 – 2 therapy sessions completed, n = 2
• 3 – 10 therapy sessions completed, n = 4
• 11 – 20 therapy sessions completed, n = 11
• All 24 therapy sessions completed, n = 7
• Withdrew before starting therapy by care team, n = 1
Completed 4-month follow-up = 79% (n = 19)
• Withdrawn, n = 1
• Unavailable, n = 4
Completed 6-month follow-up = 75% (n = 18)
• Withdrawn, n = 1
• Unavailable, n = 5
Completed both follow-ups = 70% (n = 17)
• Withdrawn, n = 1
• Unavailable, n = 6
Completed 4-month follow-up = 64% (n = 16)
• Withdrawn, n = 1
• Unavailable, n = 8
Completed 6-month follow-up = 68% (n = 17)
• Withdrawn, n = 1
• Unavailable, n = 7
Completed both follow-ups = 60% (n = 15)
• Withdrawn, n = 1
• Unavailable, n = 9




Identified as potentially eligible
(n = 131)
• Did not meet criteria, n = 12
• Participant declined, n = 18
• Care co-ordinator declined, n = 4
• No response from care co-ordinator, n = 22
• No response from participant, n = 13
• Participant died, n = 1
• Participant chose to take part in another study, n = 12
FIGURE 14 Flow diagram of recruitment and treatment allocation.
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The mean age of the sample overall was 34.9 years (SD= 13.1 years) and 31 out of the 49 participants
were male. The mean age of the participants in the CBSPp and TAU alone conditions were 32.6 years
(SD= 11.7 years) and 37.3 years (SD= 14.2 years), respectively, a difference which was not significant.
Forty-two participants were white (UK), one was white (non-UK), one was black (UK African), one was
black (UK/Caribbean African), two were Chinese, and two were of mixed ethnic background. Thirty-six
participants were single, two were married, four were divorced and seven were in common law marriages.
A total of 2, 30, 15 and 2 participants had completed UK primary, secondary, further and higher education
levels, respectively, as their highest level of educational qualification. The majority of the sample (n= 35)
were unemployed. Twenty-nine participants were atheist, 14 were Christians, one was a Hindu, four did
not specify a religion and there were missing data for one individual. Fifteen participants had attempted
suicide once, 27 had attempted suicide twice or more and seven had not previously attempted suicide.
Twenty-two participants were recruited from EI services, 26 were recruited from CMHTs and one was
recruited from AO teams. Schizophrenia (n= 18), schizoaffective disorder (n= 8), persistent delusional
disorder (n= 3), other (psychosis not otherwise specified) (n= 10) and unable to capture data/missing data
(n= 10) were the primary diagnoses. The vast majority of primary and secondary outcome measures were
significantly intercorrelated (Table 58).
As can be seen from Table 59, the repeated measures regression model indicated that there were
significant improvements in the primary outcome measures of suicidal ideation (ASIQ, treatment
effect= –12.30, SE 6.30, 95% CI –24.30 to –0.14), suicidal probability (SPS, treatment effect= –7.00,
SE= 3.90, 95% CI –15.50 to 0.00) and hopelessness (subscale of the SPS, treatment effect= –3.80,
SE= 1.70, 95% CI –7.30 to –0.50) at the follow-up periods. Suicidal ideation, the probability of suicide
and feelings of hopelessness significantly decreased in the Treatment group compared with the
TAU group.
Analysis of the secondary outcome measures indicated significant improvements in depression (treatment
effect= –3.3, SE= 1.0, 95% CI –5.3 to –1.4), self-esteem (treatment effect= 14.5, SE= 4.9, 95% CI 5.0 to
24.3), positive and negative symptom total scores (PANSS, treatment effect= –7.1, SE= 2.1, 95% CI –11.3
to –2.0), PANSS general symptoms scores (treatment effect= –4.5, SE= 1.2, 95% CI –6.8 to –2.1), PANSS
positive symptoms scores (treatment effect= –1.6, SE= 0.8, 95% CI –3.0 to –0.1), and GAF scale symptom
scores (treatment effect= 8.3, SE= 4.0, 95% CI 0.6 to 15.8). It should be noted that scores did not
improve for the treatment relative to the TAU alone group for PANSS negative symptom scores nor for the
GAF scale total or disability scores, BHS hopelessness score or BSS score.
Discussion
In general, there were improvements on all measures over the trial. CBSPp in addition to TAU successfully,
and significantly, reduced the primary and secondary outcome measures compared with TAU alone. That
is, subjective measures of suicidal ideation, estimated probability of suicide and hopelessness (as measured
by the SPS) were improved as were the associated outcomes of depression, self-esteem, symptoms of
psychosis overall, positive and general symptoms of psychosis, and the GAF scale symptoms score. There
were no significant group differences in negative symptoms or measures of overall functioning and
disability using the GAF scale. Thus, it is important to note that the intervention not only improved suicidal
thoughts and behaviours but also improved some of the known risk factors for suicide, such as depression
and symptoms of psychosis. Previous reports on the reduction of suicide behaviours have tended to be
secondary reports of larger studies, which have had more global clinical aims. For example, one study277
conducted an evaluation of an integrated community treatment including assertive community treatment,
antipsychotic medication, psychoeducational family treatment and social skills training with people
experiencing first episodes of psychosis. Similarly, the Study of Cognitive Reality Alignment Therapy in
Early Schizophrenia (SoCRATES) trial42 was an evaluation of CBT with recent onset schizophrenia aimed to
speed recovery in those suffering an acute episode of psychosis. Thus, both of these studies included
retrospective evaluations of suicide behaviour in trials that did not have a sole and dedicated aim to reduce
such behaviour. Therefore, the current study differed markedly from previous published studies in that the
intervention was derived directly from a theoretical understanding and an empirically validated model of
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the psychological mechanisms underlying suicide behaviour. The core mechanisms that have been
identified involve negatively biased attentional processes, negative appraisals of defeat, entrapment, social
support, emotional regulation and problem-solving, and the presence of an extensive suicide schema.207–211
The trial was carried out explicitly to target these underlying psychological mechanisms and thus reduce
suicide behaviour.211 Evidence from other work has shown in those experiencing psychosis that CBT
without this targeted development was disappointing in ameliorating suicidality;42 however, this issue
should be investigated with a full-scale RCT. There are a number of major difficulties in evaluating suicidal
prevention interventions. First, morbidity as a result of self-harm, although all too frequent, is an
impractical and ethically problematic outcome measure for a small clinical trial. Therefore, it was necessary
to investigate suicide behaviour by examining suicidal thoughts as a more frequently occurring proxy
outcome measure. Moreover, suicidal ideation is subjectively distressing and, thus, can be considered a
legitimate target in its own right. Second, the ethical requirements of administering a clinical study,
especially one involving an untried therapeutic intervention, preclude the participation of those who are
considered to be at current high probability of self-harm or acutely suicidal. Understandable as this is, it
means that the study focused on risk factors such as history of past attempts or current ideation. A third,
and related, issue is whether or not participation in suicide research is distressing or endangering to those
with ongoing suicidal thoughts. This is not supported by a study in which we elicited feedback from
79 service users who had participated in suicide related research. The results indicated that overall feedback
was positive, and negative feedback was rare.215 This study has a number of weaknesses. The trial was
small and not all participants were available at follow-up assessments. We used a simple design in which
TABLE 59 Mean (SD) for primary and secondary outcome measures at the three time points for the treatment and
TAU (Control) groups














Suicidal ideation (ASIQ)a 54.1 (38.8) 57.4 (38.1) 37.1 (33.6) 40.9 (40.5) 29.6 (31.3) 41.5 (34.9)
Suicide probability (SPS)a 84.8 (23.1) 83.2 (24.6) 67.3 (23.3) 73.2 (21.8) 67.5 (19.6) 70.3 (20.4)
SPS suicidal ideation 23.0 (7.8) 20.8 (10.0) 15.6 (7.7) 16.7 (8.3) 16.7 (8.6) 15.9 (8.0)
SPS hopelessnessa 27.5 (8.7) 26.4 (9.4) 19.9 (8.3) 22.8 (8.0) 20.0 (7.1) 22.9 (7.8)
SPS negative
self-evaluation
18.5 (3.6) 19.9 (3.8) 16.8 (3.5) 17.9 (4.2) 16.0 (3.1) 18.2 (4.7)




8.6 (4.9) 9.4 (4.9) 4.2 (4.1) 8.5 (6.5) 4.0 (3.8) 7.2 (5.2)
Self-esteema 68.0 (24.6) 67.6 (25.3) 88.0 (27.0) 77.3 (24.7) 90.3 (21.9) 73.4 (25.3)
PANSS totala 58.7 (10.4) 61.6 (16.4) 49.8 (12.3) 58.1 (17.1) 47.9 (11.9) 53.9 (12.8)
PANSS generala 31.3 (5.2) 31.5 (7.8) 24.3 (5.6) 29.0 (9.0) 24.4 (6.6) 27.1 (7.8)
PANSS positivea 14.8 (4.8) 16.1 (5.2) 14.0 (5.9) 15.2 (5.5) 12.4 (4.9) 14.9 (4.0)
PANSS negative 12.6 (2.6) 14.0 (5.5) 11.6 (2.9) 14.0 (5.6) 11.1 (2.3) 11.9 (3.1)
GAF total 28.7 (7.5) 30.4 (9.1) 34.0 (8.5) 36.6 (15.6) 39.2 (19) 35.7 (12.0)
GAF symptoms 31.2 (13.0) 33.9 (17.0) 42.8 (22.2) 43.2 (24.8) 47.5 (26.3) 37.5 (15.5)
GAF disability 43.2 (11.1) 42.8 (9.3) 44.1 (5.4) 47.2 (12.3) 46.9 (15.5) 44.9 (8.4)
a Significant outcome measure.
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we compared CBSPp plus TAU with TAU alone. Future work would benefit from systematically comparing
different forms of interventions, such as supportive counselling, to both a CBSPp condition and a waiting
list control. The follow-up periods were relatively short at 4 and 6 months. On the positive side, this was an
adequately powered trial of a manualised novel treatment to address an important clinical life-threatening
problem, with independent and masked random allocation, and independent and masked assessments,
using standardised measures with an at risk population recruited from a geographical cohort using public
health services. The trial hypotheses were supported and there were no evident adverse effects. The trial
was the first of its kind and, thus, was an indication of feasibility as well as estimating the efficacy of the
novel treatment.
Conclusions
The research in this chapter aimed to develop and evaluate a cognitive–behavioural approach to
understanding and preventing suicide in people with psychosis. The research was broken down into
three phases:
1. a qualitative exploration of the subjective experience of participation in schizophrenia research
2. an investigation of the psychological mechanisms underlying suicide behaviours: the role of defeat,
entrapment and resilience
3. a RCT of CBSPp.
This chapter described a series of studies to investigate suicidality in people with experience of psychosis,
leading to an understanding of the mechanisms that underlie suicide behaviours and the development of
a cognitive–behavioural intervention for this population.
The first phase of this research indicated that participants are willing to take part in research and discuss
potentially sensitive topics such as psychosis and suicide. Additionally, feedback suggested a number of
benefits for those who participate, including a sense of catharsis and therapeutic gain and a perception of
helping others. It appears that the research environment may provide a context in which issues pertaining
to mental health and suicide can be discussed in a confidential, open and non-judgemental way. This
phase of the research provided a sound basis for further exploration of the topic of suicide in people who
experience psychosis.
The second phase of the research investigated mechanisms underlying suicide behaviours to inform the
development of the CBSPp. This study suggested that defeat and entrapment fully mediated the
association between positive symptom severity and suicidal ideation. Defeat and entrapment, defined as
perceptions of loss or rejection without escape or likelihood of improvement,228 may represent one
particularly maladaptive psychological response to the difficulties posed by living with psychosis, which
may provoke suicidal ideation and behaviour as a means of escape or protest.206 This suggests that
psychological therapies aimed at reducing suicidal ideation in individuals diagnosed with schizophrenia
could focus specifically on reducing perceptions of defeat and entrapment, alongside interventions aimed
more directly at alleviating clients’ symptoms.
Additionally, this phase of the research found that positive self-appraisals moderated the impact of
hopelessness such that individuals with high levels of positive self-appraisals were significantly less likely
to experience suicidal ideation even at the highest levels of hopelessness. When specific types of
self-appraisals were examined in isolation, appraisals of emotion coping ability appeared to moderate the
impact of hopelessness, but appraisals of situation coping and social support did not show this moderating
impact. This suggests that positive self-appraisals may be an important aspect to incorporate into clinical
interventions, particularly the possibility of developing positive self-appraisals to indirectly reduce the
likelihood of suicide risk by attenuating the impact of risk.
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The final phase of the research used the information gathered in phases 1 and 2 to inform the
development of the CBSPp and evaluate this intervention in a RCT. This trial is the first study to date that
utilised an intervention that has been derived directly from a theoretical understanding and an empirically
validated model of the psychological mechanisms underlying suicide behaviour. The core mechanisms
that have been identified involve negatively biased attentional processes, negative appraisals of defeat,
entrapment, social support, emotional regulation and problem-solving and the presence of an extensive
suicide schema.207–211 The trial was carried out explicitly to target these underlying psychological
mechanisms and so, reduce suicide behaviour.
The trial results showed that CBSPp, in addition to TAU, successfully and significantly reduced the primary
and secondary outcome measures compared with TAU alone. That is, subjective measures of suicidal
ideation, estimated probability of suicide and hopelessness (as measured by the SPS) were improved as
were the associated outcomes of depression, self-esteem, symptoms of psychosis overall, positive and
general symptoms of psychosis and the GAF scale symptoms score. There were no significant group
differences in negative symptoms or measures of overall functioning and disability using the GAF scale.
Thus, it is important to note that the intervention not only improved suicidal thoughts and behaviours but
also improved some of the known risk factors for suicide, such as depression and symptoms of psychosis.
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Chapter 7 Development and evaluation of
recovery-focused cognitive–behavioural therapy
for individuals with early bipolar disorder
Background
Bipolar disorder affects over one million people in England alone and has a prevalence rate of around 2%.7
In addition to repeated periods of mania and depression, most individuals with BD experience extended
periods of distressing subsyndromal mood symptoms between episodes.9–11 Consequently, BD has a
significant impact emotionally and functionally12 and constitutes a substantial financial burden to society
with a recent estimated cost to the English economy at £5.2B per annum.8 NICE has recommended the
provision of structured psychological therapy for individuals with BD.15 To date, controlled trials of
structured psychological therapy have focused on individuals with a chronic BD.278,279
Although it might seem logical to focus interventions on individuals with established illness course, recent
psychological models of BD suggest otherwise. It has been argued that associative mechanisms build up
over repeated mood episodes in BD such that later episodes are both more readily triggered by
psychosocial circumstances previously linked to mood changes and are also less likely to be mediated by
cognitive processes.280–282 This suggests that cognitive–behavioural interventions may be more powerful
when applied earlier in the illness course before strong associative links to bipolar emotional states are
established. Consistent with this research a recent study of CBT for relapse prevention in BD found a
significant benefit only for those with fewer episodes in a post hoc analysis.43 Additionally, there is
evidence that individuals with earlier onset of BD tend to have worse clinical outcomes, leading to calls for
more timely detection and intervention.283,284 Despite the arguments in favour of earlier treatment, there
have been no RCT evaluations to date of CBT for BD specifically targeted at individuals early in their
illness course.
Research into the longer-term outcomes of pharmacological and psychological interventions for BD has
concentrated on symptom reduction and relapse prevention;278,285,286 thus, there is increasing interest in
experience of recovery,287 which is now reflected in government mental health policy in England
(Department of Health New Horizons,87 Department of Health Journey to Recovery288). Research in
psychosis indicates that reduction in symptoms of psychosis is not a necessary requirement for the
experience of recovery.19,22,111 It has also been argued by consumers that recovery in BD is not always
associated with symptomatic change.95 To date there have been very few studies that have explored this
issue systematically. Studies that have explored how individuals with BD stay well have focused primarily
on methods by which relapse is avoided and have defined recovery in terms of symptom reduction, rather
than focusing on the subjective process of recovery.289,290 Additionally, studies have focused mainly on
individuals with long-term diagnosis of BD neglecting exploration of how these processes develop earlier
on in the course of the disorder. No study has explored experiences of recovery from the perspective of the
participants early in the course of their BD.
Similarly, individuals with personal experience of severe mental illness, including BD, express dissatisfaction
with the notion that symptom and relapse reduction are the primary targets of clinical practice. Instead,
service users argue for the importance of personal recovery outcomes.19,95,291 Although clinical recovery
contributes to this process, the emphasis for many people is on social and functional recovery outcomes.
Understanding and endorsement of this recovery perspective by clinical professionals can lead to significant
benefits in terms of greater service user empowerment, enhanced use of collaborative care models
(including advanced directives) and tailoring of clinical interventions which together enhance social and
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functional outcomes.292–296 However, there have been very few studies that have explored recovery
experiences systematically in BD. Some qualitative studies have explored how individuals with BD stay well,
focusing primarily on methods by which relapse is avoided, rather than on the subjective process of
recovery, highlighting the importance of both medication and psychosocial support in the context of active
condition management by the individual.289,290 Although clinically helpful, such reports define recovery in
terms of symptom reduction and avoidance of relapse thus missing the more idiosyncratic personal
recovery experiences that are often most important to service users. They also do not incorporate research
which indicates that trajectories of symptomatic and functional improvement are often different297,298 and
that some individuals with significant residual symptoms can achieve high levels of functioning.299
Furthermore, such approaches do not offer researchers or clinicians a time-efficient tool to assess recovery
in relation to new treatments or routine clinical practice. The QPR has recently been developed, which
explores intrapersonal and interpersonal aspects of recovery from psychosis as a process32 and has already
been adopted as the primary outcome measure for a cluster RCT of a recovery-focused approach to CMHT
care.300 However, despite the promise of this measure, it was not developed to capture the unique
experiences of individuals with BD, including its varied and fluctuating nature and the need to balance
experience across phases of mania, depression and euthymia. For example, in people with BD, there is a
risk that high levels of optimism, involvement in meaningful activities and social interactions and self-
confidence may actually be indicative of mental health problems in a way that is unlikely for people
with psychosis.
In light of this, the current study begins by exploring the subjective experience of recovery in the early
stages of BD. This information will then be used to develop and evaluate a service-user informed measure
of recovery in BD (the BRQ). The final phase of this study will use an adapted CBT intervention for
individuals within the first 5 years since onset of BD. An earlier version of this intervention has already
proved to be acceptable and feasible in a single case series of seven bipolar participants.301 The present
trial builds on this pilot work in a RCT feasibility study, but also extends the intervention to incorporate a
clear focus on recovery outcomes (RfCBT) as measured by the BRQ. The intervention used in this study was
developed using evidence-based principles for effective psychological interventions for BD279 previous pilot
case series work301 and through qualitative interviews, focus group work and consultation with individuals
with experience of BD.
Phase 1: recovery in the early stages of bipolar disorder
Objectives
This study aimed to identify the range and nature of subjective recovery experiences in a group of
individuals with recent onset BD.
Method
Participants
Over a period of 4 months, nine individuals with a diagnosis of BD were recruited from mental health
services and service user groups in the north-west of England. Participants were asked to complete a
demographic sheet, two self-report measures of mood [Beck Depression Inventory302 (BDI) and the Internal
States Scale (ISS);303,304 Table 60]. Diagnosis was confirmed with the Structured Clinical Interview for
DSM-IV Disorders (SCID).305
Inclusion criteria
Participants were included in the study if they had received a diagnosis of BD I or II (according to SCID
criteria) in the previous 5 years and felt that they could reflect on their experiences of recovery in BD.
Participants were aged between 18 and 65 years at the time of interview.
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Exclusion criteria
Individuals were excluded if they were currently experiencing acute major depression or mania or had
experienced an acute mood episode of either type in the 2 months prior to interview. The presence
of subsyndromal mood symptoms did not preclude recruitment.
Interview procedure
A topic guide was used for each interview to provide a provisional structure (including possible open-ended
questions) but was intended to be flexible and did not dictate the direction of the interview or resultant
themes. The topic guide was developed by the authors in consultation with a reference group of past and
present service users with personal experience of BD. Service user feedback concerned the relevance and
appropriateness of the questions to the consideration of recovery and related issues. Issues covered in the
interview included past experiences of BD, strategies or ways of coping with BD, participant definitions of
recovery in BD, experiences of recovery and factors that were helpful or unhelpful in recovery. All interviews
were conducted in person and, depending on the participant’s preference, took place either at the
participants’ homes or at their local mental health services. Interviews lasted 1 hour on average and were
audio-recorded for later analysis.
Analysis
Interview recordings were transcribed verbatim and analysed using the qualitative method of IPA.66,306
IPA aims to describe, explore and understand the individual experiences of participants and attempts to
capture the meanings that particular phenomena hold for them. The central interpretative role of the
researchers in analysing and making sense of these experiences is recognised as part of IPA. Therefore, this
method is consistent with the primary aim of the present study to explore the subjective experience of
recovery and the idiographic nature of recovery definitions, over and above externally imposed assumptions
of what recovery is and how it occurs.
TABLE 60 Demographic and mood symptoms data for study participants
Participant
Age





score ISS-W ISS-A ISS-PC ISS-D




2 12 181 180 161 30




4 8 219 60 34 0




0 3 235 323 35 10




3 15 147 40 59 12




0 0 204 81 77 28




2 9 153 121 92 17




5 0 200 171 63 0




0 3 235 385 35 0




3 11 212 64 37 11
ISS-A, Internal States Scale activation; ISS-D, Internal States Scale depression; ISS-PC, Internal States Scale perceived conflict;
ISS-W, Internal States Scale well-being.
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Data were analysed by three authors: a clinical academic with a psychological perspective, an academic
researcher and a non-clinical academic with expertise in qualitative methodology. Consistent with the
procedures described by Smith et al.,66 each of the first three transcripts were analysed in detail by each
researcher independently. This preliminary information on key themes was then reviewed in detail by the
researchers as a group to construct key themes for each participant. These agreed theme sets were then
evaluated and integrated by the group of researchers to provide indicative themes that informed (but did
not restrict) the subsequent analysis of the remaining transcripts. To ensure the reliability and validity of the
analysis, authors met regularly to compare their independent analyses of transcripts. As a further step, the
reference group of service users were consulted on both the validity of the interpretation of participant
quotes and on the developing themes that emerged. Superordinate themes were identified from clustering
of connected themes that most strongly reflected participants’ perspectives on recovery related issues.
Results
The five key themes that emerged from participant accounts are described below.
Mood experiences as understandable and manageable
Participants described a process of coming to see their mood experiences as developing from a
combination of early experiences, developing personality and ongoing life events. Many participants
described having reached an understanding of how these elements interact and how their patterns of
interaction with the world and others might have an impact on their vulnerability to develop mood
symptoms in the future. This includes appreciating how early experiences had shaped the way they
perceived the world in some cases:
I think some of the work I did with the psychologists when I got under the EI team allowed me to
make a bit of sense of perhaps from some of the things that had happened early on in my life. There
were some quite traumatic events early on in my life . . . I guess maybe some of the things that had
happened to me previously in life had given me a lot of beliefs that perhaps were brought to the fore
when I was, when my mood was kind of all over the place.
Participant 1
For others, examples of enduring traits were identified including setting high standards for one’s self,
taking on too much or being a perfectionist which they related to potential for the development of
mood symptoms:
I think one of the problems I have is erm I set my standards really high and when I fail it’s an excuse
to beat myself up, it’s an excuse, well which leads to depression or it’s an excuse to work even harder
which is going to push me the other way into hypomanic or mixed episode.
Participant 9
A lot of people I know with bipolar are included in this, are very much perfectionists and blame
themselves when things aren’t going right and I’ve sort of, I’ve tried to stop [laughs] worrying about
every little detail of things.
Participant 2
This process of making mood experiences understandable enabled participants to develop a stronger sense
that such experiences could also be managed rather than having a ‘life of their own’:
I always felt that, certainly with, particularly with depression, that it controlled me, rather than me
having any control over it at all, so it happened to me and it was done to me, but I think now I don’t
have that belief I believe I have the control over it from having the diagnosis and doing the
work subsequently.
Participant 1
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Developing resources to self-manage health
The development over time of strategies that enabled participants to take more effective control of their
own mood typically had a profound impact on their beliefs in their own self-efficacy. Changes in
self-efficacy beliefs were often illustrated by contrasting current coping behaviour with previous, less effective,
ways of managing mood in which they would ‘charge on’ with it, or ‘go straight steaming a head through it’
(which are active strategies that may exacerbate mania) (participant 4), or would ‘sit it out’ and wait for it to
disappear (passive strategies that may exacerbate low mood). There was general acknowledgement of a
central role of the individual in managing care from diverse sources (including medication, therapy, family,
support groups, psychoeducation, etc.) to enhance mood stability and mental health:
I’ve got management tools of how to deal with the old me and that’s what I didn’t have before cause
I’ve got much more insight and I can now learn how to deal with those things and how to control it
rather than being that all over the place whirl wind, cause I wasn’t just a whirlwind, I was, it was a
very broad whirlwind [laughs].
Participant 3
Change in balance of care from perceived dependence on others to
increased autonomy and independence was regarded as an important facet
of recovery
You know as everyone’s erm been around monitoring me, and I’ve been monitoring myself, you
know, its about finding your triggers, what makes these things erm just what makes them happen
really and once you identify them then you can go around them and you know you just don’t go
straight steaming a head through it.
Participant 4
Being able to look after yourself, being able to look after the house, [. . .] err being healthy, not having
to rely on professionals or medication.
Participant 8
Recovery involved more than solely gaining mood stabilisation. Mood stability was conceptualised as aiding
progress towards a more complete recovery but not as indicating recovery in and of itself:
I don’t think any clinical measure [of mood stability] really means much. I mean it may be a means to
an end but it’s certainly not at the end.
Participant 2
Access to personally meaningful activity
Access to personally meaningful activities was highly valued by participants in relation to their recovery. For
some participants this involved becoming involved in activities that they have previously engaged in before
the onset of their BD. For some participants this included becoming involved in activities that they engaged in
before the onset of their BD, such as going back to a valued job or undertaking previously enjoyed hobbies:
I just feel like I’m getting back to how I used to be before the whole section thing and the huge mania
. . . just more happy, happier you know erm, more productive, I’ve been writing songs again which I
haven’t done for, you know, since the whole 60 songs in 2 days thing.
Participant 4
It reminded me that I can do all that stuff, I was beginning to wonder at what point if my brain was
completely fried and all the things I was able to do ten years ago, if I could still do that at all in terms
of being professional about things, and understanding finances and erm company structures and all
that sort.
Participant 2
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For other participants, recovery involved taking on of new roles, for example in the context of work
or volunteering:
I started to feel better about myself, I started to engage in more of the stuff that the early intervention
team offered. Like the STR’s there ran a football group, so I started to go and play football again and
there was opportunities to go and volunteer . . . I felt that I made quite quick steps recovery wise
because of that, and I really hold that as a strong belief now, that just those meaningful activities that
put your self-respect back, have got a massive effect on your recovery.
Participant 1
It was engagement in these activities that had a profound impact on how participants saw themselves,
helping them ‘feel productive’, regain confidence and realise their own self-worth. Lessons learned from
these activities in turn aided the (re)building of the self:
I think two trips combined have really taught me to sort out you know, what matters and what
doesn’t matter and not to get stressed out about things that you can’t do anything about, don’t get
yourself stressed out because it is just going to lead to, if I let it build up it’ll just lead to another
episode so I think I have changed and I think my travelling has got a lot to do with that.
Participant 9
Recovery as a life long process
Recovery was typically conceptualised as an ongoing process without a definite end point. In parallel with
recovery was an awareness of continuing vulnerability to mood fluctuations and a continuing need to
monitor mood to remain in recovery:
I feel like I’m well on the road to recovery, but I also don’t want to be naïve in thinking this is me
bomb proof like, for the rest of my life. [. . .] I still feel vulnerable to mental health problems and I think
I probably always need to keep a check on mood.
Participant 1
I mean from what I’ve read there’s always going to be ups and downs eventually, so I guess it’s just
remaining mindful that, yeah I have been ill and I’m probably more, more than the average person,
more susceptible to becoming ill again so I’ve got to watch out for it and just yeah take it easy and
look after myself.
Participant 4
An additional element to this theme was awareness that hypomanic states continued to be both appealing
and seductive:
How important it is to not chase your highs, just to sort of sit on them rather than let them lead you
know erm, whereas before I just used to push it as far as I could go, and then that’s when I’d get into
trouble or when things would start to fall apart, whereas now I realised that, it’s really hard though
cause they’re so seductive and you just want to go along with them.
Participant 7
When it’s mixed or manic or hypomanic, it’s very very difficult because as soon as you get an upsurge
in energy with those sorts of episodes it’s like ‘yeah great I can do this, I can do that, oh I’m going to
do this, I’m going to do that blah blah blah blah’ you know ‘I’m going to climb mountains and I’m
going to swim oceans’ [laughs] you know what I mean, it’s, and it’s easy to turn a blind eye to the
warning signs of those types of episodes.
Participant 9
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Discussion
Although there have been studies that have explored the ways in which individuals achieve mood
stabilisation, this is the first study of the understanding of recovery and recovery-related experiences from
the perspectives of individuals with recent onset BD.
It is clear that participants engaged in active processes linking their understanding of themselves with their
symptom experiences. This development of enhanced understanding over time was regarded as important
in providing participants with the tools to manage their mood symptoms. In addition to active mood
management strategies, people typically associated increased self-efficacy more widely with recovery. This
was often marked by a transition from relying on a wide range of formal and informal sources of support
early in recovery to more strategic and lower use of these resources as recovery progressed. It also seemed
that recovery was facilitated when people moved from unhelpful active or passive coping behaviours to
more functional, balanced coping methods consistent with cognitive–behavioural understandings of BD.278
A wider aspect of recovery was highlighted in the role of engaging in activities that were personally
meaningful. People either found these activities important in defining themselves as distinctly different
from their pre-bipolar self or found value in activities that were consistent with returning to their original
view of themselves. There was also evidence that recovery was perceived to be a dynamic process rather
than movement towards a fixed end point. As such most participants reported progressing through
recovery while at the same time holding a sense of vulnerability to future episodes, which could be
moderated by awareness of this risk.
Previous research
Consistent with previous research, the present study indicates varied impacts of BD. Michalak and
Murray307 identified both positive and negative effects of BD on quality of life. Studies of ‘staying well’ in
BD have indicated roles for life style management, warning sign detection/mania avoidance medication
and use of support services.289,290 These reports defined wellness in terms of absence of relapse and
recruited their sample on the basis of being out of episode for ≥ 2 years. The current study finds the
processes involved in recovery may be different. First, experience of recovery was not limited to individuals
with extensive symptom-free periods. Second, the role of medication did not emerge as a theme in
relation to recovery. Third, the specific importance of meaningful activity is highlighted in recovery in
contrast with previous wellness research. In a mixed psychiatric group, a staged model of recovery was
reported from acknowledgement/acceptance of illness initially through learning about the illness to later
stages of building independence and quality of life.308 In contrast, here a staged process of this type would
not describe the varied recovery paths reported. The similarities between the findings of our study and
those of recovery from psychosis are notable,19,22,111 with recovery identified as a process or journey that
involves increased self-efficacy and understanding of self as well as reintegration with life, social inclusion
and active participation in meaningful roles.
Strengths and limitations
Consistent with guidelines for IPA research, the sample for this study is not large but was selected to be
homogeneous with respect to diagnosis and relatively recent onset. Although drawn from a range of NHS
and service user settings across the north-west, this sample is not intended to be formally representative of
all early onset bipolar service users. Therefore, it is important to be cautious about generalising these
findings too widely. However, the sample provided a series of rich and diverse themes illustrative of the
complex recovery paths that people with BD negotiate. Care was taken to engage service users in the
planning and process of the study and comparison of independent analyses of interviews was used to
ensure reliability and validity of analyses.
Implications
Services should note that even relatively early in the course of BD, people report a wide range of recovery
experiences. Recovery in this group is an ongoing process that is facilitated by flexible provision of formal
and informal care. A crucial aspect of this process is access to activity that is personally meaningful to
the individual, whether that be paid employment, voluntary work or hobbies. The diversity of routes
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through the recovery process and the partial independence of recovery from symptom reduction presents
clinical challenges. Services need to support individualised assessment of recovery process in the patients
under their care. Services could promote recovery in a number of ways: provision of optimistic, normalising
information could facilitate people viewing mood swings and BD as both understandable and manageable;
increasing adaptive coping would also promote recovery (this could include use of medication, use of
cognitive–behavioural methods such as evaluation of problematic appraisals and behavioural experiments,
and use of lifestyle interventions such as sleep hygiene, exercise and minimising substance use); provision
of meaningful activities and promotion of ordinary lives by services should also assist recovery, as could
structured assessments, goal-setting and social and vocational interventions designed to facilitate
re-engagement with employment, education and training.
Future research should explore the relationships between the patterns observed in the current study and
those present in individuals with a more established history of BD. Assessment of recovery processes within
services would be facilitated by the development of a quantitative self-report measure informed by
research of this type, in a similar way to the user-informed recovery measure that has been developed for
use with people with psychosis.32
Phase 2: the Bipolar Recovery Questionnaire – psychometric
properties of a quantitative measure of recovery experiences
in bipolar disorder
This research was previously published as Jones S, Mulligan LD, Higginson S, Dunn G, Morrison AP. The
bipolar recovery questionnaire: psychometric properties of a quantitative measure of recovery experiences
in bipolar disorder. J Affect Disord 2013;147:34–43309 and much of this text is reproduced with permission
from Elsevier.
Objectives
This study reports on the development of a new measure: the BRQ.
The study aimed to determine whether or not the BRQ is (1) internally consistent and reliable; (2) logically
associated with measures of mental health symptoms (negative associations with depressive and manic
mood symptoms, positive association with well-being); and (3) logically associated with measures of
functioning and growth (positive associations with improved functioning and growth).
Method
Item generation methods
Potential items for the new scale (the BRQ) were generated based on both a review of recovery literature
in severe mental illness and specifically in BD and from the phase 1 qualitative study of individuals with BD
using an interpretative framework approach to explore personal definitions, experiences and accounts of
recovery. Based on these sources, 45 items were drafted by the authors intending to capture personal
understanding of self and symptoms, the role of the individual and sense of personal agency in the process
of recovery, developing meaning through active engagement in the social/occupational world and finally to
identify recovery as a dynamic process rather than a static goal.
Item reduction methods
After initial generation, all candidate items were first reviewed by a service user reference group and item
wordings amended when required on the basis of this review. No items were removed at this stage. Items
were then further reviewed and scrutinised for content and face validity by clinicians, academics and
service user consultants involved in this project. Of the 18 experts contacted, 13 responded, rating each
item on Likert scales ranging from 1 (not at all) to 5 (a great deal), for relevance to recovery (how relevant
is the item to recovery in BD?) and comprehensibility (how comprehensible is the item? Is it easy to
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understand?). Any candidate items with an average rating of < 4 for relevance to recovery were eliminated
from the item pool (n= 11). Items with an average rating of < 4 for comprehensibility were considered for
rewriting (n= 2). After rewording, these items were rerated by one of the experts who offered original
feedback. Both were rated as suitably comprehensible and relevant to recovery (i.e. > 4) and so were
included in the final item pool. The final item pool was then reviewed and approved by the service user
reference group for this project. The final BRQ scale for psychometric investigation consisted of 36 items
(see Appendix 12). Each item is scored on a 100-mm visual analogue scale from 0 to 100 anchored by
‘strongly disagree’ (0)’, disagree’ (25), ‘agree’ (75) and ‘strongly agree’ (100). Total BRQ score is calculated
by summing individual scores across all items of which 12 are reverse scored (i.e. strongly disagree would
indicate a score of 100, and strongly agree would indicate a score of zero). Higher BRQ total scores
indicate a higher degree of self-rated recovery. The scale consists of a mixture of positively and negatively
keyed items to guard against acquiescence responding biases in which the participant may tend towards
repeatedly giving high or low ratings on items independent of item content.310
Participants
Participants were included in the study if they met criteria for a diagnosis of BD I or II, confirmed using the
SCID.305 Participants had to be aged 18–65 years old and sufficiently fluent in English to be able to
complete the BRQ and other study measures.
Individuals were excluded if they were currently experiencing an acute episode of major depression or
mania, or had experienced either in the month prior to assessment. This led to the exclusion of one
potential participant.
Procedure
Participants were recruited via mental health services and service user groups across the north-west of
England. Ethical approval for the study was granted by a local NHS research ethics committee, which
operated in accordance with the Declaration of Helsinki.311 Depending on individual participant preference,
assessments were either completed at the participants’ homes or at local mental health services. Following
a SCID interview to confirm diagnostic status and to confirm absence of a current acute mood episode,
participants then completed the following measures together with the BRQ.
Symptom measures
Observer rated
Bech–Refaelsen Mania Scale (MAS):312 the MAS is an observer-rated measure of mania severity, scored over
11 items. The MAS is a widely validated scale and evidence exists for its internal consistency (α= 0.80–0.90).313
Hamilton Rating Scale for Depression (HDRS):314 the HDRS is an observer-rated measure of depression
severity, scored over 17 items. The HDRS has been shown to have a high degree of scale reliability and
evidence exists for its concurrent and discriminant validity.315,316
Self-report
Beck Depression Inventory – Second Edition (BDI-II):302 the BDI-II is a self-report inventory of depression
severity, scored over 21 items. The scale has good psychometric properties, including test–retest reliability
of 0.65–0.85 in depressed adults over periods of 1–3 weeks.302
Internal States Scale:303 the ISS is a well-established self-report measure of bipolar symptomatology, scored
across four subscales assessing Internal States Scale activation (ISS-A), Internal States Scale perceived
conflict (ISS-PC), Internal States Scale well-being (ISS-W) and Internal States Scale depression (ISS-D). The
ISS has been shown to have excellent psychometric properties across two studies.303,304
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Functioning and growth measures
Observer rated
Personal and Social Performance scale:155 the PSP is an observer-rated measure of functioning, scored
across four domains assessing socially useful activities, personal and social relationships, self-care and
aggression. The internal consistency of the overall scale has been shown to be adequate (α= 0.76).156
Self-report
Medical Outcomes Study Short Form Health Survey:317 the Medical Outcomes Study Short Form Health
Survey is a self-report measure of mental and physical health functions cored over 12 items. The mental
health and physical health summary components of the Medical Outcomes Study Short form Health Survey
demonstrate good psychometric properties (α= 0.88 and 0.86, respectively).318
Post-traumatic growth inventory (PTGI):319 the PTGI is a 21-item self-report measure of positive outcomes
following traumatic experiences. The psychometric properties of the PTGI total score are good (α= 0.90).319,320
Psychometric analysis
Internal consistency of the BRQ was computed using Cronbach’s alpha (α). External validity was assessed by
analysing cross-sectional relationships between BRQ scores and the self-reported and observer-rated
measures described above (see Symptom measures, Observer rated and Self-report). Power calculations
revealed that 60 participants were sufficient to detect correlational relationships of ≥ 0.4 between BRQ and
measures of interest with alpha set at 0.01 and beta at 0.8. This threshold was deemed sufficient to ensure
that items of potential significance associated with BRQ were not missed. To more rigorously assess the
unique associations between measures of symptoms and function and BRQ scores, those measures that were
significantly associated with BRQ were entered together into a series of regression analyses to explore the
variance accounted for by each, one exploring the variance explained by symptom measures and a second,
exploring the variance explained by measures of growth and functioning. Significant predictors from these
initial analyses were then entered into a final regression analysis to explore the specific measures that
uniquely predicted recovery. Kolmogorov–Smirnov (KS) tests were used to assess the distributions of data for
questionnaire totals and subscales. None of the scales deviated significantly from normality.
Results
Participants
Sixty participants were recruited, comprising 26 males (43%) and 34 females (57%) aged between 19 and
63 years (mean age 42.37 years, SD 11.42 years). Fifty-two participants (87%) had a diagnosis of BD I and
the remainder had a diagnosis of BD II (13%). Twenty-eight participants completed the BRQ for a second
time 4 weeks later for reliability testing. The majority of participants were not in employment despite half
the sample having completed tertiary education. Over half of the participants had experienced seven
or more episodes of depression and/or mania. A full description of participant demographics is reported in
Table 61.
TABLE 61 Demographic information for the sample
Variable Total sample (n= 60)
Age (years)
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TABLE 61 Demographic information for the sample (continued )

















Full time, part time or voluntary 27





BD I disorder 52
BD II disorder 8
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Reliability
Internal consistency
Cronbach’s alpha was calculated for the 36-item scale. Internal reliability analyses showed that the BRQ
had a good to excellent consistency (α= 0.875),321 and in no case did deleting an item lead to a significant
improvement in the internal reliability of the scale (change α> 0.02). Across all the items, endorsement in
the low range (0–10) ranged from 0% to 16.7%. In the moderate range (11–50) endorsements ranged
from 3.3% to 51.7% and from 38.3% to 96.7% in the higher range (51–100). For total BRQ scores,
skewness and kurtosis were acceptable, with values not substantially greater than zero, and within the
limits of skewness < 2 and kurtosis < 7.322,323
Test–retest reliability
Test–retest reliability was computed by comparing initial BRQ scores (time 1) with those completed
4 weeks later (time 2) in 28 participants of the total sample (47%). The results yielded strong relationships
between time 1 and time 2 BRQ scores, indicating excellent test–retest reliability (r= 0.866; p< 0.001).
Validity
Relationship between Bipolar Recovery Questionnaire recovery score and
symptom measures
The BRQ and symptom scores are presented in Table 62. Relationships between total BRQ score and
symptom measures are illustrated in Table 63. Bivariate correlations indicated that BRQ total score
correlated negatively with HDRS, BDI and ISS depression scores as well as ISS activation and perceived
conflict. A significant positive association was identified between BRQ and ISS well-being. The bivariate
association between BRQ and MAS was not significant (p< 0.05). Associations were also explored
between BRQ total score and specific depression (HDRS-D) and elevated mood items [Bech–Refaelsen
Mania Scale – mood items (MAS-M)]. The BRQ score was significantly negatively associated with both
mood items.
Relationship between Bipolar Recovery Questionnaire recovery score and measures of
appraisals, growth and functioning
Appraisal, growth and functioning scale scores are presented in Table 62. Relationships between total BRQ
score and functioning and growth measures are presented in Table 64.
Bivariate correlations indicated that BRQ total score was significantly positively associated with PSP score,
Medical Outcomes Study Short Form – mental health and PTGI. BRQ total score was also specifically
associated with an index of positive well-being composed of two Short Form questionnaire-12 items
(SF-12) items: (1) calm and peaceful and (2) energy. Bivariate correlations were also conducted to assess
the relationships between total BRQ score and individual items of PTGI to explore which elements of
post-trauma growth were most related to recovery (Table 65). There were significant associations with
15 out of the 21 PTGI items with the highest associations (> 5) with items 10 (I know better that I can
handle difficulties), 12 (I am better able to accept the way things work out), 19 (I have discovered that I’m
stronger than I thought I was), 2 (I have a greater appreciation of the value of my own life), 3 (I developed
new interests) and 4 (I have a greater feeling of self-reliance).
Predictors of total Bipolar Recovery Questionnaire recovery score
To explore more specifically which measures were uniquely associated with BRQ recovery score multiple
regressions with blockwise entry were conducted. Based on the variance inflation factor and tolerance
statistics, there were no concerns about multicollinearity. Plots did not indicate any concerns about
homoscedasticity, and standardised residuals were normal. First, each clinical symptom measure with a
significant bivariate correlation with total BRQ score was entered into the first equation. The overall regression
equation was significant [F(6,52)= 10.613; p< 0.0001]. The regression equation indicated that BDI total score
(standardised β= 0.503, t= 3.096; p< 0.01) and ISS-W score (standardised β= 0.423, t= 3.234; p< 0.01)
contributed significantly to the variance in BRQ score. Both BDI and ISS-W score each contributed to BRQ
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TABLE 62 Descriptive statistics for all variables
Variable n Mean SD
BRQ 60 2357.7 414.0
HDRS 59 6.5 6.1
MAS 59 1.9 2.6
BDI 59 14.5 11.8
ISS-PC 59 81.7 71.0
ISS-W 59 131.1 69.4
ISS-A 59 97.9 82.0
ISS-D 59 45.9 42.0
IDQ-D 59 20.1 8.2
IDQ-N 59 27.2 6.8
IDQ-E 59 6.5 3.2
HIQ-H 59 24.5 8.2
HIQ-N 59 23.2 6.1
HIQ-E 59 4.7 4.1
SF12-P 59 45.3 11.0
SF12-M 59 39.9 11.7
PSP 59 67.6 11.5
HIQ-E, Hypomanic Interpretations Questionnaire – experiences; HIQ-H, Hypomanic Interpretations Questionnaire – positive
self-dispositional appraisals; HIQ-N, Hypomanic Interpretations Questionnaire – normalising appraisals;
IDQ-D, Interpretations of Depression Questionnaire – negative self-dispositional; IDQ-E, Interpretations of Depression
Questionnaire – experiences; IDQ-N, Interpretations of Depression Questionnaire – normalising appraisals;
MOS SF12-M, Medical Outcomes Study Short Form – mental health; MOS SF12-P, Medical Outcomes Study Short Form –
physical health.
TABLE 63 Correlations between total BRQ score and symptom measures





MAS-M –0.304* –0.118 –0.236 0.519**
BDI –0.665** 0.752** 0.685** 0.373** –0.172
ISS-PC –0.448** 0.375** 0.301* 0.358** –0.155 0.563**
ISS-W 0.525** –0.391** –0.415** 0.013 0.350** –0.398** –0.261*
ISS-A –0.289* 0.254 0.171 0.514** 0.135 0.390** 0.548** 0.160
ISS-D –0.459** 0.577** 0.522** 0.347** –0.074 0.550** 0.470** –0.620** 0.171
PTGI 0.591** –0.104 –0.179 0.144 0.364** –0.298* –0.126 0.368** 0.022 –0.275*
*p< 0.05.
**p< 0.01.
HDRS-D, Hamilton Rating Scale for Depression, depression item.
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TABLE 64 Correlations between total BRQ score and measures of appraisals, growth and functioning




SF12-M 0.561** 0.290* –0.102
SF 12-WB 0.549** 0.323* 0.125 0.728**
PSP 0.489** 0.239 0.344** 0.548** 0.481**
*p< 0.05.
**p< 0.01.
MOS SF12-M, Medical Outcomes Study Short Form – mental health; MOS SF12-P, Medical Outcomes Study Short Form –
physical health; MOS SF12-WB, Medical Outcomes Study Short Form – positive well-being.
TABLE 65 Correlations between total BRQ score and individual PTGI items
PTGI item BRQ
PTGI1: ‘I changed my priorities about what is important in life’ 0.061
PTGI2: ‘I have a greater appreciation of the value of my own life’ 0.514**
PTGI3: ‘I developed new interests’ 0.457**
PTGI4: ‘I have a greater feeling of self-reliance’ 0.464**
PTGI5: ‘I have a better understanding of spiritual matters’ 0.355**
PTGI6: ‘I more clearly see that I can count on people in times of trouble’ 0.185
PTGI7: ‘I established a new path for my life’ 0.401**
PTGI8: ‘I have a greater sense of closeness with others’ 0.369**
PTGI9: ‘I am more willing to express my emotions’ 0.083
PTGI10: ‘I know better that I can handle difficulties’ 0.627**
PTGI11: ‘I am able to do better things with my life’ 0.532**
PTGI12: ‘I am better able to accept the way things work out’ 0.573**
PTGI13: ‘I can better appreciate each day’ 0.454**
PTGI14: ‘New opportunities are available which would not have been otherwise’ 0.365**
PTGI15: ‘I have more compassion for others’ 0.288*
PTGI16: ‘I put more effort into my relationships’ 0.231
PTG17: ‘I am more likely to try to change things which need changing’ 0.381**
PTGI18: ‘I have a stronger religious faith’ 0.307*
PTGI19: ‘I have discovered that I’m stronger that I thought I was’ 0.524**
PTGI20: ‘I learned a great deal about how wonderful people are’ 0.096
PTGI21: ‘I better accept needing others’ 0.101
*p< 0.05.
**p< 0.01.
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variance. In combination the two variables explained another 5% of variance in BRQ score, explaining 21% in
total. Second, each growth and functioning measure with a significant bivariate correlation with total
BRQ score was entered into another regression equation. The overall regression equation was significant
[F(3,55)= 22.261; p< 0.0001]. The equation indicated that PTGI total score (standardised β= 0.448, t= 4.708;
p< 0.001), PSP score (standardised β= 0.221, t= 2.028; p< 0.047) and mental health score of the Medical
Outcomes Study Short Form health Survey (standardised β= 0.310, t= 2.805; p< 0.005) contributed
significantly to the variance in total BRQ score. PTGI score contributed 17% to BRQ variance, PSP 3% and
Medical Outcomes Study Short Form health Survey contributed 7%. In combination the three variables
explained another 27% of variance in BRQ score, explaining 54% in total. Third, using the significant
predictors of BRQ total score from both clinical symptom measures (regression 1) and appraisals, growth and
functioning measures (regression 2), a further regression equation with blockwise entry was conducted. The
overall regression equation was significant [F(5,53)= 20.457; p< 0.0001]. The regression equation indicated
that PTGI total (standardised β= 0.363, t= 4.114; p< 0.001), ISS-W (standardised β= 0.199, t= 2.173;
p< 0.05) and BDI total (standardised β= 0.401, t= 3.097; p< 0.001) contributed significantly to the variance
in total BRQ score. PTGI contributed 11% to BRQ variance; ISS-W contributed 3% and BDI score contributed
6%. In combination the three variables explained another 9% of variance in BRQ score, explaining 29% in
total. A final regression was conducted to explore which of the PTGI items was uniquely associated with BRQ
total score. All six PTGI items with a bivariate correlation of 0.5 or higher were entered into the regression. The
overall regression equation was significant [F(6,52)= 9.536; p< 0.0001]. One item contributed significantly to
variance in BRQ score; 10 (I know better that I can handle difficulties) (standardised β= 0.384, t= 2.63;
p< 0.01) and a second showed a non-significant trend; 12 (I am better able to accept the way things work
out) (standardised β= 0.212, t= 1.84; p< 0.1). Item 10 alone explained 6% of variance in BRQ score; item 12
explained a further 3%. Total variance in BRQ score explained by all six items individually and in combination
was 52%.
Discussion
Although the importance of personal recovery in mental health is increasingly widely recognised there has
been little research into this area in relation to BD. BRQ is the first self-report tool specifically designed to
capture the subjective experience of recovery in individuals with BD. In line with Anthony’s287 proposal that
recovery experiences are highly personal and multifaceted, the BRQ items were informed by prior qualitative
research on the nature and experience of recovery in BD.291 Item relevance and comprehensibility was also
reviewed by clinical, research and consumer experts to refine the final version of BRQ. Current findings
indicate that the questionnaire is internally consistent and reliable over time. Significant associations were
observed with mood symptoms and, as expected, recovery was associated with lower levels of manic and
depressive symptoms and higher levels of well-being. The one mood measure that was not significantly
associated with BRQ was the MAS, which may be owing to very low mania scores in the current sample.
Additionally, when associations were explored between BRQ and MAS elevated mood item and HRDS
depressed mood item, both correlations were significant, consistent with the pattern of increased recovery
being linked to lower mania and improved depression. Additionally BRQ was also associated with
improvements in overall functioning, improved mental health, improved positive well-being, experience of
personal growth and improved overall functioning recovery was associated with the majority of the items
from the PTGI, with particularly strong associations with items concerned with a stronger sense of being
able to cope with challenges and greater acceptance of how life can work out. Regression analysis indicated
among the measures of mood that self-rated depression and well-being were unique associates of recovery.
Conversely, among measures of functioning and growth, both personal growth, improved overall
functioning and positive mental health were unique associates of recovery. When these variables were
combined a final regression indicated that personal growth, well-being and self-reported depression
contributed uniquely to explained variance in BRQ score. The results indicate the BRQ is not solely a measure
of either functioning or mood symptoms but appears to capture a combination of these elements consistent
with both personal reports of individuals with BD and with Anthony’s wider definition of recovery.
Neil et al.32 also found significant associations between their QPR and measures of health and quality of life
in their sample of participants with psychosis. However their study did not look specifically at the relative
contributions of symptoms and functioning to recovery experiences. A further regression analysis of the
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relationships between specific PTGI items and BRQ indicated that only one item (I know better that I can
handle my difficulties) was a unique associate suggesting the potential importance of confidence in one’s
own resources in recovery in this group.
The current findings suggest that BRQ has potential as a method for economically evaluating recovery
outcomes in research studies and clinical practice for people with BD. Employing both types of measure in
such studies offers important opportunities to understand more about which treatments are beneficial for
clinical and personal recovery, respectively, with a view to developing treatment programmes that offer an
optimal balance between these elements.
There are limitations to the current study. First, the size of the sample meant that PCA was not
appropriate. For future research, it would be appropriate to explore the factor structure of the BRQ in a
larger samples to understand more about whether it contains subscales with particular relationships to
symptoms or functioning. Second, although the BRQ was reliable over a period of 1 month in the current
sample, it would be helpful to again replicate this finding in a larger sample than that available in the
current study. Third, although the sample was drawn from across the north-west of England and from a
range of different services it is not yet established how generaliseable the current findings are to the wider
UK or international groups of people with BD.
It is also recognised that BRQ is a self-report tool and, therefore, captures the subjective experiences of
individuals. This is strength in terms of definitions of recovery which highlight its individualised, personal
and subjective nature. Although more objective observer rated tools are available for the assessment of
clinical recovery, it is unclear whether or not this is possible for personal recovery. The current findings
indicate that personal recovery and clinical recovery are linked but not synonymous for individuals with BD.
In conclusion, BRQ was developed with extensive input from individuals with personal experience of BD in
recognition of the importance of identifying personally defined recovery experience. The resulting
questionnaire appears to be a reliable and valid measure of recovery in BD. Although further research is
indicated to finalise BRQ’s factor structure, it has promise as a tool for research and clinical practice and is
currently being evaluated as an outcome measure in a RCT of new psychological intervention for BD.
Phase 3: a randomised controlled trial of recovery-focused
cognitive–behavioural therapy for individuals with early
bipolar disorder
The design of this research has previously been published as Jones S, Mulligan LD, Law H, Dunn G, Welford M,
Smith G, et al. A randomised controlled trial of recovery focused CBT for individuals with early bipolar disorder.
BMC Psychiatry 2012;12:204.324 Much of this text is reproduced from Jones et al. © 2012 Jones et al.;
licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
This research was previously published as Jones S, Smith,G, Mulligan LD, Lobban F, Law H, Dunn G, et al.
Recovery-focused cognitive–behavioural therapy for recent-onset bipolar disorder: randomised controlled
pilot trial. Br J Psychiatry 2015;206:58–66 and much of this text has been reproduced with permission
from the Royal College of Psychiatrists.325
Objectives
The primary objective of this trial was to establish the acceptability and feasibility of a new CBT-based
intervention (RfCBT), designed in collaboration with individuals with early BD to improve clinical and
personal recovery outcomes.
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Main research questions:
l to demonstrate feasibility of recruitment and consenting procedures, adherence to protocol and
retention to both arms of the trial across assessment, intervention and follow-up periods
l to provide parameter estimates of clinical outcomes with respect to, recovery, bipolar relapse, mood,
cognitive style, quality of life, functioning, hope, stigma and self-esteem, post-traumatic growth and
medication adherence.
Method
This study was a rater-blind RCT that compared up to 18 hours of RfCBT plus TAU for BD with TAU.
Participants
Recruitment took place across 11 NHS trusts in the north-west of the UK. CMHTs, out-patient clinics, GP
surgeries, primary care mental health teams and voluntary services were approached to identify potential
participants. Participants were recruited into the study if they met the inclusion criteria of DSM-IV diagnosis
of primary BD with onset in last 5 years;305 sufficient understanding of written and spoken English in order
to provide consent, engage with interviews and use the intervention; and aged between 18 and 65 years.
Participants were not included if they were assessed to be manic, hypomanic, depressed or mixed episode
currently or in the last 4 weeks. As the primary purpose of the study was to evaluate the feasibility and
acceptability of delivering the proposed intervention a formal power calculation is not appropriate. It has
been estimated that 30 participants per group will be sufficient to be able to reliably determine primary
feasibility outcomes. The recruitment target was set at 72 participants in total to allow for expected
attrition rates.
Procedure
Care co-ordinators, research nurses and research development officers were approached in order to
contact potential participants in the first instance. Potential participants were offered a participant
information sheet by their care co-ordinators or the research team, outlining the study and their role
should they wish to take part. Care co-ordinators and other relevant health professionals were informed of
a participant’s involvement in the study subject to participant consent. If a participant did not wish for their
GP or care co-ordinator to be informed about their involvement in the study, this did not prevent their
participation and contact details of all health professionals involved in their care were still taken in case of
any clinical adverse events during the study.
After the initial baseline assessment, eligible participants were randomised to via the independent Clinical
Trials Unit at The Christie NHS Foundation Trust, Manchester, with minimisation on number of bipolar
episodes and level of current mood symptoms (including depression and mania). These minimisation
variables were selected as there is preliminary evidence that clinical outcomes are better in BD for
individuals with fewer episodes43 and with less severe mood problems at inception (although this research
is clearest with respect to symptoms of depression, the high rates of manic symptoms found in individuals
in depressed states indicates the importance of allowing for both affective poles326,327). Participants were
randomised to receive RfCBT plus TAU or TAU alone. After randomisation, participants were followed up
for a period of up to 15 months. In addition to regular (3-monthly) assessments to evaluate bipolar relapse,
recovery and observer-rated mood, additional clinical outcome and process measures were completed at
baseline and then at 6-monthly intervals.
Measures and assessments
A summary of measures and their respective time points can be found in Table 66.
Primary clinical outcomes
Hypotheses for the primary clinical outcomes were that RfCBT would (1) increase self-reported recovery as
measured by the BRQ;309 (2) increase time to bipolar relapse measured by the SCID, research version
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(SCID DSM-IV: SCID Life);328 and (3) reduce mood symptoms as measured by HDRS314 and Bech-Rafaelsen
Mania Scale.312
Secondary outcomes
Hypotheses for secondary outcomes were that RfCBT would improve (1) self-reported mood symptoms as
measured by the BDI-II302 and ISS;303 (2) quality of life and social functioning as measured by Personal
and Social Functioning Scale155 and the Brief Quality of Life in Bipolar Disorder Questionnaire;307 and
(3) medication adherence measured by the Stephenson Medical Adherence Questionnaire.329
Measures to assess therapeutic alliance and adherence
Engagement in therapy was assessed by means of the Working Alliance Inventory (WAI) (Short Form,
therapist and client versions).330 Treatment fidelity was assessed by both the Cognitive Therapy Scale
Revised Version331 and the RfCBT fidelity scale specifically designed for the current study.
Individual recovery-focused cognitive–behavioural therapy intervention
The RfCBT intervention was informed by current evidence for components of effective CBT interventions279
as well as findings from a completed case series of CBT for first diagnosis bipolar clients301 supporting
importance of flexible engagement, allowing time for full consideration of meaning of diagnosis to the
client, engaging in coping skills reviews around subsyndromal exacerbations as well as prior episodes and
considering the role of appraisals of fluctuations in affect. Therapy manual development was also informed
by qualitative interviews with individuals about their experiences of recovery in BD and focus groups with
individuals with BD to consult on the draft content, format and supporting materials for the RfCBT
intervention. The intervention was delivered by mental health professionals trained to British Association
for Behavioural and Cognitive Psychotherapies (BABCP) accreditation level in CBT or equivalent. Duration
of therapy was up to 18 hours delivered over a period of approximately 6 months at client’s homes or
mental health facilities according to client preference. Initial sessions were weekly, with later sessions
fortnightly and typically lasted 45–60 minutes.













BRQ ✓ ✗ ✓ ✗ ✓ ✗
Time to bipolar relapse:
weekly LIFE scores (SCID LIFE)
✓ ✓ ✓ ✓ ✓ ✓
HDRS ✓ ✓ ✓ ✓ ✓ ✓
Bech–Refaelsen Mania Scale
(MAS)
✓ ✓ ✓ ✓ ✓ ✓
BDI ✓ ✗ ✓ ✗ ✓ ✗
ISS ✓ ✗ ✓ ✗ ✓ ✗
Brief Quality of Life in Bipolar
Disorder Questionnaire
✓ ✗ ✓ ✗ ✓ ✗
PSP ✓ ✗ ✓ ✗ ✓ ✗
Stephenson Medication
Adherence Interview
✓ ✗ ✓ ✗ ✓ ✗
LIFE, Longitudinal Interview Follow-up Evaluation.
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The following elements are contained within the RfCBT manual and reflect elements typically addressed in the
course of therapy, although the relative emphasis on each element is informed by the client’s formulation:
l introducing the recovery approach to clients
l collection of information about current and historical mood and functioning
l meaning and relevance of diagnosis
l identification of recovery informed therapy goals
l initial formulation of relationships between mood experiences and progress towards recovery goals
l identification and application of CBT techniques to address and facilitate positive coping
l consideration of wider functioning issues in relation to recovery
l development and completion of recovery plan
l sharing lessons from therapy with key stakeholders.
The therapy approach differs from standard CBT for BD in the following ways:
l explicit focus on eliciting client-focused goals rather than presuming a target of relapse prevention
l formulation driven idiosyncratic approach rather than applying a very similar model of bipolar
experience across clients
l freedom to work within whatever model the client brings
l openness to address functioning and comorbidity issues as well as mood problems.
Treatment as usual in both groups was typically characterised by routine medication (mood stabilisers,
antipsychotics and antidepressants). Participants received their medical care either through primary or
secondary services. In the latter case, most participants received maintenance appointments for their
responsible clinician and support from a care co-ordinator via a CMHT.
Statistical analysis
Feasibility
As the primary purpose of the study was to evaluate the feasibility and acceptability of delivering the
proposed intervention, a formal power calculation comparing treatment groups was not essential. With
72 subjects in total, the study was able to estimate a follow-up rate of 75% with precision ± 10%.
Clinical outcomes
All analyses were carried out using Stata. All therapy effects were estimated using a random effects
(random intercepts) model, assuming that the effects were the same for each follow-up times (having first
checked that there was no significant therapy by follow-up time interaction). The baseline value of the
relevant outcome measure was used as a covariate. The intention-to-treat principle was followed
throughout. If there had been a significant number of participants not attending their allocated sessions,
this would have been supplemented by estimation of the therapy effects in those participants who actually
receive the intervention via estimation of the Complier-Average Causal Effect;332,333 however, this proved to
be unnecessary. Time to relapse was assessed by survival analysis (differences between groups being
evaluated using the log-rank test and hazard ratios were estimated using a Cox proportional hazards
model). Missing data were assumed to be missing at random (ignorable) and automatically allowed for in
fitting the random effects or analysis of covariance models.334
Results
Feasibility outcomes
Key feasibility outcomes for this study were recruitment, retention and participation in the intervention for
those in the treatment arm. Participant flow is indicated in Figure 15. Of 128 screened for eligibility,
67 individuals were randomised to RfCBT or TAU. Of those who were not randomised, the majority
declined the opportunity to participate (n= 35), the remainder did not meet study criteria owing to
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Allocated to therapy (n = 33)
• < 5 therapy sessions, n = 1
• 6 – 10 therapy sessions, n = 4
• 11 – 15 therapy sessions, n = 4
• 16 – 19 therapy sessions, n = 4
Completed 3-month follow-up (n = 29)
• Unavailable, n = 0
• Withdrawn, n = 5
Completed 6-month follow-up (n = 22)
• Unavailable, n = 5
• Withdrawn, n = 7
Completed 9-month follow-up (n = 22)
• Unavailable, n = 5
• Withdrawn, n = 7
Completed 12-month follow-up (n = 23)
• Unavailable, n = 4
• Withdrawn, n = 7
Completed 15-month follow-up (n = 15)
• Unavailable, n = 4
• Withdrawn, n = 7
• Beyond end of study, n = 8
Completed 3-month follow-up (n = 29)
• Unavailable, n = 2
• Withdrawn, n = 2
Completed 6-month follow-up (n = 30)
• Unavailable, n = 1
• Withdrawn, n = 2
Completed 9-month follow-up (n = 29)
• Unavailable, n = 2
• Withdrawn, n = 2
Completed 12-month follow-up (n = 22)
• Unavailable, n = 9
• Withdrawn, n = 2
Completed 15-month follow-up (n = 16)
• Unavailable, n = 6
• Withdrawn, n = 2
• Beyond end of study, n = 9
Excluded (n = 58)
Did not meet inclusion criteria:  
• Diagnosis > 5 years, n = 14
• Age > 65 years, n = 2
• Participant decline, n = 35
• Client too unwell, n = 6
• Client in another study, n = 1
Assessed for eligibility
(n = 125)
FIGURE 15 Follow-up rates including partial data.
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duration of illness > 5 years (n= 14), currently in an episode (n= 6), > 65 years (n= 2) and already
participating in another intervention study (n= 1).
Of the 67 participants randomised, 77% were retained to end-of-therapy follow-up at 6 months, 76% to
9 months’ follow-up and 67% at 12 months’ follow-up. The 15-month follow-up period was tapered as
the funding for the study terminated before this assessment became due for 17 of the participants.
Of those eligible, 61% completed the 15-month follow-up.
Of the 33 participants allocated to RfCBT, 32 attended at least six sessions with a mean of 14.15 (SD 4.21)
sessions overall. Working alliance as rated by therapists was 56.55 (SD 4.94) at session 4; 58.84 (SD 4.76)
at session 8 and 61.76 (SD 4.84) at session 17. At each stage of therapy clients ratings were higher than
those of therapists: session 4, 64.72 (SD 7.01); session 8, 66.35 (SD 7.66) and 71 (SD 5.51). Both sets of
alliance ratings are comparable with those observed for psychological therapy in mild and complex patient
groups.335,336 Therapist protocol adherence was independently assessed for 33 randomly selected session
tapes. Adherence to the therapy protocol was 91% (recovery fidelity scale) while mean score for Cognitive
Therapy Scale – Revised was 35.4 (SD 7.9) which is above established threshold criteria for competence.337
Recovery fidelity and Cognitive Therapy Scale – Revised scores were moderately but significantly correlated
(r= 0.467; p< 0.006).
Participants were, on average, under 40 years of age, predominantly female on both arms and had
received their formal clinical diagnosis of BD within the last 2–3 years. The majority of participants had a
diagnosis of bipolar 1 disorder with the remainder BD II (Table 67). Participants in both groups were
receiving a mixture of antidepressants, mood stabilisers and antipsychotics. Care team arrangements were
similar with both the majority of both groups receiving care from a CMHT or primarily from a psychiatrist.
A minority of participants in both groups were under the care of their GP. There were no significant
differences between arms on any of these variables.
TABLE 67 Demographics of participants at baseline
Characteristics TAU (n= 34) Therapy (n= 33)
Age (years), mean (SD) 39.9 (10.4) 38.3 (12.8)a
Sex (female), n (%) 22 (64.7) 25 (75.8)b
Age of bipolar diagnosis (years), mean (SD) 37.4 (10.2) 35.9 (12.7)c
Diagnosis
Bipolar 1 disorder, n (%) 29 (85.3) 24 (72.7)d
Bipolar 2 disorder, n (%) 5 (14.7) 9 (27.3)
Medication at baseline
Antidepressant, n (%) 17 (50) 14 (42)e
Mood stabiliser, n (%) 22 (65) 14 (42)f
Antipsychotic, n (%) 21 (62) 20 (61)g
Care team
CMHT, n (%) 24 (70) 19 (58)
Psychiatrist, n (%) 3 (9) 4 (12)
GP, n (%) 7 (21) 10 (30)
a t= 0.58; p= 0.58.
b χ2 = 0.98; p= 0.3.
c t= –0.38; p≥ 0.70.
d χ2= 1.60; p= 0.21.
e χ2= 0.39; p≥ 0.53.
f χ2= 3.34; p= 0.07.
g χ2= 0.01; p= 0.92.
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Table 68 provides supplementary demographic information concerning marital status, ethnicity, schooling,
employment, previous episodes and hospitalisations. The two arms of the trial did not differ on any of
these variables.
TABLE 68 Supplementary demographics of participants at baseline
Variable TAU group, n (%) Therapy group, n (%)
Marital status
Single 13 (38.2) 6 (18.2)a
Married 6 (17.6) 15 (45.5)
Separated 3 (8.8) 1 (3.0)
Divorced 7 (20.6) 4 (12.1)
Cohabiting 5 (14.7) 7 (21.2)
Ethnicity
White 32 (94) 32 (97)b
Black 1 (2.9) 1 (3.0)
Asian 1 (2.9) 0
Age on leaving education (years), mean (SD) 17.9 (2.6) 17.6 (2.5)c
Schooling level
Primary 3 (8.8) 3 (9.1)d
Secondary 9 (26.5) 13 (39.4)
Further 11 (32.4) 8 (24.2)
Higher 11 (32.4) 9 (27.3)
Employment
Full time 12 (35.3) 11 (33.3)e
Part time 1 (2.9) 5 (15.2)
Unemployed 18 (52.9) 16 (48.5)
Voluntary 1 (2.9) 1 (3.0)
Retired 2 (5.9) 0
Number of previous major depressive episodes, n (%)
None 0 1 (3.0)
1–6 19 (59.4) 16 (48.5)
> 6 13 (40.6) 16 (48.5)
Number of previous manic episodes, n (%)
1–6 26 (81.3) 21 (63.6)f
> 6 6 (18.8) 12 (36.4)
Number of hospital admissions, n (%)
None 10 (30.3) 10 (30.3)g
1–6 23 (69.7) 22 (66.7)
> 6 0 1 (3.0)
a χ2= 8.58; p= 0.07.
b χ2= 5.05; p= 0.41.
c t= –1.81; p= 0.08.
d χ2= 1.39; p= 0.71.
e χ2= 4.81; p= 0.31.
f χ2= 4.40; p= 0.11.
g χ2= 1.02; p= 0.60.
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Baseline measure scores
Both groups had low levels of depression and mania at baseline consistent with entry criterion of being out
of a current mood episode. Recovery scores on the BRQ and self-reported quality of life were lower in both
groups were lower in both groups than has been reported in previous samples.307,309
Primary clinical outcomes
Random effects models were used to estimate the effect of treatment compared with TAU on BRQ from
baseline to follow-up. There was a greater recovery score in RfCBT at follow-up than TAU [310.87
(SE 120.34); 95% CI 75.00 to 546.74; p= 0.010]. There was no interaction between this effect and
follow-up point (6 or 12 months). As Table 69 indicates, not all participants completed self-report
questionnaires at assessment points despite providing relapse data in each case (BRQ data: 98% of
potential sample at baseline, 90% at 6 months, 82% at 12 months).
Follow-up data on relapse were available for 58 participants (29 from each of the two treatment arms).
Participants were followed up for a period of up to 15 months, during which time 32 were known to have
experienced a relapse of either depression or mania (20 TAU vs. 12 RfCBT). Kaplan–Meier estimates of
time to first recurrence are presented in Figure 16. Median survival times for TAU and RfCBT were
18 weeks (95% CI 8 to 40 weeks) and 56 weeks (95% CI 28 to ∞ weeks), respectively. Estimated mean
survival times were 37 weeks for TAU and 86 weeks for RfCBT. The difference in time to recurrence was
statistically significant (χ2 = 7.64; p< 0.006); estimated hazard ratio 0.38 (95% CI 0.18 to 0.78).
During the follow-up period, 30 patients experienced a depressive relapse (19 TAU vs. 11 RfCBT).
Kaplan–Meier estimates of time to first depressive recurrence are presented in Table 3. Median survival
times for TAU and RfCBT were 18 weeks (95% CI 8 to 47 weeks) and 60 weeks (95% CI 29 to ∞ weeks),
















































FIGURE 17 Kaplan–Meier estimates for time to first manic recurrence over up to 60 weeks follow-up.
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difference in time to recurrence rates was statistically significant (χ2= 7.63; p< 0.006); estimated hazard
ratio 0.37 (95% CI 0.18 to 0.77).
Manic relapses were less common, occurring in 13 of the participants (10 TAU vs. 3 RfCBT). Kaplan–Meier
estimates of time to first manic recurrence are presented in Figure 17. Median survival times for TAU and
RfCBT were 33 weeks (95% CI 23 to 58 weeks) and 60 weeks (95% CI 53 to∞ weeks), respectively.
Estimated mean survival times were 42 weeks for TAU and 76 weeks for RfCBT. This difference in time to
recurrence was statistically significant (χ2= 6.77; p< 0.009); estimated hazard ratio 0.38 (95% CI 0.19 to 0.79).
Comparisons were also made for average mood symptoms (Hamilton Depression Rating Scale and
Bech-Rafaelsen Mania Scale) across the follow-up period (Figure 18). There was no significant impact of
RfCBT compared with TAU on depressive [–0.98 (SE 1.37), 95% CI –3.66 to 1.71] or manic symptoms
[–0.66 (SE 0.53), 95% CI –1.69 to 0.37] across the follow-up period, although the direction of effect
favoured RfCBT in both cases. There is an elevation in mean HRSD score at 15-month follow-up but the
actual score remains below clinical threshold and width of error bars indicates that this is unlikely to be a
precise point estimate.
Secondary clinical outcomes
Random-effects models were used to estimate the effect of treatment compared with TAU on quality of
life (Brief Quality of Life in Bipolar Disorder Questionnaire), social functioning (PSP), self-reported mood
symptoms (BDI and ISS), and medication adherence between baseline and follow-up. Table 69 provides
summary data for each measure across assessment points.
For Quality of Life in Bipolar Disorder Questionnaire and PSP there were trends towards greater quality
of life and improved social functioning in RfCBT at follow-up compared with TAU Quality of Life in Bipolar
Disorder Questionnaire (QoL BD): estimated treatment effect 4.83 (SE 2.50), 95% CI –0.07 to 9.74;
p= 0.054; PSP: estimated treatment effect 11.24 (SE 6.79), 95% CI –2.09 to 24.56; p= 0.099]. There was
no interaction between either effect and follow-up points (6 or 12 months) for either measure.
There was no evidence for a significant differential treatment effect between RfCBT and TAU on
self-reported mood symptoms although, in all cases, the direction of effect favoured RfCBT [ISS-A:
estimated treatment effect –2.79 (SE 17.98), 95% CI –37.86 to 32.27; p= 0.88; ISS-W: estimated
treatment effect 8.09 (SE 17.04), 95% CI –25.32 to 41.51; p= 0.635; BDI: estimated treatment effect
–0.88 (SE 3.43), 95% CI –7.59 to 5.84; p= 0.798].
Discussion
This is the first study to evaluate the impact of RfCBT for early BD. RfCBT was developed in partnership with
individuals with lived experience of bipolar consistent with Mental Health Research Network good practice
guidelines,338 including service user involvement in qualitative work on recovery experiences, development of a


























































FIGURE 18 Observer-rated depression and mania rating scores.
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of individuals with personal experience of BD is consistent with the model of recovery approaches as being
empowering, individualised and grounded in the individual’s own priorities and needs. RfCBT differs from
standard CBT in that there is an explicit focus on eliciting client goals, which may not include relapse
prevention as a primary goal, whereas in CBT this target is assumed for all clients. There is also a strong
emphasis on formulation rather than applying a very similar model of bipolar experience across clients, so the
client route through therapy is different depending on their needs, giving the therapist freedom to work with
whatever model the client brings but in the context of offering evidence-based approaches. Therapists are also
explicitly permitted to focus on issues around functioning and comorbidity as well as mood problems.
Findings provide preliminary evidence in support of both feasibility and effectiveness in this client group.
With respect to feasibility outcomes, it proved possible to recruit participants for this study and we reached
94% of the target figure of 72. The primary reason for the 6% shortfall was participants becoming
unwell between initial screening and baseline. Retention to follow-up assessments was balanced across
both arms of the study and within 10% of the 75% target to the 12-month follow-up.
Participants in the therapy arm engaged with RfCBT attending an average of 14 therapy sessions with
32 out of 33 clients attending at least six sessions. Both client and therapist ratings of working alliance
were consistent with clients experiencing the therapy as worthwhile. Therapy adherence ratings indicated
that the therapy delivered was consistent with CBT good practice principles and also with the more flexible
recovery focus of RfCBT.
TABLE 69 Summary data for each measure across assessment points
Variable
TAU RfCBT
n Mean SD n Mean SD
BRQ T1 33 1934.57 543.85 33 1797.39 454.80
BRQ T2 21 2082.57 518.58 26 2378.92 578.26
BRQ T3 15 2193.40 357.74 22 2351.41 462.02
QoL BD T1 33 36.73 11.59 33 35.91 8.76
QoL BD T2 21 38.14 14.27 26 42.30 9.03
QoL BD T3 15 39.67 7.60 22 42.27 7.34
PSP T1 32 71.59 16.31 32 69.16 16.98
PSP T2 19 64.89 24.0 22 75.73 19.52
PSP T3 16 77.13 15.78 18 78.49 18.10
ISS-A-T1 32 118.22 96.70 33 115.91 90.98
ISS-A-T2 19 100.32 98.37 24 81.96 77.89
ISS-A-T3 15 93.26 76.87 22 93.86 101.93
ISS-W-T1 32 128.59 85.82 33 132.09 73.47
ISS-W-T2 19 157.00 62.63 24 165.88 69.25
ISS-W-T3 15 153.60 78.90 22 162.14 78.00
BDI T1 33 19.00 14.85 33 19.39 13.23
BDI T2 20 13.60 13.00 26 13.58 14.91
BDI T3 15 14.87 14.20 22 14.41 21.98
QoL BD, Quality of Life in Bipolar Disorder Questionnaire; T1, time 1; T2, time 2; T3, time 3.
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In terms of primary clinical outcomes, RfCBT significantly improved personal ratings of recovery at both
6- and 12-month follow-up assessments compared with TAU. RfCBT also significantly increased time to
any relapse and time to both depressive and manic relapses (if relapses occurred). Time to any relapse was
increased by 38 weeks, time to depressive relapse by 42 weeks and time to manic relapse by 27 weeks
compared with TAU. In contrast, RfCBT had no significant impact on observer ratings of residual symptoms
of depression or mania. Both HRSD and MAS scores were low throughout the study. For HRSD, scores
ranged from mild depression to no depression across follow-ups, whereas on average for MAS, mania
scores indicated absence of mania throughout.
Secondary clinical impact of RfCBT appeared to be stronger on functional than symptomatic outcomes.
Thus, quality of life and social functioning were numerically improved in RfCBT compared with TAU, the
differences approached (but did not meet) statistical significance at the 5% level. There were no group
differences on self-reported mood. Both groups scored in the no mania range on ISS-A throughout the
study, whereas for ISS-W both groups scored as mildly depressed at baseline, but outside the clinical range
at both follow-up points. Scores on the BDI indicated mild-minimal depression throughout the
study period.
Comparison to other studies
Previous studies of CBT have varied in their impact on time to relapse. Lam et al.278 reported a significant
effect over 12 months, while Ball et al.339 reported a trend (for depressive relapse), both favouring CBT in
increasing survival time. In contrast, neither the Scott et al.43 nor Meyer et al.340,341 studies identified any
benefit of CBT in relation to survival times to relapse. A post hoc finding from the Scott et al.43 study was
that that higher number of previous episodes was associated with worse outcomes leading to a suggestion
that earlier intervention might be more appropriate. Consistent with this our trial of RfCBT with individuals
within 5 years of diagnosis found strong effects on relapse. A recent study of enhanced relapse prevention
delivered by non-specialist CMHT staff indicated improvements in relapse outcomes compared with TAU,
but these did not reach statistical significance.328 It is of interest that the current study did not primarily
focus on relapse prevention but yet obtained strong impact on relapse compared with previous research.
No other studies have specifically explored recovery outcomes in BD so it is not possible to make direction
comparisons for this variable.
Strengths of the study include targeting a clearly defined sample who are currently poorly served by
available interventions, namely individuals with recent onset BD. It is also the first therapy for BD that
explicitly aims to enhance recovery outcomes which are valued by service users. Additionally, we have not
assumed expert clinician knowledge of the nature of recovery in BD, but rather grounded the intervention
in the experience and knowledge that service users have offered us with respect to recovery. The study
also recruited from across NHS primary and secondary care settings and through self-referral so that
findings should are more representative than those that solely focus on specialist mental health settings,
as only a subset of individuals with BD are in such settings long term.342
Limitations
There are weaknesses to the study that would need to be addressed in a definitive trial. First, there is no
active treatment control group so that any indications of effectiveness need to be interpreted with caution
as we will not know whether possible benefits are a function of this specific treatment or structured
treatment in general. Second, it was only possible to follow up a proportion of the sample for 15 months.
Longer follow-ups would be helpful to indicate more definitively whether or not this intervention impacts
on relapse as well as recovery.
Clinical implications
Despite these challenges, if the current study indicates that RfCBT is feasible and has potential clinical
benefits, it will be an important step towards developing evidence-based recovery interventions for people
with BD that have been lacking until now.
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Conclusions
This chapter explored the experience and process of recovery in individuals with BD. The research was
conducted in three phases:
1. an exploration of the subjective experience of recovery in the early stages of BD
2. development, coproduction and evaluation of a service user informed measure of recovery in BD
(the BRQ)
3. a RCT of RfCBT for individuals with early BD.
The research described within this chapter is the first series of studies to explore recovery and recovery-related
experiences from the perspectives of individuals with recent onset BD. Consistent with findings throughout
this research programme in relation to recovery in psychosis, these studies also highlighted that recovery in BD
is an ongoing process that is facilitated by personally meaningful activity and appears to be only partially
related to symptom reduction.
The first phase of this research elicited four key themes regarding subjective recovery experiences in
individuals with experience of recent onset BD: mood experiences as understandable and manageable;
developing resources to self-manage health; access to personally meaningful activity; and recovery as
a lifelong process. This highlighted the importance of addressing these areas to promote recovery within
services, as well as the need to develop a quantitative self-report measure informed by research of this
type, in a similar way to the user-informed recovery measure that has been developed for use with people
with psychosis.32
As a result of the findings from phase 1, the second phase of this research went on to develop the first
self-report tool specifically designed to capture the subjective experience of recovery in individuals with BD.
Items on the BRQ were directly informed by the prior qualitative research in phase 1 on the nature and
experience of recovery in BD and were further refined through consultation with SURG and a survey of
users, clinical and academic experts. The BRQ was evaluated and the results indicated that the
questionnaire is internally consistent and reliable over time. Significant associations were observed with
mood symptoms and, as expected, recovery was associated with lower levels of manic and depressive
symptoms and higher levels of well-being. Personal growth, well-being and self-reported depression
contributed uniquely to explained variance in BRQ scores. These findings suggest that the BRQ is not solely
a measure of either functioning or mood symptoms, but appears to capture a combination of these
elements consistent with both personal reports of individuals with BD and with Anthony’s wider definition
of recovery.287 The findings from phase 2 suggest that the BRQ has potential as a method for economically
evaluating recovery outcomes in research studies and clinical practice for people with BD.
The themes identified in phase 1 of this research were then used to inform the development of a recovery-
focused cognitive–behavioural intervention for early BD. This RfCBT was evaluated in a RCT conducted as
phase 3 of this research. The BRQ measure that was developed in phase 2 was used as a main outcome
measure for evaluating the intervention. RfCBT differs from standard CBT in that there is an explicit focus
on eliciting client goals, which may not include relapse prevention as a primary goal, whereas in CBT this
target is assumed for all clients. There is also a strong emphasis on formulation rather than applying a
very similar model of bipolar experience across clients, so the client route through therapy is different
depending on their needs, giving the therapist freedom to work with whatever model the client brings but
in the context of offering evidence-based approaches.
Findings from the RCT in phase 3 provide preliminary evidence in support of both feasibility and
effectiveness of RfCBT in this client group. RfCBT significantly improved personal ratings of recovery at
both 6- and 12-month follow-up assessments compared with TAU. RfCBT also significantly increased time
to any relapse and time to both depressive and manic relapses (if relapses occurred). This suggests that
RfCBT is feasible and has potential clinical benefits, which may be an important step towards developing
evidence-based recovery interventions for people with BD that have been lacking until now.
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This programme of research has provided significant advances in our understanding and facilitation of
recovery from psychosis and BD. A summary of key findings can be seen in Table 70. In terms of
conceptualisation and measurement of user-defined recovery, we have demonstrated the reliability and
validity of the BRQ (see Chapter 7) and the SEPS (see Chapter 2), which can be used to evaluate perceived
recovery in BD and the impact (both positive and negative) of dimensions of symptoms on recovery in
psychosis. These scales can be used to evaluate outcome from treatment and reflect the multidimensional
experience of psychosis (including both positive and negative aspects) and BD. Qualitative research found
that recovery is felt to be a process rather than an end point and that recovery in psychosis is
multidimensional and identified four main themes that are important to consider when conceptualising
recovery in psychosis: impacts on mental health, self-change and adaptation, social redefinition, and
adapting an individual coping style (see Chapter 2). Our research also suggests that there are different
aspects to recovery from psychosis that are not necessarily linked to alleviation or removal of symptoms.
Furthermore, it highlights the importance of ensuring that treatment is idiosyncratic in facilitating people’s
recovery. The four viewpoints identified by the Q-sort provide an interesting insight into recovery and the
different types of recovery styles: collaborative support and understanding, emotional change through
social and medical support, regaining functional and occupational goals, and self-focused recovery
(see Chapter 2).
TABLE 70 Summary of key findings







from psychosis: a service
users perspective65
l Four main themes for conceptualising recovery:
impacts on mental health, self-change and
adaptation, social redefinition, and adapting
an individual coping style





l There are different aspects to recovery from
psychosis that are not necessarily linked to
alleviation or removal of symptoms
l Four viewpoints were generated: collaborative
support and understanding, emotional change
through social and medical support, regaining
functional and occupational goals, and
self-focused recovery
3. The SEPS: psychometric
evaluation of a scale
to assess outcome in
psychosis71
l The SEPS is a reliable and valid self-report
measure of psychosis experiences
l It was developed with the direct input of
service users, both in terms of project design
and investigation and in the development of
the content and format of the measure to
ensure that the items and presentation reflect
their experience of psychosis
continued
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TABLE 70 Summary of key findings (continued )
Chapter Study Phase Key findings
3 What does recovery
mean to service users
with experience of
psychosis? A Delphi
study with experts by
experience82
N/A l A high level of consensus was reached for a
range of items, which were deemed by service
users to be important in defining recovery,
understanding what helps and hinders
recovery and what would show that someone
is recovering
l Frequently occurring themes amongst items
were knowledge and support; choice and
control; meaning and purpose; quality of life;




1. Subjective judgements of
perceived recovery
from psychosis126
l Significant correlations between the measures
of recovery and the psychological factors
suggest that higher levels of self-esteem and
hope, along with lower levels of depression
and anxiety, were associated with more





l Subjective recovery judgements were directly
associated with negative emotion (anxiety,
depression and negative self-esteem) and
internal locus of control
l Positive symptoms and internal locus of control
were indirectly associated with recovery
judgements via their relationship with
negative emotion
3. Longitudinal predictors of
subjective recovery
from psychosis153
l Subjective recovery scores at follow-up
assessments were predicted by negative
emotion, positive self-esteem, hopelessness
and to a lesser extent by symptoms and
functioning at baseline assessment
l Current recovery score was predicted by current
hopelessness and positive self-esteem scores
4. How do I know if I’m
better? Judgements of
recovery from psychosis in
everyday lifea
l Recovery judgements are variable in some
service users but more stable in others
l Those with lower baseline questionnaire
recovery scores showed greater fluctuations in
















l Participants’ willingness to participate in the
proposed partially randomised preference trial
was high
l Self-help with telephone support was the most
popular option
l Most participants reported that they would
prefer not to agree to randomisation




l Drop-out rates from the study were low and
take up of sessions offered was high
l Qualitative feedback indicated a high degree
of satisfaction from service users




from a self-help guide
and group sessions
(STAR-T)c
l Although participants had a strong preference
for particular treatments, there is little
evidence that it had any effect on their
outcomes. The interventions appeared to
be ineffective
l Treatment preferences within the trial were
surprisingly balanced, with a third of
participants choosing their TAU
l Only three participants chose to be
randomised. The Patient Preference Design
was shown to be unfeasible in a study of this
size and nature
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TABLE 70 Summary of key findings (continued )








1. The Subjective Experience
of Participation in
Schizophrenia Research215
l Findings were largely positive and support
previous studies which suggest that research
can have a number of benefits for those
who participate
l Five key themes were identified: altruism, the
value of research, therapeutic, enjoyable




behaviours: the role of
defeat, entrapment
and resilience205,209
l The relationship between positive symptoms
of psychosis and suicidal ideation is mediated
by perceptions of defeat and entrapment
l Positive self-appraisals were found to buffer
the impact of hopelessness
3. A RCT of CBSPp272 l The CBSPp intervention was superior to TAU
on the primary outcomes of suicidal ideation
and hopelessness and on secondary outcomes






1. Recovery in the early
stages of BDd
l Four key themes which emerged: mood
experiences as understandable and
manageable; developing resources to
self-manage health; change in balance of care
from perceived dependence on others to
increased autonomy and independence was
regarded as an important facet of recovery;
and access to personally meaningful activity
l Conceptualisations of recovery in BD were
similar to conceptualisations of recovery from
psychosis; however, there was a greater
emphasis on the role of medication and
symptoms in perceived recovery





l The BRQ was developed with extensive input
from individuals with personal experience of
BD in recognition of the importance of
identifying personally defined recovery
experience
l The BRQ appears to be a reliable and valid
measure of recovery in BD
3. A RCT of RfCBT for
individuals with
early BD324
l RfCBT is feasible and has potential clinical
benefits for people with BD
l Improvements were seen in personal ratings of
recovery and time to relapse for both
depressive and manic relapses
N/A, not applicable.
a Richard P Bentall, University of Liverpool, 2015, unpublished.
b Christine Barrowclough, University of Manchester, 2015, unpublished.
c Gillian Haddock, University of Manchester, 2016, unpublished.
d Steven H Jones, Lancaster University, 2015, unpublished.
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In Chapter 3 our consensus study examining service user-defined recovery found a surprisingly high level of
agreement (given the idiosyncratic nature of individual recovery journeys) about factors that define
recovery, factors which help recovery, factors that hinder recovery and factors that demonstrate that
someone is recovering. The themes from this consultation highlighted key areas that are important to
service users: knowledge including an understanding of mental health problems as well as coping and help
seeking skills such as ‘knowing what helps you get better’; social support and relationships, as well as
support from mental health services; choice and control, including having control of life and symptoms, as
well as control and choice surrounding treatment options; having goals, meaning, and purpose in life;
quality of life, even in the context of continued symptoms and mental health problems; having hope for
the future and feeling positive about yourself and your future, as well as self-esteem; and having a good,
safe place to live.
In Chapter 4, we have found consistent psychological factors that are associated with recovery from
psychosis, including negative emotions, hope and self-esteem. Concurrently, moment to moment in
everyday life and prospectively over 6 months, these factors predict subjective recovery judgements.
Symptoms also seem to be related to perceived recovery, although this appears to occur over time rather
than cross-sectionally.
In Chapter 5, our work on cognitive–behavioural approaches to guided self-help and group therapy for
recovery, has demonstrated that service users had strong preferences for treatment. The Patient Preference
Design was shown to be unfeasible in a study of this size and nature. It also appears that, although
patients had a strong preference for particular treatments, there is little evidence that they had any effect
on their outcomes. The interventions appeared to be ineffective despite the likely selection effects
(confounding) induced by letting the participants have their preferred treatment, suggesting the
interventions require significant additional improvements. The failure to randomise also has important
implications for future evaluations of these interventions and there is little to suggest that an appropriately
designed randomised trial would be feasible.
Our work on a cognitive–behavioural approach to understanding and preventing suicide in people with
psychosis (see Chapter 6) has shown that the relationship between positive symptoms of psychosis and
suicidal ideation is mediated by perceptions of defeat and entrapment while positive self-appraisals were
found to buffer the impact of hopelessness. Our RCT showed that CBSPp was superior to TAU on the
primary outcomes of suicidal ideation and hopelessness and on secondary outcomes of depression,
symptoms of psychosis and self-esteem.
In Chapter 7, our work on recovery from BD found some striking similarities from a service user perspective
to the conceptualisation of recovery from psychosis; however, there was a greater emphasis on the role of
medication and symptoms in perceived recovery. We developed the BRQ with extensive input from
individuals with personal experience of BD and the resulting questionnaire appears to be a reliable and
valid measure of recovery in BD. Our RCT of a cognitive–behavioural approach to recovery from a first
episode of BD has shown that RfCBT is feasible and has potential clinical benefits for people with BD,
demonstrating improvements in personal ratings of recovery and time to relapse for both depressive and
manic relapses.
Deliverables for the NHS
This programme of research has resulted in a number of deliverables for the NHS that will improve services
and patient experience. The Q-sort developed in our work on understanding recovery (see Appendix 7) can
be utilised for the idiosyncratic assessment and generation of recovery goals. This can be used to facilitate
a conversation that focuses on collaborative support and understanding, emotional change though social
and medical support, regaining functional and occupational goals, and self-focused recovery; these goals
can be prioritised in relation to their importance to the service user.
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Similarly, the SEPS (see Appendix 8) can be used for the assessment and monitoring of positive and
negative aspects of symptoms that are relevant to user-defined recovery; this represents a significant
advance on traditional psychiatric interviews that focus solely on presence or absence of symptoms and
their severity. A revised version of the QPR (incorporating 15 items in a single recovery factor along with a
visual analogue scale and a dichotomous recovery question: see Appendix 13) will also be valuable to
mental health services and service users in assessing and monitoring progress throughout individual
recovery journeys. The BRQ (see Appendix 12) can be utilised for similar purposes for people with BD,
rather than psychosis, and also represents a significant advance for this population.
The factors that help and hinder recovery identified from our consensus study can be utilised in a checklist
that could be used by services to evaluate how recovery-focused they are and to use for benchmarking
of services. These checklists (see Appendix 9) could also be rated by service users on a regular basis to
ensure meaningful feedback on services and to monitor the effects of service development and redesign,
which is highly relevant in the current NHS context. The experience sampling diaries (see Appendix 10)
could be used to monitor recovery in everyday life and it is likely that these could be utilised to develop
technological applications using smart phones or tablets that could be helpful in providing clinical services
with data for assessment and outcome purposes.
We have produced three treatment manuals that will be of benefit to NHS staff and which will contribute
to the dissemination of recovery-focused approaches. The manual for the cognitive–behavioural approach
to suicide prevention has been published211 and is, therefore, widely available. The recovery guide that we
produced for the preference trial will provide a valuable resource for clinical staff and service users and
carers. The recovery guide (see Appendix 11) is a supported self-help resource that includes two core
chapters (relating to the meaning of recovery, goals, resources and understanding the development of
problems) and two chapters with numerous optional sections to facilitate work on overcoming obstacles
(such as anxiety, paranoia, low self-esteem) or reaching wider recovery goals (such as finding employment,
enjoying oneself and relaxing, developing social networks). Although the specific methods of support
(telephone-delivered and group therapy) did not appear to represent significant benefits over TAU,
participant and staff feedback about the content of the manual has been very positive. The RfCBT manual
for BD will also provide a valuable resource for psychological therapists working with this population.
Finally, given that mood, self-esteem, locus of control and hope were all related to recovery, we would
recommend that the measures we employed within this research programme (HADS for anxiety and
depression, SERS-Short Form for self-esteem, BHS for hope and Multidimensional Locus of Control Scale
for locus of control) be added to the SEPS and QPR or BRQ to represent a comprehensive assessment of
recovery-related factors.
Overall limitations
The methodologies employed throughout this programme of research have a number of advantages and
disadvantages that need to be considered before making any firm conclusions or generalisations from the
findings. Although these are discussed in detail in each of the respective chapters of this report, it is
acknowledged that there are additional general limitations that apply to the research as a whole.
First, it is important to consider the participant samples within the studies and the methods used to recruit
them. The research in this report mostly consisted of individuals referred by their care teams. This may
have led to biases in the recruitment process, with care teams selecting individuals who they believed were
suitable or appropriate for the research studies, which would limit the generalisability of results. Similarly,
this report includes three clinical trials that offered some form of therapy. This could be seen as biasing the
sample to individuals who are actively help-seeking, able and willing to commit to a trial for a considerable
number of months and are deemed suitable for a research trial by their care team. This could lead to a
sample of participants with particular unique characteristics (such as motivated or high-functioning
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individuals) and consequently reduce the generalisability of results. In addition, the small numbers of
service users that are not particularly diverse who were used to generate themes or items for general
measures of recovery is potentially problematic. An alternative approach would have been to deliberately
select a maximum variance sample.
Similarly, it is acknowledged that the majority of participants in these studies were white British, which
may have limited the relevance of findings to individuals from other backgrounds. The lack of ethnic
diversity in our samples would suggest that caution is applied in generalising to other cultures and ethnic
backgrounds. Future cross-cultural research could investigate whether or not the concept of recovery, as
operationalised in our research measures, is valid in other settings.
It also possible that some of the variability in experiences and responses to interventions could be
accounted for by comorbid symptoms or diagnoses. Future research could aim to explore the impact of
comorbidity on recovery experiences and the effectiveness of interventions.
In addition, it is acknowledged that missing data may have limited statistical power, increased the possibility
of type II error and resulted in a biased sample. Missing data were not imputed for any of the studies within
this report; rather, cases were deleted when data were missing for ≥ 20% of items on particular scale. In
cases for which < 20% of items on a scale were missing, responses were prorated. Although acknowledging
that this is a limitation of the studies, it is also important to note that priorities must be with reducing
participant burden and ensuring that all participation and responses to each question are voluntary.
Longitudinal studies and research trials can be particularly high burden for participants and this is a key
ethical consideration for any such research. More specifically, it is important to recognise that despite the
work on reaching a consensus on conceptualisations of recovery, understanding of recovery is vastly variable
and can even vary within an individual and from moment to moment. Similarly, experiences of psychosis and
episodes of BD can vary significantly and, therefore, recovery may be different following each episode.
Future research should aim to explore these differences within individuals.
As discussed earlier in the introduction to this report (see Chapter 1, Cross-programme measures), the QPR
was used throughout the research programme, often as the primary outcome in a clinical trial or as the
dependent variable when examining predictors of recovery. During the course of the research programme,
it became apparent that the psychometric properties were not ideal for measuring recovery as a unitary
and independent construct. Individualised statistical analysis was conducted that resulted in a combined
measure that utilised the visual analogue scale ratings in combination with five QPR items in Chapter 4 and
subsequent studies used a 15-item version of the QPR, which was one-dimensional and had improved
psychometric properties (but this had not been available to the earlier studies).
Similarly, several studies explored the relationships between negative emotion and recovery. Within
different studies, self-esteem and hopelessness are utilised as components of the negative emotion
construct or independently of negative emotion depending on the specific research questions and the
statistical properties of the associations between these constructs. For example, if the primary research
question was to address the relationship between symptoms, recovery and negative emotion, then such
constructs would be used to produce the best latent measure of negative emotion; however, if the primary
research question was to determine the relationship between moment-to-moment changes in self-esteem,
optimism, negative emotion and recovery, then these variables would be treated separately as long as it
was statistically valid to do so.
Finally, the theme of research on BD in Chapter 7 highlighted the importance of post-traumatic growth
and its relationship to recovery. Further consideration of post-traumatic growth for people with experience
of psychosis would have been useful and may have contributed to our understanding of recovery and our
evaluations of the recovery-focused interventions.
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Future research
There are a variety of implications for future research that have arisen from this programme and these will
be described, but the order does not imply prioritisation of these implications. A summary of these future
research suggestions is provided in Table 71. Given the clear feasibility of the cognitive–behavioural
approaches to recovery from BD and the prevention of suicide in psychosis, definitive trials should be
conducted. These trials should compare the clinical effectiveness and cost-effectiveness of the psychological
intervention alone with TAU using an adequately powered study with a randomised controlled design. Key
outcomes should include recovery, symptoms, relapse rates, quality of life, treatment acceptability, social
functioning and the cost-effectiveness of the interventions.
TABLE 71 Summary of future research
Chapter Study Phase Future research
2 User-defined conceptualisation




from psychosis: a service
users perspective65
2. Exploring service users
perceptions of recovery
from psychosis: a Q-
methodological approach68
3. The SEPS: psychometric
evaluation of a scale to
assess outcome in
psychosis71
l Evaluation of the use of the Q-sort
set as a recovery-focused goal-setting
intervention
l The development of interventions
that specifically aim to increase the
positive aspects of psychotic
symptoms (as measures using
the SEPS)
3 What does recovery mean to
service users with experience
of psychosis? A Delphi study
with experts by experience
N/A l An evaluation at both individual and
service level of the factors identified
which help and hinder recovery,
using large-scale quantitative
research
l An investigation into recovery
conceptualisations and goals
throughout the recovery process and
in people experiencing their first
episode of psychosis
4 Understanding psychological
and social predictors of
recovery







3. Longitudinal predictors of
subjective recovery from
psychosis153
4. How do I know if I’m
better? Judgements of
recovery from psychosis in
everyday lifea
l Exploration of the use of recent
technology for monitoring of
subjective recovery and related
factors in everyday life (e.g. via
mobile phone applications that could
provide feedback to service users
and care teams)
l Further longitudinal research to
investigate the role of symptoms and
psychological factors (such as
negative affect, self-esteem and
hope) in relation to perceived
recovery over a longer timeframe, in
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TABLE 71 Summary of future research (continued )
Chapter Study Phase Future research
5 Development and evaluation
of cognitive–behavioural
approaches to guided self-help






mode of treatment, and
willingness to be
randomised186
2. A pilot study of a recovery-
focused self-help package
for people with psychosisb




from a self-help guide and
group sessions (STAR-T)c
l Further refinement of the delivery
of the recovery guide would be
beneficial. This could include the
possibility of traditional individual
therapy to support service users in
navigating and implementing the
guide, or the use of peer support
could be explored
l Further work on the understanding
of the development of patient
preferences would be helpful for
service planning and the design and
conduct of future clinical trials
l Additional research that seeks to
understand the role of preferences
and other factors (e.g. causal
explanations and health beliefs) in
the uptake of and response to
treatment would also be important
6 Development and evaluation
of a cognitive–behavioural
approach to understanding
and preventing suicide in
people with psychosis






behaviours: the role of
defeat, entrapment
and resilience205,209
3. A RCT of CBSPp272
l A definitive trial should be
conducted to evaluate the CBSPp.
This trial should compare the clinical
effectiveness and cost-effectiveness
of the psychological intervention
alone with TAU using an adequately
powered study with a randomised
controlled design. Key outcomes
should include recovery, symptoms,
relapse rates, quality of life, treatment
acceptability, social functioning and
the cost-effectiveness of the
intervention
7 Development and evaluation
of RfCBT for individuals with
early BD
1. Recovery in the early stages
of BDd
2. The BRQ: psychometric
properties of a quantitative
measure of recovery
experiences in BD309
3. A RCT of RfCBT for
individuals with early BD324
l A definitive trial should be
conducted to evaluate RfCBT for
individuals with early BD. This trial
should compare the clinical
effectiveness and cost-effectiveness
of the psychological intervention
alone with TAU using an adequately
powered study with a randomised
controlled design. Key outcomes
should include recovery, symptoms,
relapse rates, quality of life, treatment
acceptability, social functioning and
the cost-effectiveness of the
intervention
8 Overall programme discussion l An evaluation of training packages
on the topic of understanding and
promoting recovery that incorporate
the results from this programme and
are jointly delivered by service users
and clinicians would be beneficial.
These studies could utilise qualitative
evaluations in addition to quantitative
methods, including RCTs
l Further work to investigate recovery
context of different cultural
backgrounds
l Future research to explore the
impact of comorbidity on recovery
experiences and the effectiveness
of interventions
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TABLE 71 Summary of future research (continued )
Chapter Study Phase Future research
l Future research to explore variations
in recovery within individuals
following each experience of
psychosis or BD
l Future research to examine
post-traumatic growth in individuals
with experience of psychosis
l The development and evaluation of
methods to help service users to
make informed choices and express
treatment preferences would be




a Richard P Bentall, University of Liverpool, 2015, unpublished.
b Christine Barrowclough, University of Manchester, 2015, unpublished.
c Gillian Haddock, University of Manchester, 2016, unpublished.
d Steven H Jones, Lancaster University, 2015, unpublished.
The further refinement of the delivery of the recovery guide would also be beneficial. This could include
the possibility of traditional individual therapy to support service users in navigating and implementing the
guide, or the use of peer support could be explored. The development of interventions that specifically aim
to increase the positive aspects of psychotic symptoms would also be expected to increase perceived
recovery. In addition, it would be important to evaluate the use of the Q-sort set as a recovery-focused
goal-setting intervention. The development and evaluation of these interventions should begin with pilot
or feasibility studies, before progressing to definitive multisite RCTs if warranted. Care should be taken to
ensure appropriate comparison groups and outcome measures are selected.
The factors that help and hinder recovery, which were identified by our consensus study, should be
evaluated at both individual and service level with large-scale quantitative research. The evaluation of
training packages on the topic of understanding and promoting recovery that incorporate the results from
this programme and are jointly delivered by service users and clinicians would be beneficial. These studies
could utilise qualitative evaluations in addition to quantitative methods, including RCTs. Further work on
the understanding of the development of patient preferences would be helpful for service planning and
the design and conduct of future clinical trials. Additional research that seeks to understand the role of
preferences and other factors (e.g. causal explanations and health beliefs) in the uptake of, and response
to, treatment would also be important. Similarly, the development and evaluation of methods to help
service users to make informed choices and express treatment preferences would be valuable in facilitating
recovery and promoting autonomy and empowerment.
Clinical implications
There are a variety of clinical implications that have emerged from this research programme and these will
be described, but the order does not imply prioritisation of these implications. Clearly, it will be important
for services to regularly assess and monitor recovery in a multimodal way at both the individual and service
level. The facilitation of collaborative conversations about recovery, focusing on factors that help and
hinder recovery for that person (possibly using the checklist as a prompt), as well as identification of
idiosyncratic recovery goals (possibly using the Q-sort card set), is also likely to help make services more
acceptable and effective in achieving outcomes that are prioritised by service users and carers. Similarly, at
a service level, attempts could be made to decrease factors that hinder recovery and to increase factors
that promote recovery. It is also important to note that psychotic experiences are not always associated
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with distress and may be identified as a positive experience by service users (e.g. the companionship that is
at times provided by auditory hallucination in those who hear voices).
Services may also endeavour to deliver specific interventions which target factors that have consistently
been shown to affect recovery. These could include interventions aimed at improving mood and reducing
negative affect (such as evidence-based psychological therapies, activity scheduling and physical exercise);
promoting self-esteem (such as compassion-focused therapy and CBT); development of an internal locus of
control and optimism about the future (such as provision of optimistic, recovery-focused psychosocial
explanations of mental health problems and the use of cognitive–behavioural strategies); reduction of
defeat and entrapment appraisals (such as CBT); and optimal management of symptoms (such as
evidence-based pharmacological and psychological treatments, including an evaluation of the advantages
and disadvantages of such symptoms).
The trials of cognitive–behavioural approaches to suicide prevention in psychosis and recovery from the
early phases of BD are encouraging and suggest that these options could be considered for people
presenting with such problems. However, before such treatments can be routinely recommended in
treatment guidelines, we would need definitive trials with adequate statistical power.
The introduction of informed choices in a standard way, providing service users and carers with sufficient
information to be able to do so, and in the context of mental health services that welcome and facilitate
such choices would represent a major step forward in the treatment of psychosis and BD. It is clear that
many people hospitalised with psychosis retain treatment decision-making capacity343 and a recent review
regarding choice and decision-making in people using mental health services concluded that service users
clearly want to be offered choices about their treatment rather than just offered medication.344 This has led
to recent calls for choice between treatments and less reliance on the exclusive use of medication for
people with psychosis, as well as the suggestion that some decisions to refuse or discontinue antipsychotic
medication may represent a rational informed choice rather than an irrational decision owing to lack of
insight or symptoms such as suspiciousness.345 Such choices have been recommended within recent
NICE guidelines.346
The similarities in the themes highlighted between psychosis and BD would suggest that many of the
implications could be generic for people with serious mental health problems. However, the themes for
people with psychosis seemed to have less emphasis on the biogenetic model, medication and symptoms,
which suggests that different explanatory frameworks may be required to best engage service users and
ensure that services can act effectively as a platform on which to deliver acceptable and evidence-based
interventions. Perhaps choice of causal models could also be embraced within services.
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Appendix 1 Protocol for Chapter 2 studies
 
 
Protocol - Investigating the Psychometric Properties 
of the Service-User Defined Subjective Experiences of 
Psychotic Symptoms Scale (SEPSS). 
This study aims to examine the psychometric properties of the newly developed 
service-user defined measure of symptom recovery, the Subjective Experiences of 
Psychotic Symptoms Scale (SEPSS, in prep).  This newly developed measure aims 
to measure the experiences most relevant to the service-user in regard to assessing 
aspects important to symptom recovery in psychosis.   
 
The scale was developed to address the current void in literature regarding symptom 
recovery and service user input.  Currently, there are many measures available to 
assess symptom change in psychosis such as the Psychotic Symptoms Rating Scale 
(PSYRATS, Haddock et al, 1999), Positive and Negative Syndrome Scale (PANSS, 
Kay et al, 1989) and the Brief Psychiatric Rating Scale (BPRS, Overall and Gorham, 
1962), all of which are designed by psychiatrists and psychologists and aim to 
assess symptom change.  The issue is that many psychiatrists and psychologists 
deem symptom alleviation to be the main indicator of recovery whereas service users 
do not (Pitt et al, 2007).  This research wanted to bridge the gap between these 
different views of symptom recovery by designing a measure that has service-user 
input in both the design and development stages.  Therefore, it is hoped that the 
developed measure should cover aspects of symptom change that are important to 
the service-user. 
 
The SEPSS was generated by conducting qualitative interviews with service-users 
about their experiences of symptom recovery in psychosis. Literature and measures 
defining recovery were also explored using Q-methodology to generate items for the 
scale. Items were extracted from measures such as the Psychotic Symptoms Rating 
Scale (PSYRATS, Haddock et al, 1999), Positive and Negative Syndrome Scale 
(PANSS, Kay et al, 1989) and the Brief Psychiatric Rating Scale (BPRS, Overall and 
Gorham, 1962) as well as from research within the field of symptom recovery in 
psychosis (Buchanan et al 1993, Oulis et al, 1995, Haddock et al, 1999).  Items were  
also extracted from more service user orientated studies (Pitt et al, 2007, Neil et al, in 
press). All items/statements extracted from these means were scrutinised by service-
users in regard to relevance to recovery.  From this, the SEPSS (in prep) was 
generated.   
 
This study aims to examine the psychometric properties of the SEPSS, scrutinising 
its reliability and validity.  To measure this, the study will be divided into 3 sub-studies 
in order to measure; content/face validity, concurrent validity, predictive validity, inter-
rater reliability, test-retest reliability and internal consistency. 
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1. Content and Face validity  
 
Content validity can be defined as a systematic examination of the test content to 
determine whether it covers a representative sample of the domain to be measured.  
Face validity is ensuring that the scale appears valid, i.e. that it looks like a valid tool 
to those who use it (Anastasi and Urbina, 1996).  Both can be determined by 
examining the measures structure, content and appearance.  
 
Method - To examine this, a reference group of service-users including service-user 
researchers will meet to discuss the content of the scale to ensure its full validity in 
this area.  The items on the scale, readability, instructions and appearance are 
examples of factors that will be scrutinised.  This meeting or inspection of the scale is 
often considered suffice to ensure content and face validity (Anastasi and Urbina, 
1996) and is used in many like-minded studies (Beck et al, 1961).   
 
Hypothesis - Due to the nature of how this measure was developed (a service-user 
defined measure), the content and face validity of this tool is predicted to be high. 
 
Participants - A reference group of between 5 –8 service-users will comprise the 
group.  It will comprise 2 service-user researchers and 3 – 5 independent service-
users. The reference group will comprise, adults (18 – 65) experiencing or who have 
experienced psychotic symptoms for at least a year. 
 
Procedure - 
1. Approach the service user reference group (SURG) representative and 
arrange a meeting with the reference/steering group to assess content and face 
validity. 
2. The reference group will have a one off meeting to discuss content and face 
validity with service-user researchers facilitating the meeting 
3. Make any necessary amendments to measure 
4. Participants to be provided with the opportunity for feedback of results. 
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2. Concurrent validity, Predictive validity, Internal consistency and Test-retest 
reliability  
 
These four measures of reliability and validity defined as; Concurrent validity is the 
degree to which different measuring systems produce correlating results. This is 
scrutinised by comparing the test score to another criterion measure at 
approximately the same time that will act as a validation tool (Anastasi and Urbina, 
1996).  Predictive validity is the ability for a tool to predict outcomes over a set time 
interval (Anastasi and Urbina, 1996).  Test Retest Reliability is the extent to which 
scores on a test can be generalised over different occasions; the higher the 
reliability, the less susceptible the scores are to random changes (Anastasi and 
Urbina, 1996). Internal Consistency is a measure of the consistency between the 
items within a scale (Field, 2006).  For the scale to be consistent, the inter-
correlations between the related items on each scale of the measure need to be 
high.   
 
Method - These four measures of reliability and validity will be measured together, 
which involves three stages: 
 
Stage 1:  The participants will be invited to complete a demographics sheet, the 
SEPSS and a number of measures used in measuring the symptomatology of 
psychosis, the Positive and Negative Syndrome Scale (PANSS, Kay et al, 1989), the 
Psychotic Symptom Rating Scale (PSYRATS, Haddock, et al, 1999), the Beck 
Hopelessness Scale (BHS, Beck & Steer, 1988), the Global Assessment of 
Functioning Scale (GAF, DSM-IV; American Psychological Association, 1994), the 
Lecomte Self-Esteem Scale (Lecomte, Corbiere & Laisne, 2006), the Beck Anxiety 
Inventory (BAI, Beck et al, 1988), Calgary Depression Scale (Addington, Addington & 
Maticka-Tyndale, 1993) and the Process of Recovery Questionnaire (QPR, 
Neil, in press).   The PANSS and the PSYRATS were selected due to their frequent 
use in the assessment of psychotic symptoms.  The QPR was selected due to its 
assessment of recovery within psychosis and its development by service-users.  The 
BHS, GAF, BAI and Calgary Depression Scale and Lecomte Self Esteem Scale were 
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chosen due to their frequent use in assessing emotional functioning.  It is important 
to assess such aspects as they play an important part in recovery. 
 
Participants will be required to fill out each of these questionnaires in order to 
compare their scores for each measure. By doing so, internal consistency and 
concurrent validity will be measured. Internal consistency will be measured by 
scrutinising participants’ scores on the SEPSS through an exploratory factor 
analysis. Concurrent validity will be measured by obtaining participants’ scores for 
each measure, the SEPSS, PSYRATS, PANSS, BHS, GAF, BAI, Calgary 
Depression Scale, Lecomte self esteem scale and QPR. These scores will then be 
correlated and compared in order to act as a validation tool for the SEPSS. 
 
Stage 2 (1-2 weeks after stage 1): The participants will be invited back to re-
complete the SEPSS.  Test re-test reliability will be measured for by comparing the 
scores from the SEPSS at this stage with the scores from the SEPSS at stage 1. The 
scores will be compared using a correlational analysis. 
 
Stage 3 (10 – 12 weeks after completing stage 1):  The participants will be invited 
back to re-complete the SEPSS, PANSS, PSYRATS, GAF, BHS, BAI, Calgary 
Depression Scale and Lecomte Self-Esteem Scale and QPR. Predictive validity will 
be measured by comparing the scores from all measures at stage 3 to all scores 




Concurrent Validity -  It is predicted that the service-users score on the SEPSS will 
be positively correlated (>0.8) with their scores on the PSYRATS, positively 
correlated (>0.8) to their scores on the Lecomte self-esteem scale, positively 
correlated (>0.8) on the positive subscale on the PANSS, positively correlated (>0.8) 
to their scores on the BAI, positively correlated (>0.8) with their scores on the 
Calgary Depression Scale, positively associated (>0.8) to their scores on the BHS, 
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negatively correlated (>-0.8) with their scores on the QPR and  negatively correlated 
(>-0.8) to their scores on the GAF, 
 
Predictive Validity – It is predicted that the service-users score on the SEPSS will be 
positively associated (>0.8) with their scores on the PSYRATS, positively associated 
(>0.8) to their scores on the Lecomte self-esteem scale, positively associated (>0.8) 
on the positive subscale on the PANSS, positively associated (>0.8) to their scores 
on the BAI, positively associated (>0.8) with their scores on the Calgary Depression 
Scale, positively associated (>0.8) to their scores on the BHS, negatively associated 
(>-0.8) with their scores on the QPR, and negatively associated (>-0.8) to their 
scores on the GAF. 
 
Internal Consistency - It is predicted that all the items on the scale within their given 
factor will have a high internal consistency. 
 
Test Re-test reliability - It is predicted that the SEPSS will have good test re-test 
reliability, therefore correlations between participants’ scores at stage 1 and 2 will be 
high (>0.8, Field 2005). 
 
Participants - A sample size of 75 participants (n=75) will be recruited for analysis. 
75 participants will be asked to complete stage 1 and 3 of the analysis. Out of these 
75 participants, 30 will be asked to complete stage 2 of the study.  Participants will 
also meet the criteria outlined in 1. Content and face validity except they will have 
current experiences of psychosis and not previous experience. 
 
Materials – A Demographics Sheet, the Subjective Experiences of Psychotic 
Symptoms Scale (SEPSS, in prep), the Positive and Negative Syndrome Scale 
(PANSS, Kay et al 1989), the Psychotic Symptom Rating Scale (PSYRATS, 
Haddock et al 1999), the Beck Hopelessness Scale (BHS, Beck & Steer, 1988), the 
Global Assessment of Functioning Scale (GAF, DSM-IV; American Psychological 
Association, 1994), ), the Beck Anxiety Inventory (BAI, Beck et al, 1988), Calgary 
Depression Scale (Addington, Addington & Maticka-Tyndale, 1993), the Lecomte 
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Self-Esteem Scale (Lecomte, Corbiere & Laisne, 2006)  and the Process of 
Recovery Questionnaire (QPR, in press).   
 
1. Approach local NHS providers of Mental Health Services and user groups 
within the North West promoting the study. 
2. Ensure all participants meet the criteria for the study. 
3. Gain participant consent regarding all stages. They can consent to all three 
but still pull out at any point. 
4. Distribute and administer the Demographics Sheet, SEPSS, PANSS, 
PSYRATS, BHS, GAF, BAI, Calgary Depression Scale, Lecomte Self Esteem Scale 
and QPR to all participants for stage 1. 
5. Distribute and administer the SEPSS for stage 2. 
6.  Distribute and administer the SEPSS, PANSS, PSYRATS, BHS, GAF, BAI, 
Calgary Depression Scale, Lecomte Self Esteem Scale and QPR to all participants 
for stage 3. 
5. Conduct statistical analysis on data using appropriate correlation analysis. 
6. Interpret statistical data 
7. Participants to be provided with the opportunity for feedback results as 
appropriate. 
 
3. Inter-Rater reliability  
 
Inter-rater reliability is a measure that shows that a test is consistent when comparing 
different raters. It is imperative for a measure to have high inter-rater reliability 
otherwise it cannot be used dynamically (Anastasi and Urbina, 1996).  To measure 
this, there will be ten interviewers assessing ten interviewees using the SEPSS.  
These ten interviewees will be administered the SEPSS and videotaped.  The 
interviewer will have to rate each video using the SEPSS and all scores for each 
video will be inter-correlated to calculate the reliability of the scores. 
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Participants  
Interviewees - A sample size of 10 participants (n=10) will be recruited for analysis. 
Interviewee’s will be as described in section 2 (Concurrent validity, Predictive validity,  
Internal consistency and Test-retest reliability).   
 
Interviewers- There will be a total of 5 - 10 interviewers (n= 5 -10) for the test of inter-
rater reliability. They will have specialist knowledge of psychosis and its 
symptomatology.   The interviewer’s will be between the ages of 18 – 65, mental 
health staff or service-user researchers and have experience with working with 
people with psychosis and its symptomatology.  They will be employees of a North 
West NHS Trust. 
 
Materials – The Subjective Experiences of Psychotic Symptoms Scale (SEPSS, in 
prep).  The taped interviews; all interviewee’s will be recorded and these tapes will 
be used for the interviewers assessment.   
 
Procedure- Procedure is the same as in section 1.2(Concurrent validity, Predictive 
validity, internal consistency and test-retest reliability) with the exception of points 4, 
5, and 6.  Instead participants will be required to rate 10 tapes of interviewees 
completing the SEPSS within a 4-week period.  These 10 tapes will be picked at 
random out of all recorded SEPSS assessments. 
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Appendix 2 Protocol for Chapter 3 study
A DELPHI STUDY WITH SERVICE USERS – WHAT DOES RECOVERY
MEAN TO SERVICE USERS WITH EXPERIENCE OF PSYCHOSIS?
Aim
The overall aim of this study is to determine the extent of the consensus among service users on the
meaning of recovery from psychosis.
Objectives
1. To produce a list of statements related to the definition and conceptualisation of recovery from
psychosis as identified through a search of the literature.
2. To circulate this list of statements to a service user focus group for consultation.
3. To format the list of statements into an online survey to be circulated more widely among people with
experience of psychosis for extensive consultation.
4. Based on the above consultation process, to identify areas of consensus relating to the
conceptualisation of recovery and extrapolate other key themes emerging from the survey.
Background
The word psychosis describes a common set of experiences including hearing voices, seeing things,
unusual thoughts and unusual beliefs. Many people will have these experiences to some degree, but for
some people experience of psychosis may interrupt or disturb daily activities or cause distress. Medically,
psychosis is usually understood as a symptom of a psychiatric disorder such as schizophrenia, and from the
traditional medical paradigm, people who experience psychosis are not expected to get better or recover.
Recovery in the field of mental health is a relatively new concept and encompasses ‘recovering’ in the
traditional sense of ‘feeling well again’ but also acknowledging that recovery is a personal process
involving rebuilding life, rebuilding self and hope for a better future (Pitt et al., 2007), rather than purely
focusing on symptom reduction.19 Within the academic literature, service users themselves have led the
‘recovery movement’ by publishing personalised accounts of their recovery. This has brought a new sense
of optimism for health professionals and service users alike. Health services and policy makers have taken
on board this positive approach to mental health by advocating services which are recovery orientated.
Despite this interest in adopting a ‘recovery approach’, there is still no universally accepted and
unambiguous definition of recovery. The word has a completely different meaning to service users
compared with clinicians and academics. Generally the term recovery implies a cure or healing after illness
or injury and a return to the normal condition. However, based on this connotation, few people with
severe mental illness would ever be fully recovered.17
The service user movement in conceptualising recovery has moved away from professional classifications
towards self-definition. Service users view recovery as something very different to clinicians18 and are not
limited to purely considering recovery as the absence of symptoms, disability or reduction in the use of
mental health services.76 There is a strong belief that recovery is different for everyone and that it is a
complex process rather than an outcome or end point.19
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As part of a larger project titled ‘Understanding recovery in psychosis’, this study will aim to address the
gap in the literature by exploring what recovery from psychosis means to service users. Service users should
be recognised as ‘experts on their own experiences’ (British Psychological Society, 2000) and as such this
study will consult a large number of service users about what recovery means to them.
This study will use a method known as the Delphi process which aims to elicit the opinions of a group of
experts and reach a consensus on a given topic. In this case, the topic is defining and conceptualising
recovery from psychosis and the group of experts will be service users with experience of psychosis.
Method
Participants
Participants will be recruited via convenience sampling through mental health services (including
Community Mental Health Teams and Early Intervention Services), non-NHS groups/voluntary groups and
networks (such as MIND, RETHINK and the Hearing Voices Network), and advertising of the study by
leaflets, posters, e-mail networks and voluntary organisations websites, social media and local media
(including press releases). This is to ensure the study is advertised as widely as possible allowing as many
people as possible to submit their views.
It is also hoped that recruitment can also make use of a new pilot system being implemented at Greater
Manchester West Mental Health NHS Foundation Trust. This system (called FAIR-Free Access to
Involvement in Research) allows all service users to opt in to hearing about possible research studies.
The R&D department send letters to service users who have asked to hear about research. The letters do
not give details of the research study itself but allow people to contact the research team directly for
more information.
Participants will be included in the study if they have (or have had in the past) experience of psychosis,
are over the age of 16 and are able to understand English.
Demographic details including age, gender, location and mental health diagnosis or description will
be collected.
Participants who express an interest in the study will have the option of having the study information and
link e-mailed directly to them to facilitate easy access to the study website. Participants who do not have
access to the computer will be offered a paper copy of the survey to allow them to take part.
Participants who request a paper copy of the survey will also be given a paper version of the consent form.
Participants completing the survey online will complete an online declaration which reminds them that
once they submit their responses they are agreeing to take part in the research.
Procedure
The Delphi process will consist of three stages:
Stage 1
Elements identified as pertinent to the definition or conceptualisation of recovery from psychosis will be
identified through a literature search and collated into a list of statements. This list will then be sent via
e-mail and post to a panel of service users (experts by their experiences) to take part in this initial
consultation phase. Those who agree to take part will be asked to rate, add to and amend the list of
statements. Any amendments and new items (except duplications) will be added to the list to form the
questionnaire for the next stage.
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Stage 2
The finalised statement list from the first stage will be collated and formatted into an online questionnaire
(with a paper alternative made available). Participants will be asked to rate the importance of each item, in
relation to defining recovery, on a five point Likert scale (1-essential, 2-important, 3-do not know/depends,
4-unimportant and 5-should not be included). Responses to this stage of the consultation are analysed to
inform the final round of questionnaires. At this stage, participants are asked if they would like to provide
a contact e-mail or postal address so that they are able to take part in the final stage of the consultation.
Stage 3
In stage 3, participants will be asked to re-rate only those items that 70–79% of respondents had rated as
essential or important during stage 2. The questionnaire will take exactly the same format as above, but
will only include items which were rated as essential or important by 70–79% of the stage 2 respondents.
Materials
Materials will include advertising posters and leaflets, information sheets, consent, consent forms and the
statement list in questionnaire format. These will be made available in an online and paper version
where possible.
Analysis
Survey responses were recorded in a secure anonymised database and analysed by obtaining group
percentages. The following cut-off points were used in relation to inclusion, re-rating and exclusion criteria
for the items:
1. Items rated by 80% or more participants as essential or very important to defining or conceptualising
recovery are included as standard.
2. Items rated as essential or important to defining or conceptualising recovery by 70–79% of respondents
in stage 2 will be re-rated in stage 3.
3. Any statements that did not meet the above 2 conditions were excluded.
Potential risks/ethical issues
It is not envisaged that there will be any risks or ethical issues from taking part in this research.
Confidentiality
Participation in this study is completely anonymous. Responses are submitted online without entering any
personal identifiable information or on an anonymised paper version. All responses are anonymous.
Right to withdraw
Participants are free to withdraw at any time without detriment to their care and this will be made clear on
the information sheets and consent forms.
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Data storage
Data will be held (in accordance with University of Manchester policy) for 5 years after the last publication
of the study or for 10 years, whichever is the greater. Consent forms will be retained as essential
documents, but personal contact details will be deleted following stage 3 of the study.
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Appendix 3 Protocol for Chapter 4 studies
PSYCHOLOGICAL FUNCTIONING AND SUBJECTIVE RECOVERY
VERSION 5/23RD SEPTEMBER 2009
Background
Most research on the long-term course of severe mental illness (including randomized controlled trials) has
defined outcome in terms of symptoms or symptomatic relapse. However, this narrow focus is problematic
for two main reasons. First, symptomatic outcomes (e.g. as measured using interview schedules such as
the Positive and Negative Syndromes Scale; PANSS) correlate very poorly with other types of outcome,
such as social, occupational110 or cognitive functioning.28 Hence, it is possible for a person with psychosis
to experience a complete remission of symptoms while continuing to experience enduring social disability,
or to function well socially and occupationally despite persisting symptoms. Second, it has become
increasingly recognised that patients’ conceptions of recovery often differ from those of professionals.
For example, in a recent qualitative study it was found that service users tended to define recovery in terms
of rebuilding life, rebuilding self and hope for a better future,19 Hence it has been argued that recovery
should be seen as:
A deeply personal, unique process of changing one’s attitudes, values, feelings, goals, skills,
and/or roles. It is a way of living a satisfying, hopeful, and contributing life, even with limitations
caused by the illness. Recovery involves the development of new meaning and purpose in
one’s life287
and that, when considered in this way, recovery is much more common than has previously
been thought.347
This realisation has resulted in services in Britain and North America moving towards a ‘recovery model’ of
service provision. Although it is not always clear what this means, services of this kind tend to promote an
optimistic view of mental health outcomes encourage patients to develop their own understanding of
what recovery means, and help patients to find the best way of achieving their personally defined goals.
However, this development has been impeded by a lack of understanding of subjectively defined recovery
or how it relates to important dimensions of psychological functioning.18 Given this reconceptualization,
work is required in order to determine what factors determine recovery judgements. Why do some
patients regard themselves as recovered whereas others do not? So far very little research has addressed
this issue and our hypotheses are therefore necessarily speculative.
For example, although many investigators have been at pains to define recovery in ways that do not
include symptoms, it remains possible that patients’ appraisals about their symptoms (e.g. the extent to
which the symptoms are seen as intrusive and uncontrollable) affect whether or not they see themselves as
well (H1). Given that research shows that many psychotic patients suffer from mild cognitive impairment
and that this influences social functioning,348 it is also possible that recovery judgements are related to
either current cognitive ability (H2) or appraisals of cognitive ability (H3) (which may be uncorrelated).349
In frequently used tests of cognitive ability it has been shown that patients are able to improve on their
score, becoming comparable to controls through repetition of the task (Bellack et al., 1990) or by the
inclusion of a monetary incentive (Green et al., 1992). As it is possible that incentivised performance is a
better indicator of cognitive ability than unincentivised performance, we will also investigate whether the
inclusion of a monetary reward improves the ability of cognitive tests to predict subjective recovery (H4).
It has also been shown that emotion-related processes play an important role in psychosis, with acutely ill
patients showing extreme stress-sensitivity.350,351 As stress sensitivity is likely to affect coping, it would
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not be surprising if this kind of emotional instability affected recovery judgements (H5). Finally, recent
research has shown that instability in psychological processes may be more important than overall level
of psychological functioning in people with severe mental illness; for example self-esteem is highly unstable
(as indicated by moment-to-moment fluctuations) in patients in with paranoid delusions121 and individuals
who later develop paranoid beliefs.352,353 have shown that, in bipolar patients, approximate entropy
(a statistical measure of chaotic fluctuations in affect) indicates an imminent relapse and, if this is the
case in schizophrenia spectrum patients, it might be expected that instability of emotional and social
functioning will be associated with negative judgements about recovery (H6).
To test H1-H4, we will conduct a cross-sectional study in which patients with schizophrenia spectrum
disorders will be asked to complete four different measures of subjective recovery, together with objective
measures of clinical functioning, measures of emotional functioning and subjective measures of clinical
functioning. We will investigate associations between the four measures of recovery and use regression
analysis to examine whether symptoms, cognitive and emotional functioning predict recovery status.
In a second study with a subsample (subject to a separate ethics application), we will use the Experience
Sampling Method (ESM) to test H5 and H6 by examining the stability of affect and social cognition in
relation to recovery status.
Study design
Participants
A minimum of 120 patients meeting criteria for a lifetime diagnosis of DSM-IV schizophrenia spectrum
disorders (schizophrenia, delusional disorder, schizoaffective disorder, psychotic disorder NOS) will be
recruited to the study. We will be seeking to recruit a sample that is heterogeneous with respect to severity
of symptoms, social functioning, duration of illness, and subjective appraisal of recovery status. Hence, we
will use a broad recruitment strategy, approaching patients in hospital wards, day hospitals and CMHTs.
We will also recruit a convenience sample of 40 healthy control participants from NHS and university
academic staff, informal contacts and from local fire services, approximately matched with the patient
participants for age, sex and educational attainment (fire personnel tend to be good matches with patients
of key demographic variables). (These participants will complete only some of the assessments –
see below.)
Recovery appraisal measures
We will measure recovery appraisals using three measures, which will be administered only to the
patient participants:
The Process of Recovery from Psychosis Questionnaire (QPR) is a 22-item questionnaire measuring
subjective recovery in two domains: intrapersonal functioning and interpersonal functioning. The subscales
have good internal consistency and test–retest reliability over short periods.32
Additional recovery questions
Two additional questions will be appended to the QPR; participants will be asked: ‘Do you consider that
you have recovered from your illness?’ (YES/NO); and ‘Please place a cross on the line below to indicate
the extent to which you think you have recovered from your illness’ (10 cm analogue scale with left anchor
‘Completely recovered’ and right anchor ‘Not recovered at all’).
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Objective clinical measures (to be administered to
all participants)
The Positive and Negative Syndrome Schedule162 will be used to assess current symptoms. This is a
structured clinical interview yielding ratings of the severity of thirty symptoms over the previous week and
is used to calculate three composite scores: positive symptoms, negative symptoms, and general
psychopathology. Researchers will receive training in the administration of the schedule and will be
required to achieve the recommended lever of reliability (no scores deviating greater than 1 point from the
scores of expert raters). Additional questions will be included from the Psychotic Symptoms Rating Scale
(Psyrats; Haddock et al., 1999). An observable measure of functioning, the Personal and Social
Performance Scale (Nasrallah et al., 2008, will also be included). Administration takes approximately
50 minutes.
Antipsychotic mediation dose will be recorded and converted to chlorpromazine equivalents, using
standard tables. (These values will be zero for the healthy controls).
Brief Assessment of Cognition in Schizophrenia (Keefe et al., 2004) is a 30-minute battery designed to be
administrable by researchers without formal training in neuropsychology, which includes measures of
verbal memory, attention, working memory, motor speed, verbal fluency and executive function. The BACS
has been shown to have good test–retest reliability, to correlate with more extensive batteries, and to
predict daily living skills in patients diagnosed as suffering from schizophrenia. One of the BACS subscales,
the Tower of London (a measure of executive functioning) will be administered twice, once without and
once with monetary reinforcements (20p per correct response).
Subjective appraisals of clinical functioning
The Persecution and Deservedness Scale354 (all participants) is a 20-item questionnaire measuring severity
of persecutory ideation and the extent to which persecution is believed to be deserved.
The Interpretations of Voices Inventory355 (all participants) is a 35-item scale with three subscales
measuring beliefs about voice-hearing.
The Subjective Experiences of Psychotic Symptoms Scale (SEPPS; Haddock et al. in prep) (patient
participants only) is a recently developed 47-item scale designed to measure how much patients’ lives
are affected by their symptoms.
The Subjective Scale to Investigate Cognition in Schizophrenia (SSICS)356 (all participants) is a 21-item
scale measuring subjective cognitive deficits.
The Insight Scale132 (patient participants only) is a 10-item scale measuring perceived need
for treatment.
Emotional Functioning (all participants).
Beck Hopeless Scale357 is a 20-item scale measuring negative thoughts about the future.
The Brief Self-esteem Rating Scale76 is a 20-item scale with good reliability which has been shown to be a
valid measure of positive and negative self-esteem in psychotic patients.
The Acceptance and Avoidance Questionnaire-II (AAQ-II) is a 10-item scale with good reliability that
measures intolerance of unpleasant thoughts and emotions. We have found that it is a strong predictor of
paranoid beliefs in non-clinical samples (Udachina, et al. in submission).
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Multidimensional locus of control scale131 is a reliable 24-item scale measuring dimensions of internality,
belief in powerful others and belief in chance. In previous studies358 it has been found that paranoid
patients scored abnormally highly on the ‘powerful others’ subscale.
Anticipation of future threats359 is a simple questionnaire in which individuals are asked, first, to state how
often 7 common positive (e.g. a friend helps you), 7 neutral (e.g. you receive a letter) and 7 common
negative events (e.g. a friend ignores you) have occurred over the last month. Participants are then asked
to rate the future probability of these events for themselves and ‘other people’ using seven point
analogue scales.
Relationships Questionnaire360 is a two-minute questionnaire measuring security of current attachment
relations. Participants read four brief vignettes describing different styles of relating to others. They are
asked to chose the description which best describes them, and then to rate how similar they are to each
description using 7 point analogue scales.
Brooding subscale of the Ruminative Responses Scale361 is a 5-item questionnaire measure of rumination,
which has been shown to predict persistence of negative affect.
Hospital Anxiety and Depression Scale128 is a 14-item questionnaire with subscales for anxiety and depression.
The measures will be administered over two sessions separated by a few days, with the PANSS, QPR,
SEPSS, BHS, LeComte, and PSYRATS administered on the first session and all remaining measures
administered on the subsequent session.
Analysis
Patterns of association and concordance between the four measures of recovery will be examined through
the use of the kappa statistic.
We will divide patients in to ‘recovered’ and non-recovered’ groups by means of a median split of QPR.
We will then conduct two-way sex x group (recovered, non-recovered, healthy controls) ANOVAs on key
psychological variables. We will normalise any data as required using the appropriate transformation and,
in the event of group differences in age and educational attainment, include these as covariates.
We will use a multiple regression approach to analysing predictors of recovery, first centering and
normalising scores for predictor and outcome variables. Prior to analysis, we will seek to reduce the
number of predictor variables using appropriate techniques (e.g. PCA). For example, given that depression
and anxiety measures typically correlate by about 0.6 in both clinical and non-clinical samples362 we will
almost certainly collapse the two HADS scales into a single measure of dysphoria. A final analysis
incorporating all three measures of recovery will involve the use of a structural equation model to evaluate
whether the predictors are common to the four or whether there are specific influences.
We will use the method of363 to study potential mediational affects between objective measures (e.g.
positive symptoms on the PANSS; cognitive functioning on the BACS) and perceived recovery, using the
relevant subjective appraisal measures (e.g. subjective impact of symptoms measured by the SEPPS;
subjective cognitive functioning measured by the SSICS) as mediators.
However, one of the frequently unrecognised difficulties for the interpretation of these analyses is the
possibility of confounding between putative mediator and final outcome (i.e. variables that have an
influence on both). We will therefore attempt to identify and condition on potential confounders, and also
investigate the possibility of the use of instrumental variable methods to allow for the effects of
unmeasured confounders (see Dunn and Bentall, 2007).
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UNDERSTANDING RECOVERY IN EVERYDAY LIFE: AN EXPERIENCE
SAMPLING STUDY VERSION 8: 20TH DECEMBER 2011
Most research on the long-term course of severe mental illness (including randomized controlled trials) has
defined outcome in terms of symptoms or symptomatic relapse. However, this narrow focus is problematic
for two main reasons. First, symptomatic outcomes (e.g. as measured using interview schedules such as
the Positive and Negative Syndromes Scale; PANSS) correlate very poorly with other types of outcome,
such as social, occupational110 or cognitive functioning.28 Hence, it is possible for a person with psychosis
to experience a complete remission of symptoms while continuing to experience enduring social disability,
or to function well socially and occupationally despite persisting symptoms. Second, it has become
increasingly recognised that patients’ conceptions of recovery often differ from those of professionals.
For example, in a recent qualitative study it was found that service users tended to define recovery in terms
of rebuilding life, rebuilding self and hope for a better future.19 Hence it has been argued that recovery
should be seen as:
A deeply personal, unique process of changing one’s attitudes, values, feelings, goals, skills, and/
or roles. It is a way of living a satisfying, hopeful, and contributing life, even with limitations
caused by the illness. Recovery involves the development of new meaning and purpose in
one’s life287
and that, when considered in this way, recovery is much more common than has previously
been thought.347
This realisation has resulted in services in Britain and North America moving towards a ‘recovery model’ of
service provision. Although it is not always clear what this means, services of this kind tend to promote an
optimistic view of mental health outcomes, encourage patients to develop their own understanding of
what recovery means, and help patients to find the best way of achieving their personally defined goals.
Unfortunately, this development has been impeded by a lack of understanding of subjectively defined
recovery or how it relates to important dimensions of psychological functioning.18 Given this
reconceptualization, work is required to determine what factors determine recovery judgements. Are
recovery judgements stable over time, or do patients fluctuate in their judgements about mental wellness?
Why do some patients regard themselves as recovered whereas others do not? So far very little research
has addressed this issue. Our study is therefore designed to address a series of hypotheses that are
necessarily speculative.
Mood and self-esteem
In healthy individuals, challenges to self-esteem are the most potent elicitors of secretion of the stress
hormone cortisol.364 Research using various diary methods has shown that exacerbations of positive
symptoms are preceded by increases in negative mood and decreases in self-esteem.121,365 Service users
report that a positive sense of self is an important component of being recovered.19 Together, these
findings suggest a close association between self-esteem and mental well-being. A complication is that
self-esteem is a complex process, and it is therefore important to distinguish between explicit self-esteem,
conscious judgements about how we feel about ourselves at a particular moment, and implicit self-esteem,
that is more enduring beliefs about our self-worth that we may not be aware of for much of the time.366
It seems likely that explicit self-esteem will be associated with immediate judgements of wellness, whereas
implicit self-esteem will be a better predictor of long-term mental health (H1). To test this hypothesis we
will administer appropriate measures of explicit and implicit self-esteem, and also assess self-esteem in
daily life using the experience sampling method (ESM), a sophisticated diary methodology.
DOI: 10.3310/pgfar04050 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 5
219
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Morrison et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
Childhood trauma, dissociation and hallucinations
It is commonly believed that most auditory hallucinations are to be considered a psychotic symptom,
whereas some are dissociative experiences (Moskowitz and Cortens, 2008).However, recent findings suggest
that not only do auditory hallucinations (AH) not have to occur as a symptom of a psychotic disorder, but
that AH and dissociation are aetiologically associated (Moskowitz and Cortens, 2008). Studies investigating
both non-clinical (Glickson and Barret, 2003; Morrison and Peterson, 2003) and clinical populations
(Perona-Garcelán et al., 2008) have found strong associations between hallucination-proneness and
dissociative experiences. Furthermore, research has repeatedly noted a relationship between experience of
childhood trauma and dissociation (Glaser, van Os, Portegijs, and Myin-Germeys et al., 2003; Myin-Germeys,
et al., 2003) and AH (Read and Argyle, 1999; Ross, Anderson, and Clark, 1994). Due to the associations
observed between childhood trauma and AH and dissociation, it would be beneficial to investigate whether
a mediating relationship between these factors exists – they may be important in conceptualising recovery,
or be potential mediators in recovery trajectories (traumatic life experiences, ability to self-soothe an
appraisal of symptoms). It is expected that dissociation will mediate the relationship between childhood
trauma scores and hallucination-proneness. To test this hypothesis we will administer measures of child
abuse and trauma, hallucination-proneness and dissociative experiences.
Interpretation of hallucinations
Research suggests that the emotional and behavioural consequences of hallucinatory experiences may not
be caused by the content, but by the beliefs about the experience (Chadwick and Birchwood, 1994). Wells
and Butler (1997) proposed that positive beliefs about hallucinations are associated with efforts to engage
with the experience, whereas negative beliefs about hallucinations are thought to be associated with
unhelpful coping strategies. Furthermore, studies have shown that hallucinatory experiences are not
reserved to those diagnosed with psychotic disorders, but occur in the non-clinical population also
(Verdoux and van Os, 2002). These findings indicate that hallucinations are not necessarily pathological,
and in some cases can be a positive experience, depending on the individuals own interpretation; therefore
a further understanding could be beneficial to improved support in recovery. Based on the aforementioned
research, it is expected that the individuals’ interpretation of their voices will be related to the positivity
of the experience. To test this hypothesis, a scale measuring the individuals’ interpretation of their
hallucinations as well as measures of self-esteem, mood, depression and assessment of everyday
self-esteem and mood using experience sampling methodology will be used.
Self-compassion
Self-compassion is a strong predictor of well-being (Neff 2003). Compassion Focused Therapy (CFT) aims
to increase self-compassion and was recently shown to result in recovery-focused outcomes with a group
of 4 people experiencing negative and malevolent voices. Interestingly, CFT resulted in much less threat
associated with voice hearing experiences, and an increase in desire to engage in social relationships
(Mayhew and Gilbert, 2008). Self-Compassion is thought to reflect a well developed affiliative soothing
system – a form of positive emotion with a specialised neural pathway (Depue and Morrone Stupinsky,
2005). This forms the basis of a sense of connection to others; thus reducing the malevolence in all social
relationships, both with voices and with other people. We therefore predict self-compassion will be
associated with lower distress in relation to voices (H1) and a lower levels of paranoia about other
people (H2).
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Dynamic aspects of recovery
Recent research has also emphasized the dynamic and changing nature of psychosis, and that the process
of symptomatic recovery is often unpredictable and formally (in the mathematical sense) chaotic.367 In a
study by353 it was shown that, in bipolar patients, approximate entropy (a statistical measure of chaotic
fluctuations in affect) indicates an imminent relapse, and it seems likely that the same will be true of
patients with diagnoses in the schizophrenia spectrum. Hence, instability in psychological processes may be
more important than overall level of psychological functioning in people with severe mental illness.
Consistent with this idea, we have shown that mood and self-esteem are highly unstable (as indicated by
moment-to-moment fluctuations) in patients in with paranoid delusions121 and in individuals who later
develop paranoid beliefs.352 No study to date has investigated the stability of feelings of subjective wellness
(momentary feelings of well-being) or how these relate to changes in mood or reward processing.
We expect that patients who believe themselves to be recovered will show more stable judgements of
subjective wellness than those who do not believe themselves to be recovered (H3), and that experiences
of subjective wellness will be influenced by mood and savouring in everyday life (H4). We also predict that
those who show highest entropy in their self-esteem and mood scores will feel themselves to be less
recovered, and will make more use of services, on long-term (6 month) follow-up. The use of ESM will
allow us to test these hypotheses.
Our overall approach will be to conduct a study in which patients with schizophrenia spectrum disorders
will be asked to complete four different measures of subjective recovery, together with measures of clinical
functioning, sensitivity to reward stimuli, self-esteem, and level of occupational and social functioning.
Some of these measures will be interview based, some questionnaires, and some by ESM. ESM is a means
of collecting information pertaining to the context and content of the daily life experiences of individuals,
which we have previously used successfully with patients suffering from psychosis.121 Participants are issued
with a signalling device, for instance a sports watch or hand held electronic device similar to a personal
digital assistant. The device provides alerts at pseudo random intervals as programmed by the researcher.
On the signal the participant is required to complete a diary entry. The strength of the method thus is its
ecological validity; information is sampled at the moment an experience occurs and in the environments
participants typically inhabit. This avoids potential distortions associated with questionnaires that rely on
retrospective judgments. It also allows many samples to be made in one day so intra-individual variation in
data can be investigated.
In the cross-sectional phase of the study, we will compare the patients with healthy controls on all of our
measures. Within the patient groups, we will examine the stability of recovery judgements over time and
the stability of affect and social cognition in relation to recovery status.
At monthly intervals and at 6 months we will reassess, with patients only, recovery judgements, symptoms
and social functioning, as well as use of services over the follow-up period. This will allow us to test
whether entropy in affect and self-esteem in phase 1 predicts these outcomes.
Study design
Participants
80 people meeting criteria for a diagnosis of ICD-10 schizophrenia spectrum disorders (schizophrenia,
delusional disorder, schizoaffective disorder, psychotic disorder) will be recruited to the study. We will be
seeking to recruit a sample that is heterogeneous with respect to severity of symptoms, social functioning,
duration of illness, and subjective appraisal of recovery status. Hence, we will use a broad recruitment
strategy, approaching patients in hospital wards, day hospitals and CMHTs. Participants will complete a
baseline recovery measure allowing us to separate them into two groups: (1) 40 who consistently describe
themselves as recovered on three measures (a yes/no judgment, analogue scale and QPR); (2) 40 who
consistently describe themselves a not recovered on the same three measures.
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A healthy control group of 40 will also be recruited opportunistically from NHS statutory staff, non-academic
university staff and through participant panels at the School of Psychological Sciences at the University of
Manchester and the School of Psychology at the University of Bangor. This group will be screened using the
Positive and Negative Symptoms of Schizophrenia scale (PANSS) to ensure that they are not experiencing any
psychotic symptoms. They will also be asked whether they have at any time in the past been treated for
psychiatric disorder; and an affirmative answer will result in exclusion from the study.
In phase 1, participants will complete a series of questionnaires followed by a 6-day diary of individual
experiences at ten pseudo-random time points throughout the day separated by at least fifteen minutes.
By means of this methodology, we will measure environmental context, and psychological experiences in
everyday life.
Phase 1 baseline questionnaires
Recovery appraisal measures
We will measure recovery appraisals using three measures:
The Process of Recovery from Psychosis Questionnaire (QPR) is a 22-item questionnaire measuring
subjective recovery in two domains: intrapersonal functioning and interpersonal functioning. The subscales
have good internal consistency and test–retest reliability over short periods.32
Additional recovery questions. Two additional questions will be appended to the QPR; participants will be
asked: ‘Do you consider that you have recovered from your illness?’ (YES/NO); and ‘Please place a cross on
the line below to indicate the extent to which you think you have recovered from your illness’ (10 cm
analogue scale with left anchor ‘Completely recovered’ and right anchor ‘Not recovered at all’).
Objective clinical measures
The Positive and Negative Syndrome Schedule162 will be used to assess current symptoms. This is a
structured clinical interview yielding ratings of the severity of thirty symptoms over the previous week
and is used to calculate three composite scores: positive symptoms, negative symptoms, and general
psychopathology. Researchers will receive training in the administration of the schedule and will be
required to achieve the recommended lever of reliability (no scores deviating greater than 1 point from the
scores of expert raters). Additional questions will be included from the Psychotic Symptoms Rating Scale
(Psyrats; Haddock et al., 1999). An observable measure of functioning, the Personal and Social
Performance Scale (Nasrallah et al., 2008) will also be included. Administration takes approximately
50 minutes. Furthermore, additional questions about age of onset, state of remission and description of
symptoms regarding hallucinations and paranoia will be included.
Antipsychotic mediation dose will be recorded and converted to chlorpromazine equivalents, using
standard tables.
Hamilton Rating Scale for Depression (HRSD)314 is a 21-item questionnaire used to rate the severity of
symptoms of depression such as low mood, insomnia, agitation, anxiety and weight loss. Researchers
choose the possible responses to each question by interviewing the patient and by observing the
patient's symptoms.
Bech-Rafaelsen Mania Scale368 is a short interview measure of manic symptoms that is designed to be
administered with the HRSD. We are including this measure because there is consistent evidence of overlap
between manic symptoms and psychosis at the phenomenological (e.g.369) neuropharmacological370 and
genetic371 level. Furthermore, we have found that mania and hypomania are related to excessive reward
responsivity.372 Hence, any attempt to investigate the role of reward processes in psychosis must consider
comorbid hypomanic/manic symptoms.
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Self-report scales
The Persecution and Deservedness Scale (PaDS354) a 10-item measure of paranoid thinking, which we are
including because the PANSS does not record some aspects of paranoia (e.g. whether the participant feels
that persecution is deserved) adequately for our purposes.
Behavioural Activation System Scale (BAS373) is a 24-item yes/no measure of subjective reward sensitivity.
We have reduced this to a 14-item BAS only scale in the interest of reducing unnecessary questions;
the study is not concerned with findings from the BIS scale.
Self-Esteem Rating Scale–Short Form (SERS; Lecomte et al
comprising 20 Likert-based items: 10 positive statements about the self that provide a measure of positive
self-esteem; and 10 negative statements about the self that provide a measure of negative self-esteem.
The SERS has demonstrated good validity, internal consistency, and test–retest reliability in the general
population and in those with schizophrenia.76
Implicit Associations Test (IAT374) is a computerised test that is the most widely used assessment of implicit
self-esteem. A large body of literature supports its validity and it has recently been successfully used in
studies investigating implicit self-esteem in individuals psychosis.375,376 Stimulus words, which are positive
and negative personality traits, are presented in the middle of the computer screen and respondents are
required to sort them into categories at the two different sides of the screen by pressing buttons on the
corresponding sides of the keyboard. If a participant makes an error, a red cross appears on the screen and
participants are asked to respond by correcting the error.
The version we will use will comprise eight blocks of trials. The first two blocks are practice blocks in which
participants are required to practice sorting words into ‘me’ and ‘other’ categories. The categories swap
sides between blocks one and two, in order to allow practice sorting ‘me’ and ‘other’ words to both sides.
The third and fourth blocks are practice blocks in which participants are required to practice sorting words
into ‘bad’ and ‘good’ categories. Again, the categories are swapped between sides between blocks.
The last four blocks participants are required to sort the two sets of stimuli at once. Therefore in these
blocks, a ‘me’ or ‘other’ word or a ‘bad’ or ‘good’ word might appear in the centre of the screen. In two
of the blocks, individuals are asked to sort ‘me’ and ‘good’ words to the same side and ‘other’ and ‘bad’
words to the same side (congruent conditions). In the other two blocks, they are asked to sort ‘me’ and
‘bad’ words to the same side and ‘other’ and ‘good’ words to the same side (incongruent conditions).
The categories swap sides between the two congruent blocks and between the two incongruent blocks to
control for any differences in sorting to either side. Implicit self-esteem is calculated by subtracting
response times for the congruent conditions from the response times for the congruent conditions.
The Acceptance and Avoidance Questionnaire-II (AAQ-II) is a 10-item scale with good reliability that
measures intolerance of unpleasant thoughts and emotions. We have found that it is a strong predictor of
paranoid beliefs in nonclinical samples (Udachina, et al. in submission).
Beck Hopeless Scale357 is a 20-item scale measuring negative thoughts about the future.
The Stigma Scale (King et al., 2007) is a 28-item scale measuring perceived discrimination, disclosure and
positive aspects about mental health problems.
The Child Abuse and Trauma Scale (Sanders and Becker-Launsen, 1995) is a 38-item multidimensional
measure of the perceived degree of stress and trauma experienced at childhood. Additional questions will
be added following the CATS to ask whether the participant has been asked questions about traumatic
experiences in early life, how they feel about being asked, and whether they have been offered help.
A supporting leaflet will also be provided to those who have experienced sexual or physical abuse
containing contacts and information on where to get additional support.
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. 2006) is a measure of explicit self-esteem
The revised Dissociative Experiences Scale (Carlson and Putnam, 1993) is a 28-item self-report measure
designed to assess dissociative experiences in both clinical and non-clinical populations.
The revised Launay-Slade Hallucination Scale (Bentall and Slade, 1985) is a 12-item self-reported scale of
hallucinatory proneness.
The Interpretations of Voices Inventory (Morrison et al., 2002) is a 26-item self-report measure designed to
assess positive and negative interpretations of auditory hallucinations.
The Self-Compassion Scale (SCS; Neff, 2003 a,b). is a 26-item scale designed to accurately measure
self-compassion as conceptualised in Buddhist teachings. The scale includes subscales for the following:
self-kindness (5 items), self-judgment (5 items), Common Humanity (4 items), Isolation (4 items),
Mindfulness (4 items); and an Over-Identification subscale (4 items). Responses are given on a 5-point
Likert scale, ranging from 1=Almost never, to 5=Almost always. All 6 subscales have been shown to be
highly inter-correlated and confirmatory factor analysis determined that a single higher order factor of
self-compassion explained these inter-correlations (Neff, 2003). The SCS has been demonstrated to have
good internal consistency reliability (.92) as well as good test–retest reliability (r=.93) (Neff, 2003).
Experience sampling method
ESM, which we have successfully used with patients with severe mental illness,121 is a method of
measuring cognitive and emotional functioning in everyday life. Participants wear electronic wrist-watches
or use a palm computer programmed to bleep 10 times a day on a pseudorandom schedule between
7.30 am and 10 pm. Participants are asked to complete a short diary (taking approximately 2 minutes) on
hearing a bleep. Participants are asked to wear the watches or use the palm computers for 6 days.
The procedure can cope with a high level of missing data; we will include data from any participant with
> 19 diary entries. Multilevel modelling, with repeated measures regression analysis will be used to analyse
reported activities and subjective responses, variations in these variables, and causal relationships
between them.
Items measuring psychological experiences in the diary are typically on a 7-point Likert scale. As in
our previous studies, we will include questions measuring affect (positive and negative) self-esteem,
activity-related stress and self-efficacy. We have adapted our existing diaries to include questions on the
following recovery-related variables: rumination, recovery status and savouring ability. Each diary entry
typically takes about 2 minutes to complete.
Phase 2 follow-up assessments
At 6 months, clinical participants will be interviewed with the PANSS, and also asked to complete the QPR
with additional recovery questions. They will also be asked to complete a simple service receipt schedule
(based on our previous work with the SoCRATES trial377) which will record the following information:
(a) total number of appointments with CPNs, psychiatrists and other mental health workers over the
6 month period; (b) total number of primary care appointments over the 6 month period; and (c) total
number of days spent in day hospital, inpatient facilities, or under section.
At the 3-month follow-up point prior to the 6-month follow-up, a briefer interview focusing on subjective
well-being will be conducted over the telephone. This will consist of the mood, self-esteem questions from
the ESM, together with the QPR questions reworded so that they cover the past month. We will also ask a
short schedule of qualitative questions regarding subjective well-being.
Safe working
Please refer to ‘Recovery Programme Safe Working Practices – Project 2 Version (latest version 01.03.2011)’.
APPENDIX 3
NIHR Journals Library www.journalslibrary.nihr.ac.uk
224
Distress procedure
In the event of a participant experiencing distress during the study, please follow procedures outlined on
page 17 of ‘Recovery Programme Safe Working Practices – Project 2 Version (latest version 01.03.2011)’.
Analysis
Patient participants will be divided into two groups, subjectively recovered vs. non-recovered, on the basis
of a median split of QPR scores. We will compare these groups on the baseline questionnaire measures
and IAT using analysis of variance. We have conducted power calculations for these analyses using our
own data from studies either published or in submission.
Based on data collected by378 expected scores for the three groups on the BAS total scores are shown in
Table 72 below (all figures rounded to nearest integer), based on extrapolation from extreme scores in a
large (N> 300) healthy sample. Estimated scores for the SERS are based on actual patient vs. healthy control
comparisons in a pilot study (N= 24 patients and 12 healthy controls) conducted recently in Bangor.
TABLE 72 Expected scores for recovered and non-recovered patients, and health controls for BAS and SERS
negative subscale
Non-recovered Recovered Controls
Measure Mean SD Mean SD Mean SD
BAS total 14 2 16 2 18 2
SERS negative 43 17 37 9 26 9
Sample sizes were estimated using G*power software. Assuming a power of 0.8 and an alpha of 0.01,
we will require only 8 participants to detect differences in BAS total (ES= 0.82). For SERS (ES= 0.54)
18 are required in each group.
Participants will only be retained for the analyses of the ESM data if they have > 19 completed data points
(in practice, we have found that we loose about 5% of patients because of the failure to meet this
minimum requirement). Summary scores, e.g. mean scores for self-esteem, positive affect, negative affect,
and also fluctuations in mood and affect using momentary (change from last recording), daily (maximum
and minimum scores within the day) and weekly (within-participant SD in scores) can be compared
between groups using a standard analysis of variance approach. This can also be done with values for
approximate entropy (ApEn), which we will calculate separately for positive affect, negative affect and
self-esteem using standard methods.353
A multilevel modelling approach is required to investigate the relationship between subjective recovery and
psychological processes by modelling stability of processes using momentary (change from last recording),
daily (maximum and minimum scores within the day) and weekly (within-participant SD in scores). Data will
be analysed using maximum likelihood random coefficient models to minimise loss to attrition by ensuring
that we make full use of participants who provide incomplete data (under an assumption of MAR missing
data mechanism). It is difficult to calculate power estimates for this approach, but we note that previous
studies, e.g. 123 and 121 have reported group differences in stability of self-esteem and stress sensitivity with
total samples of 42–60 patients. Hence, including 40 in each group is a conservative approach.
We will use regression with selected baseline measures (e.g. SERS scores, ApEn for self-esteem, BAS) to
predict outcomes defined in terms of positive symptoms at 6 months, total service utilisation over the
follow-up period, and average QPR scores over the follow-up period. A widely accepted convention is that
10 participants are required for each predictor variable, allowing us to chose up to 8 predictors;137 Norman,
1994). With this number of predictors, we will be able to detect effect sizes of 0.29 or more with an alpha
of 0.01 and a power of 0.80.
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Appendix 4 Protocol for Chapter 5 studies
PROTOCOL VERSION 3 22/12/10 EVALUATION OF DIFFERENT
LEVELS OF SUPPORT IN USING A RECOVERY GUIDE FOR PEOPLE
WITH PSYCHOSIS AND THE IMPACT OF CHOICE ON OUTCOMES
Introduction
Although recent government guidelines (National Institute for Clinical Effectiveness, 2004) have
recommended that people with persistent psychosis be supported using psychological intervention
approaches such as cognitive–behaviour therapy, the widespread current lack of trained therapists to
deliver this type of intervention means that provision of this type of intervention is likely to be limited. As a
result, exploration of how this support can be provided to the greatest numbers of people is urgently
needed. One way that is currently being explored within other domains is the stepped care approach first
described in the United States in relation to the delivering of health care within primary care. Stepped care
assumes that the least restrictive treatment or the minimum of therapist time is delivered that still brings
about a significant improvement to the individual receiving it (Bower and Gilbody, 2005).
The stepped care approach has been examined in the UK in relation to the development of services for
people with non-psychotic disorders. Much of this has been related to cognitive–behavioural interventions
that appear to lend themselves well to a stepped care approach. For example, using CBT oriented
bibliography (Cuijpers, 1997), computerised treatment (Marks et al., 2003), telephone treatment (Lovell
et al., 2006) as well as face to face contact and ’full-blown’ CBT. Despite these developments within the
primary care domain, little has been little explored within services for people with severe mental illness.
However, these CBT approaches may well lend themselves extremely well to this client group whose ability
to access ‘traditional talking treatments’ may be limited by lack of availability and by their difficulty in
attending and travelling to travel to clinics.
One recent study, carried out by our group, has evaluated the applicability of one such approach with
service users with psychosis. This study used a CBT oriented Recovery Guide with support from a CBT
therapist delivered over the phone (over 6 months) and evaluated its impact using qualitative and
quantitative methods. A comparison no intervention group was included although this was a small pilot
trial, not a randomised controlled trial. Findings revealed that the approach was acceptable to the majority
of participants (n= 15) and there were few drop-outs. Qualitative feedback from therapists and
participants indicated that the content of the guide was relevant and that the support provided by
telephone was useful and appropriate for providing support for the guide (Pitt et al., 2009). However,
findings revealed that some participants would prefer different levels of support in the use of the guide,
for example, some would have preferred face to face therapy support rather than delivered over
the telephone.
This qualitative finding was also confirmed by other methods. A study investigating the factors contributing
to service user’s preferences for levels of psychological treatment was also carried out (n= 90 Gerrard
et al., 2009). Service users were presented with detailed information about the Recovery Guide and
about different levels of therapy support for using the guide (low support = telephone support; high
support = telephone therapy plus group support). Service users were asked to say whether they would be
willing to take part in a trial involving these types of interventions, to say whether they would be willing to
be randomised and to indicate whether they had a preference for treatment and is so, what treatment
they would prefer (none, low support or high support) if they were to take part. Findings revealed that
90% would be willing to take part in a trial of psychological treatments although 57% of the participants
said they were unwilling to be randomised. In addition, 22% said that if they were to take part they would
prefer not to receive the psychological treatment. Of those who preferred treatment, 43% said they
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would prefer low support and 33% said they would prefer high support. These findings suggest that
service users have strong preferences about the type of psychological treatments they would prefer.
These preferences have not been taken into account in previous psychological treatment trials although
such preferences can make the interpretation of outcomes and their implementation in services
problematic as variables related to preference may also be related to outcome (e.g. Janevic et al., 2003).
First, service users may either refuse to enter trials in case they do not receive their preferred treatment,
or they may drop out of trials early because they are unhappy with the condition they have been allocated.
Second, people may have feel resentful and demoralised (Bradley, 1993) if they do not get their preferred
treatment choice, whereas those randomised to choice may have a morale boost. Such effects make the
efficacy of the actual treatments difficult to evaluate. In order to take account of patient preferences,
partially randomised PPTs where patients with treatment preferences are allowed their treatment without
randomisation and those who do not have preference are randomised in the usual way have been
suggested (Brewin and Bradley, 1989).
Clearly there are methodological problems with PPTs, the chief being that any comparison that uses non
randomised groups is potentially unreliable because of unknown confounds (e.g. differences at baseline
such as previous treatment history that might influence perceptions of effectiveness of treatments offered).
However, ways of reducing the impact of such problems include: performing at least one comparison of
the ‘true’ randomised arms alone; collecting information on potential confounds including ascertaining
reasons for choice, then adjusting for these where the analysis includes non randomised people; using
randomisation status (random/non-random) as a covariate in analyses. Because of the information required
about patient preferences, it is therefore important to conduct adequate assessments about patient choice
prior to conducting the preference trial.
In the case of the proposed trial we would argue that the potential benefits of a PPT outweigh the
methodological problems, particularly as the preparatory work on patient choice has been conducted and
the adjustments suggested above are included in the design and analysis. Such benefits include the
likelihood that we will be able to recruit people who would otherwise refuse to take part in a traditional
RCT and thus the sample will be more representative of all service users. A PPT will also improve the
external validity of the trial and will likely be more commensurate with the nature of service users seen in
routine practice. Moreover, the information about patient preferences and outcomes will inform services
not only about the efficacy of treatments but also about patient preferences and likely take up of
alternative methods of treatment delivery.
Aims
As this is a trial which allows the participant choice about the treatment they receive, it is expected that
similar impacts will be seen across all three groups in the trial regardless of whether they receive therapy
or not. With this in mind, specific aims are:
1. To evaluate the feasibility and acceptability of the Recovery Guide (Barrowclough et al., 2009) when
provided with either low or high support for people with psychosis.
2. To assess the relative impact of the guide in relation to low and high support and no- treatment1 on
psychotic symptoms, affect, well-being and functioning.
3. To investigate the role of emotion and beliefs in relation to recovery.
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As a result it is hypothesised that:
1. The Self-Help Recovery Guide will be acceptable and feasible to use by service users with psychosis as
judged by retention in the treatment (assuming retention of 70%) and from qualitative interviews and
this will not differ between those receiving high and low support.
2. There will be significant improvements in the disruption and distress caused by psychosis, affect,
functioning and well-being and effect sizes will be comparable across groups (both no treatment and
high and low support).
Exploratory aims also include:
1. To evaluate the impact of the two different modes of treatment on the working alliance between client
and therapist.
2. To explore the relationship between change in symptoms, compassion, affect and cognitive processes
associated with emotion in relation to recovery.
3. To explore the relationship between core schema and the experience of psychosis.
*As this is a pilot study and not a definite trial, estimates of the impact of treatment will be explored so
that effect sizes can guide subject numbers required to carry out a subsequent study of effectiveness.
Method
Participants
Participants will meet the following inclusion criteria:
1. ICD-10 diagnosis of schizophrenia, schizophreniform disorder, schizoaffective disorder, delusional
disorder or psychotic disorder (not otherwise specified).
2. Receiving mental health services in North West NHS trust of (insert 5 names).
3. Able to give informed consent.
Potential participants will be excluded if they have a primary organic disorder.
Participants who do not speak/read English will be excluded as the assessment measures, interview
schedules and Recovery Guide are in English and we do not have the means to translate these.
Participants experiencing an acute exacerbation of symptoms requiring inpatient or other changes to
treatment are unable to take part in the study.
Recruitment
Recruitment will take place in 4 mental health trusts and through voluntary groups within the North West
of England. Within the mental health trusts, care coordinators, responsible medical officers, etc. will be
provided with information about the study by the research team and will be asked to share this with
potential participants. In addition, information providing sessions will be provided by the research teams to
recruitment sites. If participants wish to be approached to receive more information about the research,
a risk assessment will be carried out with the Care Coordinator. This assessment will then inform the best
way to approach participants. They will then be approached and provided with information about the
study. They will be given 24 hours to consider the information and, if they wish to proceed will be asked
to sign a consent form. Once the participant has given consent, the Research Assistants will carry out an
initial screen to ensure that the participant meets inclusion criteria. Participants meeting criteria will then be
assessed using the battery of measures listed below. Participants will be recruited from voluntary groups
using a similar procedure. Voluntary group organisations will be approached to publicise the research to
their members and the project team will conduct information providing sessions. Interested members will
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be asked whether they would be willing to allow the research team to liaise with their Mental Health Care
Coordinator (or clinical team). If yes, the Care coordinator will be approached to ensure that there is
continuity between the Research Team and Clinical Services and to allow the appropriate risk assessment
to be carried out. These participants will then be approached in the manner described above.
Measures
Primary outcome
Recovery: The Questionnaire Promoting Recovery from Psychosis (QPR; Neill et al., 2009) and Service User
Experience of Psychosis Scale (SEPS; Haddock et al., 2009). Two self-report measures assessing different
aspects of the impact of psychosis.
Secondary outcomes
1. Symptoms of psychosis
i. Positive and Negative Syndrome Schedule (positive and negative scales only; PANSS; Kay et al., 1989),
ii. Psychotic Symptom Rating Scales (PSYRATS; Haddock et al., 1999) and recordings of symptom
content. These are semistructured interviews aimed at eliciting and describing participants’
experience of psychosis
iii. Calgary Depression Scale (Addington and Addington, 2001). This is a semistructured interview aimed
at eliciting and describing participants’ experience of depression
2. The substance use section of The Opiate Treatment Index (OTI) (Darke et al., 1992). This is a measure of
substance use severity and is in the form of a structured interview that lasts approximately 5–10 minutes.
3. Questions relating to contact with services:
i. When was your first contact with mental health services?
ii. When was your first contact with mental health services for reasons to do with psychosis?
4. Emotion and emotional processes (all self-report questionnaires)
i. Beck Anxiety Inventory (BAI; Beck et al., 1988)
ii. Positive Facets Scale (WHO-QOL; WHOQOL Group, 1998)
iii. Metacognition in emotion scales (comprising scales of rumination worry, etc.)
5. Self-beliefs: Brief Core Schema Scales (ref) and the LeCompte Self-Esteem Scale (LeCompte et al.,
2006). These are self-report questionnaires.
6. Compassion scale (Neff, 2003b)
7. Personal and Social performance Scale (PSP; Morosini et al., 2000)
8. Demographic questionnaire
9. Types of positive affect scale (Gilbert 2008).
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It is anticipated that the interview based assessments will take approximately 40–45 minutes, and the
questionnaires will take approximately 30 minutes to complete. All measures (1 to 6) will be administered
at baseline, 9 and 15 months by an RA blind to treatment condition. In order to ensure that participants
are comfortable in completing the interviews and assessments, they will be given the option of completing
them over more than one session. In addition, the general scale of the PANSS will not be administered
reducing the interview time for completing the symptom assessments to approximately 40 minutes rather
than 1.5 hours.
Other measures
In addition, in order to assess therapeutic alliance, preference for psychological treatment and gain
feedback on the experience of taking part, participants will also be asked to complete:
1. Interview about preference for psychological treatment (PPT). These interviews will be used to explain
the options for psychological treatment and to facilitate the service user making an informed choice
about what treatment they would prefer.
2. Working Alliance Inventory a self-report questionnaire of the therapeutic alliance completed by service
users and their therapists.
3. Qualitative assessments of the experience of using the Self-Help Recovery Guide with Service Users and
Care Coordinators.
The WAI and PPT scales will be administered by a therapist or Service User Researcher, trial manager or
another worker allied to the trial who is not blind to treatment group, at a separate time to the other
assessments. The PPT will be administered at baseline only and the WAI will be administered at session 3
and session 12 (where appropriate). Qualitative interviews will be carried out following the end of therapy
by Service User Researchers. This aspect of the project will be guided by topic guides developed and used
in piloting of the guide and by thematic analysis approaches (e.g. Braun and Clarke, 2006).
Procedure
Following recruitment, all participants will complete the above assessments (apart from the PPT and WAI
scales) with an independent Research Assistant who will remain blind to treatment received. Participants
will then complete the PPT scales with a therapist, service user researcher or trial manager. These scales
will determine the preference they have for the type of psychological therapy they wish to receive. Once
completed, if participants wish to participate in therapy they will be allocated a CBT therapist who will
make initial contact to commence therapy (either low or high support; see below for details). Therapy will
take place over 9 months and will consist of up to 30 sessions approximately once per week. Participants
will then be followed up at 9 and 15 months by the RA blind to treatment condition and assessed using
the measures described above (apart from PPT and WAI scales). Qualitative interviews will take place
(n= 6–10 participants per treatment arm and 8–10 Care Coordinators) after therapy is completed. In
addition, interviews with up to 8 participants form the different treatment arms and geographical locations
will be conducted prior to therapy period commencement. Data will be stored on NHS or university
premises in locked cabinets. All participants will be allocated a code number and records will
be anonymised.
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Therapy
Clients who choose to receive therapy will have the opportunity to choose whether they receive high or
low support therapy.
1. Low support: this therapy will be delivered over 9 months and will consist of the following
i. Receive a copy of the Self-Help Recovery Guide (Barrowclough et al., 2009). This guide is a
comprehensive self-help guide to recovery designed and written with clinicians and service users.
It has been piloted in earlier work and has been shown to be acceptable and feasible for service
users to use with some support.
ii. Support for the guide will be delivered in up to 30 weekly sessions provided by a
cognitive–behaviour therapist who will facilitate the participant to use the guide during telephone
sessions. The CBT therapist will telephone the participant on a number of their choice and will
provide help and guidance in sessions lasting approximately 45 minutes.
2. High support: this therapy will also be delivered over 9 months. It will consist of all the components of
low support i.e. participants will receive:
i. A copy of the Self-Help Recovery Guide
ii. Up to 30 telephone sessions with a CBT therapist.
However, in addition, participants will also receive additional support in the form of group sessions. These
will be co-facilitated by CBT therapists and Service user researchers and will run approximately fortnightly
over the 9 month period (approximately 15 sessions). The groups will provide additional guidance and
support in the use of the Recovery Guide and will allow participants to meet other Service Users who are
using the guide. The group sessions will consist of a mixture of information provision, discussion of topics
in the guide and peer support.
Data and statistical analysis
All analyses will be carried out under the direction of Professor Graham Dunn from the Biomedical and
Statistics Unit of the University of Manchester. Participants will be randomised to psychological treatment
using remote randomisation by telephone administered by the Christie Hospitals Trials Unit using a
randomised permuted blocks procedure. In relation to sample size, a trial of size 120 (80 in the
intervention group and 40 controls) will have a power of about 85% to detect a true standardised effect
size of 0.60, using an independent groups t-test with two-sided significance level of 0.05. Feasibility,
acceptability and retention will be estimated by proportions of total sample with 95% confidence intervals.
Impact of the interventions will be assessed using an analysis of co-variance allowing for co-variates that
would have a potential confounding effect on treatment outcome when people choose their treatment
of choice.
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Appendix 5 Protocol for Chapter 6 studies
COGNITIVE–BEHAVIOURAL SUICIDE PREVENTION FOR PSYCHOSIS
(CBSPP), 24/04/2015, VERSION 3 PROTOCOL
Background
Psychotic disorders often cause extreme distress to patients and carers, are often associated with life long
disability and a high risk of suicide, and are associated with substantial costs to individuals, health and
social care services and the nation. The heightened risk for completed suicide in people with a diagnosis of
schizophrenia has been well documented (e.g. Caldwell and Gottesman, 1990; 1992; Harris and
Barraclough, 1997; Heila, Isometsa, Henriksson et al., 1997). Estimates indicate that between nearly 5
and 10 patients in every 100 will kill themselves (Caldwell and Gottesman, 1990; Palmer, Pankratz, and
Bostwick 2005). These estimates vary depending on the methodology, either proportional mortality (the
percentage of the dead who died by suicide: approximately 10%) or case fatality (the percentage of the
original sample who died by suicide: approximately 4%), used for the estimation of life time risk (Palmer
et al., 2005). Suicidal ideation and suicide attempts are common with as many as half of all patients with
schizophrenia experiencing suicidal ideation at any point in time or having a history of attempts (Fenton,
2000; Fenton McGlashan, Victor and Blyler 1997; Harkavy-Friedman et al., 2003; Kontaxakis et al., 2004;
Nieto, Vieta, Gasto, Vallejo and Cirera, 1992; Tarrier, Barrowclough, Andrews and Gregg, 2004; Tarrier,
Khan, Carter and Picken, 2007a). It has been argued that suicidal ideation and planning are important
steps that lead to an attempt of self-harm that may lead to death (Kontaxakis et al., 2004) with previous
unsuccessful suicide attempts increasing the risk for later successful suicide (Hawton, Sutton, Haw, Sinclair,
and Deeks, 2005).
A body of literature has identified a number of socio-demographic and clinical factors which are predictive
of increased suicide risk in the general population and which also apply to schizophrenia. These include
being male, of younger age, being socially isolated, misusing substances, being depressed and/or hopeless,
having previously attempted suicide, and having a family history of suicide (Caldwell and Gottesman,
1990; De Hert and Peuskens, 2000; Hawton, et al., 2005; Joiner and Rudd, 2000; Pinikahana, 2003; Sher,
2006; Sinclair, Mullee, King, and Baldwin, 2004; Tandon and Jibson, 2003; Tremeau, 2005; Verdoux,
et al., 1999; Tarrier et al., 2006). Being within 5-10 years of diagnosis and with an illness course
characterised by multiple relapses, deterioration or repeated brief hospitalisations, low adherence to
treatment and less than an optimal duration of hospitalisation also contribute to suicide risk (Hawton
et al., 2005; Herings and Erkins, 2003; Kuo, Tsai, Lo, Wang, and Chen, 2005; Potkin et al., 2003; Qin and
Nordentoft, 2005). Although descriptively useful, focusing on these types of clinical and demographic risk
profiles is problematic for two reasons. First, from a clinical perspective, it offers limited assistance during
assessment because the risk factors are common and identify a relatively large group of people (e.g. Drake
and Cotton, 1986; Westermayer, Harrow and Marengo, 1991; Young, Neuchterlein, Mintz et al., 1998).
Second, the approach is atheoretical (Bolton, Gooding, Kapur, Barrowclough and Tarrier, 2007). Even
though researchers have identified psychologically relevant variables, and have offered post-hoc
interpretations invoking psychological factors (e.g. Hawton et al., 2005; Joiner, Brown and Wingate, 2005),
there have been few well-articulated and empirically tested models or approaches to explaining suicidal
behaviour in schizophrenia. Similar criticisms have also been levelled at suicide research in general
(see O'Connor and Sheehy, 2001).
Numerous studies have shown that psychotic symptoms are influenced by understandable psychological
processes that can sometimes be changed by psychological treatments such as cognitive–behaviour
therapy (CBT) (Tarrier and Wykes, 2004; Wykes et al., 2008). Studies of patients’ own experiences show
that recovery must be conceived of in much broader terms than symptom remission; recovery is an
ongoing process, in which building a positive sense of self, learning how to pursue a meaningful life and
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maintaining hopefulness may be the most important components. There is evidence that the absence of
hope is a major factor determining patients’ decisions to commit suicide. The aim of this project is to
evaluate a suicide prevention intervention (Cognitive–Behavioural Suicide Prevention for Psychosis; CBSPp)
developed from our on-going research to understand the cognitive architecture of suicide behaviour in
patients suffering a psychosis.
This research is part of an NHS (NIHR) funded programme grant (RECOVERY) the aim of which is to
conduct a series of linked investigations, including small-scale randomized trials, to: (a) develop a
meaningful and patient-centred measure of recovery; (b) study psychological processes that impeded or
assist the process of recovery in different domains; (c) investigate the causes of patient suicide and identify
methods of preventing suicide; (d) evaluate individual, group and self-help psychological interventions to
maximise recovery in patients with schizophrenia; and (e) assess the extent to which our research and
treatment findings from schizophrenia patients can be applied to patients with bipolar disorder, who have
been less often studied. The research programme will culminate in recommendations for more effective
and patient-centred assessment and treatment strategies. We have an excellent track record in conducting
research which has been directly translated into improvements in NHS service provision, and this
programme will lead to the dissemination of clinical strategies that more effectively promote psychological
well-being, bringing substantial benefits to patients, the public and the NHS.
There is very consistent evident from RCTs and systematic reviews that cognitive–behavioural therapy for
psychosis (CBTp) results in significant clinical benefits of reduced psychotic symptoms, reduced depression
and anxiety and improved functioning (Wykes et al., 2008). Meta-analysis indicates that generic CBTp does
not improve hopelessness (Wykes et al., 2008) and although a large multicentred trial of CBTp with acutely
ill patients indicated a reduction of suicide behaviour in the long term this result was not significant. We
propose, that notwithstanding the clinical benefits of CBTp, it is necessary to modify and refine a CBT
intervention to reduce and prevent suicide behaviour, and that this intervention should be based upon
a theoretical understanding of the psychological mechanisms underlying suicide behaviour. Suicide is not
a random event it happens for a reason and we have moved some way in understanding the reasons
underlying suicide behaviour in psychotic patients.
Williams has produced a theoretical model of suicide, the Cry of Pain model, which describes the
psychological conditions under which suicide is likely to occur and possible intervention strategies. Tarrier
and colleagues have applied this model to psychotic patients) and elaborated upon the psychological
architecture specific to psychosis including the appraisal of situation (including psychotic experiences and
symptoms), self and future (Bolton et al., 2007; Johnson, Gooding and Tarrier et al., 2008). We suggested
a modification to the Cry of Pain which replaces concepts of defeat, entrapment and lack of rescue with
a four stage appraisal process in conjunction with information processing biases and suicidal schema.
Thus there are three important elements within the explanation of suicide behaviour in our model,
The Schematic Appraisal Model of Suicide (SAMS): 1) biases in information processing; 2) appraisal; and 3)
suicide schema. Our experimental research so far (Ethics applications; 08/H1012/21, 08/H1012/39, and
08/H1012/22) has supported the SAMS model (Tarrier et al., 2007 a; b; Johnson, Tarrier and Gooding,
2008). Thus, significant advances have been made in this theoretical understanding so that a series of
confirmatory studies are required to formalise the targeting of a specific psychological architecture that
increases risk of suicide.
Our preventative intervention is based on our theoretical model and on the favourable results of our
systematic review and meta-analysis of CBT approaches to suicide prevention across all disorders and
patient groups (Tarrier, Taylor and Gooding, 2008).
Our programme of intervention evaluation follows MRC guidelines on the evaluation of complex interventions:
The phases distinguished were; 1) pre-clinical or theoretical, 2) phase 1 or modelling, 3) phase 2 or exploratory
trial, 4) phase 3 or main or definitive RCT, 5) phase 4 or long term implementation (MRC, 2000). We have
progressed through phases 1 and 2 and now intend to carry out a phase 2 or exploratory trial.
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Based upon our explanatory model of suicide behaviour in psychotic patients the CBSPp intervention will
consist of three phases to each address and change the three aspects of the model. These are: 1) methods
to change information processing biases; 2) methods to change appraisals; and, 3) methods to change
suicide schema. These methods are an amalgam of clinical techniques already used in clinical practice.
Treatment will take place over 12 weeks. Patients will be seen twice weekly. In addition to this trial,
participants will also be recruited to test one particular aspect of the intervention in a brief, additional and
optional session. This session will test the Broadminded Affective Coping (BMAC) procedure, which
involves the recall of a positive memory. This is usually incorporated into therapy, but this session will aim
to examine the effectiveness of the procedure when it is in isolation. Participants who have had previous
suicide attempts, will also be invited to take part in a qualitative interview exploring the key themes
associated with peoples personal accounts of their experience of suicidal behaviour. The aim of the
qualitative interview is to explore whether individuals’ own descriptions of their experiences are in line with
the suggested cognitive architecture of suicide behaviour in psychosis, and also to investigate whether any
additional themes emerge.
A treatment manual has been produced with feedback from the service user consultant involved in the
RECOVERY project (Tarrier and Gooding, 2008). Initial application with service users indicates that the
treatment is feasible and both acceptable to, and welcomed by, service users.
Participants
50 participants will need to be recruited into the trial to allow for 25 to be allocated to each treatment
group, allowing for drop outs we intend to recruit 60 patients. 60 participants will also be recruited into
the session which tests the BMAC procedure. Taking part in this session is not mandatory or exemptive for
being part of the trial. 8-10 participants who have had previous suicide attempts will also be recruited into
the qualitative interview. Taking part in this interview is not mandatory or exemptive for being part of the
trial. Participants will be identified through their care co-ordinators. They will be included if they have:
1) a DSM IV diagnosis of schizophrenia, schizophreniform disorder, schizoaffective disorder, delusional
disorder or psychotic disorder not otherwise specified (NOS); 2) have had previous suicide attempts or
current suicidal ideation; 3) are not currently acutely suicidal or considered a danger to themselves
or others; 4) are receiving appropriate anti-psychotic medication; 5) are under the care of an appropriate




The 12 week trial will be an exploratory randomised controlled trial to test the feasibility and assess the
potential efficacy of a suicide prevention programme(CBSPp) with patients suffering from schizophrenia
and schizophrenia-spectrum disorders. The comparison will be between patients receiving CBSPp in
addition to treatment as usual (TAU) and TAU alone.
The primary outcome measures will be an assessment of suicide behaviour (Beck Scale for Suicidal Ideation
(BSS) and The Suicide Probability Scale (SPS) and hopelessness (Beck Hopelessness Scale, BHS) at the end
of the intervention and at follow-up. Secondary outcomes will be of psychotic symptoms, social
adjustment, self-esteem and recovery measures.
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Measures
Core recovery measures of the RECOVERY Programme
l Questionnaire about the process of Recovery (QPR) (Neil, S.T; 2007 Unpublished Doctoral Thesis
Submitted to The University of Liverpool. Publication in process)
l Self-Esteem rating Scale (SERS) (LeCompte et al., 2006)
l Beck Hopelessness Scale (BHS) (Beck, 1987)
l Calgary Depression Scale for Schizophrenia; Addington et al., 1990)
l The Subjective Experiences of Psychotic Symptoms Scale (SEPSS).
Core symptom measures
l Positive and Negative Symptom Scale (PANSS; Kay et al., 1989) to assess severity of symptoms
l PSYRATS (Haddock et al., 1999) to assess control over symptoms
l Global assessment of functioning (DSM IV, 1994) to assess overall functioning
l Beck Anxiety Inventory (BAI; Beck et al., 1988).
Suicide Behaviour
l Beck Scale for Suicidal Ideation (BSS; Beck, Kovacs and Weissman, 1979)
l Suicide Probability Scale (SPS; Cull and Gill, 1988)
l Adult Suicidal Ideation Questionnaire (ASIQ; Reynolds, 1991b).
Patient notes will be examined at recruitment, 3 and 6 months to assess for suicide attempts, serious
incidents and clinical deterioration.
Patients who are receiving the intervention will also be interviewed using a cognitive–behavioural
formulation (standard clinical practice) regarding the determinants of suicide behaviour. In addition those
patients who have received the intervention will be asked to give feedback on their experience of the
intervention and comment on its helpfulness, benefit or otherwise.
Procedure
Patients will be identified through their care co-ordinator and approached by a research assistant to explain
the study and obtain informed consent. Once consented patients will be assessed with the measures
described above and then they will be randomised to one of two groups, the experimental; treatment or
control group by an independent trials unit. Those allocated to the experimental treatment will receive
CBSPp as described in the manual in addition to treatment as usual (TAU). The control group will receive
TAU alone. All patients will be re-assessed at 3 months and at 6 months. All patients will be included in
the analyses as randomised.
BMAC session
Design
Participants will be randomly allocated to taking part in either the BMAC or a control task. The primary
outcome measure will be positive and negative effect experienced following the task, 2 hours later, and
2 days later.
Measures of mood
l Positive and Negative Affect Scales (PANAS; Watson, Clark and Tellegen, 1988)
l Visual Analogue Scales of six mood states (happiness; sadness; defeat; frustration; energy; calmness).
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Tasks
l BMAC: This procedure involves the assisted recall and re-experiencing of a past positive memory.
That is, participants are asked to remember a positive past experience, then are guided through the
recall of images, sensations and emotions associated with the memory. The procedure begins with
some relaxation exercises and ends with a debriefing session, and altogether should take around
20-30 minutes. More detailed instructions can be found in a forthcoming paper by Tarrier
(in submission).
l Control task: This will require participants to recall a positive memory and write about this.
Procedure
Participants will be recruited in the same manner as for the controlled trial, and can take part in this
session in addition to the trial if they choose.
At the beginning of the session participants will be asked to read a separate participant information sheet
and to complete a separate consent form (attached). At the beginning of the session, participants will first
be asked to complete measures of mood. Following this they will either take part in the BMAC procedure,
or a control task. The control task requests participants to recall a past positive memory and write it down.
All participants will then complete the same measures of mood again. 2 hours later, participants will be
re-contacted by phone and asked to complete the measures of mood a third time. Finally, two days later,
participants will be re-contacted by phone and asked to complete measures of mood a fourth time.
Qualitative interview
Procedure
Participants will be recruited in the same manner as for the controlled trial, and those participants who
have had a previous suicide attempt can take part in this interview in addition to the trial if they choose.
The recommended approach for IPA is to employ a semistructured interview, which in this case will focus
on individual’s experience of suicidal behaviour. The project service user reference group will be consulted
to ensure the relevance and appropriateness of target questions in the semistructured interview. All
interviews will be tape recorded and transcribed verbatim. Each transcript will be read and subjected to
content analysis to identify themes. Emerging themes from each report will be discussed with the research
team to ensure agreement.
Potential risks
There is concern that for those suffering a mental disorder and especially psychosis that taking part in
research is a burden and may have aversive consequences detrimental to their health. Jorm, Kelly and
Morgan (2007) carried out a systematic review of 46 studies which examined distress following
participation in research. They examined studies of both non-patient and patient populations that involved
the assessment of psychiatric state or associated risk factors. They found that a minority of participants
became distressed immediately after participation, with distress more likely in studies of traumatic
experiences. There was little indication of adverse long-term impact. Positive reactions to participation were
more common than negative reactions, and participants who reported distress may also have a positive
evaluation of the research. There was little evidence of a causal role of participation leading to persistent
distress, including research on suicidality. In a study of adult participants suffering severe mental illness
(Boothroyd, 2000), almost all (96%) reported positive experience. Negative experiences were also reported
in the form of anxiety (9%), fear of disclosure (17%) and regarding questions as invasive (17%). From the
available evidence it is possible to conclude that the vast majority of participants rate the experience as
positive although some experience emotional distress and have some concerns regarding the process, this
is largely mild and short lived.
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Maintenance of confidentiality and data storage
The responses given in the experiment will be coded by participant number and not by any form of
personal identity. Only age and gender will be collected. Participant responses are therefore entirely
confidential as they will not be associated with personal identity information.
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Appendix 6 Protocol for Chapter 7 studies
AN EXPLORATORY RANDOMISED CONTROLLED TRIAL OF
A COGNITIVE–BEHAVIOURAL THERAPY-BASED RECOVERY
INTERVENTION FOR EARLY BIPOLAR DISORDER. VERSION 6,
23/10/2012
A trial of a recovery intervention for early Bipolar Disorder –
Lead Steven Jones Protocol
Background
Recently the National Institute for Clinical Excellence Bipolar Guideline recommended that individual
structured psychological treatment is offered to individuals with a diagnosis of bipolar disorder.379 Their
review of the evidence concluded that psychological interventions (primarily cognitive–behavioural therapy
(CBT)) which included psychoeducation, stabilisation of social rhythms, detecting and coping with early signs
of an affective episode, and enhancement of general coping skills are associated with reductions in relapse
risk in individuals with a diagnosis of bipolar disorder. To date all published studies of structured
psychological therapy have focused on individuals with a chronic bipolar disorder. For example, participants
in the Lam, Watkins, Hayward, et al. (2003) study had experienced a mean of 5.8 depressive and 5.5 manic
episodes. Indeed, it might appear logical that an intervention requiring significant therapist time is best
reserved for individuals with an established illness course. However the most recent study of CBT for relapse
prevention in bipolar disorder found that there was a significant interaction between number of episodes
and outcome, with only those with fewer episodes benefiting significantly.43 This finding would also be
consistent with recent psychological models of bipolar disorder which have proposed that associative
mechanisms build up over repeated mood episodes such that later episodes are both readily triggered by
psychosocial circumstances previously linked to mood changes and are also less likely to be mediated by
cognitive processes (Barnard, 2004; Jones, 2001, Jones, Mansell and Waller, 2005). This suggests that
cognitive–behavioural interventions may be more powerful when applied earlier in the illness course
before strong associative links to bipolar emotional states are established. Nevertheless, to date no
cognitive–behaviour therapy interventions have been specifically designed for delivery to individuals early in
their illness course. Our group has therefore devised an adapted CBT intervention for individuals after first
diagnosis of bipolar disorder. This has proved to be acceptable and feasible in a single case series of 7 bipolar
participants (Jones and Burrell-Hodgson, 2008). Substantial reductions in subsyndromal symptoms were
observed during intervention and six month follow-up along with changes in appraisal styles and stability of
sleep/wake cycles. This suggests that psychological intervention for individuals early in their course of bipolar
disorder is both effective and acceptable to service users. A key feature of this project will therefore be to
further develop this cognitive–behavioural approach for individuals early in their course of bipolar disorder.
The recovery literature in mental health research increasingly shows that individual definitions of recovery
are diverse and rarely focus solely on the eradication of symptoms. Two mental health professionals with
personal experience of bipolar disorder380 proposed the following as key facets of a recovery scenario for
bipolar disorder: hope for the future, taking personal responsibility for health, education and learning,
self-advocacy for personally relevant support and mutual social and peer support. A qualitative analysis of
the experience of recovery in the early stages of bipolar disorder carried out by our group during phase 1
of the study (REC reference number: 08/H1013/77) found similar themes which included; making sense of
self and symptoms, the centrality of the self in recovery: changing self-efficacy, and consolidating the self
in recovery through personally meaningful activity. Therefore, a second feature of the project will be to
incorporate into the intervention, the key recovery principles found in our group’s qualitative analysis
of recovery.
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It is also important that we have appropriate tools for the assessment of recovery relevant outcomes in
individuals with bipolar disorder so that new interventions and routine service outcomes can be assessed
with respect to factors which are valued by individual service users. The recovery themes found in phase 1
of the study have been used to inform the development of an assessment tool to measure recovery, the
Bipolar Recovery Questionnaire (BRQ), which aims to assess aspects of recovery that are important and
meaningful to service users. The BRQ has been found to be an acceptable tool for service users, and has
been shown to be a reliable and valid measure. Therefore, in order to ensure that outcomes in the trial are
assessed with respect to aspects of recovery that are valued by service users, the BRQ will constitute one of
the primary outcome measures of the trial.
Participants
Participants will be identified from care co-ordinators and psychiatrists in mental health services, from GP’s
in primary care sites, and also from voluntary sectors.
Participants will have either; received a clinical diagnosis of bipolar disorder within the last 5 years or meet
DSM criteria for first episode mania within the last 5 years, or hypomania (with a previous episode of major
depression) within the last 5 years (confirmed by SCID interview.305 Individuals who are current inpatients
will not be recruited into the trial until they are discharged to the community. All participants will enter the
trial when neither acutely depressed nor manic. However, on the basis of previous longitudinal research it
is expected that significant levels of subsyndromal symptoms will be present.
Trial design and outcomes
A rater blind randomised controlled trial is proposed. As this is an exploratory trial we wish to determine
effect sizes for the primary and secondary outcome measures to inform the development of a definitive
study. Primary outcomes are time to bipolar relapse and self-reported recovery score. Secondary outcomes
are levels of affective and psychotic symptoms, level of functioning, levels depressive and hypomanic
appraisal style, levels of hope, stigma and self-esteem, changes in medication adherence, and levels of
self-compassion and positive affect.
Individual recovery-focused CBT intervention
The intervention has been developed through collaboration between a multidisciplinary group of mental
health professionals and service users with experience of bipolar disorder. Focus groups have taken place
with individuals who took part in the first phase of the project (the qualitative analysis of recovery themes)
to ensure that the intervention is appropriate and acceptable to individuals early in the course of bipolar
disorder. Furthermore, a service user consultation group have also been consulted on the development of
the intervention (as well as the design of the study as a whole).
The elements of the intervention have been informed by 3 sources:
1. Current evidence for components of effective CBT interventions which include mood monitoring and
awareness, regularisation of routines, enhancing prodromal coping and problem-solving training.381
2. Our case series study of first diagnosis bipolar clients, which indicates the importance of maintaining a
very flexible engagement approach, allowing time for full consideration of meaning of diagnosis to the
client, engaging in coping skills reviews around subsyndromal exacerbations as well as prior episodes
and considering the role of appraisals of fluctuations in affect.
3. The recovery relevant elements found in phase 1 and agreed by the multidisciplinary group which
include making sense of self and symptoms, changing self-efficacy, and consolidating the self in
recovery through personally meaningful activity.
The intervention will be delivered by mental health professionals trained to BABCP accreditation level in
CBT. Therapy will consist of up to 18 sessions delivered over a period of approximately six months and
delivered either at client’s homes or mental health facilities according to client preference. Initial session
will be weekly, with later sessions fortnightly. Sessions will be typically 45–60 minutes long. The
competency of the therapist will be assessed using two therapist fidelity measures.
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Therapist fidelity measures
1. The Cognitive Therapy Scale – Revised (CTS-R; Blackburn, James, Milne, Baker, Standart, Garland and
Reichelt, 2001) is a measure of therapist adherence to cognitive therapy. It covers many areas of
therapist competence, including agenda setting and adherence, feedback, collaboration, pacing and
efficient use of time, interpersonal effectiveness, eliciting of appropriate emotional expression, eliciting
key cognitions, eliciting and planning behaviours, guided discovery, conceptual integration, application
of change methods and homework setting. Each of these performance areas are rated on a 7 point
Likert scale ranging from 0–6, 0 indicating minimal adherence, and 7 indicating maximum adherence
and skill. Therapy sessions will be audio-taped and reviewed by the principal investigator or a suitably
qualified member of the research team. The CTS-R has received good psychometric support (Blackburn
et al., 2001).
2. The Working Alliance Inventory – Short Form (WAI-S) (Tracey and Kokotovic, 1989) is a 12 item
questionnaire that measures the strength of the therapeutic alliance between both therapist and client,
on a 7 point Likert scale ranging from 1 (never) to 7 (always). The WAI-S measures 3 dimensions of
alliance, namely, bond, goals, and tasks. Two versions of the WAI-S will be used; one specific for the
client, and one for the therapist, both of which will be administered twice across the 18 therapy
sessions. All clients will be given the choice of whether to complete the questionnaire immediately or
outside the therapy session. They will similarly be provided with an addressed and sealed envelope
(to ensure confidentiality) and have the choice of whether to return this to the therapist, or send this by
post to the principal investigator. The WAI-S has received psychometric support, has good overall
internal consistency (α=.94), and good internal consistency for each dimension of alliance, including
bond (α=.84), goals (α=.88) and tasks (α=.90) (Tracey and Kokotovic, 1989).
Schedule of assessments
Follow-up will period will be 15 months from initial randomisation for the majority of participants (a small
minority will only receive a 12 month follow up period due to restrictions in project timescales). In addition
to regular (3 monthly) assessments to evaluate bipolar relapse, assessment of recovery, bipolar symptoms
and functioning will also be conducted at inception, end of treatment and follow-up (6 and 12 months).
Measurement of primary outcomes
1. Time to bipolar relapse: measured using analysis of DSM-IV episodes (mania, hypomania, mixed
affective episode or major depression) defined according to DSM criteria using SCID-LIFE assessed every
3 months from baseline,328 an approach which our group have already successfully employed to
evaluate primary outcome in the recent MRC trial of CBT for chronic and severe bipolar disorder.43
2. Self-reported recovery score will be assessed using the Bipolar Recovery Questionnaire developed in
phase 2 of the same project (REC ref: 08/H1013/77), administered at inception and then every six
months until the end of the study period.
Measurement of secondary outcomes
Self-report and observer rated assessments of bipolar symptomatology, functioning and of cognitions
associated with bipolar disorder, applied at inception and then six monthly to the end of follow-up, namely:
1. Beck Depression Inventory (Second Edition), (BDI-II) – The BDI-II382 (is a 21 item self-report inventory
that assesses for symptoms of depression. Total score cut offs are: 0–9 (normal/minimal depression),
10–18 (mild depression), 19–26 (moderate depression), and > 26 (severe depression).
2. Internal States Scale (ISS) – This is a 15 item self-report questionnaire that assesses for symptoms of
mania and depression. It comprises four subscales, these being activation (ISS-ACT), perceived conflict
(ISS-PC), well-being (ISS-WB) and depression (ISS-DEP). Each statement is rated based on how the
individual has felt in the past 24 hours. A cut off score of 200 on activation scale has been validated
as indicative of the presence of (hypo)mania.303
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3. Hamilton depression rating scale(HRDS) – The HDRS314 is another observer rated measure based on
clinical observation that assesses for seventeen symptoms of depression. Total HDRS score is
categorised as follows: < 10 (no depression), 10–13 (mild depression), 14–17 (mild to moderate
depression) and > 17 (moderate to severe depression).
4. MAS – The MAS312 is an observer rated measure that assesses for eleven symptoms of mania or
hypomania based on observations during clinical interview. The total MAS score is categorised as follows:
0–5 (no mania), 6–9 (hypomania), 10–14 (probable mania) and > 15 (definite mania).
5. Personal and Social Performance Scale (PSP). The PSP is an observer-rated measure of severity of personal
and social dysfunction which assesses functioning in four main areas: 1) socially useful activities; 2) personal
and social relationships; 3) self-care; and 4) disturbing and aggressive behaviours. Operational criteria to rate
the levels of disabilities are defined for. Good inter-rater reliability has been reported (Morosini et al., 2000).
6. Hypomanic Interpretations Questionnaire (HIQ). The HIQ (Jones, Mansell and Waller, 2006) is a
10 item self-report questionnaire which evaluates appraisals for 10 common hypomania-relevant
experiences each followed by two explanations; (1) positive self-dispositional appraisals (HIQ-H) and
(2) normalising appraisal (HIQ-NE). Participants also indicated using a yes/no scale whether they had
experienced each situation in the preceding three months. The HIQ has been found to have good
internal reliability; HIQ-H α=0.87 and HIQ-NE α=0.76 (Jones, Mansell and Waller, 2006).
7. Interpretation of Depression Questionnaire (IDQ). The IDQ (Jones and Day, 2008) is a 10 item
self-report questionnaire analogous in structure to the HIQ, which evaluates appraisals of
depression-relevant situations each followed by two explanation; (1) negative self-dispositional
(IDQ-D); and (2) normalising appraisals (IDQ-N). Participants complete a yes/no scale indicating
whether they had experienced each situation in the preceding three months.
8. The Brief Quality of Life in Bipolar Disorder (QoL.BD; Michalak and Murray, in press) is a 12 item
disorder-specific quality of life measure in Bipolar Disorder. Each item is rated on a 5 point Likert scale
(1= strongly disagree, 5= strongly agree). Initial field testing of the Quality of Life in Bipolar Disorder
supports use of the instrument as a feasible, reliable and valid disorder-specific QoL measure for BD
(Michalak and Murray, in press).
9. Post Traumatic Growth Inventory (PTGI). The PTGS (Tedeschi and Calhoun, 1996) is a 21-item self-report
measure of positive outcomes following traumatic experiences. Each item is rated on a 6-point Likert
format scale (0= “I did not experience this change as a result of my crisis” 5= “I experienced this
change to a very great degree as a result of my crisis”). The total score can range from 0–105, with
higher scores indicating greater growth. Five subscales can also be scored: (a) Relating to Others,
(b) New Possibilities, (c) Personal Strength, (d) Spiritual Change, and (e) Appreciation of Life. The
psychometric properties of the PTGI have been found to be adequate; Relating to Others α= .89,
New Possibilities α= ,89, Personal Strength α= .84, Spiritual Change α= .65, Appreciation of Life α= .89.
(Jaarsma, Pool, Sanderman and Ranchor, 2006).
10. Self-Esteem Rating Scale- Short Form (SERS; Lecomte et al 2006) is a measure of explicit self-esteem
comprising 20 Likert-based items: 10 positive statements about the self that provide a measure of
positive self-esteem; and 10 negative statements about the self that provide a measure of negative
self-esteem. The SERS has demonstrated good validity, internal consistency, and test–retest reliability in
the general population and in those with schizophrenia (Lecomte, Corbiere, and Laisne, 2006).
11. Herth Hope Index (HHI; Herth, 1992) is a 12 item questionnaire that measures feelings of hope on a
4 point Likert scale, ranging from 1 (strongly disagree) to 4 (strongly agree). Participants are instructed to
rate each statements in terms of how they are feeling at the present time, resulting in a total hope score
ranging from 12-48. Higher scores indicate a greater degree of hope. The HHI has been shown to have
good internal consistency (α=.97), validity and good test re-test reliability (r=.91) (Herth, 1992).
12. Self-Esteem and Stigma Questionnaire (SESQ; Hayward, Wong, Bright and Lam, 2002) is a 14-item
questionnaire measuring two important constructs in Bipolar disorder; self-esteem (6 items) and stigma
(8 items). All items are scored on a 6-point Likert scale ranging from 1 (strongly agree) to 6 (strongly
disagree), with lower scores in the self-esteem scale indicating higher confidence and self-esteem, and
higher scores in the stigma scale indicating higher feelings of stigmatisation. The psychometric
properties for the SESQ have been found to be adequate; for both self-esteem (α=.71) and stigma
scales (α=.79) (Hayward et al., 2002).
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13. Stephenson Medication Adherence Interview (SMAI; Stephenson, Rowe, Haynes, Macharia, and Leon,
1993) is a short structured interview that assesses change in medication adherence over the last week,
and previous month. The SMAI contains 7 questions overall, assessing current medication, missed
medications and medication overuse, and the possible reasons behind such activity. The SMAI has
been used in numerous RCTs and is considered a reliable and insightful measure of medication
adherence (Scott and Pope, 2002).
14. Self-Compassion Scale (SCS)383 is a validated 26 item measure that assesses how individuals typically
act towards themselves in times of difficulty. The SCS is composed of 6 subscales, including
self-kindness (5 items), self-judgment (5 items), common humanity (4 items), isolation (4 items),
mindfulness (4 items) and over-identification (4 items).Each item is rated on a 5 point Likert scale
ranging from 1 (almost never) to 5 (almost always). The SCS has been shown to have good test–retest
reliability (r= .90), and discriminant validity with other self-esteem measures (Neff, 2003).
15. The types of Positive Affect Scale (TPAS; Gilbert et al., 2008) is a validated 18 item measure that
assesses the frequency to which people experience positive feelings. The TPAS consists of 3 subscales,
including active positive affect (8 items), relaxed positive affect (6), and safe/warmth positive affect
(4 items). Respondents are asked to rate 18 positive ‘feeling’ words on a 5 point Likert scale to indicate
how characteristic it is of them, ranging from 0 (not characteristic of me) to 4 (very characteristic
of me). The scale has proven to have good psychometric properties for all subscales, with Cronbach’s
alpha scores ranging from .73-.83 (Gilbert et al., 2008).
Power
The proposed sample size will permit us to make reasonable estimates of feasibility of patient recruitment
and consent to participate, adherence to protocol, retention within both arms across assessment,
intervention and follow-up periods and outcome parameter estimates. In addition, we will be able to
determine if the intervention is acceptable to service users. Therefore, our outcomes will include
information regarding acceptability and feasibility, retention rates in the two arms of the study, and effect
size estimates for proposed primary and secondary outcome measures. Professor Dunn, our trialist and
statistician, has confirmed that the proposed sample size is suitable for these purposes. The research team
will be able to then use this important information to mount a subsequent definitive pragmatic trial soon
after programme completion, should the pilot study justify such an application. It would not provide value
for money for DH/NHS to conduct a large scale RCT at this stage, since the feasibility data has yet to be
collected, and cognitive–behavioural interventions with a first episode bipolar population have not been
attempted under research conditions. As this form of intervention is new it is not possible to provide
power calculations based on directly relevant previous trials. An indication of possible power for the
proposed trial was obtained through calculations informed by the results of the recent studies of CBT for
chronic bipolar disorder43,278 and a recent meta-analysis.384 With 60 patients a two-tailed chi-squared test
will have 64% power to detect an absolute difference in twelve-month (post-treatment) relapse rates of
25% (from 40% for TAU to 15% for CBT). We intend to enter 72 into the trial to allow for 20%
drop outs.
Analysis plan
All treatment effects will first be estimated using the intention-to-treat principle, supplemented by
estimation of the treatment effects in those participants who actually receive the intervention via estimation
of the Complier-Average Causal effect.332,333 Time to relapse will be assessed by survival analysis (using
either proportional hazard or accelerated life-time models). Each of the secondary outcome measures will
be analysed with analysis of covariance through the use of generalised linear models (the data distribution
and link function being dependent upon the outcome under consideration). Adjustments for missing data
will be made assuming that the missing data mechanism is either ignorable or latently ignorable.334
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Appendix 7 Q-sort package (see Chapter 2)
Q-sort items
Least important Not sure Most important
0 1 2 3 4 5 6 7 8 9 10 11 12
1. How depressed my experiences make me feel.
2. How much I dwell on my experiences.
3. How unpleasant my experiences/voices are.
4. How pleasant my experiences/voices are.
5. How much control I have over my experiences.
6. How often my experiences happen.
7. How much time in my life they take up.
8. Amount to which my voices are inside my head compared to outside my head.
9. How loud my voices are.
10. My belief that my experiences come from my own mind.
11. How positive I view my experiences to be.
12. How much religion/spirituality was involved with my experiences.
13. The amount I think about harming myself as a result of my experiences.
14. How my experience effect how energetic I feel.
15. How helpful I feel my medication is with my experiences.
16. How helpful I feel psychological therapies are with my experiences.
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17. How convinced I am that my experiences are real.
18. The amount of support I get from other service users.
19. How my experiences effect the quality/and or amount of sleep I get.
20. How my experiences effect my personal freedoms and rights.
21. How my experiences effect the amount of anger and frustration I feel.
22. How my experiences have effect my memory and concentration.
23. How my experiences effect my ability to look after myself.
24. How active I was in seeking help with my experiences.
25. How well I was able to recognise the early signs of becoming unwell.
26. How my experiences effect how happy I feel.
27. How anxious or stressed I am from my experiences.
28. How withdrawn I am as a result of my experiences.
29. How trusting of others I am as a result of my experiences.
30. How much I socialise as a result of my experiences.
31. How my experiences effect how positive I am for the future.
32. How enjoyable I find hobbies/activities as a result of my experiences.
33. How my experiences effect my relationships with friends and loved ones.
34. How much I understand my experiences.
35. How much support I get from loved ones in helping with my experiences.
36. How empowered I feel over my experiences.
37. How ashamed and/or embarrassed I feel about my experiences.
38. How my experiences effect the amount of emotion I feel.
39. How bothered I am about the stigma/being judged about my experiences.
40. How much I feel mental health services are helpful with my experiences.
41. How my experiences alter my ability to control my own thoughts.
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42. How clearly I can think about my experiences.
43. The amount to which I can cope with my experiences.
44. In alcohol and drug use that worsens my experiences.
45. How much I have changed as a person/personality since I have had these experiences.
46. My living arrangements as a result of my experiences.
47. My ability to find work as a result of my experiences.
48. How financially stable I am as a result of my experiences.
49. How concerned I am of the side effects of taking medication for my experiences.
50. How vulnerable I feel as a result of my experiences.
51. How motivated I feel about changing my experiences.
52. How concerned I am that my experiences will happen again.
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Appendix 8 The subjective experience of
psychosis scale (see Chapter 2)
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Appendix 9 Delphi study checklists
(see Chapter 3)
Checklist: what helps recovery?
Item
Having a good, safe place to live.
Having the support of others.
Having a good understanding of your mental health problems.
Living in the kind of place you like.
Knowing what helps you get better.
Knowing how to take care of yourself.
Recognising the positive things you have done.
Knowing that there are mental health services that do help.
Working on things that are personally important.
Being strongly motivated to get better.
Being able to identify the early warning signs of becoming unwell.
Having a positive outlook on life.
Having a plan for how to stay or become well.
Having goals/purpose in life.
Accomplishing worthwhile and satisfying things in life.
Being able to develop positive relationships with other people.
Knowing that there are things that you can do that help you deal with unwanted symptoms/experiences.
Being able to handle stress.
Feeling part of society rather than isolated.
Being hopeful about the future.
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Learning from mistakes.
Accepting that you may have set backs.
Being able to come to terms with things that have happened in the past and move on with life.
Receiving treatment for distressing/unusual thoughts and feelings.
Taking medication as prescribed.
Having healthy habits.
Having a desire to succeed.
Health professionals and service users working collaboratively as equals.
Knowing that even when you don’t care about yourself, other people do.
Spending time with people to feel connected and better about yourself.
Being able to fully understand mental health problems/experiences.
Having courage.
Allowing personalisation or choice within health services.
Knowing that even when you don’t believe in yourself, other people do.
Knowing that you can handle what happens next in your life.
Knowing that all people with experience of psychosis can strive for recovery.
Being able to make sense of distressing experiences.
Making a valuable contribution to life.
Knowing that recovery from mental health problems is possible no matter what you think may cause them.
When services understand/consider the culture and beliefs of the individual.
Continuing to have new interests.
Knowing that you are the person most responsible for your own improvement.
Being able to assert yourself.
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Checklist: what hinders recovery?
Item
When health services do not provide help and support to recover.
When a person feels lost or hopeless for much of the time.
When a person feels isolated or alone even when with family of friends.
When a person feels discriminated against or excluded from the community because of mental
health problems.
Health professionals who do not accept that their views are not the only way of looking at things.
The impact of a loved one’s mental health problems on their family.
When a person cannot find the kind of place you want to live in.
When a person deliberately stopping taking medication although the doctor recommends taking it regularly.
Medication that can affect concentration and memory.
When no one will employ the person owing to past mental health problems.
When other people are always making decisions about the person’s life.
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Checklist: what shows that someone is recovering?
Item
When the person is able to find time to do the things they enjoy.
When the person is able to ask for help when they need it.
When the person can trust themselves to make good decisions and positive changes in life.
When the person knows when to ask for help.
When the person is able to take control of aspects of their life.
When the person feels reasonably confident that they can manage their mental health problems.
When the person is able to actively engage with life.
When the person feels like they are coping well with mental or emotional problems on a day to day basis.
When symptoms/experiences of psychosis interfere less and less with daily life.
When the person is able to define and work towards achieving a personal goal.
When fear doesn’t stop the person from living the life they want to.
When the person knows a great deal about coping strategies.
When symptoms/experiences of psychosis don’t get in the way of doing things they want or need to do.
When the person finds places and situations in which they can make friends.
When the person feels in touch with their own emotions again.
When the person knows a great deal about their own symptoms/experiences.
When the person knows a great deal about their treatment options.
When the person is able to access independent support.
When coping with mental health problems is no longer the main focus of a person’s life.
When the people who are important to someone are actively supporting their mental health treatment.
When symptoms/experiences of psychosis are a problem for shorter periods of time each time they occur.
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Appendix 10 Example page from Experience
Sampling Methodology diary (see Chapter 4)
DOI: 10.3310/pgfar04050 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 5
263
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Morrison et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.

Appendix 11 Sample pages from the self-help
recovery guide 9 (see Chapter 5)
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Appendix 12 The Bipolar Recovery Questionnaire
(see Chapter 7)
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Appendix 13 The Questionnaire about the
Process of Recovery (used throughout the
research programme)
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